uniprot_id,wildtype,position,mutation,pdb_id,pdb_pos,phenotypic_annotation,interaction,binding,function,phosphorylation,ubiquination,glycosylation,sumoylation,acetylation,other_ptm,methylation,ribosylation,subcell_localization_change,mimetic_ptm,folding,expression,identifier
P31749,K,8,R,1unp:A,8,"Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation as well as IGF1-induced membrane recruitment. Decrease in ubiquitination and phosphorylation at T-308 as well as impaired association with the membrane",,,-1.0,-1.0,-1.0,,,,,,,1.0,,,,P31749_K_8_R
P31749,K,14,Q,1unp:A,14,"Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment.",,-1.0,-1.0,-1.0,,,,,,,,1.0,,,,P31749_K_14_Q
P31749,K,14,R,1unp:A,14,"Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment.",,-1.0,-1.0,-1.0,-1.0,,,,,,,1.0,,,,P31749_K_14_R
P31749,K,20,Q,1unp:A,20,"Substantial reduction of phosphorylation at T-308 and S-473, reduced AKT activation, and reduced binding to PIP3 as well as IGF1-induced membrane recruitment. Loss of membrane localization",,-1.0,-1.0,-1.0,,,,,,,,1.0,,,,P31749_K_20_Q
P31749,T,308,D,6npz:B,308,5-fold activation and 18-fold activation,,,1.0,,,,,,,,,,,,,P31749_T_308_D
Q86WA6,S,139,A,2oci:A,122,<0.1% of wild type activity.,,,-1.0,,,,,,,,,,,,,Q86WA6_S_139_A
Q86WA6,D,244,N,2oci:A,227,<0.1% of wild type activity.,,,-1.0,,,,,,,,,,,,,Q86WA6_D_244_N
Q86WA6,H,272,A,2oci:A,255,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q86WA6_H_272_A
Q8N4E7,S,204,A,5z8j:A,144,Increases ferroxidase activity and iron binding.,,1.0,1.0,,,,,,,,,,,,,Q8N4E7_S_204_A
Q01973,C,482,G,6tu9:A,482,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q01973_C_482_G
Q01974,D,482,G,3zzw:B,482,Slight increase in kinase activity.,,,1.0,,,,,,,,,,,,,Q01974_D_482_G
Q00535,S,159,A,1unl:A,159,No phenotype.,0.0,,0.0,,,,,,,,,,,,,Q00535_S_159_A
Q00536,K,194,A,5g6v:A,194,Loss of kinase activity. Abolishes effect on insulin secretion.,,,-1.0,,,,,,,,,,,,,Q00536_K_194_A
Q00536,K,194,R,5g6v:A,194,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q00536_K_194_R
O95257,A,47,R,2wal:A,47,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,-1.0,,,,,,,,,,,,,O95257_A_47_R
O95257,I,76,E,2wal:A,76,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,-1.0,,,,,,,,,,,,,O95257_I_76_E
O95257,L,80,E,2wal:A,80,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,-1.0,,,,,,,,,,,,,O95257_L_80_E
O95257,A,83,R,2wal:A,83,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,-1.0,,,,,,,,,,,,,O95257_A_83_R
O95257,E,87,K,2wal:A,87,Reduced growth inhibition activity,,,-1.0,,,,,,,,,,,,,O95257_E_87_K
O95257,D,89,K,2wal:A,89,Reduced growth inhibition activity,,,-1.0,,,,,,,,,,,,,O95257_D_89_K
P21673,Y,140,F,2b4b:B,140,Reduces activity by 95%.,,,-1.0,,,,,,,,,,,,,P21673_Y_140_F
P07711,C,138,S,3of9:A,26,Catalytically inactive. Unable to autocleave procathepsin L.,,,-1.0,,,,,,,,,,,,,P07711_C_138_S
P51857,Y,58,A,3cas:A,58,Loss of activity.,,,-1.0,,,,,,,,,,,,,P51857_Y_58_A
P51857,E,120,A,3cas:A,120,Loss of activity.,,,-1.0,,,,,,,,,,,,,P51857_E_120_A
P49789,I,10,W,2fit:A,10,Strongly reduces affinity for substrates and impairs apoptosis,,-1.0,-1.0,,,,,,,,,,,,,P49789_I_10_W
P49789,L,25,W,2fit:A,25,Reduces affinity for substrates and impairs apoptosis. Strongly reduces affinity for substrates and impairs apoptosis,,-1.0,-1.0,,,,,,,,,,,,,P49789_L_25_W
P49789,H,35,N,2fit:A,35,50% decrease in catalytic activity. No loss in substrate binding.,,0.0,-1.0,,,,,,,,,,,,,P49789_H_35_N
P49789,H,94,N,2fit:A,94,75% decrease in catalytic activity. No loss in substrate binding.,,0.0,-1.0,,,,,,,,,,,,,P49789_H_94_N
P49789,H,96,D,2fit:A,96,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P49789_H_96_D
P49789,H,96,G,2fit:A,96,Total loss of catalytic activity. Rescuable with free imidazole.,,,-1.0,,,,,,,,,,,,,P49789_H_96_G
P49789,H,96,N,2fit:A,96,Total loss of catalytic activity. No loss in substrate binding.,,0.0,-1.0,,,,,,,,,,,,,P49789_H_96_N
P49789,H,98,N,2fit:A,98,98% decrease in catalytic activity.,,,-1.0,,,,,,,,,,,,,P49789_H_98_N
P05231,A,173,V,4cni:C,145,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P05231_A_173_V
P05231,W,185,R,4cni:C,157,No loss of activity.,,,0.0,,,,,,,,,,,,,P05231_W_185_R
P05231,S,204,P,4cni:C,176,87% loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_S_204_P
P05231,R,210,K,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_K
P05231,R,210,E,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_E
P05231,R,210,Q,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_Q
P05231,R,210,T,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_T
P05231,R,210,A,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_A
P05231,R,210,P,4cni:C,182,Loss of activity.,,,-1.0,,,,,,,,,,,,,P05231_R_210_P
P62979,K,48,R,3axc:A,48,No effect on HLTF-mediated polyubiquitination of PCNA.,,,0.0,,,,,,,,,,,,,P62979_K_48_R
P62979,K,63,R,3axc:A,63,Abolishes HLTF-mediated polyubiquitination of PCNA.,,,-1.0,,,,,,,,,,,,,P62979_K_63_R
P62979,S,65,D,3axc:A,65,Phosphomimetic mutant that binds and activates PRKN.,1.0,,1.0,,,,,,,,,,1.0,,,P62979_S_65_D
P62979,H,68,G,3axc:A,68,Loss of DTX3L-mediated polyubiquitination of histone H3 and H4.,-1.0,,-1.0,,,,,,,,,,,,,P62979_H_68_G
P62979,R,72,G,3axc:A,72,No effect on ADP-ribosylation.,,,0.0,,,,,,,,0.0,,,,,P62979_R_72_G
Q7L266,T,168,A,4o0d:A,168,Abolishes activation by autocleavage. Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q7L266_T_168_A
Q7L266,T,168,C,4o0d:A,168,Abolishes activation by autocleavage. Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q7L266_T_168_C
Q7L266,T,168,S,4o0d:A,168,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q7L266_T_168_S
P10275,E,898,A,1xj7:A,897,Reduced transcription activation in the presence of androgen.,,,-1.0,,,,,,,,,,,,,P10275_E_898_A
P10275,E,898,Q,1xj7:A,897,Reduced transcription activation in the presence of androgen.,,,-1.0,,,,,,,,,,,,,P10275_E_898_Q
P10275,E,898,K,1xj7:A,897,Loss of transcription activation in the presence of androgen.,,,-1.0,,,,,,,,,,,,,P10275_E_898_K
P10275,E,898,R,1xj7:A,897,Loss of transcription activation in the presence of androgen.,,,-1.0,,,,,,,,,,,,,P10275_E_898_R
Q8TDX7,Y,28,A,6s75:A,28,Significant decrease in catalytic activity,,,-1.0,,,,,,,,,,,,,Q8TDX7_Y_28_A
Q8TDX7,L,31,A,6s75:A,31,Significant decrease in catalytic activity,,,-1.0,,,,,,,,,,,,,Q8TDX7_L_31_A
Q8TDX7,N,33,D,6s75:A,33,Significant decrease in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8TDX7_N_33_D
Q8TDX7,Y,97,A,6s75:A,97,5-fold increase in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8TDX7_Y_97_A
Q8TDX7,Y,97,F,6s75:A,97,Moderate increase in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8TDX7_Y_97_F
Q8TDX7,Y,97,L,6s75:A,97,Moderate increase in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8TDX7_Y_97_L
Q9BT30,L,110,Q,4qkb:A,110,Does not affect ability to trigger programmed necrosis.,,,0.0,,,,,,,,,,,,,Q9BT30_L_110_Q
Q9UMS0,G,189,A,2m5o:A,39,Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.,-1.0,-1.0,-1.0,,,,,,,,,,,-1.0,,Q9UMS0_G_189_A
Q9UMS0,G,189,K,2m5o:A,39,Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.,-1.0,-1.0,-1.0,,,,,,,,,,,-1.0,,Q9UMS0_G_189_K
O15091,D,409,N,4rou:A,409,Abolishes ribonuclease activity.,,,-1.0,,,,,,,,,,,,,O15091_D_409_N
O15091,D,478,N,4rou:A,478,Abolishes ribonuclease activity.,,,-1.0,,,,,,,,,,,,,O15091_D_478_N
O15091,D,479,N,4rou:A,479,Abolishes ribonuclease activity.,,,-1.0,,,,,,,,,,,,,O15091_D_479_N
O15091,P,480,G,4rou:A,480,Does not affect ribonuclease activity.,,,0.0,,,,,,,,,,,,,O15091_P_480_G
P35240,S,518,D,4zrj:B,518,No effect on phosphorylation. Defective nuclear accumulation. Significant decrease in binding to DCAF1 and in ability to inhibit cell proliferation.,-1.0,,-1.0,0.0,,,,,,,,1.0,,,,P35240_S_518_D
Q92830,E,575,A,5h86:A,81,Catalytically dead mutant,,,-1.0,,,,,,,,,,,,,Q92830_E_575_A
Q92830,D,615,A,5h86:A,121,Catalytically dead mutant,,,-1.0,,,,,,,,,,,,,Q92830_D_615_A
Q9UKL6,C,63,A,1ln2:A,63,Reduces activity by 20%.,,,-1.0,,,,,,,,,,,,,Q9UKL6_C_63_A
P21453,E,121,Q,3v2y:A,121,Slight activation of the receptor at maximal ligand concentration.,,,-1.0,,,,,,,,,,,,,P21453_E_121_Q
P21453,F,210,L,3v2w:A,210,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,-1.0,,,,,,,,,,,,,P21453_F_210_L
P21453,F,265,L,3v2y:A,265,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,-1.0,,,,,,,,,,,,,P21453_F_265_L
P21453,W,269,F,3v2y:A,269,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,-1.0,,,,,,,,,,,,,P21453_W_269_F
P21453,W,269,L,3v2y:A,269,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,-1.0,,,,,,,,,,,,,P21453_W_269_L
Q9Y6E0,K,65,A,4qmx:A,53,Loss of activity and autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,Q9Y6E0_K_65_A
Q9Y6E0,T,190,A,4qmx:A,178,Loss of activity and autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,Q9Y6E0_T_190_A
P01236,G,157,D,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_D
P01236,G,157,F,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_F
P01236,G,157,L,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_L
P01236,G,157,N,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_N
P01236,G,157,R,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_R
P01236,G,157,V,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_V
P01236,G,157,Y,1rw5:A,129,Inhibits signaling via PRLR,,,-1.0,,,,,,,,,,,,,P01236_G_157_Y
O60760,D,96,N,6w58:A,96,Increases PGD2 synthesis. Loss of activation by calcium or magnesium ions.,,-1.0,1.0,,,,,,,,,,,,,O60760_D_96_N
O60760,D,97,N,6w58:A,97,Reduces PGD2 synthesis by 99%. Loss of activation by calcium or magnesium ions.,,-1.0,-1.0,,,,,,,,,,,,,O60760_D_97_N
P17844,K,53,R,4a4d:A,53,"Abolishes sumoylation, abolishes interaction with HDAC1, increases TP53 coactivation and promotes polyubiquitination.",-1.0,,1.0,,1.0,,-1.0,,,,,,,,,P17844_K_53_R
P17844,K,144,R,4a4d:A,144,Abolishes RNA helicase activity.,,,-1.0,,,,,,,,,,,,,P17844_K_144_R
P17735,I,294,A,3dyd:A,294,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,P17735_I_294_A
Q09013,K,100,A,2vd5:A,100,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q09013_K_100_A
Q9NYG5,C,23,S,6q6h:C,23,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_23_S
Q9NYG5,C,26,S,6q6h:C,26,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_26_S
Q9NYG5,C,34,S,6q6h:C,34,Slightly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_34_S
Q9NYG5,C,37,S,6q6h:C,37,Slightly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_37_S
Q9NYG5,C,44,S,6q6h:C,44,Slightly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_44_S
Q9NYG5,C,51,S,6q6h:C,51,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_51_S
Q9NYG5,H,53,S,6q6h:C,53,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_53_S
Q9NYG5,H,56,S,6q6h:C,56,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_56_S
Q9NYG5,H,58,S,6q6h:C,58,Slightly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_58_S
Q9NYG5,C,59,S,6q6h:C,59,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_59_S
Q9NYG5,C,73,S,6q6h:C,73,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_73_S
Q9NYG5,C,76,S,6q6h:C,76,Greatly reduces autoubiquitination activity,,,-1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_76_S
Q96LI5,E,240,A,3ngo:A,240,Loss of deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q96LI5_E_240_A
Q96LI5,F,484,A,3ngq:A,484,Loss of deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q96LI5_F_484_A
Q96LI5,D,489,A,3ngq:A,489,Loss of deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q96LI5_D_489_A
Q96LI5,H,529,A,3ngq:A,529,Loss of deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q96LI5_H_529_A
Q9NYG8,G,98,I,4rue:B,124,"Strongly increases basal level of channel activity, decreases further activation by pressure and abolishes further activation by arachidonic acid.",,-1.0,1.0,,,,,,,,,,,,,Q9NYG8_G_98_I
Q9NYG8,W,236,S,4rue:B,262,"Increases basal level of channel activity and decreases further activation by pressure, but has little effect on further activation by arachidonic acid.",,0.0,1.0,,,,,,,,,,,,,Q9NYG8_W_236_S
Q96RG2,K,1028,R,3dls:A,1028,Loss of autophosphorylating activity.,,,-1.0,-1.0,,,,,,,,,,,,Q96RG2_K_1028_R
Q96RG2,R,1058,A,3dls:A,1058,Induces lower protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q96RG2_R_1058_A
Q96RG2,R,1058,K,3dls:A,1058,Does not affect protein kinase activity.,,,0.0,,,,,,,,,,,,,Q96RG2_R_1058_K
Q96RG2,A,1151,K,3dls:A,1151,Induces lower protein kinase activity and ability to autophosphorylate.,,,-1.0,-1.0,,,,,,,,,,,,Q96RG2_A_1151_K
Q96RG2,Y,1152,F,3dls:A,1152,Induces lower protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q96RG2_Y_1152_F
Q96RG2,T,1161,A,3dls:A,1161,Loss of catalytic activity (PubMed,,,-1.0,,,,,,,,,,,,,Q96RG2_T_1161_A
Q96RG2,T,1165,A,3dls:A,1165,Loss of catalytic activity. Does not affect protein translation.,,,-1.0,,,,,,,,,,,,,Q96RG2_T_1165_A
Q9UGB7,K,127,S,2ibn:A,127,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9UGB7_K_127_S
P15428,Q,148,A,2gdz:A,148,Loss of activity.,,,-1.0,,,,,,,,,,,,,P15428_Q_148_A
P15428,Y,151,A,2gdz:A,151,Loss of activity.,,,-1.0,,,,,,,,,,,,,P15428_Y_151_A
P15428,Y,151,F,2gdz:A,151,Loss 15-hydroxyprostaglandin dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P15428_Y_151_F
P15428,K,155,Q,2gdz:A,155,Loss 15-hydroxyprostaglandin dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P15428_K_155_Q
Q96Q83,R,131,A,2iuw:A,131,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_R_131_A
Q96Q83,L,177,A,2iuw:A,177,Loss of activity against 1-methyladenine.,,,-1.0,,,,,,,,,,,,,Q96Q83_L_177_A
Q96Q83,L,177,N,2iuw:A,177,Loss of activity against 1-methyladenine.,,,-1.0,,,,,,,,,,,,,Q96Q83_L_177_N
Q96Q83,L,177,E,2iuw:A,177,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_L_177_E
Q96Q83,L,177,Q,2iuw:A,177,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_L_177_Q
Q96Q83,L,177,I,2iuw:A,177,Decreases activity against 1-methyladenine.,,,-1.0,,,,,,,,,,,,,Q96Q83_L_177_I
Q96Q83,L,177,M,2iuw:A,177,No effect.,,,0.0,,,,,,,,,,,,,Q96Q83_L_177_M
Q96Q83,N,179,A,2iuw:A,179,Decreases activity by about 60%.,,,-1.0,,,,,,,,,,,,,Q96Q83_N_179_A
Q96Q83,Y,181,A,2iuw:A,181,Strong decrease of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_Y_181_A
Q96Q83,D,189,A,2iuw:A,189,"Strongly increases activity towards dsDNA, possibly by facilitating access to the active site.",,1.0,-1.0,,,,,,,,,,,,,Q96Q83_D_189_A
Q96Q83,H,191,A,2iuw:A,191,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_H_191_A
Q96Q83,D,193,A,2iuw:A,193,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96Q83_D_193_A
O60704,R,78,A,3ap1:A,78,Strongly reduced enzymatic activity.,,,-1.0,,,,,,,,,,,,,O60704_R_78_A
O60704,E,99,A,3ap1:A,99,Loss of sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,O60704_E_99_A
O60704,R,101,A,3ap1:A,101,Prevents dimerization and strongly decreases enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,O60704_R_101_A
O60704,W,113,A,3ap1:A,113,Prevents dimerization and decreases enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,O60704_W_113_A
O60704,K,158,A,3ap1:A,158,Nearly complete loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,O60704_K_158_A
O60704,T,198,A,3ap1:A,198,Slightly decreased sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,O60704_T_198_A
O60704,S,285,A,3ap1:A,285,Abolishes sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,O60704_S_285_A
Q9UGP5,K,312,A,3hx0:A,312,Reduces dRP lyase activity by over 90%.,,,-1.0,,,,,,,,,,,,,Q9UGP5_K_312_A
Q9UGP5,D,427,A,3hx0:A,427,Loss of polymerase activity,,,-1.0,,,,,,,,,,,,,Q9UGP5_D_427_A
Q9UGP5,D,429,A,3hx0:A,429,Loss of polymerase activity,,,-1.0,,,,,,,,,,,,,Q9UGP5_D_429_A
Q9UGP5,Y,505,A,3hx0:A,505,No effect on polymerase activity. Reduces terminal transferase activities.,,,-1.0,,,,,,,,,,,,,Q9UGP5_Y_505_A
Q9UGP5,F,506,G,3hx0:A,506,Strongly reduces polymerase and terminal transferase activities.,,,-1.0,,,,,,,,,,,,,Q9UGP5_F_506_G
Q9UGP5,F,506,R,3hx0:A,506,Strongly reduces polymerase and terminal transferase activities.,,,-1.0,,,,,,,,,,,,,Q9UGP5_F_506_R
P54762,K,651,R,5mjb:A,651,"Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL.",-1.0,,-1.0,-1.0,-1.0,,,,,,,,,,,P54762_K_651_R
P19474,C,16,A,5olm:B,16,Loss of E3 ubiquitin-protein ligase activity. Does not inhibit NF-kappa-B-induced gene expression.,,,-1.0,,,,,,,,,,,,,P19474_C_16_A
Q00987,C,438,L,5mnj:G,438,No loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_C_438_L
Q00987,C,449,A,5mnj:G,449,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_C_449_A
Q00987,C,449,S,5mnj:G,449,No substantial decrease of ubiquitin ligase E3 activity.,,,0.0,,,,,,,,,,,,,Q00987_C_449_S
Q00987,H,452,A,5mnj:G,452,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_H_452_A
Q00987,T,455,A,5mnj:G,455,Significant decrease of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_T_455_A
Q00987,H,457,S,5mnj:G,457,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_H_457_S
Q00987,C,461,S,5mnj:G,461,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_C_461_S
Q00987,C,464,A,5mnj:G,464,"Loss of ubiquitin ligase E3 activity, enhances protein stability. Does not inhibit interaction with APEX1, but inhibits its ubiquitin ligase E3 activity on APEX1.",0.0,,-1.0,,,,,,,,,,,1.0,,Q00987_C_464_A
Q00987,C,475,G,5mnj:G,475,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_C_475_G
Q00987,C,478,S,5mnj:G,478,Loss of ubiquitin ligase E3 activity.,,,-1.0,,,,,,,,,,,,,Q00987_C_478_S
O75365,C,49,A,1r6h:A,52,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,O75365_C_49_A
O75365,D,71,A,1r6h:A,74,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,O75365_D_71_A
O75365,D,72,A,1r6h:A,75,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,O75365_D_72_A
O75365,C,104,A,1r6h:A,107,95% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,O75365_C_104_A
O75365,C,104,S,1r6h:A,107,95% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,O75365_C_104_S
O75365,A,111,S,1r6h:A,114,Enhances catalytic activity.,,,1.0,,,,,,,,,,,,,O75365_A_111_S
P41146,Q,107,A,5dhh:B,1171,Impairs G protein-mediated inhibition of adenylate cyclase.,,,-1.0,,,,,,,,,,,,,P41146_Q_107_A
P41146,D,110,A,5dhh:B,1174,Abolishes G protein-mediated inhibition of adenylate cyclase. No effect on antagonist-mediated inhibition of G protein-mediated signaling.,,,-1.0,,,,,,,,,,,,,P41146_D_110_A
P41146,D,130,A,5dhh:B,1194,Abolishes G protein-mediated inhibition of adenylate cyclase. Abolishes antagonist-mediated inhibition of G protein-mediated signaling.,,,-1.0,,,,,,,,,,,,,P41146_D_130_A
P41146,Y,131,A,5dhh:B,1195,Impairs G protein-mediated inhibition of adenylate cyclase.,,,-1.0,,,,,,,,,,,,,P41146_Y_131_A
P41146,Q,280,A,5dhh:A,280,Impairs G protein-mediated inhibition of adenylate cyclase.,,,-1.0,,,,,,,,,,,,,P41146_Q_280_A
P41146,Y,309,A,5dhh:A,309,Mildly impairs G protein-mediated inhibition of adenylate cyclase. Abolishes antagonist-mediated inhibition of G protein-mediated signaling.,,,-1.0,,,,,,,,,,,,,P41146_Y_309_A
Q02297,K,181,E,1hre:A,181,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,-1.0,,,,,,,,,,,,,Q02297_K_181_E
Q02297,K,185,E,1hre:A,185,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,-1.0,,,,,,,,,,,,,Q02297_K_185_E
Q02297,K,187,E,1hre:A,187,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,-1.0,,,,,,,,,,,,,Q02297_K_187_E
Q96RU2,C,171,A,6h4h:A,171,Abolishes deubiquitinase activity.,,,-1.0,,,,,,,,,,,,,Q96RU2_C_171_A
P62491,S,25,N,6djl:F,25,"Dominant-negative mutant. Induces increased number of binucleated cells, indicating defects in cytokinesis. Inhibits the transport of NPC1L1 to the plama membrane. Disrupts the trafficking of CDH1 to the plasma membrane and promotes accumulation of CDH1 in RAB11A endosomes in nonpolarized cells. Promotes mistargeting of CDH1 to the apical membrane in polarized cells.",,,-1.0,,,,,,,,,,,,,P62491_S_25_N
P62491,F,36,A,6djl:F,36,Nearly abolishes SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_F_36_A
P62491,L,38,P,6djl:F,38,Decreases SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_L_38_P
P62491,S,40,F,6djl:F,40,Nearly abolishes SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_S_40_F
P62491,K,41,A,6djl:F,41,Mildly decreases SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_K_41_A
P62491,K,41,P,6djl:F,41,Abolishes SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_K_41_P
P62491,I,44,A,6djl:F,44,Abolishes SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_I_44_A
P62491,Q,70,L,6djl:F,70,Constitutively active mutant. Decreases GTPase activity. Disrupts the trafficking of CDH1 to the plasma membrane and promotes accumulation of CDH1 in RAB11A endosomes in nonpolarized cells. Promotes mistargeting of CDH1 to the apical membrane in polarized cells.,,,-1.0,,,,,,,,,,,,,P62491_Q_70_L
P62491,R,82,C,6djl:F,82,Decreases SH3BP5-mediated guanine nucleotide exchange.,,,-1.0,,,,,,,,,,,,,P62491_R_82_C
P61619,Y,344,H,6w6l:1,344,Reduces cotranslational translocation of APLN precursor/preproapelin.,,,-1.0,,,,,,,,,,,,,P61619_Y_344_H
Q9Y2H1,T,75,A,5xqz:D,75,Decreased kinase activity. Reduced binding of S100B.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y2H1_T_75_A
O94766,E,281,A,1fgg:A,281,Absence of enzymatic activity in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA). Does not increase PXYLP1-induced 2-phosphoxylose phosphatase activity in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA).,,,-1.0,,,,,,,,,,,,,O94766_E_281_A
O94766,C,301,A,1fgg:A,301,Enzyme inactivation and loss of glycosylation.,,,-1.0,,,-1.0,,,,,,,,,,O94766_C_301_A
Q9BYP7,D,294,A,5o2c:A,294,Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters.,,,-1.0,,,,,,,,,,,,,Q9BYP7_D_294_A
Q9BQ50,D,14,A,1y97:B,14,Loss of enzyme activity,,,-1.0,,,,,,,,,,,,,Q9BQ50_D_14_A
Q9BQ50,E,16,A,1y97:B,16,Loss of enzyme activity,,,-1.0,,,,,,,,,,,,,Q9BQ50_E_16_A
Q9BQ50,D,123,A,1y97:B,123,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BQ50_D_123_A
Q13641,K,76,A,4cnc:B,76,Strongly reduces Wnt inhibitory function.,,,-1.0,,,,,,,,,,,,,Q13641_K_76_A
Q13641,F,97,T,4cnc:B,97,Strongly reduces Wnt inhibitory function.,,,-1.0,,,,,,,,,,,,,Q13641_F_97_T
Q13641,Y,325,A,4cnm:A,325,Reduces Wnt inhibitory function.,,,-1.0,,,,,,,,,,,,,Q13641_Y_325_A
O15527,K,249,Q,2xhi:A,249,Loss of activity.,,,-1.0,,,,,,,,,,,,,O15527_K_249_Q
O15527,D,268,E,2xhi:A,268,No effect on activity.,,,0.0,,,,,,,,,,,,,O15527_D_268_E
O15527,D,268,Q,2xhi:A,268,No effect on activity.,,,0.0,,,,,,,,,,,,,O15527_D_268_Q
O15527,D,268,N,2xhi:A,268,Decreases activity about 65-fold.,,,-1.0,,,,,,,,,,,,,O15527_D_268_N
Q6XQN6,D,19,A,4yub:A,19,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_D_19_A
Q6XQN6,Y,21,A,4yub:A,21,"Partial loss of activity in the presence of ATP, complete loss in the absence of ATP.",,,-1.0,,,,,,,,,,,,,Q6XQN6_Y_21_A
Q6XQN6,G,169,A,4yub:A,169,Partial loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_G_169_A
Q6XQN6,G,209,A,4yub:A,209,Partial loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_G_209_A
Q6XQN6,H,213,A,4yub:A,213,Partial loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_H_213_A
Q6XQN6,D,288,A,4yub:A,288,Partial loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_D_288_A
Q6XQN6,R,318,A,4yub:A,318,"Partial loss of activity in the presence of ATP, almost complete loss in the absence of ATP.",,,-1.0,,,,,,,,,,,,,Q6XQN6_R_318_A
Q6XQN6,N,357,A,4yub:A,357,Small loss of activity.,,,-1.0,,,,,,,,,,,,,Q6XQN6_N_357_A
Q96MU7,K,361,L,2yud:A,32,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_K_361_L
Q96MU7,S,362,A,2yud:A,33,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_S_362_A
Q96MU7,L,387,E,2yud:A,58,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_L_387_E
Q96MU7,L,399,E,2yud:A,70,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_L_399_E
Q96MU7,F,401,D,2yud:A,72,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_F_401_D
Q96MU7,S,402,A,2yud:A,73,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_S_402_A
Q96MU7,F,409,D,2yud:A,80,Abolishes RNA-binding and ability to influence alternative splice site selection.,,-1.0,-1.0,,,,,,,,,,,,,Q96MU7_F_409_D
Q96MU7,G,411,I,2yud:A,82,Abolishes RNA-binding and ability to influence alternative splice site selection.,,-1.0,-1.0,,,,,,,,,,,,,Q96MU7_G_411_I
Q96MU7,W,428,D,2yud:A,99,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_W_428_D
Q96MU7,W,447,D,2yud:A,118,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_W_447_D
Q96MU7,N,466,D,2yud:A,137,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_N_466_D
Q96MU7,R,475,D,2yud:A,146,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_R_475_D
Q96MU7,D,476,K,2yud:A,147,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_D_476_K
Q9NX09,S,103,L,3lq9:B,103,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_103_L
Q9NX09,S,103,W,3lq9:B,103,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_103_W
Q9NX09,R,133,A,3lq9:B,133,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_R_133_A
Q9NX09,S,137,A,3lq9:B,137,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_137_A
Q9NX09,S,137,D,3lq9:B,137,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_137_D
Q9NX09,P,139,A,3lq9:B,139,Abolishes inhibition of mTORC1.,,,-1.0,,,,,,,,,,,,,Q9NX09_P_139_A
Q9NX09,C,140,S,3lq9:B,140,Mildly reduces inhibition of mTORC1.,,,-1.0,,,,,,,,,,,,,Q9NX09_C_140_S
Q96HS1,H,105,A,5muf:A,105,Loss of phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q96HS1_H_105_A
Q9NXA8,T,69,A,4hda:B,69,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NXA8_T_69_A
Q9NXA8,R,105,M,4hda:B,105,Increases the KM for desuccinylation. Does not affect deacetylase activity.,,-1.0,0.0,,,,,,,,,,,,,Q9NXA8_R_105_M
Q9NXA8,H,158,A,4hda:B,158,Abolishes desuccinylation and deglutarylation activity.,,,-1.0,,,,,,,,,,,,,Q9NXA8_H_158_A
P06702,E,36,Q,5i8n:A,36,Loss of resistance to bacterial invasion,,,-1.0,,,,,,,,,,,,,P06702_E_36_Q
P06702,M,63,A,5i8n:A,63,Loss of antifungal activity.,,,-1.0,,,,,,,,,,,,,P06702_M_63_A
P06702,E,78,Q,5i8n:A,78,Loss of resistance to bacterial invasion,,,-1.0,,,,,,,,,,,,,P06702_E_78_Q
P06702,M,81,A,5i8n:A,81,No effect on antifungal activity.,,,0.0,,,,,,,,,,,,,P06702_M_81_A
P06702,M,83,A,5i8n:A,83,Loss of antifungal activity.,,,-1.0,,,,,,,,,,,,,P06702_M_83_A
P10646,K,64,I,4bqd:A,36,Abolishes inhibition of VII(a)/TF.,,,-1.0,,,,,,,,,,,,,P10646_K_64_I
P10646,R,135,L,1adz:A,24,Abolishes inhibition of X(a).,,,-1.0,,,,,,,,,,,,,P10646_R_135_L
P10646,R,227,L,1irh:A,18,Abolishes inhibition of VII(a)/TF.,,,-1.0,,,,,,,,,,,,,P10646_R_227_L
P60891,S,132,A,3efh:A,132,Reduces catalytic activity.,,,-1.0,,,,,,,,,,,,,P60891_S_132_A
P60891,S,132,F,3efh:A,132,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_S_132_F
P60891,N,144,H,3efh:A,144,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_N_144_H
P60891,Y,146,F,3efh:A,146,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_Y_146_F
P60891,Y,146,M,3efh:A,146,Reduces catalytic activity.,,,-1.0,,,,,,,,,,,,,P60891_Y_146_M
O95747,K,46,A,3dak:D,46,Loss of autophosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,O95747_K_46_A
O95747,K,46,M,3dak:D,46,"Loss of RELT, RELL1 and RELL2 phosphorylation. Retention of some autophosphorylation activity may be due to complex formation with other endogenous kinases in the assay.",,,-1.0,-1.0,,,,,,,,,,,,O95747_K_46_M
Q9UBZ9,D,570,A,3gqc:B,570,Abolishes transferase activity,,,-1.0,,,,,,,,,,,,,Q9UBZ9_D_570_A
Q9UBZ9,E,571,A,3gqc:B,571,Abolishes transferase activity,,,-1.0,,,,,,,,,,,,,Q9UBZ9_E_571_A
Q96GX9,Q,96,A,4m6r:A,96,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q96GX9_Q_96_A
Q96GX9,C,97,A,4m6r:A,97,Almost complete loss of enzyme activity. Abolishes protection against pyroptosis. No effect on anti-apoptotic activity.,,,-1.0,,,,,,,,,,,,,Q96GX9_C_97_A
Q96GX9,H,115,A,4m6r:A,115,Almost complete loss of enzyme activity. Abolishes protection against pyroptosis. No effect on anti-apoptotic activity.,,,-1.0,,,,,,,,,,,,,Q96GX9_H_115_A
Q96GX9,E,139,A,4m6r:A,139,Almost complete loss of enzyme activity. Abolishes protection against pyroptosis. No effect on anti-apoptotic activity.,,,-1.0,,,,,,,,,,,,,Q96GX9_E_139_A
Q9UBL3,R,296,K,6pwv:D,202,Abolishes methylation.,,,-1.0,,,,,,,,,,,,,Q9UBL3_R_296_K
Q9UBL3,R,300,K,6pwv:D,206,Slightly decreased methylation.,,,-1.0,,,,,,,,,,,,,Q9UBL3_R_300_K
Q9H0H5,F,289,G,4b6d:A,289,Cytokinesis failure.,,,-1.0,,,,,,,,,,,,,Q9H0H5_F_289_G
Q9H0H5,K,292,L,4b6d:A,292,Cytokinesis failure. Abolishes localization at the cell membrane.,,,-1.0,,,,,,,,,1.0,,,,Q9H0H5_K_292_L
Q9H0H5,R,306,L,4b6d:A,306,Cytokinesis failure. Abolishes localization at the cell membrane.,,,-1.0,,,,,,,,,1.0,,,,Q9H0H5_R_306_L
Q9H0H5,F,309,A,4b6d:A,309,Cytokinesis failure. Abolishes localization at the cell membrane.,,,-1.0,,,,,,,,,1.0,,,,Q9H0H5_F_309_A
Q9H0H5,C,316,G,4b6d:A,316,Cytokinesis failure.,,,-1.0,,,,,,,,,,,,,Q9H0H5_C_316_G
Q9H0H5,R,385,A,5c2j:A,385,Abolishes GAP activity towards RAC1. Abolishes GAP activity towards CDC42 in prometaphase. Induces multiple blebs during cytokinesis.,,,-1.0,,,,,,,,,,,,,Q9H0H5_R_385_A
Q13822,S,170,E,4zg9:B,170,Reduces lysophospholipase activity by about 70%.,,,-1.0,,,,,,,,,,,,,Q13822_S_170_E
Q13822,T,210,A,4zg9:B,210,Loss of lysophospholipase activity and ability to hydrolyze sphingosylphosphorylcholine.,,,-1.0,,,,,,,,,,,,,Q13822_T_210_A
Q13822,F,211,Y,4zg9:B,211,Reduces lysophospholipase activity by about 70%.,,,-1.0,,,,,,,,,,,,,Q13822_F_211_Y
Q13822,A,218,V,4zg9:B,218,Reduces lysophospholipase activity by about 50%.,,,-1.0,,,,,,,,,,,,,Q13822_A_218_V
Q13822,N,231,A,4zg9:B,231,Strongly reduced lysophospholipase activity.,,,-1.0,,,,,,,,,,,,,Q13822_N_231_A
Q13822,Y,307,Q,4zg9:B,307,Reduces lysophospholipase activity by about 70%.,,,-1.0,,,,,,,,,,,,,Q13822_Y_307_Q
Q13822,H,316,Q,4zg9:B,316,Loss of ability to hydrolyze sphingosylphosphorylcholine.,,,-1.0,,,,,,,,,,,,,Q13822_H_316_Q
Q13822,H,360,Q,4zg9:B,360,Loss of ability to hydrolyze sphingosylphosphorylcholine.,,,-1.0,,,,,,,,,,,,,Q13822_H_360_Q
P48426,G,131,L,2ybx:B,131,Abolishes catalytic activity,,,-1.0,,,,,,,,,,,,,P48426_G_131_L
P48426,Y,138,F,2ybx:A,138,Abolishes catalytic activity,,,-1.0,,,,,,,,,,,,,P48426_Y_138_F
Q9Y2Z4,S,200,E,2pid:B,200,Loss of tRNA ligase activity.,,,-1.0,,,,,,,,,,,,,Q9Y2Z4_S_200_E
Q9Y2Z4,Q,202,A,2pid:B,202,Mildly decreased tRNA ligase activity.,,,-1.0,,,,,,,,,,,,,Q9Y2Z4_Q_202_A
Q93009,C,223,A,5j7t:A,223,Complete loss of activity. Localized in the nucleus and does not inhibit FOXO4-dependent transcriptional activity. Loss of ability to deubiquitinate CRY2.,,,-1.0,,,,,,,,,1.0,,,,Q93009_C_223_A
Q93009,C,223,S,5j7t:A,223,Catalytically inactive mutant. No effect on p53/TP53 and PTEN binding but is defective in deubiquitinating p53/TP53 and PTEN. Partial loss of KMT2E/mml5 deubiquitination. Decreases deubiquitinase activity toward 'Lys-48'-polyubiquitinated ALKBH3. Reduced deubiquitination of REST.,0.0,,-1.0,,,,,,,,,,,,,Q93009_C_223_S
Q93009,H,456,A,5j7t:A,456,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q93009_H_456_A
Q93009,H,464,A,5j7t:A,464,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q93009_H_464_A
Q00613,K,80,Q,2ldu:A,82,Loss of nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock. No change in homotrimerization upon heat shock.,0.0,-1.0,-1.0,,,,,,,,,1.0,,,,Q00613_K_80_Q
Q00613,K,80,R,2ldu:A,82,Does not change interaction with XRCC5 and XRCC6. Loss of nuclear stress bodies localization. Decreased nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock.,0.0,-1.0,-1.0,,,,,,,,,1.0,,,,Q00613_K_80_R
Q00613,T,120,A,2ldu:A,122,No effect on binding HSE nor on transcriptional activity.,0.0,,0.0,,,,,,,,,,,,,Q00613_T_120_A
Q00613,S,121,A,2ldu:A,123,Increased binding HSE and transcriptional activity. Greatly reduced binding to HSP90AA1. No effect on MAPKAPK2 binding.,-1.0,,0.0,,,,,,,,,,,,,Q00613_S_121_A
Q00613,S,121,D,2ldu:A,123,Some inhibition of binding HSE and transcriptional activity. No change in binding HSP90AA1. Inhibits MAPKAPK2 binding. Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner,-1.0,,-1.0,,,,,,,,,,,,,Q00613_S_121_D
Q9BVM4,E,82,A,3juc:A,82,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BVM4_E_82_A
Q9BVM4,E,82,Q,3juc:A,82,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BVM4_E_82_Q
Q9H0P0,D,88,N,2jga:A,38,Loss of nucleotidase and phosphotransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H0P0_D_88_N
Q9H0P0,F,89,A,2jga:A,39,Almost complete loss of nucleotidase and phosphotransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H0P0_F_89_A
Q9H0P0,D,90,N,2jga:A,40,Loss of nucleotidase and phosphotransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H0P0_D_90_N
Q9H0P0,E,135,D,2jga:A,85,No effect on nucleotidase activity. Almost complete loss of phosphotransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H0P0_E_135_D
Q9H0P0,D,232,N,2jga:A,182,No effect on nucleotidase and phosphotransferase activity.,,,0.0,,,,,,,,,,,,,Q9H0P0_D_232_N
Q9H0P0,F,233,A,2jga:A,183,Almost complete loss of nucleotidase and phosphotransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H0P0_F_233_A
Q9H0P0,D,234,N,2jga:A,184,No effect on nucleotidase and phosphotransferase activity.,,,0.0,,,,,,,,,,,,,Q9H0P0_D_234_N
O15217,Y,9,F,3ik7:A,9,Reduces catalytic activity 70-fold.,,,-1.0,,,,,,,,,,,,,O15217_Y_9_F
Q86TM6,C,329,S,6a3z:A,51,Abolishes E3 ligase activity.,,,-1.0,,,,,,,,,,,,,Q86TM6_C_329_S
Q96AB6,C,75,A,6a0i:A,75,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AB6_C_75_A
Q96AB6,C,75,S,6a0i:A,75,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AB6_C_75_S
Q96AB6,C,75,T,6a0i:A,75,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AB6_C_75_T
P08631,K,290,E,5h09:A,295,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P08631_K_290_E
P08631,E,305,A,5h09:A,310,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P08631_E_305_A
P08631,D,381,E,5h09:A,386,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P08631_D_381_E
P08631,Y,411,A,5h09:A,416,Reduced catalytic activity and higher affinity for target peptides.,,1.0,-1.0,,,,,,,,,,,,,P08631_Y_411_A
P08631,Y,522,F,5h09:A,527,"Constitutively activated kinase, leading to cellular transformation.",,,1.0,,,,,,,,,,,,,P08631_Y_522_F
Q9Y5P4,E,472,A,5zym:A,446,Reduces ceramide transfer.,,,-1.0,,,,,,,,,,,,,Q9Y5P4_E_472_A
Q9Y5P4,Q,493,A,5zym:A,467,No effect on ceramide transfer activity.,,,0.0,,,,,,,,,,,,,Q9Y5P4_Q_493_A
Q9Y5P4,W,499,A,5zym:A,473,Reduces affinity for membranes. Abolishes ceramide transfer,,,-1.0,,,,,,,,,,,,,Q9Y5P4_W_499_A
Q9Y5P4,N,530,A,5zym:A,504,Reduces ceramide transfer.,,,-1.0,,,,,,,,,,,,,Q9Y5P4_N_530_A
Q9Y5P4,W,588,A,5zym:A,562,Abolishes ceramide transfer,,,-1.0,,,,,,,,,,,,,Q9Y5P4_W_588_A
P20132,C,303,A,1p5j:A,303,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P20132_C_303_A
Q9H3L0,F,165,A,5cv0:A,165,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_F_165_A
Q9H3L0,M,186,A,5cv0:A,186,Decreases methylcobalamin levels. No effect on interaction with MMACHC.,0.0,,-1.0,,,,,,,,,,,,,Q9H3L0_M_186_A
Q9H3L0,W,189,A,5cv0:A,189,Decreases methylcobalamin levels. Impairs interaction with MMACHC.,-1.0,,-1.0,,,,,,,,,,,,,Q9H3L0_W_189_A
Q9H3L0,C,212,A,5cv0:A,212,No effect on cobalamin levels.,,,0.0,,,,,,,,,,,,,Q9H3L0_C_212_A
Q9H3L0,Y,237,A,5cv0:A,237,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_Y_237_A
Q9H3L0,R,266,A,5cv0:A,266,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_R_266_A
Q9H3L0,W,270,A,5cv0:A,270,Decreases methylcobalamin levels.,,,-1.0,,,,,,,,,,,,,Q9H3L0_W_270_A
Q9H3L0,S,278,A,5cv0:A,278,Marginally decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_S_278_A
Q9H3L0,F,280,A,5cv0:A,280,No effect on cobalamin levels.,,,0.0,,,,,,,,,,,,,Q9H3L0_F_280_A
Q5VVQ6,C,160,S,4boq:A,160,Abolishes deubiquitinase activity without affecting interaction with VCP. Specifically blocks a step in the course of dislocation and/or degradation of endoplasmic reticulum-resident proteins destined for proteasomal degradation. Prevents the macroautophagy of damaged lysosome membranes decorated with K48-linked ubiquitin chains.,,,-1.0,,,,,,,,,,,,,Q5VVQ6_C_160_S
Q9Y4P1,C,74,S,2cy7:A,74,Complete loss of protease activity.,,,-1.0,,,,,,,,,,,,,Q9Y4P1_C_74_S
Q9Y4P1,W,142,A,2cy7:A,142,Strongly reduced protease activity.,,,-1.0,,,,,,,,,,,,,Q9Y4P1_W_142_A
Q9Y4P1,R,229,A,2d1i:A,229,Strongly reduced protease activity.,,,-1.0,,,,,,,,,,,,,Q9Y4P1_R_229_A
Q9Y4P1,D,278,A,2d1i:A,278,Complete loss of protease activity.,,,-1.0,,,,,,,,,,,,,Q9Y4P1_D_278_A
Q9Y4P1,H,280,A,2d1i:A,280,Complete loss of protease activity.,,,-1.0,,,,,,,,,,,,,Q9Y4P1_H_280_A
Q01581,C,129,A,2p8u:A,129,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q01581_C_129_A
Q01581,C,129,S,2p8u:A,129,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q01581_C_129_S
P43155,Y,452,F,1s5o:A,431,Increases the KM for carnitine 320-fold and reduces enzyme activity 10000-fold.,,-1.0,-1.0,,,,,,,,,,,,,P43155_Y_452_F
P43155,T,465,A,1s5o:A,444,Increases the KM for carnitine almost 70-fold and reduces enzyme activity 450-fold.,,-1.0,-1.0,,,,,,,,,,,,,P43155_T_465_A
P43155,R,518,Q,1s5o:A,497,Increases the KM for carnitine 230-fold and reduces enzyme activity almost 100-fold.,,-1.0,-1.0,,,,,,,,,,,,,P43155_R_518_Q
P43155,F,566,A,1s5o:A,545,Increases the KM for carnitine 18-fold and reduces enzyme activity 100-fold.,,-1.0,-1.0,,,,,,,,,,,,,P43155_F_566_A
P43155,F,566,Y,1s5o:A,545,No effect.,0.0,0.0,0.0,0.0,,,,,,,,,,,,P43155_F_566_Y
Q6NYC1,Y,131,F,6mev:A,131,Abolishes 2-oxoglutarate-binding and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q6NYC1_Y_131_F
Q6NYC1,H,187,A,6mev:A,187,Loss of histone arginine demethylase and lysyl-hydroxylase activities. Abolishes homooligomerisation. Loss of arginine demethylase and a lysyl-hydroxylase activities,-1.0,,-1.0,,,,,,,,,,,,,Q6NYC1_H_187_A
Q6NYC1,D,189,A,6mev:A,189,Loss of arginine demethylase and a lysyl-hydroxylase activities,,,-1.0,,,,,,,,,,,,,Q6NYC1_D_189_A
Q6NYC1,K,204,A,6mev:A,204,Impairs enzyme activity without affecting 2-oxoglutarate-binding.,,0.0,-1.0,,,,,,,,,,,,,Q6NYC1_K_204_A
Q6NYC1,E,231,A,6mev:A,231,Impairs both hydroxylation activity and 2-oxoglutarate turnover assays.,,,-1.0,,,,,,,,,,,,,Q6NYC1_E_231_A
Q6NYC1,H,273,A,6mev:A,273,Loss of arginine demethylase and a lysyl-hydroxylase activities,,,-1.0,,,,,,,,,,,,,Q6NYC1_H_273_A
Q6NYC1,T,285,A,6mev:A,285,Impairs enzyme activity and 2-oxoglutarate-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q6NYC1_T_285_A
Q6NYC1,N,287,A,6mev:A,287,Impairs enzyme activity.,,,-1.0,,,,,,,,,,,,,Q6NYC1_N_287_A
Q9H1R2,C,85,S,1yz4:A,88,Loss of phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9H1R2_C_85_S
O75554,W,150,A,2jxw:A,29,Nearly abolishes activation of pre-mRNA splicing. Abolishes interaction with WBP11.,-1.0,,-1.0,,,,,,,,,,,,,O75554_W_150_A
O75554,W,191,A,2jxw:A,70,Nearly abolishes activation of pre-mRNA splicing. Abolishes interaction with WBP11.,-1.0,,-1.0,,,,,,,,,,,,,O75554_W_191_A
P28907,C,119,K,6vua:A,119,Loss of cADPr hydrolase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_119_K
P28907,C,119,R,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_119_R
P28907,C,119,E,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_119_E
P28907,C,119,A,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_119_A
P28907,C,160,A,6vua:A,160,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_160_A
P28907,C,173,A,6vua:A,173,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_173_A
P28907,C,201,D,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_201_D
P28907,C,201,K,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_201_K
P28907,C,201,A,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_201_A
P28907,C,201,E,6vua:A,201,Loss of cADPr hydrolase activity.,,,-1.0,,,,,,,,,,,,,P28907_C_201_E
P23219,S,529,N,6y3c:A,530,Abolishes cyclooxygenase activity.,,,-1.0,,,,,,,,,,,,,P23219_S_529_N
P27694,C,500,S,1l1o:C,500,Loss of function in DNA replication and mismatch repair without effect on DNA-binding activity,,0.0,-1.0,,,,,,,,,,,,,P27694_C_500_S
P27694,C,503,S,1l1o:C,503,Loss of function in DNA replication and mismatch repair without effect on DNA-binding activity,,0.0,-1.0,,,,,,,,,,,,,P27694_C_503_S
P27695,C,65,A,4qh9:A,65,Abolishes the redox activity. Does not abolish the AP endodeoxyribonuclease and phosphodiesterase activities. Reduces protection from granzyme A-mediated cell death,,,-1.0,,,,,,,,,,,,,P27695_C_65_A
P27695,C,65,S,4qh9:A,65,Does not abolish NO-induced nitrosylation. Enhances NO-induced nuclear export.,,,1.0,,,,,,,,,,,,,P27695_C_65_S
P27695,N,68,A,4qh9:A,68,Nearly abolishes AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_N_68_A
P27695,D,70,A,4qh9:A,70,Strongly reduces AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_D_70_A
P27695,C,93,A,4qh9:A,93,Abolishes partially the redox activity.,,,-1.0,,,,,,,,,,,,,P27695_C_93_A
P27695,E,96,A,4qh9:A,96,Lacks MYC CRD RNA cleavage activity.,,,-1.0,,,,,,,,,,,,,P27695_E_96_A
P27695,C,99,A,4qh9:A,99,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_99_A
P27695,C,138,A,4qh9:A,138,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_138_A
P27695,Y,171,A,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_Y_171_A
P27695,Y,171,F,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_Y_171_F
P27695,Y,171,H,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_Y_171_H
P27695,C,208,A,4qh9:A,208,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_208_A
P27695,D,210,A,4qh9:A,210,Abolishes the AP endodeoxyribonuclease activity. Reduces protection from granzyme A-mediated cell death,,,-1.0,,,,,,,,,,,,,P27695_D_210_A
P27695,D,210,N,4qh9:A,210,Abolishes the AP endodeoxyribonuclease activity. Reduces protection from granzyme A-mediated cell death,,,-1.0,,,,,,,,,,,,,P27695_D_210_N
P27695,N,212,A,4qh9:A,212,Abolishes AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_N_212_A
P27695,N,212,Q,4qh9:A,212,Decreases AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_N_212_Q
P27695,N,212,D,4qh9:A,212,Decreases AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_N_212_D
P27695,F,266,A,4qh9:A,266,Strongly reduces AP endodeoxyribonuclease activity.,,,-1.0,,,,,,,,,,,,,P27695_F_266_A
P27695,D,283,A,4qh9:A,283,"Strongly reduces AP endodeoxyribonuclease activity, but does not affect RNA cleavage activity. Nearly abolishes AP endodeoxyribonuclease activity",,,-1.0,,,,,,,,,,,,,P27695_D_283_A
P27695,C,296,A,4qh9:A,296,Does not abolish the redox activity.,,,-1.0,,,,,,,,,,,,,P27695_C_296_A
P27695,D,308,A,4qh9:A,308,Reduces AP endodeoxyribonuclease activity. Nearly abolishes AP endodeoxyribonuclease activity,,,-1.0,,,,,,,,,,,,,P27695_D_308_A
P27695,H,309,N,4qh9:A,309,Abolishes AP endodeoxyribonuclease activity. Lacks MYC CRD RNA cleavage activity.,,,-1.0,,,,,,,,,,,,,P27695_H_309_N
P27695,H,309,S,4qh9:A,309,Abolishes AP endodeoxyribonuclease activity. Lacks MYC CRD RNA cleavage activity.,,,-1.0,,,,,,,,,,,,,P27695_H_309_S
P27695,C,310,A,4qh9:A,310,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_310_A
P27695,C,310,S,4qh9:A,310,Does not abolish NO-induced nitrosylation. Abolishes NO-induced nitrosylation and translocation from the nucleus to the cytoplasm,,,0.0,,,,,,,,,1.0,,,,P27695_C_310_S
Q9H7Z6,K,274,A,3qah:A,274,Abolishes histone acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H7Z6_K_274_A
Q9H7Z6,K,274,R,3qah:A,274,Abolishes histone acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H7Z6_K_274_R
Q9H7Z6,C,316,S,3qah:A,316,Strongly reduces histone acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H7Z6_C_316_S
Q9H7Z6,E,350,Q,3qah:A,350,Abolishes histone acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H7Z6_E_350_Q
Q9BSD7,E,114,T,2i3b:A,113,"Reduced activity, especially towards ATP, GTP and TTP.",,,-1.0,,,,,,,,,,,,,Q9BSD7_E_114_T
Q9BSD7,G,116,H,2i3b:A,115,"Reduced activity, especially towards ATP, GTP and TTP.",,,-1.0,,,,,,,,,,,,,Q9BSD7_G_116_H
Q05086,F,750,D,1d5f:A,727,"Disrupt trimer formation, 50-fold reduction in E3 ligase activity.",-1.0,,-1.0,,,,,,,,,,,,,Q05086_F_750_D
Q9NRG4,E,187,K,5v3h:A,187,Abolishes methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_E_187_K
Q9NRG4,E,189,K,5v3h:A,189,Strongly reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_E_189_K
Q9NRG4,E,190,K,5v3h:A,190,Strongly reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_E_190_K
Q9NRG4,H,207,A,5v3h:A,207,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9NRG4_H_207_A
Q9NRG4,Y,240,F,5v3h:A,240,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9NRG4_Y_240_F
Q9NRG4,Y,245,F,5v3h:A,245,Strongly reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_Y_245_F
Q9NRG4,D,252,R,5v3h:A,252,Slightly reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_D_252_R
Q9NRG4,R,253,Q,5v3h:A,253,No effect on methyltransferase activity on p53/TP53.,,,0.0,,,,,,,,,,,,,Q9NRG4_R_253_Q
Q9NRG4,R,306,E,5v3h:A,306,No effect on methyltransferase activity on p53/TP53.,,,0.0,,,,,,,,,,,,,Q9NRG4_R_306_E
Q9NRG4,Y,374,A,5v3h:A,374,Abolishes methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_Y_374_A
Q9NRG4,E,429,K,5v3h:A,429,Reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_E_429_K
Q9NRG4,E,431,K,5v3h:A,431,Strongly reduces methyltransferase activity on p53/TP53.,,,-1.0,,,,,,,,,,,,,Q9NRG4_E_431_K
P53602,N,17,A,3d4j:A,17,15-fold inflation in KM for mevalonate diphosphate.,,-1.0,1.0,,,,,,,,,,,,,P53602_N_17_A
Q99685,Y,194,F,3hju:A,194,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_Y_194_F
Q99685,C,201,A,3hju:A,201,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_C_201_A
Q99685,C,208,A,3hju:A,208,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_C_208_A
Q99685,C,242,A,3hju:A,242,Reduced 1-monoacylglycerol lipase activity.,,,-1.0,,,,,,,,,,,,,Q99685_C_242_A
Q13131,V,307,G,4red:B,298,Activates the kinase activity.,,,1.0,,,,,,,,,,,,,Q13131_V_307_G
Q13131,V,307,Q,4red:B,298,Activates the kinase activity.,,,1.0,,,,,,,,,,,,,Q13131_V_307_Q
Q9HAS3,S,568,P,6ksw:A,569,Decreased uridine transport. Normal localization to the cell membrane.,,,-1.0,,,,,,,,,0.0,,,,Q9HAS3_S_568_P
P61956,K,11,R,2awt:A,11,Abolishes the formation of poly(SUMO) chains.,,,-1.0,,,,,,,,,,,,,P61956_K_11_R
P61956,K,33,E,2awt:A,33,Significantly impairs sumoylation of MTA1.,,,-1.0,,,,,,,,,,,,,P61956_K_33_E
P61956,K,35,E,2awt:A,35,Significantly impairs sumoylation of MTA1.,,,-1.0,,,,,,,,,,,,,P61956_K_35_E
P61956,K,42,E,2awt:A,42,Significantly impairs sumoylation of MTA1.,,,-1.0,,,,,,,,,,,,,P61956_K_42_E
O94804,K,65,I,6eim:B,65,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O94804_K_65_I
Q9H221,G,216,D,5do7:D,216,Loss of ATPase activity.,,,-1.0,,,,,,,,,,,,,Q9H221_G_216_D
Q9H227,E,165,D,2e9m:A,165,2-fold decreased glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_E_165_D
Q9H227,E,165,Q,2e9m:A,165,Loss of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_E_165_Q
Q9H227,V,168,Y,2e9m:A,168,No change in temperature or pH dependence. Decreased glucosidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_V_168_Y
Q9H227,F,225,S,2e9m:A,225,Decreased glucosidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_F_225_S
Q9H227,Y,308,F,2e9m:A,308,Decreased glucosidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_Y_308_F
Q9H227,Y,308,A,2e9m:A,308,Decreased glucosidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_Y_308_A
Q9H227,E,373,D,2e9m:A,373,2-fold decreased glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_E_373_D
Q9H227,E,373,Q,2e9m:A,373,Loss of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,Q9H227_E_373_Q
P19440,K,100,N,4gg2:A,100,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_K_100_N
P19440,E,102,Q,4gg2:A,102,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_E_102_Q
P19440,R,107,K,4gg2:A,107,Reduces enzyme gamma-glutamyltranspeptidase activity by 99%.,,,-1.0,,,,,,,,,,,,,P19440_R_107_K
P19440,R,107,Q,4gg2:A,107,Abolishes gamma-glutamyltranspeptidase activity.,,,-1.0,,,,,,,,,,,,,P19440_R_107_Q
P19440,R,107,H,4gg2:A,107,Abolishes gamma-glutamyltranspeptidase activity.,,,-1.0,,,,,,,,,,,,,P19440_R_107_H
P19440,E,108,Q,4gg2:A,108,Reduces gamma-glutamyltranspeptidase activity by 98%.,,,-1.0,,,,,,,,,,,,,P19440_E_108_Q
P19440,R,112,Q,4gg2:A,112,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_112_Q
P19440,R,139,Q,4gg2:A,139,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_139_Q
P19440,R,147,Q,4gg2:A,147,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_147_Q
P19440,R,150,Q,4gg2:A,150,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_150_Q
P19440,C,192,W,4gg2:A,192,"Loss of autocatalytic cleavage, cell membrane localization and decrease in gamma-glutamyltranspeptidase activity",,,-1.0,,,,,,,,,1.0,,,,P19440_C_192_W
P19440,E,193,Y,4gg2:A,193,"Loss of autocatalytic cleavage, cell membrane localization and decrease in gamma-glutamyltranspeptidase activity",,,-1.0,,,,,,,,,1.0,,,,P19440_E_193_Y
P19440,H,383,A,6xpb:B,383,Reduces gamma-glutamyltranspeptidase activity by 66%.,,,-1.0,,,,,,,,,,,,,P19440_H_383_A
P19440,S,385,A,6xpb:B,385,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_385_A
P19440,S,413,A,6xpb:B,413,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_413_A
P19440,D,422,A,6xpb:B,422,Reduces enzyme gamma-glutamyltranspeptidase activity by 90%.,,,-1.0,,,,,,,,,,,,,P19440_D_422_A
P19440,D,423,A,6xpb:B,423,Abolishes gamma-glutamyltranspeptidase activity. Increases KM for D-gamma-glutamyl-p-nitroanalide by over 1000-fold.,,-1.0,-1.0,,,,,,,,,,,,,P19440_D_423_A
P19440,S,425,A,6xpb:B,425,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_425_A
P19440,S,451,A,6xpb:B,451,Reduces gamma-glutamyltranspeptidase activity by 99%. Abolishes activity,,,-1.0,,,,,,,,,,,,,P19440_S_451_A
P19440,S,452,A,6xpb:B,452,Reduces gamma-glutamyltranspeptidase activity by 99%. Abolishes activity,,,-1.0,,,,,,,,,,,,,P19440_S_452_A
P19440,C,454,A,6xpb:B,454,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_C_454_A
P19440,H,505,A,6xpb:B,505,Reduces gamma-glutamyltranspeptidase activity by 90%.,,,0.0,,,,,,,,,,,,,P19440_H_505_A
P19440,Q,545,K,6xpb:B,545,Reduces enzyme activity by 97%.,,,-1.0,,,,,,,,,,,,,P19440_Q_545_K
Q16512,K,644,E,4otd:A,650,Abolishes Serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q16512_K_644_E
Q16513,D,700,E,4crs:A,700,Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function,,,-1.0,,,,,,,,,,,,,Q16513_D_700_E
Q16513,T,816,A,4crs:A,816,Reduces catalytic activity.,,,-1.0,,,,,,,,,,,,,Q16513_T_816_A
Q16513,T,958,A,4crs:A,958,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q16513_T_958_A
P20823,N,127,W,1ic8:B,127,Abolishes transcription activation.,,,-1.0,,,,,,,,,,,,,P20823_N_127_W
P20823,E,132,K,1ic8:B,132,Abolishes transcription activation.,,,-1.0,,,,,,,,,,,,,P20823_E_132_K
P20823,F,177,S,1ic8:B,177,No significant effect on transcription activation.,,,0.0,,,,,,,,,,,,,P20823_F_177_S
P20823,N,202,D,1ic8:B,202,Reduces transcription activation by 70%.,,,-1.0,,,,,,,,,,,,,P20823_N_202_D
P20823,V,246,D,1ic8:B,246,Reduces transcription activation by 75%.,,,-1.0,,,,,,,,,,,,,P20823_V_246_D
P20823,N,257,W,1ic8:B,257,Reduces transcription activation by 70%.,,,-1.0,,,,,,,,,,,,,P20823_N_257_W
Q9H816,D,14,N,7a1f:L,14,In Apm3: abolishes exonuclease activity and function on telomere maintenance. Impairs interaction with SPAG5,-1.0,,-1.0,,,,,,,,,,,,,Q9H816_D_14_N
Q9H816,H,33,A,7a1f:L,33,In Apm1: abolishes exonuclease activity and function on telomere maintenance; when associated with N-35,,,-1.0,,,,,,,,,,,,,Q9H816_H_33_A
Q9H816,D,35,N,7a1f:L,35,In Apm2:abolishes exonuclease activity and function on  telomere maintenance. In Apm1; abolishes exonuclease activity and  function on telomere maintenance; when associated with A-33,,,-1.0,,,,,,,,,,,,,Q9H816_D_35_N
Q9BWF3,Y,37,A,2dnq:A,37,Abrogates regulation of alternative splice site selection,,,-1.0,,,,,,,,,,,,,Q9BWF3_Y_37_A
Q9BWF3,F,39,A,2dnq:A,39,Abrogates regulation of alternative splice site selection,,,-1.0,,,,,,,,,,,,,Q9BWF3_F_39_A
P31941,R,28,E,2m65:A,28,No effect on deaminase activity despite an altered restriction activity towards genetic invaders.,,,0.0,,,,,,,,,,,,,P31941_R_28_E
P31941,H,29,A,2m65:A,29,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_H_29_A
P31941,K,30,F,2m65:A,30,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_K_30_F
P31941,N,57,A,2m65:A,57,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_N_57_A
P31941,K,60,A,2m65:A,60,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_K_60_A
P31941,R,69,A,2m65:A,69,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_R_69_A
P31941,H,70,R,2m65:A,70,Altered deaminase activity.,,,-1.0,,,,,,,,,,,,,P31941_H_70_R
P31941,E,72,Q,2m65:A,72,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_E_72_Q
P31941,W,98,L,2m65:A,98,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_W_98_L
P31941,C,106,S,2m65:A,106,Altered deaminase activity.,,,-1.0,,,,,,,,,,,,,P31941_C_106_S
P31941,R,128,A,2m65:A,128,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_R_128_A
P31941,Y,130,A,2m65:A,130,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_Y_130_A
P31941,D,131,N,2m65:A,131,No effect on deaminase activity despite an altered restriction activity towards genetic invaders.,,,0.0,,,,,,,,,,,,,P31941_D_131_N
P31941,D,133,N,2m65:A,133,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_D_133_N
P31941,Y,136,A,2m65:A,136,Altered deaminase activity and restriction activity towards genetic invaders.,,,-1.0,,,,,,,,,,,,,P31941_Y_136_A
Q13356,Y,389,H,1zkc:A,389,No peptidyl-prolyl cis-trans isomerase activity,,,-1.0,,,,,,,,,,,,,Q13356_Y_389_H
Q13356,Y,389,W,1zkc:A,389,Gain of a peptidyl-prolyl cis-trans isomerase activity,,,1.0,,,,,,,,,,,,,Q13356_Y_389_W
Q96DA2,Q,68,L,6s5f:A,68,Constitutively active mutant locked in the active GTP-bound form.,,,1.0,,,,,,,,,,,,,Q96DA2_Q_68_L
Q96MF7,C,169,A,2yu4:A,10,Induces a strong decrease in SUMO ligase activity.,,,-1.0,,,,,,,,,,,,,Q96MF7_C_169_A
Q96MF7,C,185,A,2yu4:A,26,Induces a strong decrease in SUMO ligase activity.,,,-1.0,,,,,,,,,,,,,Q96MF7_C_185_A
Q96MF7,H,187,A,2yu4:A,28,Induces a strong decrease in SUMO ligase activity.,,,-1.0,,,,,,,,,,,,,Q96MF7_H_187_A
Q96MF7,C,210,A,2yu4:A,51,Induces a strong decrease in SUMO ligase activity.,,,-1.0,,,,,,,,,,,,,Q96MF7_C_210_A
Q96MF7,C,215,A,2yu4:A,56,Induces a strong decrease in SUMO ligase activity.,,,-1.0,,,,,,,,,,,,,Q96MF7_C_215_A
P17213,C,163,A,1ewf:A,132,No impairment of secretion and/or biological activity. Loss of dimer formation.,-1.0,,0.0,,,,,,,,,0.0,,,,P17213_C_163_A
P17213,C,166,S,1ewf:A,135,Poorly secreted. Loss of LPS-binding and biological activity.,-1.0,,-1.0,,,,,,,,,1.0,,,,P17213_C_166_S
Q14914,R,56,A,1zsv:A,56,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2.,,,-1.0,,,,,,,,,,,,,Q14914_R_56_A
Q14914,Y,245,A,1zsv:A,245,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2 and (3E)-3-nonen-2-one.,,,-1.0,,,,,,,,,,,,,Q14914_Y_245_A
Q14914,Y,245,F,1zsv:A,245,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2 and (3E)-3-nonen-2-one.,,,-1.0,,,,,,,,,,,,,Q14914_Y_245_F
P37088,C,394,S,6bqn:A,394,Increased channel activity.,,,1.0,,,,,,,,,,,,,P37088_C_394_S
P60953,G,12,V,2ngr:A,12,Constitutively active. Interacts with PARD6 proteins. Does not inhibit filopodia formation. No effect on NR3C2 transcriptional activity.,1.0,,1.0,,,,,,,,,,,,,P60953_G_12_V
P60953,T,17,N,2ngr:A,17,Constitutively inactive. Does not interact with PARD6 proteins. Inhibits filopodia formation. No effect on NR3C2 transcriptional activity.,-1.0,,-1.0,,,,,,,,,,,,,P60953_T_17_N
P60953,Q,61,L,2ngr:A,61,Constitutively active. Interacts with PARD6 proteins.,1.0,,1.0,,,,,,,,,,,,,P60953_Q_61_L
Q9HCP0,N,169,A,2cmw:A,169,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9HCP0_N_169_A
O14684,Q,36,E,4yl1:A,36,Keeps about 40-50% of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_Q_36_E
O14684,D,49,A,4yl1:A,49,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_D_49_A
O14684,D,49,N,4yl1:A,49,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_D_49_N
O14684,E,66,A,4yl1:A,66,Reduces protaglandin-E synthase activity by 50%.,,,-1.0,,,,,,,,,,,,,O14684_E_66_A
O14684,R,67,A,4yl1:A,67,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_67_A
O14684,R,70,A,4yl1:A,70,Slightly reduced protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_70_A
O14684,R,70,S,4yl1:A,70,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_R_70_S
O14684,H,72,A,4yl1:A,72,Reduces protaglandin-E synthase activity by 70%.,,,-1.0,,,,,,,,,,,,,O14684_H_72_A
O14684,R,73,A,4yl1:A,73,Retains partial of protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_R_73_A
O14684,R,73,L,4yl1:A,73,Loss of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_73_L
O14684,R,110,A,4yl1:A,110,Loss of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_110_A
O14684,R,110,S,4yl1:A,110,Loss of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_110_S
O14684,R,110,T,4yl1:A,110,Retains 17.8% of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_110_T
O14684,T,114,V,4yl1:A,114,Retains 21.3% activity of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_T_114_V
O14684,Y,117,A,4yl1:A,117,Loss of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_Y_117_A
O14684,Y,117,F,4yl1:A,117,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_Y_117_F
O14684,R,126,A,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_126_A
O14684,R,126,L,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_126_L
O14684,R,126,K,4yl1:A,126,Loss of prostaglandin-E synthase activity. Transforms prostaglandin-E synthase activity to prostaglandin-F(2alpha)synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_126_K
O14684,R,126,Q,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_R_126_Q
O14684,S,127,A,4yl1:A,127,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_S_127_A
O14684,Y,130,I,4yl1:A,130,Loss of protaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_Y_130_I
O14684,Q,134,E,4yl1:A,134,Keeps about 40-50% of prostaglandin-E synthase activity.,,,-1.0,,,,,,,,,,,,,O14684_Q_134_E
Q16647,C,441,H,2iag:A,441,Abolishes prostaglandin-I synthase activity.,,,-1.0,,,,,,,,,,,,,Q16647_C_441_H
O15530,S,241,A,4xx9:A,241,No activation.,,,-1.0,,,,,,,,,,,,,O15530_S_241_A
O15530,A,277,V,4xx9:A,277,3-fold increase in kinase activity.,,,1.0,,,,,,,,,,,,,O15530_A_277_V
O15530,S,410,A,1w1h:B,410,No effect.,0.0,,0.0,0.0,,,,,,,,,,,,O15530_S_410_A
O15530,T,513,E,1w1h:B,513,Enhanced kinase activity towards PKB.,,,1.0,,,,,,,,,,,,,O15530_T_513_E
Q9UNE7,K,30,A,6efk:A,30,"Loss of interaction with FOXP3 and its ability to ubiquitinate FOXP3. Loss of interaction with SMAD3, HSPA8, HSP90AA1 and HSP90AB1.",-1.0,,-1.0,,,,,,,,,,,,,Q9UNE7_K_30_A
Q16878,R,60,Q,6bgf:A,60,Reduces enzyme activity by 70%. Reduces iron and zinc incorporation by 50%.,,-1.0,-1.0,,,,,,,,,,,,,Q16878_R_60_Q
Q16878,C,93,S,6bgf:A,93,Reduces enzyme activity and iron incorporation by 50%. Zinc incorporation increased by 20%.,,,-1.0,,,,,,,,,,,,,Q16878_C_93_S
Q16878,Y,157,F,6bgf:A,157,Almost total loss of enzyme activity and iron incorporation. Reduces zinc incorporation by 20%.,,-1.0,-1.0,,,,,,,,,,,,,Q16878_Y_157_F
Q16878,C,164,S,6bgf:A,164,Reduces enzyme activity by 20%. Little effect on iron incorporation. No effect on zinc incorporation.,,,-1.0,,,,,,,,,,,,,Q16878_C_164_S
P09936,Q,73,R,4jkj:A,73,No effect on enzymatic parameters.,,,0.0,,,,,,,,,,,,,P09936_Q_73_R
P09936,C,90,S,4jkj:A,90,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P09936_C_90_S
P09936,H,97,Q,4jkj:A,97,"2-fold increase in affinity for ubiquitin ethyl ester, slight reduction in enzymatic activity.",,-1.0,-1.0,,,,,,,,,,,,,P09936_H_97_Q
P09936,H,97,N,4jkj:A,97,"2-fold increase in affinity for ubiquitin ethyl ester, slight reduction in enzymatic activity.",,-1.0,-1.0,,,,,,,,,,,,,P09936_H_97_N
P09936,H,161,D,4jkj:A,161,10000-fold decrease in enzymatic activity,,,-1.0,,,,,,,,,,,,,P09936_H_161_D
P09936,H,161,K,4jkj:A,161,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P09936_H_161_K
P09936,H,161,Q,4jkj:A,161,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P09936_H_161_Q
P09936,H,161,N,4jkj:A,161,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P09936_H_161_N
P09936,H,161,Y,4jkj:A,161,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P09936_H_161_Y
P09936,F,204,A,4jkj:A,204,Almost complete loss of activity.,,,-1.0,,,,,,,,,,,,,P09936_F_204_A
Q03426,E,19,D,2r3v:A,19,No change in protein stability. Weak decrease in kinase activity. Approximately 2-fold decrease in Vmax. Approximately 2-fold decrease affinity for ATP and mevalonate.,,-1.0,-1.0,,,,,,,,,,,0.0,,Q03426_E_19_D
Q03426,I,56,A,2r3v:A,56,"No effect on kinase activity. Approximately 4- and 5-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_I_56_A
Q03426,T,104,A,2r3v:A,104,No effect on kinase activity. Approximately 4-fold increase affinity for ATP. Normal affinity for mevalonate.,,1.0,0.0,,,,,,,,,,,,,Q03426_T_104_A
Q03426,S,145,A,2r3v:A,145,Modest changes in KM for ATP. 20-fold increase in KM for mevalonate. Approximately 2-fold decrease in Vmax.,,-1.0,-1.0,,,,,,,,,,,,,Q03426_S_145_A
Q03426,S,146,A,2r3v:A,146,Modest changes in KM for ATP. 20-fold increase in KM for mevalonate. 4000-fold decrease in Vmax.,,-1.0,-1.0,,,,,,,,,,,,,Q03426_S_146_A
Q03426,Y,149,A,2r3v:A,149,"No effect on kinase activity. Approximately 4- and 8-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_Y_149_A
Q03426,E,193,Q,2r3v:A,193,"No change in protein stability. Decreased kinase activity. Approximately 50-fold decrease in Vmax. Approximately 20- and 40-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,-1.0,,,,,,,,,,,0.0,,Q03426_E_193_Q
Q03426,I,196,A,2r3v:A,196,"No effect on kinase activity. Approximately 2- and 3-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_I_196_A
Q03426,S,201,A,2r3v:A,201,Modest changes in KM for ATP. 100-fold increase in KM for mevalonate. Approximately 2-fold increase in Vmax.,,-1.0,-1.0,,,,,,,,,,,,,Q03426_S_201_A
Q03426,D,204,A,2r3v:A,204,No change in protein stability. Loss of kinase activity. Normal affinities for ATP and mevalonate.,,0.0,-1.0,,,,,,,,,,,0.0,,Q03426_D_204_A
Q03426,D,204,N,2r3v:A,204,No change in protein stability. Loss of kinase activity. Normal affinities for ATP and mevalonate.,,0.0,-1.0,,,,,,,,,,,0.0,,Q03426_D_204_N
Q03426,T,243,A,2r3v:A,243,Modest changes in KM for ATP. 40-fold increase in KM for mevalonate. Approximately 2-fold decrease in Vmax.,,-1.0,-1.0,,,,,,,,,,,,,Q03426_T_243_A
Q03426,E,296,Q,2r3v:A,296,No change in protein stability. No effect on kinase activity.,,,0.0,,,,,,,,,,,0.0,,Q03426_E_296_Q
Q9NS91,I,27,A,2y43:A,27,Lower activity toward PCNA monoubiquitination.,,,-1.0,,,,,,,,,,,,,Q9NS91_I_27_A
P80192,K,171,A,4uy9:B,171,Loss of kinase activity and threonine phosphorylation.,,,-1.0,,,,,,,,,,,,,P80192_K_171_A
P80192,T,304,A,4uy9:B,304,Reduces threonine phosphorylation. Impairs JNK activation.,-1.0,,-1.0,,,,,,,,,,,,,P80192_T_304_A
P80192,T,305,A,4uy9:B,305,Little effect on threonine phosphorylation. Mildly impairs JNK activation.,-1.0,,0.0,,,,,,,,,,,,,P80192_T_305_A
P80192,T,312,A,4uy9:B,312,Loss of threonine phosphorylation. Strongly impairs JNK activation.,-1.0,,-1.0,,,,,,,,,,,,,P80192_T_312_A
O14757,K,38,R,2ydi:A,38,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,O14757_K_38_R
O14757,D,130,A,2ydi:A,130,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,O14757_D_130_A
P16455,Y,114,A,1eh6:A,114,Decreases activity towards methylated DNA over 1000-fold. Slightly reduced reactivity with O6-benzylguanine.,,-1.0,-1.0,,,,,,,,,,,,,P16455_Y_114_A
P16455,Y,114,E,1eh6:A,114,Loss of DNA repair activity. Slightly reduced reactivity with O6-benzylguanine.,,-1.0,-1.0,,,,,,,,,,,,,P16455_Y_114_E
P16455,R,128,A,1eh6:A,128,Decreases activity towards methylated DNA over 1000-fold. No effect on reactivity with O6-benzylguanine.,,0.0,-1.0,,,,,,,,,,,,,P16455_R_128_A
P16455,R,128,D,1eh6:A,128,Decreases activity towards methylated DNA over 1000-fold. No effect on reactivity with O6-benzylguanine.,,0.0,-1.0,,,,,,,,,,,,,P16455_R_128_D
P16455,R,128,G,1eh6:A,128,Loss of DNA repair activity.,,,-1.0,,,,,,,,,,,,,P16455_R_128_G
P16455,R,128,K,1eh6:A,128,Slightly reduced DNA repair activity.,,,-1.0,,,,,,,,,,,,,P16455_R_128_K
P16455,R,128,L,1eh6:A,128,Slightly reduced DNA repair activity.,,,-1.0,,,,,,,,,,,,,P16455_R_128_L
P16455,C,145,A,1eh6:A,145,Loss of DNA repair activity.,,,-1.0,,,,,,,,,,,,,P16455_C_145_A
P16455,Y,158,A,1eh6:A,158,Reduced DNA repair activity. Decreased reactivity with O6-benzylguanine.,,-1.0,-1.0,,,,,,,,,,,,,P16455_Y_158_A
P16455,Y,158,F,1eh6:A,158,Slightly reduced DNA repair activity.,,,-1.0,,,,,,,,,,,,,P16455_Y_158_F
Q8NHV1,R,103,D,3zjc:E,103,Abolishes GTPase activity. No effect on GTP binding and on dimerization.,0.0,0.0,-1.0,,,,,,,,,,,,,Q8NHV1_R_103_D
Q8NHV1,E,136,W,3zjc:E,136,Impairs dimerization and abolishes GTPase activity. No effect on GTP binding.,-1.0,0.0,-1.0,,,,,,,,,,,,,Q8NHV1_E_136_W
Q9Y6U3,M,310,D,5a1m:A,310,Increases calcium-independent actin-severing activity.,,,1.0,,,,,,,,,,,,,Q9Y6U3_M_310_D
Q9Y6U3,E,314,S,5a1m:A,314,Increases calcium-independent actin-severing activity.,,,1.0,,,,,,,,,,,,,Q9Y6U3_E_314_S
P10586,C,1548,S,6kr4:C,1548,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10586_C_1548_S
P51617,D,340,N,6bfn:A,340,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51617_D_340_N
P51617,T,387,A,6bfn:A,387,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51617_T_387_A
O00267,R,696,K,2e70:A,696,Increases promoter association and enhances transcriptional elongation,,1.0,1.0,,,,,,,,,,,,,O00267_R_696_K
O00267,R,698,A,2e70:A,698,Enhances transcriptional elongation. Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation,1.0,,1.0,,,,,,,,,,,,,O00267_R_698_A
O00267,R,698,K,2e70:A,698,Increases promoter association and enhances transcriptional elongation,,1.0,1.0,,,,,,,,,,,,,O00267_R_698_K
O00267,G,1002,D,6er0:A,42,Defective in regulation of transcriptional elongation.,,,-1.0,,,,,,,,,,,,,O00267_G_1002_D
Q9H2K2,M,1054,V,4hyf:A,1054,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9H2K2_M_1054_V
Q15208,K,118,A,6bxi:A,118,Loss of autophosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,Q15208_K_118_A
Q15208,S,281,A,6bxi:A,281,Loss of autophosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,Q15208_S_281_A
Q9H2K8,D,165,A,6bdn:A,165,Loss of serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q9H2K8_D_165_A
Q9H2K8,T,181,A,6bdn:A,181,No autophosphorylation and no kinase activity,,,-1.0,-1.0,,,,,,,,,,,,Q9H2K8_T_181_A
Q9H2K8,Y,183,F,6bdn:A,183,No autophosphorylation and no kinase activity,,,-1.0,-1.0,,,,,,,,,,,,Q9H2K8_Y_183_F
Q06124,C,459,S,4rdd:A,459,Abolishes phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q06124_C_459_S
Q7L1W4,T,44,C,6m04:A,44,Alters channel anion selectivity.,,,-1.0,,,,,,,,,,,,,Q7L1W4_T_44_C
Q9NRX4,K,21,A,2ozw:A,21,Decreased affinity for substrate and strongly reduced catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9NRX4_K_21_A
Q9NRX4,R,45,A,2ozw:A,45,"Slightly decreased affinity for substrate, but no effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q9NRX4_R_45_A
Q9NRX4,H,53,A,2ozw:A,53,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NRX4_H_53_A
Q9NRX4,R,78,A,2ozw:A,78,Decreased affinity for substrate and reduced catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9NRX4_R_78_A
Q9NRX4,S,94,A,2ozw:A,94,Decreased affinity for substrate and strongly reduced catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9NRX4_S_94_A
Q9NRX4,H,102,A,2ozw:A,102,Decreased affinity for substrate and slightly reduced catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9NRX4_H_102_A
P09488,Y,7,F,2f3m:A,6,Reduces catalytic activity 100-fold.,,,-1.0,,,,,,,,,,,,,P09488_Y_7_F
P09488,H,108,Q,2f3m:A,107,Reduces catalytic activity by half.,,,-1.0,,,,,,,,,,,,,P09488_H_108_Q
P09488,H,108,S,2f3m:A,107,Changes the properties of the enzyme toward some substrates.,,,-1.0,,,,,,,,,,,,,P09488_H_108_S
P09488,M,109,I,2f3m:A,108,Reduces catalytic activity by half.,,,-1.0,,,,,,,,,,,,,P09488_M_109_I
P09488,Y,116,A,2f3m:A,115,Reduces catalytic activity 10-fold.,,,-1.0,,,,,,,,,,,,,P09488_Y_116_A
P09488,Y,116,F,2f3m:A,115,Slight increase of catalytic activity.,,,1.0,,,,,,,,,,,,,P09488_Y_116_F
P38398,I,26,A,1jm7:A,26,"Disrupts the interaction with E2 enzymes, thereby abolishing the E3 ubiquitin-protein ligase activity.",-1.0,,-1.0,,,,,,,,,,,,,P38398_I_26_A
P38398,I,26,E,1jm7:A,26,No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage.,,,-1.0,,,,,,,,,,,,,P38398_I_26_E
P29466,C,285,A,6f6r:A,285,Loss of protease activity. Loss of SPHK2 cleavage and release in apoptotic cells.,,,-1.0,,,,,,,,,,,,,P29466_C_285_A
P29466,C,285,S,6f6r:A,285,Loss of protease activity. Loss of SPHK2 cleavage and release in apoptotic cells.,,,-1.0,,,,,,,,,,,,,P29466_C_285_S
P29466,W,294,A,6f6r:A,294,Mediates autoprocessing but is unable to interact with Gasdermin-D (GSDMD) and mediate its cleavage.,-1.0,,-1.0,,,,,,,,,,,,,P29466_W_294_A
P29466,I,318,N,3e4c:A,318,Mediates autoprocessing but is unable to interact with Gasdermin-D (GSDMD) and mediate its cleavage.,-1.0,,-1.0,,,,,,,,,,,,,P29466_I_318_N
P29466,K,320,A,3e4c:A,320,Abolishes cleavage of Gasdermin-D (GSDMD).,,,-1.0,,,,,,,,,,,,,P29466_K_320_A
Q9Y606,D,146,A,4nz6:B,146,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y606_D_146_A
Q8NBK3,S,333,A,1y1g:X,333,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q8NBK3_S_333_A
Q8NBK3,S,333,T,1y1g:X,333,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q8NBK3_S_333_T
Q8NBK3,C,336,S,1y1g:X,336,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q8NBK3_C_336_S
Q8NBK3,H,337,A,1y1g:X,337,Reduces activity 5-fold.,,,-1.0,,,,,,,,,,,,,Q8NBK3_H_337_A
Q8NBK3,Y,340,F,1y1g:X,340,No effect.,,,0.0,,,,,,,,,,,,,Q8NBK3_Y_340_F
Q8NBK3,C,341,S,1y1g:X,341,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q8NBK3_C_341_S
P62820,N,124,I,3sfv:A,124,Dominant negative mutant. Strongly reduces the levels of CASR present at the cell-surface.,,,-1.0,,,,,,,,,,,,,P62820_N_124_I
Q8IYU8,D,185,A,6k7y:J,185,Abolishes mitochondrial Ca(2+) uptake,,,-1.0,,,,,,,,,,,,,Q8IYU8_D_185_A
Q8IYU8,D,375,A,6k7y:J,375,Abolishes mitochondrial Ca(2+) uptake,,,-1.0,,,,,,,,,,,,,Q8IYU8_D_375_A
Q8IYU8,E,386,A,6k7y:J,386,Abolishes mitochondrial Ca(2+) uptake,,,-1.0,,,,,,,,,,,,,Q8IYU8_E_386_A
P01588,S,127,E,1buy:A,100,Decreased erythrocyte proliferation,,,-1.0,,,,,,,,,,,,,P01588_S_127_E
O95989,G,50,A,6pcl:A,50,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_50_A
O95989,G,50,V,6pcl:A,50,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_50_V
O95989,G,51,A,6pcl:A,51,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_51_A
O95989,G,52,A,6pcl:A,52,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_52_A
O95989,G,52,V,6pcl:A,52,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_52_V
O95989,E,66,Q,6pcl:A,66,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_E_66_Q
O95989,E,70,Q,6pcl:A,70,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_E_70_Q
O95989,G,72,A,6pcl:A,72,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_72_A
O95989,G,75,A,6pcl:A,75,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_75_A
O95989,G,78,A,6pcl:A,78,No effect.,,,0.0,,,,,,,,,,,,,O95989_G_78_A
O95989,G,78,V,6pcl:A,78,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_78_V
O95989,G,82,A,6pcl:A,82,Loss of function.,,,-1.0,,,,,,,,,,,,,O95989_G_82_A
O95989,F,84,Y,6pcl:A,84,"Induces a strong decrease in Ap6A and [PP]-InsP4 hydrolysis, while it only weakly affects PP-InsP5 hydrolysis.",,,-1.0,,,,,,,,,,,,,O95989_F_84_Y
O95989,H,91,L,6pcl:A,91,"Induces a strong decrease in Ap6A and [PP]-InsP4 hydrolysis, while it only weakly affects PP-InsP5 hydrolysis.",,,-1.0,,,,,,,,,,,,,O95989_H_91_L
Q6DN90,E,620,K,5nly:B,498,Abolishes guanosine nucleotide exchange factor activity.,,,-1.0,,,,,,,,,,,,,Q6DN90_E_620_K
P01584,F,233,C,1iob:A,117,No effect on binding to IL1R or on IL1B activity. Markedly reduced activity,-1.0,,-1.0,,,,,,,,,,,,,P01584_F_233_C
O95983,H,30,K,6cc8:A,30,No effect. Confers strong binding to methylated CpG (in vitro),0.0,1.0,0.0,,,,,,,,,,,,,O95983_H_30_K
P01033,H,30,A,1uea:B,7,Nearly abolishes metalloproteinase inhibition.,,,-1.0,,,,,,,,,,,,,P01033_H_30_A
P01033,Q,32,A,1uea:B,9,Nearly abolishes metalloproteinase inhibition.,,,-1.0,,,,,,,,,,,,,P01033_Q_32_A
P33981,D,664,A,6gvj:A,664,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P33981_D_664_A
P33981,T,686,A,6gvj:A,686,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P33981_T_686_A
Q9Y4E8,C,298,A,6crn:A,298,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y4E8_C_298_A
Q9Y4E8,C,812,A,6crn:D,502,Loss of activity towards polyubiquitin.,,,-1.0,,,,,,,,,,,,,Q9Y4E8_C_812_A
Q6PHW0,R,101,A,5yak:E,101,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,Q6PHW0_R_101_A
Q6PHW0,R,101,H,5yak:E,101,Reduces activity.,,,-1.0,,,,,,,,,,,,,Q6PHW0_R_101_H
Q6PHW0,F,105,A,5yak:E,105,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_F_105_A
Q6PHW0,F,105,Y,5yak:E,105,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_F_105_Y
Q6PHW0,I,116,V,5yak:E,116,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_I_116_V
P43490,D,219,N,4kfn:B,219,"No effect on activity towards nicotinamide. Alters specificity, so that the enzyme acquires activity towards nicotinic acid.",,1.0,1.0,,,,,,,,,,,,,P43490_D_219_N
P43490,D,219,S,4kfn:B,219,"No effect on activity towards nicotinamide. Alters specificity, so that the enzyme acquires activity towards nicotinic acid.",,1.0,1.0,,,,,,,,,,,,,P43490_D_219_S
P43490,H,247,A,4kfn:B,247,Reduces activity towards nicotinamide.,,-1.0,-1.0,,,,,,,,,,,,,P43490_H_247_A
P43490,R,311,D,4kfn:B,311,Reduces activity towards nicotinamide.,,-1.0,-1.0,,,,,,,,,,,,,P43490_R_311_D
P15531,F,60,W,3l7u:A,60,No loss of activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P15531_F_60_W
P15531,H,118,F,3l7u:A,118,Loss of serine/threonine kinase activity. Some loss of motility of carcinoma cells.,,,-1.0,,,,,,,,,,,,,P15531_H_118_F
P15531,H,118,G,3l7u:A,118,Loss of activity.,,,-1.0,,,,,,,,,,,,,P15531_H_118_G
P46063,K,119,A,2wwy:A,119,Abrogates helicase activity.,,,-1.0,,,,,,,,,,,,,P46063_K_119_A
Q92729,C,1085,S,6sub:A,1085,Loss of phosphatase activity toward CTNNB1. Loss of the inhibitory effect on CTNNB1 transcriptional activity without effect on interaction with CTNNB1,-1.0,,-1.0,,,,,,,,,,,,,Q92729_C_1085_S
P42765,C,92,A,4c2k:D,92,Decreased acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,P42765_C_92_A
P42765,C,92,S,4c2k:D,92,Decreased acyl-CoA hydrolase activity,,,-1.0,,,,,,,,,,,,,P42765_C_92_S
P42765,C,382,S,4c2k:D,382,Decreased acyl-CoA hydrolase activity,,,-1.0,,,,,,,,,,,,,P42765_C_382_S
Q15831,K,48,R,2wtk:F,48,"Enhanced phosphorylation at Thr-336 and Ser-428, enhanced cytoplasmic localization and increased kinase activity.",,,1.0,1.0,,,,,,,,1.0,,,,Q15831_K_48_R
Q15831,K,78,I,2wtk:F,78,"Loss of kinase activity, leading to greatly reduced autophosphorylation.",,,-1.0,-1.0,,,,,,,,,,,,Q15831_K_78_I
Q15831,K,78,M,2wtk:F,78,"Loss of kinase activity, leading to reduced autophosphorylation and acting as a dominant-negative mutant.",,,-1.0,-1.0,,,,,,,,,,,,Q15831_K_78_M
Q15831,K,96,R,2wtk:F,96,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q15831_K_96_R
Q15831,K,97,R,2wtk:F,97,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q15831_K_97_R
Q15831,D,194,A,2wtk:C,194,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q15831_D_194_A
Q15831,F,204,A,2wtk:C,204,No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39,-1.0,,0.0,,,,,,,,,,,,,Q15831_F_204_A
Q9UHD2,K,30,R,6o8b:B,30,"Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity",,,-1.0,-1.0,-1.0,,,,,,,,,,,Q9UHD2_K_30_R
Q9UHD2,D,33,A,6o8b:B,33,Decreases phosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_D_33_A
Q9UHD2,K,38,A,6o8b:B,38,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UHD2_K_38_A
Q9UHD2,D,135,N,6o8b:B,135,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UHD2_D_135_N
Q9UHD2,S,172,A,6o8b:B,172,Loss of kinase activity. No effect on dimerization.,0.0,,-1.0,,,,,,,,,,,,,Q9UHD2_S_172_A
Q9UHD2,S,172,E,6o8b:B,172,Decreased kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UHD2_S_172_E
Q9UHD2,L,316,E,6o8b:B,316,Decreases kinase activity. No effect on phosphorylation.,,,-1.0,0.0,,,,,,,,,,,,Q9UHD2_L_316_E
Q9UHD2,Y,325,E,6o8b:B,325,Abolishes phosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_Y_325_E
Q9UHD2,E,355,R,6o8b:B,355,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_E_355_R
Q9UHD2,R,357,A,6o8b:B,357,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_R_357_A
Q9UHD2,K,401,R,6o8b:B,401,"Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity",,,-1.0,-1.0,-1.0,,,,,,,,,,,Q9UHD2_K_401_R
Q9UHD2,E,448,R,6o8b:B,448,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_E_448_R
Q9UHD2,H,459,E,6o8b:B,459,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,-1.0,0.0,,,,,,,,,,,,Q9UHD2_H_459_E
Q9UHD2,I,466,E,6o8b:B,466,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,-1.0,0.0,,,,,,,,,,,,Q9UHD2_I_466_E
Q9UHD2,F,470,E,6o8b:B,470,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,-1.0,0.0,,,,,,,,,,,,Q9UHD2_F_470_E
Q9UHD2,R,547,D,6o8b:B,547,Decreases phosphorylation and kinase activity. Abolishes dimerization.,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_R_547_D
Q9UHD2,Y,577,A,6o8b:B,577,Decreases kinase activity. Reduced phosphorylation of STING1.,,,-1.0,,,,,,,,,,,,,Q9UHD2_Y_577_A
Q9UHD2,N,578,A,6o8b:B,578,Reduced phosphorylation of STING1.,,,-1.0,,,,,,,,,,,,,Q9UHD2_N_578_A
Q9UHD2,E,580,A,6o8b:B,580,Decreases kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UHD2_E_580_A
Q9UHD2,Q,581,A,6o8b:B,581,Reduced phosphorylation of STING1.,,,-1.0,,,,,,,,,,,,,Q9UHD2_Q_581_A
Q9UHD2,I,582,A,6o8b:B,582,Decreases kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UHD2_I_582_A
Q9UHD2,K,589,D,6o8b:B,589,Decreases phosphorylation and kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9UHD2_K_589_D
Q9NPH0,R,58,A,4jod:A,58,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_R_58_A
Q9NPH0,H,59,A,4jod:A,59,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_H_59_A
Q9NPH0,R,62,A,4jod:A,62,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_R_62_A
Q9NPH0,Y,106,F,4jod:A,106,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_Y_106_F
Q9NPH0,Y,110,F,4jod:A,110,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_Y_110_F
Q9NPH0,R,168,A,4jod:A,168,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_R_168_A
Q9NPH0,A,257,F,4jod:A,257,Decreases enzyme activity by interfering with water access to the active site cavity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_A_257_F
Q9NPH0,A,257,L,4jod:A,257,Decreases enzyme activity by interfering with water access to the active site cavity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_A_257_L
Q9NPH0,A,257,W,4jod:A,257,Abolishes enzyme activity by interfering with water access to the active site cavity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_A_257_W
Q9NPH0,S,285,W,4jod:A,285,"Decreases activity toward substrates with medium and long aliphatic chains, but not toward substrates with short aliphatic chains.",,,-1.0,,,,,,,,,,,,,Q9NPH0_S_285_W
Q9NPH0,L,289,W,4jod:A,289,"Decreases activity toward substrates with medium and long aliphatic chains, but not toward substrates with short aliphatic chains.",,,-1.0,,,,,,,,,,,,,Q9NPH0_L_289_W
Q9NPH0,H,334,A,4jod:A,334,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_H_334_A
Q9NPH0,D,335,A,4jod:A,335,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NPH0_D_335_A
Q9HC16,R,213,A,2kem:A,23,Slightly reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_213_A
Q9HC16,R,213,E,2kem:A,23,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_213_E
Q9HC16,R,215,A,2kem:A,25,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_215_A
Q9HC16,R,215,E,2kem:A,25,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_215_E
Q9HC16,T,218,A,2kem:A,28,Loss of phosphorylation. No effect on cytidine deaminase activity or HIV-1 restriction activity.,,,0.0,-1.0,,,,,,,,,,,,Q9HC16_T_218_A
Q9HC16,T,218,E,2kem:A,28,Phosphomimetic mutant which shows loss of cytidine deaminase activity and HIV-1 restriction activity.,,,-1.0,,,,,,,,,,1.0,,,Q9HC16_T_218_E
Q9HC16,C,221,S,2kem:A,31,Does not decrease cytidine deaminase activity.,,,0.0,,,,,,,,,,,,,Q9HC16_C_221_S
Q9HC16,N,244,A,2kem:A,54,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_N_244_A
Q9HC16,R,256,E,2kem:A,66,Strongly reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_256_E
Q9HC16,H,257,A,2kem:A,67,Decreases cytidine deaminase activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_H_257_A
Q9HC16,E,259,A,2kem:A,69,Loss of cytidine deaminase activity and significant decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_E_259_A
Q9HC16,E,259,Q,2kem:A,69,Decreases cytidine deaminase activity and antiviral activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_E_259_Q
Q9HC16,W,285,A,2kem:A,95,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_W_285_A
Q9HC16,C,288,A,2kem:A,98,Decreases cytidine deaminase activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_C_288_A
Q9HC16,C,291,A,2kem:A,101,Decreases cytidine deaminase activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_C_291_A
Q9HC16,C,291,S,2kem:A,101,Decreases cytidine deaminase activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_C_291_S
Q9HC16,R,313,A,2kem:A,123,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_313_A
Q9HC16,R,313,E,2kem:A,123,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_313_E
Q9HC16,Y,315,A,2kem:A,125,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_Y_315_A
Q9HC16,R,320,A,2kem:A,130,Slightly reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_320_A
Q9HC16,R,320,E,2kem:A,130,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9HC16_R_320_E
Q9HC16,E,323,Q,2kem:A,133,Does not decrease cytidine deaminase activity.,,,0.0,,,,,,,,,,,,,Q9HC16_E_323_Q
P10114,G,12,V,1kao:A,12,Dominant active. 2-fold decrease in GDP dissociation rate constant and GTPase activity. No change in interaction with TNIK.,0.0,-1.0,-1.0,,,,,,,,,,,,,P10114_G_12_V
P10114,T,35,A,1kao:A,35,Decreases affinity for GTP and 3-fold reduction of GTPase activity.,,-1.0,-1.0,,,,,,,,,,,,,P10114_T_35_A
P04746,D,212,A,1u33:A,197,Abolishes activity.,,,-1.0,,,,,,,,,,,,,P04746_D_212_A
P04746,D,212,N,1u33:A,197,Abolishes activity.,,,-1.0,,,,,,,,,,,,,P04746_D_212_N
P04746,E,248,A,1u33:A,233,Reduces activity.,,,-1.0,,,,,,,,,,,,,P04746_E_248_A
P04746,E,248,Q,1u33:A,233,Reduces activity.,,,-1.0,,,,,,,,,,,,,P04746_E_248_Q
P04746,D,315,A,1u33:A,300,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,P04746_D_315_A
P04746,D,315,N,1u33:A,300,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,P04746_D_315_N
P24666,C,13,S,4z99:A,12,Inactive.,,,-1.0,-1.0,,,,,,,,,,,,P24666_C_13_S
P24666,Y,132,F,4z99:A,131,Reduced phosphorylation and activity.,,,0.0,-1.0,,,,,,,,,,,,P24666_Y_132_F
P24666,Y,133,F,4z99:A,132,Reduced phosphorylation. No effect on activity.,,,-1.0,,,,,,,,,,,,,P24666_Y_133_F
O94817,K,54,D,4gdk:A,54,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_K_54_D
O94817,V,62,R,4gdk:A,62,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_V_62_R
O94817,G,63,D,4gdk:A,63,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_G_63_D
O94817,K,72,D,4gdk:A,72,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_K_72_D
O94817,W,73,A,4gdk:A,73,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_W_73_A
O94817,D,113,V,4gdk:A,113,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_D_113_V
O94817,C,122,W,4gdk:A,122,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_C_122_W
O94817,A,138,R,4gdk:A,138,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_A_138_R
O94817,W,139,F,4gdk:A,139,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_W_139_F
O94817,W,139,Y,4gdk:A,139,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,-1.0,,,,,,,,,,,,,O94817_W_139_Y
Q14654,V,64,M,6c3o:A,64,Displays gain of function,,,1.0,,,,,,,,,,,,,Q14654_V_64_M
O43681,G,46,R,6so5:A,46,"Abolishes ATPase activity, dominantly inhibits the TA protein insertion pathway.",,,-1.0,,,,,,,,,,,,,O43681_G_46_R
O43681,K,86,D,6so5:A,86,Reduces TA protein insertion pathway.,,,-1.0,,,,,,,,,,,,,O43681_K_86_D
Q99873,V,92,A,6nt2:A,92,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,-1.0,,,,,,,,,1.0,,,,Q99873_V_92_A
Q99873,L,93,A,6nt2:A,93,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,-1.0,,,,,,,,,1.0,,,,Q99873_L_93_A
Q99873,D,94,A,6nt2:A,94,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,-1.0,,,,,,,,,1.0,,,,Q99873_D_94_A
Q99873,Y,280,A,6nt2:A,280,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,-1.0,,,,,,,,,,,,,Q99873_Y_280_A
Q99873,Y,322,A,6nt2:A,322,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,-1.0,,,,,,,,,,,,,Q99873_Y_322_A
Q99873,L,359,A,6nt2:A,359,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,-1.0,,,,,,,,,,,,,Q99873_L_359_A
O43683,K,821,A,5dmz:A,821,Loss of activity.,,,-1.0,,,,,,,,,,,,,O43683_K_821_A
Q16873,S,36,E,2uui:A,36,Reduced leukotriene-C4 synthase activity by nearly 80%.,,,-1.0,,,,,,,,,,,,,Q16873_S_36_E
Q16873,T,40,A,2uui:A,40,Leukotriene-C4 synthaseactivity is reduced by 30%.,,,-1.0,,,,,,,,,,,,,Q16873_T_40_A
Q16873,R,51,T,2uui:A,51,Loss of leukotriene-C4 synthase activity.,,,-1.0,,,,,,,,,,,,,Q16873_R_51_T
Q16873,R,51,I,2uui:A,51,Loss of leukotriene-C4 synthase activity.,,,-1.0,,,,,,,,,,,,,Q16873_R_51_I
Q16873,N,55,A,2uui:A,55,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_N_55_A
Q16873,Y,59,F,2uui:A,59,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_Y_59_F
Q16873,Y,93,F,2uui:A,93,Reduces Leukotriene-C4 synthase activity and increases the optimum for pH-dependent activity.,,,-1.0,,,,,,,,,,,,,Q16873_Y_93_F
Q16873,Y,97,F,2uui:A,97,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_Y_97_F
Q4FZB7,G,229,F,3s8p:B,229,Km for H4K20me1rise to 17 uM. 8-fold decrease in catalytic efficiency.,,-1.0,-1.0,,,,,,,,,,,,,Q4FZB7_G_229_F
Q4FZB7,G,229,Y,3s8p:B,229,Abolishes histone methyltransferase activity (H4-K20 specific).,,,-1.0,,,,,,,,,,,,,Q4FZB7_G_229_Y
Q4FZB7,S,251,A,3s8p:B,251,Abolishes histone methyltransferase activity (H4-K20 specific).,,,-1.0,,,,,,,,,,,,,Q4FZB7_S_251_A
Q4FZB7,W,264,A,3s8p:B,264,Abolishes histone methyltransferase activity (H4-K20 specific).,,,-1.0,,,,,,,,,,,,,Q4FZB7_W_264_A
Q4FZB7,F,281,A,3s8p:B,281,Abolishes histone methyltransferase activity (H4-K20 specific).,,,-1.0,,,,,,,,,,,,,Q4FZB7_F_281_A
Q4FZB7,F,311,A,3s8p:B,311,Km for H4K20me1rise to 8.5 uM. 3-fold decrease in catalytic efficiency.,,-1.0,-1.0,,,,,,,,,,,,,Q4FZB7_F_311_A
Q99683,K,709,M,5vil:A,709,Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX.,-1.0,,-1.0,,,,,,,,,,,,,Q99683_K_709_M
Q99683,K,709,R,5vil:A,709,Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Loss of RC3H2-mediated ubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,Q99683_K_709_R
Q14019,K,75,A,1wnj:A,78,Abolishes actin-binding activity.,-1.0,,-1.0,,,,,,,,,,,,,Q14019_K_75_A
Q14019,K,130,A,1wnj:A,133,No effect on 5LO-binding activity.,0.0,,0.0,,,,,,,,,,,,,Q14019_K_130_A
Q14019,K,131,A,1wnj:A,134,Abolishes 5LO-binding activity.,-1.0,,-1.0,,,,,,,,,,,,,Q14019_K_131_A
Q14019,K,131,E,1wnj:A,134,Abolishes 5LO-binding activity.,-1.0,,-1.0,,,,,,,,,,,,,Q14019_K_131_E
Q14019,K,131,R,1wnj:A,134,No effect on 5LO-binding activity.,0.0,,0.0,,,,,,,,,,,,,Q14019_K_131_R
P02489,N,123,D,6t1r:A,123,Impairs chaperone activity.,,,-1.0,,,,,,,,,,,,,P02489_N_123_D
Q8N159,Y,441,F,4k30:A,441,15% reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N159_Y_441_F
Q8N159,N,479,A,4k30:A,479,7-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N159_N_479_A
Q8N159,Y,485,F,4k30:A,485,10-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N159_Y_485_F
O14929,D,62,A,6vo5:A,62,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_D_62_A
O14929,E,64,A,6vo5:A,64,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_E_64_A
O14929,E,187,Q,6vo5:A,187,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_E_187_Q
O14929,W,199,A,6vo5:A,199,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_W_199_A
O14929,E,276,Q,6vo5:A,276,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_E_276_Q
O14929,D,277,N,6vo5:A,277,Strongly reduces HAT activity.,,,-1.0,,,,,,,,,,,,,O14929_D_277_N
O43353,K,47,A,5ng3:A,47,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,O43353_K_47_A
O43353,D,146,N,5ng3:A,146,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,O43353_D_146_N
Q96FJ0,E,292,A,2znr:A,292,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96FJ0_E_292_A
Q96FJ0,F,332,A,2znr:A,332,"12-fold decrease in substrate affinity, little effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q96FJ0_F_332_A
Q96FJ0,T,353,A,2znr:A,353,"19-fold decrease in activity, no change in substrate affinity.",,0.0,-1.0,,,,,,,,,,,,,Q96FJ0_T_353_A
Q96FJ0,F,355,A,2znr:A,355,"161-fold decrease in activity, no change in substrate affinity.",,0.0,-1.0,,,,,,,,,,,,,Q96FJ0_F_355_A
Q96FJ0,S,357,A,2znr:A,357,34-fold decrease in activity.,,,-1.0,,,,,,,,,,,,,Q96FJ0_S_357_A
Q96FJ0,S,358,A,2znr:A,358,"10-fold decrease in activity, no change in substrate affinity.",,0.0,-1.0,,,,,,,,,,,,,Q96FJ0_S_358_A
Q96FJ0,D,360,A,2znr:A,360,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96FJ0_D_360_A
Q96FJ0,M,370,A,2znr:A,370,"18-fold decrease in substrate affinity, little effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q96FJ0_M_370_A
Q96FJ0,C,402,S,2znr:A,402,"402-fold decrease in activity, slight increase in substrate affinity.",,1.0,-1.0,,,,,,,,,,,,,Q96FJ0_C_402_S
Q96FJ0,F,407,A,2znr:A,407,"35-fold decrease in activity, slight increase in substrate affinity.",,1.0,-1.0,,,,,,,,,,,,,Q96FJ0_F_407_A
Q99538,E,190,K,4fgu:A,190,Increases catalytic activity at pH 5.5.,,,1.0,,,,,,,,,,,,,Q99538_E_190_K
Q99538,N,323,D,4fgu:A,323,Loss of autoactivation.,,,-1.0,,,,,,,,,,,,,Q99538_N_323_D
Q99538,N,323,Q,4fgu:A,323,Loss of autoactivation.,,,-1.0,,,,,,,,,,,,,Q99538_N_323_Q
Q99538,N,323,S,4fgu:A,323,Loss of autoactivation.,,,-1.0,,,,,,,,,,,,,Q99538_N_323_S
Q8N1G2,K,203,A,4n4a:A,203,Reduces both mRNA cap binding and catalytic activity of the enzyme.,,-1.0,-1.0,,,,,,,,,,,,,Q8N1G2_K_203_A
Q8N1G2,R,228,A,4n4a:A,228,No effect.,,0.0,0.0,,,,,,,,,,,,,Q8N1G2_R_228_A
Q8N1G2,K,239,A,4n4a:A,239,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N1G2_K_239_A
Q8N1G2,D,364,A,4n48:B,364,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N1G2_D_364_A
Q8N1G2,K,404,A,4n48:B,404,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8N1G2_K_404_A
P11086,E,185,A,2obf:B,685,Strongly reduced enzyme activity. Increases affinity for S-adenosyl-L-methionine.,,1.0,-1.0,,,,,,,,,,,,,P11086_E_185_A
P11086,E,185,Q,2obf:B,685,Strongly reduced enzyme activity. Increases affinity for S-adenosyl-L-methionine.,,1.0,-1.0,,,,,,,,,,,,,P11086_E_185_Q
P11086,E,185,D,2obf:B,685,Strongly reduced enzyme activity. Decreases affinity for substrate and S-adenosyl-L-methionine 3-fold.,,-1.0,-1.0,,,,,,,,,,,,,P11086_E_185_D
P11086,E,219,A,2obf:B,719,Reduced enzyme activity. Decreases affinity for substrate 6-fold. Decreases affinity for S-adenosyl-L-methionine 2-fold.,,-1.0,-1.0,,,,,,,,,,,,,P11086_E_219_A
P11086,D,267,A,2obf:B,767,Strongly reduced enzyme activity. Decreases affinity for substrate 200-fold. Decreases affinity for S-adenosyl-L-methionine 3-fold.,,-1.0,-1.0,,,,,,,,,,,,,P11086_D_267_A
P11086,D,267,N,2obf:B,767,Strongly reduced enzyme activity. Decreases affinity for substrate 200-fold. Decreases affinity for S-adenosyl-L-methionine 3-fold.,,-1.0,-1.0,,,,,,,,,,,,,P11086_D_267_N
Q96RS0,F,655,A,3gdh:A,655,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96RS0_F_655_A
Q96RS0,T,673,A,3gdh:A,673,Decreases catalytic activity to 13 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_T_673_A
Q96RS0,D,696,A,3gdh:A,696,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96RS0_D_696_A
Q96RS0,N,704,A,3gdh:A,704,Decreases catalytic activity to 5 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_N_704_A
Q96RS0,D,719,A,3gdh:A,719,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96RS0_D_719_A
Q96RS0,N,731,A,3gdh:A,731,Decreases catalytic activity to 4 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_N_731_A
Q96RS0,S,763,A,3gdh:A,763,Decreases catalytic activity to 26 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_S_763_A
Q96RS0,W,766,A,3gdh:A,766,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96RS0_W_766_A
Q96RS0,R,807,A,3gdh:A,807,Decreases catalytic activity to 6 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_R_807_A
Q96RS0,N,808,A,3gdh:A,808,Decreases catalytic activity to 11 percent of wild type.,,,-1.0,,,,,,,,,,,,,Q96RS0_N_808_A
O60231,K,428,A,6ff7:q,429,Impairs pre-mRNA splicing activity.,,,-1.0,,,,,,,,,,,,,O60231_K_428_A
O60231,D,520,A,6ff7:q,521,Impairs pre-mRNA splicing activity.,,,-1.0,,,,,,,,,,,,,O60231_D_520_A
O60231,H,523,A,6ff7:q,524,No loss of pre-mRNA splicing activity.,,,0.0,,,,,,,,,,,,,O60231_H_523_A
O60231,S,552,L,6ff7:q,553,Dominant-negative mutant. Impairs pre-mRNA splicing activity.,,,-1.0,,,,,,,,,,,,,O60231_S_552_L
O60231,G,724,N,6ff7:q,725,Dominant-negative mutant. Impairs pre-mRNA splicing activity.,,,-1.0,,,,,,,,,,,,,O60231_G_724_N
Q9Y2J8,D,123,N,4n2l:A,123,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_123_N
Q9Y2J8,D,125,A,4n2l:A,125,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_125_A
Q9Y2J8,D,166,A,4n2l:A,166,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_166_A
Q9Y2J8,D,169,A,4n2l:A,169,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_169_A
Q9Y2J8,D,177,A,4n2l:A,177,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_177_A
Q9Y2J8,W,348,A,4n2i:A,348,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_W_348_A
Q9Y2J8,Q,350,A,4n2i:A,350,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_Q_350_A
Q9Y2J8,E,354,A,4n2i:A,354,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_E_354_A
Q9Y2J8,D,370,A,4n2i:A,370,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_370_A
Q9Y2J8,R,373,A,4n2i:A,373,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_R_373_A
Q9Y2J8,D,374,A,4n2i:A,374,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_374_A
Q9Y2J8,D,389,A,4n2i:A,389,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_D_389_A
Q9Y2J8,E,412,A,4n2i:A,412,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_E_412_A
Q9Y2J8,C,647,A,4n2i:A,647,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2J8_C_647_A
Q8N1Q8,G,160,A,4ae7:A,160,Strongly reduces enzyme activity. Abolishes enzyme activity,,,-1.0,,,,,,,,,,,,,Q8N1Q8_G_160_A
Q8N1Q8,D,167,A,4ae7:A,167,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q8N1Q8_D_167_A
Q8N1Q8,T,183,A,4ae7:A,183,Reduces enzyme activity. Abolishes enzyme activity,,,-1.0,,,,,,,,,,,,,Q8N1Q8_T_183_A
Q9NYY3,N,210,A,4i6b:A,210,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9NYY3_N_210_A
Q16654,Y,157,F,2e0a:A,157,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q16654_Y_157_F
Q16654,R,161,A,2e0a:A,161,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q16654_R_161_A
P48059,F,42,A,2kbx:B,42,Loss of interaction with ILK and loss of localization to focal adhesion.,-1.0,,-1.0,,,,,,,,,1.0,,,,P48059_F_42_A
P03372,I,386,C,3q95:B,386,"Loss of transmembrane localization, no effect on peripheral membrane localization. Impairs activation of estrogen-induced activation of NOS3 and production of nitric oxide. No effect on binding to ERES.",0.0,,-1.0,,,,,,,,,1.0,,,,P03372_I_386_C
Q8IZI9,K,57,A,3hhc:A,24,51 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_K_57_A
Q8IZI9,D,58,A,3hhc:A,25,43 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_D_58_A
Q8IZI9,V,118,A,3hhc:A,85,68 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_V_118_A
Q8IZI9,Q,121,A,3hhc:A,88,46 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_Q_121_A
Q8IZI9,F,176,A,3hhc:B,143,40 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_F_176_A
Q8IZI9,F,179,A,3hhc:B,146,650 fold decrease in antiviral activity.,,,-1.0,,,,,,,,,,,,,Q8IZI9_F_179_A
Q9BX68,H,149,A,6ypx:AAA,149,Loss of adenosine phosphoramidase activity.,,,-1.0,,,,,,,,,,,,,Q9BX68_H_149_A
Q9BV86,Y,19,A,5cvd:A,19,Decreased methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_Y_19_A
Q9BV86,Y,19,F,5cvd:A,19,Decreased methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_Y_19_F
Q9BV86,W,20,A,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_W_20_A
Q9BV86,W,20,M,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_W_20_M
Q9BV86,W,20,Y,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_W_20_Y
Q9BV86,W,136,L,5cvd:A,136,Strongly reduces methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_W_136_L
Q9BV86,D,167,A,5cvd:A,167,Does not affect methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q9BV86_D_167_A
Q9BV86,D,167,N,5cvd:A,167,Abolishes methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_167_N
Q9BV86,D,167,Q,5cvd:A,167,Abolishes methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_167_Q
Q9BV86,N,168,A,5cvd:A,168,Decreased methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_N_168_A
Q9BV86,N,168,K,5cvd:A,168,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_N_168_K
Q9BV86,D,177,A,5cvd:A,177,Induces a slight decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_177_A
Q9BV86,D,177,K,5cvd:A,177,Induces a strong decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_177_K
Q9BV86,D,177,N,5cvd:A,177,Strongly reduces methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_177_N
Q9BV86,D,180,A,5cvd:A,180,Induces a decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_180_A
Q9BV86,D,180,K,5cvd:A,180,Induces a strong decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_180_K
Q9BV86,D,180,N,5cvd:A,180,Reduced methyltransferase activity with CENPA.,,,-1.0,,,,,,,,,,,,,Q9BV86_D_180_N
Q9BV86,S,182,A,5cvd:A,182,Induces a slight decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_S_182_A
Q9BV86,S,182,K,5cvd:A,182,Induces a strong decrease in methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BV86_S_182_K
P49888,K,85,A,4jvl:A,85,Does not have decreased sulfonation activity towards the estrogens and DHEA.,,,0.0,,,,,,,,,,,,,P49888_K_85_A
P49888,H,107,A,4jvl:A,107,Complete loss of sulfonation activity towards all substrates tested.,,,-1.0,,,,,,,,,,,,,P49888_H_107_A
P49888,S,137,A,4jvl:A,137,Decreased gradually the sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,P49888_S_137_A
P49888,S,137,C,4jvl:A,137,Decreased gradually the sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,P49888_S_137_C
P49888,V,145,E,4jvl:A,145,Substrate specificity constants for estradiol and estrone are reduced. Dramatic 400-fold increase in the ability to sulfonate dopamine.,,,1.0,,,,,,,,,,,,,P49888_V_145_E
O60942,E,234,A,3s24:A,234,No effect on GTase activity.,,,0.0,,,,,,,,,,,,,O60942_E_234_A
O60942,K,294,A,3s24:A,294,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_K_294_A
O60942,R,299,A,3s24:A,299,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_R_299_A
O60942,E,345,A,3s24:A,345,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_E_345_A
O60942,K,458,A,3s24:F,458,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_K_458_A
O60942,K,460,A,3s24:F,460,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_K_460_A
O60942,R,528,A,3s24:F,528,Strongly reduced GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_R_528_A
O60942,R,530,A,3s24:F,530,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_R_530_A
O60942,D,532,A,3s24:F,532,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_D_532_A
O60942,K,533,A,3s24:F,533,Loss of GTase activity.,,,-1.0,,,,,,,,,,,,,O60942_K_533_A
P51449,A,327,F,3l0l:B,327,Completely abolishes transcriptional activity.,,,-1.0,,,,,,,,,,,,,P51449_A_327_F
P51449,F,378,Q,3l0l:B,378,Completely abolishes transcriptional activity.,,,-1.0,,,,,,,,,,,,,P51449_F_378_Q
P51449,I,397,N,3l0l:B,397,Nearly abolishes transcriptional activity.,,,-1.0,,,,,,,,,,,,,P51449_I_397_N
P16442,E,303,A,5bxc:A,303,Decreases specific activity of group B transferase almost to zero.,,,-1.0,,,,,,,,,,,,,P16442_E_303_A
Q9NZK5,W,362,G,3lgg:A,336,Reduces dimerization and enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,Q9NZK5_W_362_G
Q8N5Y8,H,152,A,6hxs:A,152,Loss of ADP-ribosyltransferase activity,,,-1.0,,,,,,,,,,,,,Q8N5Y8_H_152_A
Q8N5Y8,H,152,Q,6hxs:A,152,ADP-ribosyltransferase activity is only 6% of wild-type,,,-1.0,,,,,,,,,,,,,Q8N5Y8_H_152_Q
Q8N5Y8,Y,182,A,6hxs:A,182,ADP-ribosyltransferase activity is only 6% of wild-type,,,-1.0,,,,,,,,,,,,,Q8N5Y8_Y_182_A
Q3MIT2,D,344,A,2v9k:A,344,Abolished tRNA pseudouridine synthase without affecting ability to promote miRNA processing.,,,-1.0,,,,,,,,,,,,,Q3MIT2_D_344_A
Q5TDH0,D,252,N,4rgh:A,220,Abolishes aspartic protease activity.,,,-1.0,,,,,,,,,,,,,Q5TDH0_D_252_N
Q96L73,R,1914,C,3ooi:A,63,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q96L73_R_1914_C
Q96L73,R,1952,W,3ooi:A,101,Nearly abolished enzyme activity.,,,-1.0,,,,,,,,,,,,,Q96L73_R_1952_W
Q9BY11,I,125,E,3hai:A,125,Reduces membrane-binding. Abolishes membrane tubulation.,,-1.0,-1.0,,,,,,,,,,,,,Q9BY11_I_125_E
Q9BY11,M,126,E,3hai:A,126,Reduces membrane-binding. Abolishes membrane tubulation.,,-1.0,-1.0,,,,,,,,,,,,,Q9BY11_M_126_E
Q9UBN7,H,611,A,5edu:A,611,Reduces histone deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q9UBN7_H_611_A
P10599,C,32,S,1cqh:A,32,"Loses its reducing activity, interaction with APEX1 and transcription activation",-1.0,,-1.0,,,,,,,,,,,,,P10599_C_32_S
P10599,C,35,S,1cqh:A,35,"Loses its reducing activity, interaction with APEX1 and transcription activation",-1.0,,-1.0,,,,,,,,,,,,,P10599_C_35_S
P10599,C,62,S,1cqh:A,62,Retains its reducing activity. Retains interaction with APEX1 and transcription activation,0.0,,0.0,,,,,,,,,,,,,P10599_C_62_S
P10599,C,69,S,1cqh:A,69,"No effect on reducing activity, interaction with APEX1 and on S-nitrosylation of C-73. Retains interaction with APEX1 and transcription activation",0.0,,0.0,,,,,,,,,,,,,P10599_C_69_S
P10599,E,70,A,1cqh:A,70,Strongly reduced interaction with CASP3,-1.0,,-1.0,,,,,,,,,,,,,P10599_E_70_A
P10599,K,72,A,1cqh:A,72,Strongly reduced interaction with CASP3,-1.0,,-1.0,,,,,,,,,,,,,P10599_K_72_A
P10599,C,73,D,1cqh:A,73,Strongly reduced S-nitrosylation of CASP3.,,,-1.0,,,,,,,,,,,,,P10599_C_73_D
P10599,C,73,S,1cqh:A,73,"Loss of nitrosylation, and loss of S-nitrosylating activity towards CASP3. Retains interaction with APEX1 and transcription activation",0.0,,-1.0,,,,,,,,,,,,,P10599_C_73_S
P29218,K,36,Q,6giu:A,36,50-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,P29218_K_36_Q
P29218,D,93,N,6giu:A,93,Loss of activity.,,,-1.0,,,,,,,,,,,,,P29218_D_93_N
P29218,S,165,A,6giu:A,165,Reduced enzyme activity with myo-inositol 1-phosphate.,,,-1.0,,,,,,,,,,,,,P29218_S_165_A
P29218,S,165,I,6giu:A,165,Reduced enzyme activity with myo-inositol 1-phosphate.,,,-1.0,,,,,,,,,,,,,P29218_S_165_I
P29218,E,213,Q,6giu:A,213,Strongly reduced affinity for myo-inositol 1-phosphate and strongly reduced enzyme activity with myo-inositol 1-phosphate.,,-1.0,-1.0,,,,,,,,,,,,,P29218_E_213_Q
O00187,R,444,Q,1zjk:A,444,Abolishes autocatalytic cleavage.,,,-1.0,,,,,,,,,,,,,O00187_R_444_Q
P13716,C,122,A,5hms:A,122,Reduces enzyme activity about 1000000-fold,,,-1.0,,,,,,,,,,,,,P13716_C_122_A
P13716,C,124,A,5hms:A,124,Reduces enzyme activity about 1000000-fold,,,-1.0,,,,,,,,,,,,,P13716_C_124_A
P13716,H,131,A,5hms:A,131,No effect on catalytic activity,,,0.0,,,,,,,,,,,,,P13716_H_131_A
P13716,C,132,A,5hms:A,132,Reduces enzyme activity about 1000000-fold,,,-1.0,,,,,,,,,,,,,P13716_C_132_A
P13716,C,223,A,5hms:A,223,No effect on catalytic activity,,,0.0,,,,,,,,,,,,,P13716_C_223_A
Q12884,R,123,A,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_R_123_A
Q12884,R,123,M,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_R_123_M
Q12884,R,123,E,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_R_123_E
Q12884,E,203,A,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_203_A
Q12884,E,203,D,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_203_D
Q12884,E,203,Q,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_203_Q
Q12884,E,204,A,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_204_A
Q12884,E,204,D,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_204_D
Q12884,E,204,Q,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,-1.0,,,,,,,,,,,,,Q12884_E_204_Q
Q12884,S,624,A,6y0f:C,624,"Reduces dipeptidyl peptidase and gelatinolytic activities. Does not inhibit cell adhesion, migration and invasion.",,,-1.0,,,,,,,,,,,,,Q12884_S_624_A
Q12884,Y,656,F,6y0f:C,656,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_Y_656_F
Q12884,A,657,F,6y0f:C,657,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_A_657_F
Q12884,A,657,V,6y0f:C,657,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_A_657_V
Q12884,A,657,Q,6y0f:C,657,Inhibits endopeptidase activity. No change in dipeptidyl peptidase activity.,,,-1.0,,,,,,,,,,,,,Q12884_A_657_Q
Q12884,A,657,S,6y0f:C,657,Reduces strongly endopeptidase activity. No change in dipeptidyl peptidase activity.,,,-1.0,,,,,,,,,,,,,Q12884_A_657_S
Q12884,A,657,T,6y0f:C,657,Reduces strongly endopeptidase activity. No change in dipeptidyl peptidase activity.,,,-1.0,,,,,,,,,,,,,Q12884_A_657_T
Q12884,N,704,A,6y0f:C,704,Reduces dipeptidyl peptidase and endopeptidase activities.,,,-1.0,,,,,,,,,,,,,Q12884_N_704_A
Q92995,W,221,A,2l80:A,34,Does not abolish ability to stabilize SIAH2.,,,0.0,,,,,,,,,,,,,Q92995_W_221_A
Q92995,K,233,A,2l80:A,46,Does not abolish ability to stabilize SIAH2.,,,0.0,,,,,,,,,,,,,Q92995_K_233_A
Q92995,F,273,A,2l80:A,86,Impairs ability to stabilize SIAH2.,,,-1.0,,,,,,,,,,,,,Q92995_F_273_A
Q92995,M,664,E,2lbc:A,13,Impairs ability to stabilize SIAH2. Abolishes ability to stabilize SIAH2,,,-1.0,,,,,,,,,,,,,Q92995_M_664_E
Q92995,M,739,E,2lbc:A,88,Impairs ability to stabilize SIAH2. Abolishes ability to stabilize SIAH2,,,-1.0,,,,,,,,,,,,,Q92995_M_739_E
O00329,R,894,P,5vlr:A,894,Abolishes lipid and protein kinase activities.,,,-1.0,,,,,,,,,,,,,O00329_R_894_P
P07451,K,64,H,3uyq:A,64,Enhanced proton transfer in catalysis.,,,1.0,,,,,,,,,,,,,P07451_K_64_H
P07451,R,67,H,3uyq:A,67,Enhanced proton transfer in catalysis.,,,1.0,,,,,,,,,,,,,P07451_R_67_H
P07451,F,197,L,3uyq:A,197,Enhanced activity by at least 10-fold.,,,1.0,,,,,,,,,,,,,P07451_F_197_L
Q86VW2,L,301,E,2rgn:B,301,Abolishes its exchange activity on RHOA.,,,-1.0,,,,,,,,,,,,,Q86VW2_L_301_E
Q86VW2,F,471,A,2rgn:B,471,Reduces exchange activity mediated by GNAQ activation,,,-1.0,,,,,,,,,,,,,Q86VW2_F_471_A
Q86VW2,L,472,A,2rgn:B,472,Reduces exchange activity mediated by GNAQ activation,,,-1.0,,,,,,,,,,,,,Q86VW2_L_472_A
Q86VW2,L,475,A,2rgn:B,475,Reduces exchange activity mediated by GNAQ activation,,,-1.0,,,,,,,,,,,,,Q86VW2_L_475_A
Q86VW2,P,478,A,2rgn:B,478,Reduces exchange activity mediated by GNAQ activation,,,-1.0,,,,,,,,,,,,,Q86VW2_P_478_A
Q86VW2,I,479,A,2rgn:B,479,Reduces exchange activity mediated by GNAQ activation,,,-1.0,,,,,,,,,,,,,Q86VW2_I_479_A
P29320,V,133,E,4l0p:A,133,Loss of EFNA5-binding ability and function.,-1.0,,-1.0,,,,,,,,,,,,,P29320_V_133_E
P29320,F,152,L,4l0p:A,152,Loss of EFNA5-binding ability and function.,-1.0,,-1.0,,,,,,,,,,,,,P29320_F_152_L
P29320,Y,742,F,3fxx:A,742,Full kinase activity,,,0.0,,,,,,,,,,,,,P29320_Y_742_F
P29320,S,768,A,3fxx:A,768,Full kinase activity,,,0.0,,,,,,,,,,,,,P29320_S_768_A
P62837,C,85,A,2clw:A,85,Catalytically inactive. Loss of ability to promote FBXW2-mediated GCM1 ubiquitination. Inhibition of TNF-alpha-induced degradation of NFKBIA.,,,-1.0,,,,,,,,,,,,,P62837_C_85_A
Q9P246,D,80,A,2l5y:A,80,No effect on inhibitory activity,,,0.0,,,,,,,,,,,,,Q9P246_D_80_A
Q9P246,E,91,A,2l5y:A,91,No effect on inhibitory activity,,,0.0,,,,,,,,,,,,,Q9P246_E_91_A
Q9BXR0,D,279,N,6h42:A,279,Loss of transglycosylase activity.,,,-1.0,,,,,,,,,,,,,Q9BXR0_D_279_N
P20155,P,45,A,2jxd:A,23,No effect on inhibitory activity towards trypsin.,,,0.0,,,,,,,,,,,,,P20155_P_45_A
P20155,R,46,A,2jxd:A,24,Loss of inhibitory activity towards trypsin.,,,-1.0,,,,,,,,,,,,,P20155_R_46_A
P20155,H,47,A,2jxd:A,25,Reduces inhibitory activity towards trypsin.,,,-1.0,,,,,,,,,,,,,P20155_H_47_A
P20155,F,48,A,2jxd:A,26,Reduces inhibitory activity towards trypsin.,,,-1.0,,,,,,,,,,,,,P20155_F_48_A
P09234,C,25,S,2vrd:A,25,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,P09234_C_25_S
Q9H1B7,C,715,A,2cs3:A,18,Loss of transcription activity.,,,-1.0,,,,,,,,,,,,,Q9H1B7_C_715_A
Q9UKK6,I,114,R,1jkg:A,114,70% reduction in mRNA export activity.,,,-1.0,,,,,,,,,,,,,Q9UKK6_I_114_R
Q9UKK6,R,134,D,1jkg:A,134,57% reduction in mRNA export activity and loss of nuclear rim staining.,,,-1.0,,,,,,,,,,,,,Q9UKK6_R_134_D
Q9Y251,E,225,A,5la7:A,225,Loss of heparanase activity. No effect on HPSE-mediated cell adhesion.,,,-1.0,,,,,,,,,,,,,Q9Y251_E_225_A
Q9Y251,E,343,A,5la7:A,343,Loss of heparanase activity.,,,-1.0,,,,,,,,,,,,,Q9Y251_E_343_A
Q9Y251,D,367,A,5la7:A,367,Strong decrease in heparanase activity.,,,-1.0,,,,,,,,,,,,,Q9Y251_D_367_A
Q9Y251,E,378,A,5la7:A,378,No reduction in heparanase activity.,,,0.0,,,,,,,,,,,,,Q9Y251_E_378_A
Q9Y251,E,396,A,5la7:A,396,No reduction in heparanase activity.,,,0.0,,,,,,,,,,,,,Q9Y251_E_396_A
Q9Y251,V,414,K,5la7:A,414,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_V_414_K
Q9Y251,K,417,E,5la7:A,417,No effect on processing nor secretion. No enzyme activity detected.,,,-1.0,,,,,,,,,0.0,,,,Q9Y251_K_417_E
Q9Y251,P,525,G,5la7:A,525,No effect on processing nor secretion. No enzyme activity detected.,,,-1.0,,,,,,,,,0.0,,,,Q9Y251_P_525_G
Q9Y251,F,527,R,5la7:A,527,No effect on processing nor secretion. No enzyme activity detected.,,,-1.0,,,,,,,,,0.0,,,,Q9Y251_F_527_R
Q9Y251,S,528,K,5la7:A,528,No effect on processing nor secretion. No enzyme activity detected.,,,-1.0,,,,,,,,,0.0,,,,Q9Y251_S_528_K
Q9Y251,Y,529,A,5la7:A,529,No effect on processing nor secretion. No enzyme activity detected.,,,-1.0,,,,,,,,,0.0,,,,Q9Y251_Y_529_A
Q9Y251,F,531,R,5la7:A,531,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_F_531_R
Q9Y251,V,533,R,5la7:A,533,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_V_533_R
Q9Y251,I,534,D,5la7:A,534,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_I_534_D
Q9Y251,R,535,A,5la7:A,535,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_R_535_A
Q9Y251,N,536,A,5la7:A,536,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_N_536_A
Q9Y251,A,537,K,5la7:A,537,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_A_537_K
Q9Y251,K,538,A,5la7:A,538,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_K_538_A
Q9Y251,V,539,A,5la7:A,539,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_V_539_A
Q9Y251,A,540,K,5la7:A,540,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_A_540_K
Q9Y251,A,541,K,5la7:A,541,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_A_541_K
Q9Y251,C,542,A,5la7:A,542,"Abolishes processing, secretion and enzyme activity.",,,-1.0,,,,,,,,,1.0,,,,Q9Y251_C_542_A
P28039,T,61,A,5w78:A,61,Loss of glycosylation. No effect on enzyme activity or localization to cytoplasmic vesicles.,,,0.0,,,-1.0,,,,,,0.0,,,,P28039_T_61_A
P28039,K,173,E,5w7c:C,173,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P28039_K_173_E
P28039,S,263,A,5w7c:C,263,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P28039_S_263_A
P28039,S,263,L,5w7c:C,263,Nearly abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,P28039_S_263_L
P28039,R,345,E,5w7c:C,345,No effect on enzyme activity,,,0.0,,,,,,,,,,,,,P28039_R_345_E
P28039,G,372,M,5w7c:C,372,"Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.",,,-1.0,,,,,,,,,,,,,P28039_G_372_M
P28039,K,379,E,5w7c:C,379,No effect on enzyme activity,,,0.0,,,,,,,,,,,,,P28039_K_379_E
P28039,P,419,M,5w7c:C,419,"Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.",,,-1.0,,,,,,,,,,,,,P28039_P_419_M
Q13029,C,106,Y,2jv0:A,106,Reduced histone methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q13029_C_106_Y
Q13029,A,159,V,2jv0:A,159,Reduced histone methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q13029_A_159_V
Q99836,R,196,A,2js7:A,52,"Reduced interaction with TIRAP, and strongly reduced activity. Strongly reduced interaction with TIRAP",-1.0,,-1.0,,,,,,,,,,,,,Q99836_R_196_A
Q99836,D,197,A,2js7:A,53,Slightly reduced activity.,,,-1.0,,,,,,,,,,,,,Q99836_D_197_A
Q99836,R,217,A,2js7:A,73,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,Q99836_R_217_A
Q99836,K,282,A,2js7:A,138,Slightly reduced activity.,,,-1.0,,,,,,,,,,,,,Q99836_K_282_A
Q99836,R,288,A,2js7:A,144,"Slightly reduced activity, and reduced interaction with TIRAP. Strongly reduced interaction with TIRAP",-1.0,,-1.0,,,,,,,,,,,,,Q99836_R_288_A
Q9Y6H6,D,90,N,2ndj:A,90,Decreases current 4-fold in KCNH2/KCNE3 channel.,,,-1.0,,,,,,,,,,,,,Q9Y6H6_D_90_N
Q5TA50,F,42,A,4k80:A,42,Increases phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_F_42_A
Q5TA50,L,43,R,4k80:A,43,Nearly abolishes phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_L_43_R
Q5TA50,F,50,R,4k80:A,50,Slightly reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_F_50_R
Q5TA50,I,53,N,4k80:A,53,Slightly decreases phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_I_53_N
Q5TA50,D,56,V,4k80:A,56,Slightly decreases phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_D_56_V
Q5TA50,K,60,A,4k80:A,60,Nearly abolishes phosphoceramide transfer. Induces autophagy in a dominant negatif manner.,,,-1.0,,,,,,,,,,,,,Q5TA50_K_60_A
Q5TA50,R,97,L,4k80:A,97,No effect.,,,-1.0,,,,,,,,,,,,,Q5TA50_R_97_L
Q5TA50,R,106,L,4k80:A,106,Nearly abolishes phosphoceramide transfer. Induces autophagy in a dominant negatif manner.,,,-1.0,,,,,,,,,,,,,Q5TA50_R_106_L
Q5TA50,R,110,L,4k80:A,110,Reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_R_110_L
Q5TA50,R,113,E,4k80:A,113,Strongly reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_R_113_E
Q5TA50,R,113,L,4k80:A,113,Strongly reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_R_113_L
Q5TA50,W,117,A,4k80:A,117,Slightly reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_W_117_A
Q5TA50,L,118,R,4k80:A,118,Abolishes phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_L_118_R
Q5TA50,Y,149,A,4k80:A,149,Reduces phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_Y_149_A
Q5TA50,V,158,N,4k80:A,158,Abolishes phosphoceramide transfer.,,,-1.0,,,,,,,,,,,,,Q5TA50_V_158_N
P42575,C,320,S,2p2c:A,155,Loss of function.,,,-1.0,,,,,,,,,,,,,P42575_C_320_S
P42575,A,369,T,1pyo:D,222,Loss of function.,,,-1.0,,,,,,,,,,,,,P42575_A_369_T
Q9NPI6,D,20,A,4b6h:A,20,Lowers decapping activity.,,,-1.0,,,,,,,,,,,,,Q9NPI6_D_20_A
Q9NPI6,R,59,A,4b6h:A,59,Lowers decapping activity.,,,-1.0,,,,,,,,,,,,,Q9NPI6_R_59_A
Q8N543,H,155,A,4nhy:A,155,Loss of function.,,,-1.0,,,,,,,,,,,,,Q8N543_H_155_A
Q8N543,D,157,A,4nhy:A,157,Loss of function.,,,-1.0,,,,,,,,,,,,,Q8N543_D_157_A
P35520,C,272,A,4l3v:A,272,Reduced heme content and cystathionine beta-synthase activity.,,,-1.0,,,,,,,,,,,,,P35520_C_272_A
P35520,C,275,S,4l3v:A,275,Reduced heme content and cystathionine beta-synthase activity.,,,-1.0,,,,,,,,,,,,,P35520_C_275_S
P35523,I,290,C,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_C
P35523,I,290,E,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_E
P35523,I,290,F,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_F
P35523,I,290,G,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_G
P35523,I,290,K,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_K
P35523,I,290,L,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_L
P35523,I,290,Q,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_Q
P35523,I,290,T,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_T
P35523,I,290,V,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_V
P35523,I,290,Y,6qvu:A,290,Changed chloride channel activity,,,-1.0,,,,,,,,,,,,,P35523_I_290_Y
P35523,E,291,D,6qvu:A,291,No effect on calcium channel activity.,,,0.0,,,,,,,,,,,,,P35523_E_291_D
P35523,E,291,L,6qvu:A,291,Loss of calcium channel activity.,,,0.0,,,,,,,,,,,,,P35523_E_291_L
P35523,R,496,K,6qvu:A,496,Changed gating of the channel.,,,-1.0,,,,,,,,,,,,,P35523_R_496_K
P35523,G,499,K,6qvu:A,499,Changed gating of the channel.,,,-1.0,,,,,,,,,,,,,P35523_G_499_K
P35523,G,499,E,6qvu:A,499,Changed gating of the channel.,,,-1.0,,,,,,,,,,,,,P35523_G_499_E
P35523,G,499,Q,6qvu:A,499,No effect on gating of the channel.,,,0.0,,,,,,,,,,,,,P35523_G_499_Q
P35523,E,500,Q,6qvu:A,500,No effect on channel function.,,,0.0,,,,,,,,,,,,,P35523_E_500_Q
P04179,Y,58,A,5t30:A,34,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P04179_Y_58_A
P04179,Y,58,H,5t30:A,34,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P04179_Y_58_H
P04179,Y,58,N,5t30:A,34,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P04179_Y_58_N
P04179,Y,58,V,5t30:A,34,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P04179_Y_58_V
P04179,Y,58,F,5t30:A,34,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P04179_Y_58_F
Q05823,K,392,R,4oau:C,392,Complete loss of enzymatic activity and enzyme dimerization. No change in binding to 2-5A and RNA.,-1.0,0.0,-1.0,,,,,,,,,,,,,Q05823_K_392_R
Q05823,H,583,A,4oau:C,583,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_H_583_A
Q05823,P,584,A,4oau:C,584,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_P_584_A
Q05823,W,632,A,4oav:D,632,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_W_632_A
Q05823,D,661,A,4oav:D,661,Complete loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q05823_D_661_A
Q05823,R,667,A,4oav:D,667,Complete loss of enzymatic activity. No change in 2-5A binding and enzyme dimerization.,0.0,0.0,-1.0,,,,,,,,,,,,,Q05823_R_667_A
Q05823,H,672,A,4oav:D,672,Complete loss of enzymatic activity. No change in 2-5A binding activity and enzyme dimerization.,0.0,0.0,-1.0,,,,,,,,,,,,,Q05823_H_672_A
P54753,K,665,R,5l6p:A,665,Kinase-dead. Loss of autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,P54753_K_665_R
Q8WYN0,C,81,A,2p82:B,81,Reduces the redox sensitivity and retains activity in presence of H(2)O(2).,,,0.0,,,,,,,,,,,,,Q8WYN0_C_81_A
Q9Y3R4,D,46,A,2f25:A,46,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y3R4_D_46_A
Q9Y3R4,E,218,A,2f25:A,218,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y3R4_E_218_A
Q9Y3R4,E,218,Q,2f25:A,218,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y3R4_E_218_Q
Q9Y3R4,Q,270,E,2f25:A,270,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9Y3R4_Q_270_E
P49336,D,173,A,5xs2:A,173,Abrogates kinase activity and TFIIH-dependent transcriptional repression.,,,-1.0,,,,,,,,,,,,,P49336_D_173_A
P63000,G,12,V,2rmk:A,12,Constitutively active. Interacts with PARD6 proteins. Increases nuclear localization and up-regulates transcriptional activity of NR3C2. Doesn't interact with CYRIB. Increases interaction with GARRE1.,,,1.0,,,,,,,,,1.0,,,,P63000_G_12_V
P63000,T,17,N,2rmk:A,17,Constitutively inactivated. Abolishes interaction with PARD6 proteins. No effect on NR3C2 transcriptional activity. No interaction with PPP5C. Doesn't activate PPP5C phosphatase activity and translocate PPP5C to the plasma membrane. Doesn't interact with CYRIB.,,,-1.0,,,,,,,,,,,,,P63000_T_17_N
P63000,Q,61,L,2rmk:A,61,"Constitutively active. Interacts with PARD6 proteins. Interacts with PPP5C, activates its phosphatase activity and translocates PPP5C to the plasma membrane. No effect on interaction with RAPH1. Interacts with CYRIB. No interaction with PPP5C",,,1.0,,,,,,,,,,,,,P63000_Q_61_L
Q8IVH4,K,290,A,2www:D,290,Abolishes binding to GTP and GTPase activity,,-1.0,-1.0,,,,,,,,,,,,,Q8IVH4_K_290_A
Q8IVH4,D,292,A,2www:D,292,Abolishes binding to GTP and GTPase activity,,-1.0,-1.0,,,,,,,,,,,,,Q8IVH4_D_292_A
Q15759,T,180,A,3gc8:A,180,Inactivation.,,,-1.0,,,,,,,,,,,,,Q15759_T_180_A
Q15759,Y,182,F,3gc8:A,182,Inactivation.,,,-1.0,,,,,,,,,,,,,Q15759_Y_182_F
Q5JS13,L,148,A,3qxl:A,148,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q5JS13_L_148_A
Q96DC9,G,47,P,4fjv:A,47,Affects its ability to cleave 'K63'-linked ubiquitin.,,,-1.0,,,,,,,,,,,,,Q96DC9_G_47_P
Q96DC9,C,51,S,4fjv:A,51,Loss of function in vitro.,,,-1.0,,,,,,,,,,,,,Q96DC9_C_51_S
Q96DC9,N,226,A,4fjv:A,226,Abolishes deubiquitinase activity.,,,-1.0,,,,,,,,,,,,,Q96DC9_N_226_A
P49427,N,85,Q,4mdk:C,85,Inhibits both mono and polyubiquitination of NFKBIA.,,,-1.0,,,,,,,,,,,,,P49427_N_85_Q
P49427,Y,87,A,4mdk:C,87,Decreases polyubiquitination of NFKBIA.,,,-1.0,,,,,,,,,,,,,P49427_Y_87_A
P49427,C,93,S,4mdk:C,93,Loss of function.,,,-1.0,,,,,,,,,,,,,P49427_C_93_S
P49427,C,93,A,4mdk:C,93,Loss of function.,,,-1.0,,,,,,,,,,,,,P49427_C_93_A
P49427,S,95,D,4mdk:C,95,Inhibits both mono and polyubiquitination of NFKBIA.,,,-1.0,,,,,,,,,,,,,P49427_S_95_D
P49427,L,97,S,4mdk:C,97,Loss of function.,,,-1.0,,,,,,,,,,,,,P49427_L_97_S
P49427,E,112,A,4mdk:A,112,Inhibits both mono andpolyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_E_112_A
P49427,S,129,L,4mdk:A,129,"No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,0.0,,,,,,,,,,,,,P49427_S_129_L
P49427,S,129,R,4mdk:A,129,"Complete loss of activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,-1.0,,,,,,,,,,,,,P49427_S_129_R
P49427,E,133,R,4mdk:A,133,"No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,0.0,,,,,,,,,,,,,P49427_E_133_R
P49427,S,138,A,4mdk:A,138,Decreases monoubiquitination of NFKBIA and inhibits polyubiquitination of NFKBIA.,,,-1.0,,,,,,,,,,,,,P49427_S_138_A
P49427,D,143,A,4mdk:A,143,Inhibits polyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_D_143_A
P49427,M,147,A,4mdk:A,147,Inhibits polyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_M_147_A
P49427,R,149,A,4mdk:A,149,Inhibits polyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_R_149_A
P49427,K,150,A,4mdk:A,150,Inhibits polyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_K_150_A
P49427,E,153,A,4mdk:A,153,Inhibits polyubiquitination of NFKBIA,,,-1.0,,,,,,,,,,,,,P49427_E_153_A
Q96QB1,R,1114,E,3kuq:A,1114,No catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96QB1_R_1114_E
P10746,S,63,A,1jr2:A,63,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_S_63_A
P10746,R,65,A,1jr2:A,65,Slightly affects enzymatic activity.,,,-1.0,,,,,,,,,,,,,P10746_R_65_A
P10746,T,103,A,1jr2:A,103,Slightly affects enzymatic activity.,,,-1.0,,,,,,,,,,,,,P10746_T_103_A
P10746,E,127,A,1jr2:A,127,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_E_127_A
P10746,Y,168,F,1jr2:A,168,Impairs enzymatic activity.,,,-1.0,,,,,,,,,,,,,P10746_Y_168_F
P10746,S,197,A,1jr2:A,197,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_S_197_A
P10746,K,220,A,1jr2:A,220,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_K_220_A
P10746,T,227,A,1jr2:A,227,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_T_227_A
P10746,T,228,A,1jr2:A,228,Impairs enzymatic activity.,,,-1.0,,,,,,,,,,,,,P10746_T_228_A
Q9ULW5,T,77,N,2g6b:A,77,"Inactive, constitutively GDP-bound. Abolishes location at Golgi membranes. Impairs transport of ADRA2A and ADRA2B from the Golgi to the cell membrane.",,,-1.0,,,,,,,,,1.0,,,,Q9ULW5_T_77_N
Q9ULW5,N,177,I,2g6b:A,177,"Inactive, due to loss of GNP binding. Abolishes location at Golgi membranes. Impairs transport of ADRA2A and ADRA2B from the Golgi to the cell membrane.",,,-1.0,,,,,,,,,1.0,,,,Q9ULW5_N_177_I
Q9HCE7,K,28,A,3pyc:A,28,Fails to ubiquitinate RHOA,,,-1.0,,,,,,,,,,,,,Q9HCE7_K_28_A
Q9HCE7,K,85,A,3pyc:A,85,Fails to ubiquitinate RHOA,,,-1.0,,,,,,,,,,,,,Q9HCE7_K_85_A
P09917,D,359,N,3o8y:A,358,No loss of activity.,,,0.0,,,,,,,,,,,,,P09917_D_359_N
P09917,F,360,W,3o8y:A,359,Loss of (5S)-lipoxygenase activity,,,-1.0,,,,,,,,,,,,,P09917_F_360_W
P09917,H,363,S,3o8y:A,362,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_363_S
P09917,H,363,N,3o8y:A,362,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_363_N
P09917,H,368,S,3o8y:A,367,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_368_S
P09917,H,368,N,3o8y:A,367,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_368_N
P09917,H,368,A,3o8y:A,367,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_368_A
P09917,H,373,S,3o8y:A,372,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_373_S
P09917,H,373,N,3o8y:A,372,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_373_N
P09917,E,377,Q,3o8y:A,376,No activity.,,,-1.0,,,,,,,,,,,,,P09917_E_377_Q
P09917,H,391,A,3o8y:A,390,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_391_A
P09917,H,391,S,3o8y:A,390,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_391_S
P09917,H,391,N,3o8y:A,390,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_391_N
P09917,H,400,A,3o8y:A,399,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_400_A
P09917,H,400,S,3o8y:A,399,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_400_S
P09917,H,400,N,3o8y:A,399,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_400_N
P09917,A,425,I,3o8y:A,424,Loss of (5S)-lipoxygenase activity,,,-1.0,,,,,,,,,,,,,P09917_A_425_I
P09917,N,426,M,3o8y:A,425,Loss of (5S)-lipoxygenase activity,,,-1.0,,,,,,,,,,,,,P09917_N_426_M
P09917,H,433,N,3o8y:A,432,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P09917_H_433_N
P09917,H,433,A,3o8y:A,432,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P09917_H_433_A
P09917,H,551,N,3o8y:A,550,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_551_N
P09917,H,551,A,3o8y:A,550,No activity.,,,-1.0,,,,,,,,,,,,,P09917_H_551_A
P09917,A,604,I,3o8y:A,603,Loss of (5S)-lipoxygenase activity. Loss of (5S)-lipoxygenase activity,,,-1.0,,,,,,,,,,,,,P09917_A_604_I
O15519,Y,360,F,3h11:A,360,Decreases apoptosis-inducing activity. Reduces interaction with caspase-3 and proteolytic processing.,-1.0,,-1.0,,,,,,,,,,,,,O15519_Y_360_F
O15516,S,38,E,4h10:B,38,Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity.,,0.0,0.0,,,,,,,,,,1.0,,,O15516_S_38_E
O15516,S,42,E,4h10:B,42,Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity.,,0.0,0.0,,,,,,,,,,1.0,,,O15516_S_42_E
O15516,E,116,K,6qpj:A,116,3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity,,,1.0,,,,,,,,,,,,,O15516_E_116_K
P11413,K,171,Q,2bh9:A,171,Inhibits catalytic activity. Does not impair dimerization.,0.0,,-1.0,,,,,,,,,,,,,P11413_K_171_Q
P11413,K,171,R,2bh9:A,171,Inhibits catalytic activity. Does not impair dimerization.,0.0,,-1.0,,,,,,,,,,,,,P11413_K_171_R
P11413,K,386,Q,2bh9:A,386,Impairs dimerization and reduces catalytic activity.,-1.0,,-1.0,,,,,,,,,,,,,P11413_K_386_Q
P11413,K,386,R,2bh9:A,386,Does not impair dimerization and catalytic activity.,0.0,,0.0,,,,,,,,,,,,,P11413_K_386_R
P11413,K,403,Q,2bh9:A,403,Impairs dimerization and reduces catalytic activity in cells under oxidative stress.,-1.0,,-1.0,,,,,,,,,,,,,P11413_K_403_Q
P11413,K,403,R,2bh9:A,403,Does not impair dimerization and catalytic activity.,0.0,,0.0,,,,,,,,,,,,,P11413_K_403_R
A1L3X0,H,150,A,6y7f:B,150,Loss of activity,,,-1.0,,,,,,,,,,,,,A1L3X0_H_150_A
A1L3X0,H,151,A,6y7f:B,151,Loss of activity,,,-1.0,,,,,,,,,,,,,A1L3X0_H_151_A
Q96G97,H,67,R,6ds5:A,67,Loss of oligomerization and function in lipid droplet formation,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_H_67_R
Q96G97,Y,70,A,6ds5:A,70,Loss of oligomerization and function in lipid droplet formation,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_Y_70_A
Q96G97,Y,151,A,6ds5:A,151,Loss of oligomerization and function in lipid droplet biogenesis,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_Y_151_A
Q96G97,L,156,D,6ds5:A,156,Loss of oligomerization and function in lipid droplet formation,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_L_156_D
Q96G97,L,169,D,6ds5:A,169,Loss of oligomerization and function in lipid droplet formation,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_L_169_D
Q96G97,Q,175,A,6ds5:A,175,Loss of oligomerization and function in lipid droplet formation,-1.0,,-1.0,,,,,,,,,,,,,Q96G97_Q_175_A
Q96EK6,E,156,D,3cxp:A,156,Slightly reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96EK6_E_156_D
P51580,R,152,E,2h11:A,152,Decreases affinity for 6-mercaptopurine. Slightly decreases catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,P51580_R_152_E
Q03154,H,80,A,1q7l:A,80,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_H_80_A
Q03154,D,113,A,1q7l:A,113,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_D_113_A
Q03154,E,147,A,1q7l:A,147,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_E_147_A
Q03154,E,147,Q,1q7l:A,147,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_E_147_Q
Q03154,E,147,D,1q7l:A,147,Decreased protein stability. Loss of enzyme activity.,,,-1.0,,,,,,,,,,,-1.0,,Q03154_E_147_D
Q03154,E,148,A,1q7l:A,148,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_E_148_A
Q03154,E,175,A,1q7l:A,175,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_E_175_A
Q03154,H,373,A,1q7l:B,373,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q03154_H_373_A
P10619,S,178,A,1ivy:A,150,Inactivates the enzyme.,,,-1.0,,,,,,,,,,,,,P10619_S_178_A
P10619,H,457,Q,1ivy:A,429,Inactivates the enzyme.,,,-1.0,,,,,,,,,,,,,P10619_H_457_Q
Q8NI60,A,339,G,4ped:A,339,Enables autophosphorylation but inhibits coenzyme Q biosynthesis in vivo.,,,-1.0,1.0,,,,,,,,,,,,Q8NI60_A_339_G
O14773,H,236,A,3edy:A,236,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,O14773_H_236_A
O14773,D,360,A,3edy:A,360,Inactive. Impaired processing.,,,-1.0,,,,,,,,,,,,,O14773_D_360_A
O14773,S,475,A,3edy:A,475,Inactive. Impaired processing.,,,-1.0,,,,,,,,,,,,,O14773_S_475_A
O14773,D,517,A,3edy:A,517,Inactive. Impaired processing.,,,-1.0,,,,,,,,,,,,,O14773_D_517_A
P15260,V,61,Q,1fg9:D,44,Loss of function in the interferon-gamma-mediated signaling pathway.,,,-1.0,,,,,,,,,,,,,P15260_V_61_Q
P61086,D,94,E,3e46:A,94,Decreased lysine reactivity and impaired formation of free polyubiquitin chains.,,-1.0,-1.0,,,,,,,,,,,,,P61086_D_94_E
P62068,C,44,S,5cvo:B,44,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P62068_C_44_S
P13569,M,1137,R,6o1v:A,1137,"Abolishes channel activity. Impairs protein maturation, suggesting the protein is retained in the endoplasmic reticulum.",,,-1.0,,,,,,,,,1.0,,,,P13569_M_1137_R
P13569,I,1139,V,6o1v:A,1139,"Decreases channel activity, no visible effect on protein maturation.",,,-1.0,,,,,,,,,,,,,P13569_I_1139_V
P13569,D,1154,G,6o1v:A,1154,"Decreases channel activity, no visible effect on protein maturation.",,,-1.0,,,,,,,,,,,,,P13569_D_1154_G
Q9BU89,H,56,A,4d50:A,56,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_H_56_A
Q9BU89,E,57,A,4d50:A,57,Loss of deoxyhypusine monooxygenase activity. No effect on iron-binding.,,0.0,-1.0,,,,,,,,,,,,,Q9BU89_E_57_A
Q9BU89,H,89,A,4d50:A,89,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_H_89_A
Q9BU89,E,90,A,4d50:A,90,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_E_90_A
Q9BU89,H,207,A,4d50:A,207,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_H_207_A
Q9BU89,E,208,A,4d50:A,208,Loss of deoxyhypusine monooxygenase activity. No effect on iron-binding.,,0.0,-1.0,,,,,,,,,,,,,Q9BU89_E_208_A
Q9BU89,H,240,A,4d50:A,240,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_H_240_A
Q9BU89,E,241,A,4d50:A,241,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU89_E_241_A
Q9NUN7,D,19,G,6g7o:A,19,Mildly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NUN7_D_19_G
Q9NUN7,E,22,G,6g7o:A,22,Strongly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NUN7_E_22_G
Q9NUN7,N,24,G,6g7o:A,24,Strongly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NUN7_N_24_G
Q9NUN7,S,99,A,6g7o:A,99,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9NUN7_S_99_A
Q9NUN7,Y,149,A,6g7o:A,149,Decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NUN7_Y_149_A
Q9NUN7,S,228,A,6g7o:A,228,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9NUN7_S_228_A
Q8WTS6,K,294,A,1h3i:A,294,Significantly reduces the catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8WTS6_K_294_A
Q8WTS6,H,297,A,1h3i:A,297,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8WTS6_H_297_A
Q8WTS6,H,297,G,1h3i:A,297,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8WTS6_H_297_G
Q9Y2G5,E,54,A,4ap6:A,54,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_E_54_A
Q9Y2G5,W,92,A,4ap6:A,92,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_W_92_A
Q9Y2G5,W,152,A,4ap6:A,152,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_W_152_A
Q9Y2G5,W,273,A,4ap6:A,273,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_W_273_A
Q9Y2G5,R,294,A,4ap6:A,294,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_R_294_A
Q9Y2G5,D,297,A,4ap6:A,297,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y2G5_D_297_A
Q9Y2G5,E,396,A,4ap6:A,396,Reduces enzyme activity. No enhanced secretion of ADASMTS13,,,-1.0,,,,,,,,,0.0,,,,Q9Y2G5_E_396_A
Q6NS38,D,173,A,3bu0:A,173,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q6NS38_D_173_A
Q6NS38,H,236,A,3bu0:A,236,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q6NS38_H_236_A
P13804,R,249,A,2a1u:A,249,Loss of electron transfer activity.,,,-1.0,,,,,,,,,,,,,P13804_R_249_A
Q03393,S,19,A,3i2b:A,19,Decrease in activity,,,-1.0,,,,,,,,,,,,,Q03393_S_19_A
P08172,N,58,A,5zkb:A,58,Nearly abolishes signaling via downstream effectors.,,,-1.0,,,,,,,,,,,,,P08172_N_58_A
P08172,D,103,E,5zkb:A,103,Reduced affinity for acetylcholine. Abolishes signaling via downstream effectors.,,-1.0,-1.0,,,,,,,,,,,,,P08172_D_103_E
P08172,Y,206,F,5zkb:A,206,Abolishes signaling via downstream effectors.,,,-1.0,,,,,,,,,,,,,P08172_Y_206_F
P08172,N,404,Q,5zkb:A,404,Reduced affinity for acetylcholine. Reduces signaling via downstream effectors.,,,-1.0,,,,,,,,,,,,,P08172_N_404_Q
O76064,C,406,S,4orh:G,406,Abolishes ubiquitin-ligase activity.,,,-1.0,,,,,,,,,,,,,O76064_C_406_S
P16444,E,141,C,1itu:A,125,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P16444_E_141_C
P16444,E,141,D,1itu:A,125,Abolished dipeptidase activity. Does not affect ability to bind neutrophils.,,0.0,-1.0,,,,,,,,,,,,,P16444_E_141_D
P16444,E,141,Q,1itu:A,125,Partial loss of activity.,,,-1.0,,,,,,,,,,,,,P16444_E_141_Q
P05109,C,42,A,5hlo:B,42,Loss of antifungal activity.,,,-1.0,,,,,,,,,,,,,P05109_C_42_A
P30038,S,352,A,3v9g:A,352,Reduced affinity for NAD. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P30038_S_352_A
O95365,P,14,S,2nn2:A,14,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_P_14_S
O95365,S,22,R,2nn2:A,22,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,,,,,O95365_S_22_R
O95365,K,60,R,2nn2:A,60,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_K_60_R
O95365,D,78,E,2if5:A,77,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_D_78_E
O95365,R,112,C,2if5:A,111,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_R_112_C
Q08499,D,503,N,3g58:A,367,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q08499_D_503_N
P06132,D,86,E,3gw3:A,86,5-10% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P06132_D_86_E
P06132,D,86,G,3gw3:A,86,Very low activity. Binds substrate with similar geometry as wild-type.,,0.0,-1.0,,,,,,,,,,,,,P06132_D_86_G
P06132,D,86,N,3gw3:A,86,No activity. Unable to bind substrate.,,0.0,-1.0,,,,,,,,,,,,,P06132_D_86_N
P06132,Y,164,F,3gw3:A,164,25-30% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P06132_Y_164_F
Q9H0M0,E,614,A,5hpt:A,614,Reduces ubiquitin transfer.,,,-1.0,,,,,,,,,,,,,Q9H0M0_E_614_A
Q9H0M0,H,621,A,5hpt:A,621,Strongly reduces ubiquitin transfer.,,,-1.0,,,,,,,,,,,,,Q9H0M0_H_621_A
Q9H0M0,D,675,A,5hpt:A,675,Reduces ubiquitin transfer.,,,-1.0,,,,,,,,,,,,,Q9H0M0_D_675_A
Q9H0M0,E,798,A,5hpt:A,798,Reduces ubiquitin transfer. Strongly reduces ubiquitin transfer,,,-1.0,,,,,,,,,,,,,Q9H0M0_E_798_A
Q9H0M0,M,804,P,5hpt:A,804,Strongly reduces ubiquitin transfer,,,-1.0,,,,,,,,,,,,,Q9H0M0_M_804_P
Q9H0M0,E,806,P,5hpt:A,806,Strongly reduces ubiquitin transfer,,,-1.0,,,,,,,,,,,,,Q9H0M0_E_806_P
Q9H0M0,R,845,A,5hpt:A,845,No effect.,,,0.0,,,,,,,,,,,,,Q9H0M0_R_845_A
Q9H0M0,Q,848,A,5hpt:A,848,Abolishes ubiquitin transfer,,,-1.0,,,,,,,,,,,,,Q9H0M0_Q_848_A
Q9H0M0,R,855,A,5hpt:A,855,Abolishes ubiquitin transfer,,,-1.0,,,,,,,,,,,,,Q9H0M0_R_855_A
Q9BV79,S,85,A,1zsy:A,69,Reduces catalytic activity by 68%.,,,-1.0,,,,,,,,,,,,,Q9BV79_S_85_A
Q9BV79,Y,94,F,1zsy:A,78,Reduces catalytic activity by 95%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,-1.0,,,,,,,,,,,,,Q9BV79_Y_94_F
Q9BV79,T,170,A,1zsy:A,154,Reduces catalytic activity by 69%.,,,-1.0,,,,,,,,,,,,,Q9BV79_T_170_A
Q9BV79,W,311,A,1zsy:A,295,Reduces catalytic activity by 98%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,-1.0,,,,,,,,,,,,,Q9BV79_W_311_A
Q9BV79,W,311,L,1zsy:A,295,Reduces catalytic activity by 87%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,-1.0,,,,,,,,,,,,,Q9BV79_W_311_L
P13639,H,599,P,4v6x:Az,599,Strongly reduced phosphorylation at Thr-57.,,,-1.0,,,,,,,,,,,,,P13639_H_599_P
Q96EY1,H,121,Q,6iws:A,35,Loss of modulation of apoptosis.,,,-1.0,,,,,,,,,,,,,Q96EY1_H_121_Q
P00492,K,69,A,1bzy:A,68,"Reduced affinity for hypoxanthine, phosphoribosylpyrophosphate and IMP. Reduced catalytic activity.",,-1.0,-1.0,,,,,,,,,,,,,P00492_K_69_A
Q6IQ20,Q,158,S,4qn9:B,158,Impairs homodimerization resulting in loss of activity,-1.0,,-1.0,,,,,,,,,,,,,Q6IQ20_Q_158_S
Q6IQ20,Y,159,S,4qn9:B,159,Impairs homodimerization resulting in loss of activity,-1.0,,-1.0,,,,,,,,,,,,,Q6IQ20_Y_159_S
Q6IQ20,L,207,F,4qn9:B,207,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q6IQ20_L_207_F
Q6IQ20,R,257,A,4qn9:B,257,Impairs binding to bile acids resulting in loss of activity.,,-1.0,-1.0,,,,,,,,,,,,,Q6IQ20_R_257_A
Q6IQ20,H,380,R,4qn9:B,380,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q6IQ20_H_380_R
P04183,T,163,S,1w4r:A,163,140-fold lower K(m) for AZT.,,,1.0,,,,,,,,,,,,,P04183_T_163_S
P78417,C,32,A,6mhd:A,32,Loss of activity.,,,-1.0,,,,,,,,,,,,,P78417_C_32_A
P04180,E,173,A,4x96:A,149,Increased activity towards PAPC. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_A
P04180,E,173,D,4x96:A,149,Little change in enzyme specific activity nor in PAPC/POPC activity ratio.,,,0.0,,,,,,,,,,,,,P04180_E_173_D
P04180,E,173,K,4x96:A,149,Decreased enzyme specific activity. Increased PAPC/POPC activity ratio.,,,-1.0,,,,,,,,,,,,,P04180_E_173_K
P04180,E,173,L,4x96:A,149,Increased activity towards PAPC. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_L
P04180,E,173,Q,4x96:A,149,Decreased enzyme specific activity. Increased PAPC/POPC activity ratio.,,,-1.0,,,,,,,,,,,,,P04180_E_173_Q
P15880,K,58,R,4v6x:AC,58,Does not affect readthrough on the poly(A)-stall sequences,,,0.0,,,,,,,,,,,,,P15880_K_58_R
P15880,K,275,R,4v6x:AC,275,Does not affect readthrough on the poly(A)-stall sequences,,,0.0,,,,,,,,,,,,,P15880_K_275_R
Q9Y4U1,R,230,Q,3sc0:A,230,Reduced activity in dealkylation of methylcobalamin.,,,-1.0,,,,,,,,,,,,,Q9Y4U1_R_230_Q
Q08345,N,211,Q,4ag4:A,211,"Sustained phosphorylation regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation. Located intracellularly and at the cell surface. Displays a reduced rate of receptor internalization, which is not altered in the presence of collagen. Able to bind collagen as wild-type. Exhibits enhanced collagen-independent receptor dimerization. Complete loss of the collagen-independent constitutive activation",1.0,,1.0,,,,,,,,,,,,,Q08345_N_211_Q
Q08345,S,213,A,4ag4:A,213,"Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.",,,1.0,,,,,,,,,,,,,Q08345_S_213_A
Q08345,N,260,Q,4ag4:A,260,"Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.",,,-1.0,,,,,,,,,,,,,Q08345_N_260_Q
Q08345,K,655,A,6fio:A,655,Loss of kinase activity. Complete loss of the collagen-independent constitutive activation,,,-1.0,,,,,,,,,,,,,Q08345_K_655_A
Q08345,G,707,A,6fio:A,707,Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation.,,,1.0,,,,,,,,,,,,,Q08345_G_707_A
P17643,Y,362,F,5m8o:A,362,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_Y_362_F
P17643,R,374,S,5m8o:A,374,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_R_374_S
P17643,T,391,V,5m8o:A,391,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_T_391_V
Q9UQQ1,E,416,A,4twe:A,416,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9UQQ1_E_416_A
Q9BXW9,S,222,A,6vae:B,222,"Reduces phosphorylation by ATM. No effect on ubiquitination, foci formation or DNA repair ability, but impairs S-phase checkpoint activation.",,,0.0,-1.0,0.0,,,,,,,,,,,Q9BXW9_S_222_A
P08069,Y,980,F,1p4o:B,950,"Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10.",-1.0,,-1.0,,,,,,,,,,,,,P08069_Y_980_F
P08069,K,1033,A,1p4o:B,1003,"Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1.",-1.0,,-1.0,,,,,,,,,,,,,P08069_K_1033_A
Q9UKV8,L,140,W,6mdz:A,140,No effect.,0.0,,0.0,,,,,,,,,,,,,Q9UKV8_L_140_W
Q9UKV8,K,533,A,4w5t:A,533,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_K_533_A
Q9UKV8,Q,545,A,4w5t:A,545,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_Q_545_A
Q9UKV8,K,570,A,4w5t:A,570,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_K_570_A
Q9UKV8,D,597,A,4w5t:A,597,Abrogates RNA cleavage but does not affect binding to siRNA or translational repression.,,0.0,-1.0,,,,,,,,,,,,,Q9UKV8_D_597_A
Q9UKV8,Q,633,A,4w5t:A,633,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_Q_633_A
Q9UKV8,Q,633,R,4w5t:A,633,Abrogates RNA cleavage. Binds siRNA.,,0.0,-1.0,,,,,,,,,,,,,Q9UKV8_Q_633_R
Q9UKV8,H,634,P,4w5t:A,634,Abrogates RNA cleavage. Binds siRNA.,,0.0,-1.0,,,,,,,,,,,,,Q9UKV8_H_634_P
Q9UKV8,H,634,A,4w5t:A,634,Abrogates RNA cleavage. Binds siRNA.,,0.0,-1.0,,,,,,,,,,,,,Q9UKV8_H_634_A
Q9UKV8,D,669,A,4w5t:A,669,Abrogates RNA cleavage but does not affect binding to siRNA.,,0.0,-1.0,,,,,,,,,,,,,Q9UKV8_D_669_A
Q9UKV8,E,673,A,4w5t:A,673,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_E_673_A
Q9UKV8,E,673,G,4w5t:A,673,No effect on RNA cleavage.,,,0.0,,,,,,,,,,,,,Q9UKV8_E_673_G
Q9UKV8,F,676,A,4w5t:A,676,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_A
Q9UKV8,F,676,I,4w5t:A,676,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_I
Q9UKV8,F,676,M,4w5t:A,676,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_M
Q9UKV8,F,676,R,4w5t:A,676,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_R
Q9UKV8,F,676,Y,4w5t:A,676,Impairs RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_Y
Q9UKV8,F,676,V,4w5t:A,676,Abrogates RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_F_676_V
Q9UKV8,H,682,Y,4w5t:A,682,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_H_682_Y
Q9UKV8,E,683,G,4w5t:A,683,No effect on RNA cleavage.,,,0.0,,,,,,,,,,,,,Q9UKV8_E_683_G
Q9UKV8,F,704,Y,4w5t:A,704,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_F_704_Y
Q9UKV8,T,744,Y,4w5t:A,744,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_T_744_Y
Q9UKV8,H,807,A,4w5t:A,807,Abrogates RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_H_807_A
Q9UKV8,H,807,R,4w5t:A,807,Abrogates RNA cleavage.,,,-1.0,,,,,,,,,,,,,Q9UKV8_H_807_R
Q9UKV3,D,1093,A,6g6s:A,1093,Abolishes cleavage by CASP3 and chromatin condensation activity.,,,-1.0,,,,,,,,,,,,,Q9UKV3_D_1093_A
Q9Y6K1,F,732,A,4u7p:A,732,Loss of activity du to the incapacity to bind the regulatory subunit DNMT3L.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y6K1_F_732_A
P35354,Q,189,N,5ikq:B,204,Increases two-electron hydroperoxide reduction. Has no effect on cyclooxygenase activity.,,,1.0,,,,,,,,,,,,,P35354_Q_189_N
P35354,Q,189,R,5ikq:B,204,Impairs two-electron hydroperoxide reduction and cyclooxygenase activity.,,,-1.0,,,,,,,,,,,,,P35354_Q_189_R
P35354,Q,189,V,5ikq:B,204,Impairs two-electron hydroperoxide reduction.,,,-1.0,,,,,,,,,,,,,P35354_Q_189_V
P35354,H,193,A,5ikq:B,208,Reduces two-electron hydroperoxide reduction and cyclooxygenase activity. Catalyzes predominantly one-electron hydroperoxide reduction.,,,-1.0,,,,,,,,,,,,,P35354_H_193_A
P35354,S,516,T,5ikq:B,531,Decreased enzyme activity with arachidonic acid. Loss of cyclooxygenase activity,,,-1.0,,,,,,,,,,,,,P35354_S_516_T
P35354,G,519,V,5ikq:B,534,Loss of cyclooxygenase activity. Loss of cyclooxygenase activity,,,-1.0,,,,,,,,,,,,,P35354_G_519_V
P35354,C,555,S,5ikq:B,570,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P35354_C_555_S
P08263,Y,9,F,1pl1:A,9,Decreased isomerase activity.,,,-1.0,,,,,,,,,,,,,P08263_Y_9_F
P08263,I,71,A,1pl1:A,71,No significant effect on enzyme activity. Reduces protein stability.,,,0.0,,,,,,,,,,,-1.0,,P08263_I_71_A
P08263,I,71,V,1pl1:A,71,No significant effect on enzyme activity. Reduces protein stability.,,,0.0,,,,,,,,,,,-1.0,,P08263_I_71_V
P08263,A,216,H,1pl1:A,216,Confers ability to hydrolyze S-glutathionyl benzoate to glutathione and benzoic acid.,,,1.0,,,,,,,,,,,,,P08263_A_216_H
P62993,P,49,L,1gri:A,49,Ineffective in DNA synthesis. Abolishes interaction with SHB,-1.0,,-1.0,,,,,,,,,,,,,P62993_P_49_L
P62993,G,203,R,1gri:A,203,Ineffective in DNA synthesis. Abolishes interaction with SOS1.,-1.0,,-1.0,,,,,,,,,,,,,P62993_G_203_R
O76083,H,312,A,4gh6:A,252,Completely abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,O76083_H_312_A
O76083,H,356,A,4gh6:A,296,"Reduces catalytic activity, but has no effect on substrate affinity.",,0.0,-1.0,,,,,,,,,,,,,O76083_H_356_A
O76083,E,466,A,4gh6:A,406,Decreased affinity and catalytic activity for cGMP and cAMP.,,,-1.0,,,,,,,,,,,,,O76083_E_466_A
Q8NFU3,C,79,A,6bev:B,79,Leads to the loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8NFU3_C_79_A
Q8NFU3,C,79,S,6bev:B,79,Leads to the loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q8NFU3_C_79_S
Q92743,S,328,A,3nzi:A,328,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q92743_S_328_A
O43809,L,218,R,3mdg:B,218,Reduces interactions with CPSF6 and CPSF7 and decreases mRNA 3'-processing activity.,-1.0,,-1.0,,,,,,,,,,,,,O43809_L_218_R
Q8NFG4,S,406,A,6ulg:L,406,Impaired ability to regulate autophagy,,,-1.0,,,,,,,,,,,,,Q8NFG4_S_406_A
Q8NFG4,S,537,A,6ulg:L,537,Impaired ability to regulate autophagy,,,-1.0,,,,,,,,,,,,,Q8NFG4_S_537_A
Q8NFG4,S,542,A,6ulg:L,542,Impaired ability to regulate autophagy,,,-1.0,,,,,,,,,,,,,Q8NFG4_S_542_A
Q9BSA9,R,35,A,6wc9:A,35,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_R_35_A
Q9BSA9,F,39,V,6wc9:A,39,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_F_39_V
Q9BSA9,S,40,A,6wc9:A,40,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_S_40_A
Q9BSA9,D,41,A,6wc9:A,41,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_D_41_A
Q9BSA9,D,41,E,6wc9:A,41,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_D_41_E
Q9BSA9,D,41,N,6wc9:A,41,Impaired potassium channel activity.,,,-1.0,,,,,,,,,,,,,Q9BSA9_D_41_N
Q9BSA9,I,46,N,6wc9:A,46,Impaired selectivity,,,-1.0,,,,,,,,,,,,,Q9BSA9_I_46_N
Q9BSA9,V,50,A,6wc9:A,50,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_V_50_A
Q9BSA9,L,53,A,6wc9:A,53,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_53_A
Q9BSA9,I,271,N,6wc9:B,271,Impaired selectivity,,,-1.0,,,,,,,,,,,,,Q9BSA9_I_271_N
Q9BSA9,L,275,A,6wc9:B,275,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_275_A
Q9BSA9,L,278,A,6wc9:B,278,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_278_A
Q9NPJ3,N,50,A,3f5o:A,50,Reduced acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NPJ3_N_50_A
Q9NPJ3,D,65,A,3f5o:A,65,Loss of acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NPJ3_D_65_A
Q9NPJ3,D,65,E,3f5o:A,65,Reduced acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NPJ3_D_65_E
Q9NPJ3,D,65,N,3f5o:A,65,Reduced acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NPJ3_D_65_N
Q9NPJ3,S,83,A,3f5o:A,83,Reduced acyl-CoA hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NPJ3_S_83_A
Q8WVQ1,D,112,A,1s1d:A,42,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_112_A
Q8WVQ1,D,114,A,1s1d:A,44,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_114_A
Q8WVQ1,S,139,C,1s1d:A,69,Reduces GDPase and ADPase activities 1.7-fold. Severe loss of dimer formation,-1.0,,-1.0,,,,,,,,,,,,,Q8WVQ1_S_139_C
Q8WVQ1,G,152,E,1s1d:A,82,Slightly reduced activity.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_G_152_E
Q8WVQ1,E,160,Y,1s1d:A,90,Increases GDPase activity 2-fold and ADPase activity 5-fold. Forms dimer even at suboptimal Ca(2+) concentrations.,1.0,,1.0,,,,,,,,,,,,,Q8WVQ1_E_160_Y
Q8WVQ1,R,163,A,1s1d:A,93,Reduces activity by 98%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_R_163_A
Q8WVQ1,E,166,Q,1s1d:A,96,Reduces activity by 95%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_E_166_Q
Q8WVQ1,S,168,A,1s1d:A,98,Reduces activity by over 99.9%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_S_168_A
Q8WVQ1,D,169,N,1s1d:A,99,Reduces activity by 96%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_169_N
Q8WVQ1,D,181,A,1s1d:A,111,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_181_A
Q8WVQ1,D,182,N,1s1d:A,112,Reduces activity by over 99.9%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_182_N
Q8WVQ1,I,200,C,1s1d:A,130,Reduces GDPase activity 2-fold and ADPase activity 2.5-fold. No effect on dimer formation,0.0,,-1.0,,,,,,,,,,,,,Q8WVQ1_I_200_C
Q8WVQ1,S,202,C,1s1d:A,132,Reduces GDPase activity 1.7-fold and ADPase activity 1.5-fold. No effect on dimer formation,0.0,,-1.0,,,,,,,,,,,,,Q8WVQ1_S_202_C
Q8WVQ1,D,205,A,1s1d:A,135,Slightly reduced activity.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_D_205_A
Q8WVQ1,E,215,Q,1s1d:A,145,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_E_215_Q
Q8WVQ1,E,246,M,1s1d:A,176,Increases activity 5-fold.,,,1.0,,,,,,,,,,,,,Q8WVQ1_E_246_M
Q8WVQ1,S,256,C,1s1d:A,186,No effect on GDPase and ADPase activities. No effect on dimer formation,0.0,,0.0,,,,,,,,,,,,,Q8WVQ1_S_256_C
Q8WVQ1,C,287,S,1s1d:A,217,Reduces GDPase and ADPase activities 1.3-fold.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_C_287_S
Q8WVQ1,R,301,A,1s1d:A,231,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q8WVQ1_R_301_A
Q8WVQ1,S,308,C,1s1d:A,238,Reduces GDPase activity 1.3-fold and ADPase activity 2-fold. Severe loss of dimer formation,-1.0,,-1.0,,,,,,,,,,,,,Q8WVQ1_S_308_C
Q8WVQ1,A,317,C,1s1d:A,247,Reduces GDPase activity 1.7-fold and ADPase activity 1.5-fold. Severe loss of dimer formation,-1.0,,-1.0,,,,,,,,,,,,,Q8WVQ1_A_317_C
Q9UI30,L,8,D,6kmr:A,8,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,-1.0,,,,,,,,,,,,,Q9UI30_L_8_D
Q9UI30,L,9,D,6kmr:A,9,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,-1.0,,,,,,,,,,,,,Q9UI30_L_9_D
Q9UI30,I,113,D,6kmr:A,113,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,-1.0,,,,,,,,,,,,,Q9UI30_I_113_D
Q7L5D6,D,84,K,6au8:A,84,Reduces tail-anchored protein delivery.,,,-1.0,,,,,,,,,,,,,Q7L5D6_D_84_K
P52564,S,207,A,3vn9:A,207,Inactivation.,,,-1.0,,,,,,,,,,,,,P52564_S_207_A
P52564,S,207,E,3vn9:A,207,Constitutive activation according to PubMed,,,1.0,,,,,,,,,,,,,P52564_S_207_E
P52564,T,211,A,3vn9:A,211,Inactivation.,,,-1.0,,,,,,,,,,,,,P52564_T_211_A
P52564,T,211,E,3vn9:A,211,Constitutive activation according to PubMed,,,1.0,,,,,,,,,,,,,P52564_T_211_E
O75695,Q,116,A,3bh7:B,116,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,-1.0,,,,,,,,,,,,,O75695_Q_116_A
O75695,R,118,A,3bh7:B,118,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,-1.0,,,,,,,,,,,,,O75695_R_118_A
O75695,F,177,A,3bh7:B,177,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,-1.0,,,,,,,,,,,,,O75695_F_177_A
Q9UIV1,D,40,N,4gmj:B,40,Abolishes RNA deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q9UIV1_D_40_N
Q9UIV1,E,42,Q,4gmj:B,42,Abolishes RNA deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q9UIV1_E_42_Q
Q9UIV1,D,161,N,4gmj:B,161,Abolishes RNA deadenylase activity. Drastically reduces the rate of deadenylation and decay of CBEP3-tethered mRNA.,,,-1.0,,,,,,,,,,,,,Q9UIV1_D_161_N
Q9UIV1,H,225,A,4gmj:B,225,Abolishes RNA deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q9UIV1_H_225_A
Q9UIV1,D,230,N,4gmj:B,230,Abolishes RNA deadenylase activity.,,,-1.0,,,,,,,,,,,,,Q9UIV1_D_230_N
P27338,C,5,S,6yt2:A,5,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_5_S
P27338,C,156,S,6yt2:A,156,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_C_156_S
P27338,T,158,A,6yt2:A,158,Dramatic loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_T_158_A
P27338,C,172,S,6yt2:A,172,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_172_S
P27338,C,192,S,6yt2:A,192,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_192_S
P27338,C,297,S,6yt2:A,297,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_297_S
P27338,C,312,S,6yt2:A,312,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_312_S
P27338,C,365,S,6yt2:A,365,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_C_365_S
P27338,H,382,R,6yt2:A,382,Significant loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_H_382_R
P27338,K,386,M,6yt2:A,386,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_K_386_M
P27338,C,389,A,6yt2:A,389,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_C_389_A
P27338,C,389,S,6yt2:A,389,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_389_S
P27338,S,394,A,6yt2:A,394,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_S_394_A
P27338,C,397,S,6yt2:A,397,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P27338_C_397_S
Q7Z2E3,H,274,A,4ndg:A,260,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q7Z2E3_H_274_A
Q7Z2E3,C,333,A,4ndg:A,319,Abolishes DNA-binding and enzyme activity,,-1.0,-1.0,,,,,,,,,,,,,Q7Z2E3_C_333_A
Q7Z2E3,C,336,A,4ndg:A,322,Abolishes DNA-binding and enzyme activity,,-1.0,-1.0,,,,,,,,,,,,,Q7Z2E3_C_336_A
Q8IU85,K,52,A,6t6f:A,52,Catalytically inactive form.,,,-1.0,,,,,,,,,,,,,Q8IU85_K_52_A
P30711,H,176,Q,2c3t:A,176,"Increases activity towards alkylhalogenides, but not hydroperoxides.",,,1.0,,,,,,,,,,,,,P30711_H_176_Q
P30711,W,234,R,2c3t:A,234,Facilitates binding of substrates and increases catalytic activity.,,1.0,1.0,,,,,,,,,,,,,P30711_W_234_R
Q53HL2,T,230,A,2kdd:A,230,Decrease in AURKB activity and dimer disruption. Decrease in AURKB activity and almost no phosphorylation by TTK,,,-1.0,-1.0,,,,,,,,,,,,Q53HL2_T_230_A
Q53HL2,T,230,V,2kdd:A,230,Decrease in AURKB activity and no effect on the structure.,,,-1.0,,,,,,,,,,,0.0,,Q53HL2_T_230_V
P82251,P,482,A,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_A
P82251,P,482,G,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_G
P82251,P,482,S,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_S
P82251,P,482,V,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_V
P82251,P,482,F,6li9:B,482,Decreased amino acid transport activity.,,,-1.0,,,,,,,,,,,,,P82251_P_482_F
P82251,P,482,I,6li9:B,482,Decreased amino acid transport activity.,,,-1.0,,,,,,,,,,,,,P82251_P_482_I
P82251,P,482,M,6li9:B,482,Decreased amino acid transport activity.,,,-1.0,,,,,,,,,,,,,P82251_P_482_M
P82251,P,482,W,6li9:B,482,Decreased amino acid transport activity.,,,-1.0,,,,,,,,,,,,,P82251_P_482_W
P41180,R,69,E,5fbk:A,69,Abolishes G-protein coupled receptor signaling pathway.,,,-1.0,,,,,,,,,,,,,P41180_R_69_E
P41180,N,102,I,5fbk:A,102,Abolishes G-protein coupled receptor activity.,,,-1.0,,,,,,,,,,,,,P41180_N_102_I
P41180,T,145,A,5k5t:A,145,Abolishes G-protein coupled receptor activity.,,,-1.0,,,,,,,,,,,,,P41180_T_145_A
P41180,S,147,A,5k5t:A,147,Nearly abolished G-protein coupled receptor activity.,,,-1.0,,,,,,,,,,,,,P41180_S_147_A
P41180,S,170,A,5k5t:A,170,Abolishes G-protein coupled receptor activity.,,,-1.0,,,,,,,,,,,,,P41180_S_170_A
P41180,Y,218,S,5k5t:A,218,Abolishes G-protein coupled receptor activity.,,,-1.0,,,,,,,,,,,,,P41180_Y_218_S
P41180,E,297,I,5k5t:A,297,Abolishes ability to sense calcium or magnesium levels.,,,-1.0,,,,,,,,,,,,,P41180_E_297_I
P41180,S,417,L,5k5t:A,417,Abolishes G-protein coupled receptor signaling pathway.,,,-1.0,,,,,,,,,,,,,P41180_S_417_L
P41180,W,458,A,5k5t:A,458,Decreased G-protein coupled receptor signaling pathway.,,,-1.0,,,,,,,,,,,,,P41180_W_458_A
P41180,C,482,S,5k5t:A,482,Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.,,-1.0,-1.0,,,,,,,,,,,,,P41180_C_482_S
P41180,C,482,Y,5k5t:A,482,Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.,,-1.0,-1.0,,,,,,,,,,,,,P41180_C_482_Y
P19099,I,112,P,6xz8:B,112,Increases 11-beta- and 18-hydroxylase activities toward 11-deoxycorticosterone,,,1.0,,,,,,,,,,,,,P19099_I_112_P
P19099,D,147,E,6xz8:B,147,Increases 11-beta-hydroxylase activity toward 11-deoxycorticosterone and 11-deoxycortisol.,,,1.0,,,,,,,,,,,,,P19099_D_147_E
P19099,K,152,N,6xz8:B,152,No significant effect on hydroxylase activities toward 11-deoxycorticosterone and 11-deoxycortisol.,,,0.0,,,,,,,,,,,,,P19099_K_152_N
Q2MKA7,R,66,A,4cdk:E,66,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_R_66_A
Q2MKA7,R,66,W,4cdk:E,66,Reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_R_66_W
Q2MKA7,R,70,C,4cdk:E,70,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_R_70_C
Q2MKA7,R,70,E,4cdk:E,70,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_R_70_E
Q2MKA7,Q,71,E,4cdk:E,71,No effect on activation of Wnt signaling.,,,0.0,,,,,,,,,,,,,Q2MKA7_Q_71_E
Q2MKA7,Q,71,R,4cdk:E,71,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_Q_71_R
Q2MKA7,G,73,E,4cdk:E,73,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_G_73_E
Q2MKA7,G,73,R,4cdk:E,73,Strongly reduces activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_G_73_R
Q2MKA7,R,87,A,4cdk:E,87,Nearly abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_R_87_A
Q2MKA7,F,106,A,4cdk:E,106,Abolishes activation of Wnt signaling. Abolishes LGR4 binding.,-1.0,,-1.0,,,,,,,,,,,,,Q2MKA7_F_106_A
Q2MKA7,F,106,E,4cdk:E,106,Abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_F_106_E
Q2MKA7,F,110,A,4cdk:E,110,Nearly abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_F_110_A
Q2MKA7,F,110,E,4cdk:E,110,Abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,Q2MKA7_F_110_E
Q13303,Y,90,F,1zsx:A,76,No effect on its activity in promoting KCNA4 channel closure.,,,0.0,,,,,,,,,,,,,Q13303_Y_90_F
Q96PM5,M,176,E,2jrj:A,48,Abolishes E3 ubiquitin-protein ligase activity.,,,-1.0,,,,,,,,,,,,,Q96PM5_M_176_E
Q96PM5,C,186,A,2jrj:A,58,Abolishes E3 ubiquitin-protein ligase activity.,,,-1.0,,,,,,,,,,,,,Q96PM5_C_186_A
O60218,K,125,L,4ga8:A,125,Increased affinity and reduced catalytic activity towards all-trans-retinaldehyde.,,1.0,-1.0,,,,,,,,,,,,,O60218_K_125_L
O60218,C,299,S,4ga8:A,299,Decreased affinity and reduced catalytic activity towards 4-hydroxynonenal.,,-1.0,-1.0,,,,,,,,,,,,,O60218_C_299_S
O60218,V,301,L,4ga8:A,301,Reduced catalytic activity towards all-trans-retinaldehyde.,,,-1.0,,,,,,,,,,,,,O60218_V_301_L
Q9ULV1,Y,250,F,6bd4:A,250,Reduced signaling activity in presence of NDP/norrin.,,,-1.0,,,,,,,,,,,,,Q9ULV1_Y_250_F
Q9ULV1,R,253,C,6bd4:A,253,Reduced signaling activity in presence of NDP/norrin.,,,-1.0,,,,,,,,,,,,,Q9ULV1_R_253_C
Q9ULV1,Y,265,A,6bd4:A,265,Slight increase in signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_265_A
Q9ULV1,Y,269,A,6bd4:A,269,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_269_A
Q9ULV1,E,341,A,6bd4:A,341,Reduced signaling activity in presence of NDP/norrin.,,,-1.0,,,,,,,,,,,,,Q9ULV1_E_341_A
Q9ULV1,D,371,A,6bd4:A,371,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_D_371_A
Q9ULV1,Y,378,A,6bd4:A,378,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_378_A
Q9ULV1,N,381,A,6bd4:A,381,Slight increase in signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_N_381_A
Q9ULV1,L,399,F,6bd4:A,399,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_L_399_F
Q9ULV1,S,418,N,6bd4:A,418,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_S_418_N
Q9ULV1,Y,444,A,6bd4:A,444,Reduced signaling activity.,,,-1.0,,,,,,,,,,,,,Q9ULV1_Y_444_A
Q9ULV1,Y,444,F,6bd4:A,444,Reduced signaling activity.,,,-1.0,,,,,,,,,,,,,Q9ULV1_Y_444_F
Q9ULV1,E,458,A,6bd4:A,458,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_E_458_A
Q9ULV1,K,480,A,6bd4:A,480,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_K_480_A
Q9ULV1,W,494,L,6bd4:A,494,Reduced signaling activity.,,,-1.0,,,,,,,,,,,,,Q9ULV1_W_494_L
Q9ULV1,W,496,A,6bd4:A,496,Reduced signaling activity.,,,-1.0,,,,,,,,,,,,,Q9ULV1_W_496_A
O94762,D,157,A,5lb3:B,157,Abolishes helicase activity.,,,-1.0,,,,,,,,,,,,,O94762_D_157_A
O94760,L,30,A,6szq:D,30,Reduces enzyme activity and affinity for asymmetric dimethylarginine about 12-fold.,,-1.0,-1.0,,,,,,,,,,,,,O94760_L_30_A
O94760,E,78,A,6szq:D,78,"Reduces enzyme activity about 1000-fold, and affinity for asymmetric dimethylarginine about 100-fold.",,-1.0,-1.0,,,,,,,,,,,,,O94760_E_78_A
O94760,L,271,G,6szq:D,271,"Reduces enzyme activity about 10-fold, and affinity for asymmetric dimethylarginine about 7-fold.",,-1.0,-1.0,,,,,,,,,,,,,O94760_L_271_G
Q9ULV8,Y,244,A,3op0:A,244,Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination.,-1.0,,-1.0,,,,,,,,,,,,,Q9ULV8_Y_244_A
Q9ULV8,Y,244,F,3op0:A,244,No effect on interaction with EGFR and SRC as well as on SRC ubiquitination.,0.0,,0.0,,,,,,,,,,,,,Q9ULV8_Y_244_F
Q9ULV8,R,264,A,3op0:A,264,Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination.,-1.0,,-1.0,,,,,,,,,,,,,Q9ULV8_R_264_A
Q9ULV8,P,265,L,3op0:A,265,Enhances interaction with EGFR and SRC as well as SRC ubiquitination.,1.0,,1.0,,,,,,,,,,,,,Q9ULV8_P_265_L
Q9ULV8,S,266,A,3op0:A,266,Decreases interactions with EGFR and SRC as well as SRC ubiquitination.,-1.0,,-1.0,,,,,,,,,,,,,Q9ULV8_S_266_A
Q9ULV8,T,268,A,3op0:A,268,Abolishes interaction with EGFR. Decreases interaction with and ubiquitination of SRC.,-1.0,,-1.0,,,,,,,,,,,,,Q9ULV8_T_268_A
Q9ULV8,G,276,E,3op0:A,276,"No effect on interaction with RET. Binds slightly to SRC, this interaction is independent of SRC phosphorylation. Strongly decreases SRC ubiquitination. Abolishes interaction with EGFR.",-1.0,,-1.0,,,,,,,,,,,,,Q9ULV8_G_276_E
O94768,K,62,A,6y6h:A,62,Loss of activity and of apoptotic function.,,,-1.0,,,,,,,,,,,,,O94768_K_62_A
Q13415,R,720,Q,7jpo:A,720,Abolished ATPase activity.,,,-1.0,,,,,,,,,,,,,Q13415_R_720_Q
Q8IU60,E,147,Q,5qon:A,147,Loss of decapping activity,,,-1.0,,,,,,,,,,,,,Q8IU60_E_147_Q
Q8IU60,E,148,Q,5qon:A,148,Strongly reduced decapping activity.,,,-1.0,,,,,,,,,,,,,Q8IU60_E_148_Q
P07333,L,301,S,4liq:E,301,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,P07333_L_301_S
P07333,D,802,V,2ogv:A,802,Constitutive kinase activity. Loss of inhibition by imatinib.,,,1.0,,,,,,,,,,,,,P07333_D_802_V
P07333,Y,809,F,2ogv:A,809,"Reduced kinase activity. Reduced interaction with SRC, FYN and YES1.",-1.0,,-1.0,,,,,,,,,,,,,P07333_Y_809_F
P04406,C,152,S,6m61:O,152,Markedly reduced glycolytic activity,,,-1.0,,,,,,,,,,,,,P04406_C_152_S
P04406,C,156,S,6m61:O,156,Markedly reduced glycolytic activity,,,-1.0,,,,,,,,,,,,,P04406_C_156_S
P04406,C,247,S,6m61:O,247,Markedly reduced glycolytic activity,,,-1.0,,,,,,,,,,,,,P04406_C_247_S
Q8TF76,E,492,A,6z5a:A,492,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,-1.0,,,,,,,,,,,,,Q8TF76_E_492_A
Q8TF76,K,511,A,6z5a:A,511,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q8TF76_K_511_A
Q8TF76,H,651,A,6z5a:A,651,"Strongly reduced enzyme activity, markedly reduced affinity for histone H3.",-1.0,,-1.0,,,,,,,,,,,,,Q8TF76_H_651_A
Q8TF76,D,707,L,6z5a:A,707,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,-1.0,,,,,,,,,,,,,Q8TF76_D_707_L
Q8TF76,D,709,N,6z5a:A,709,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,-1.0,,,,,,,,,,,,,Q8TF76_D_709_N
Q8TF76,G,713,F,6z5a:A,713,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,-1.0,,,,,,,,,,,,,Q8TF76_G_713_F
Q8TF76,D,716,L,6z5a:A,716,Markedly reduced histone H3 phosphorylation.,,,-1.0,,,,,,,,,,,,,Q8TF76_D_716_L
Q13418,E,359,K,6mib:A,359,Inactivation of ILK.,,,-1.0,,,,,,,,,,,,,Q13418_E_359_K
P11172,D,312,N,3mw7:A,123,Loss of OMPdecase activity.,,,-1.0,,,,,,,,,,,,,P11172_D_312_N
P04439,T,158,K,6o9c:A,134,"Impairs binding to TAP1-TAP2 transporter, resulting in impaired presentation of intracellular peptides.",-1.0,,-1.0,,,,,,,,,,,,,P04439_T_158_K
P11177,D,319,A,3exi:B,289,Inhibits interaction with DLAT. Does not affect pyruvate decarboxylase activity. Loss of multienzyme pyruvate dehydrogenase complex activity.,-1.0,,0.0,,,,,,,,,,,,,P11177_D_319_A
P11177,D,319,N,3exi:B,289,Reduces interaction with DLAT. Reduces multienzyme pyruvate dehydrogenase complex activity. Does not affect pyruvate decarboxylase activity.,-1.0,,0.0,,,,,,,,,,,,,P11177_D_319_N
Q6P988,S,232,A,4uz9:A,232,Abolishes enzyme activity. Unable to mediate serine depalmitoleoylation of WNT proteins.,,,-1.0,,,,,,,,,,,,,Q6P988_S_232_A
Q9NZI5,R,427,A,5mpf:B,427,Loss of activity as transcriptional activator. Strongly decreases affinity for target DNA.,,-1.0,-1.0,,,,,,,,,,,,,Q9NZI5_R_427_A
Q9NZI5,R,427,Q,5mpf:B,427,Loss of activity as transcriptional activator. Nearly abolishes affinity for target DNA. Causes steric hindrance that impedes DNA-binding by neighboring residues.,,-1.0,-1.0,,,,,,,,,,,,,Q9NZI5_R_427_Q
Q15782,S,143,D,4p8u:A,143,Confers chitinase activity,,,1.0,,,,,,,,,,,,,Q15782_S_143_D
Q15782,I,145,E,4p8u:A,145,Confers chitinase activity,,,1.0,,,,,,,,,,,,,Q15782_I_145_E
Q13572,K,18,A,2odt:X,18,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_K_18_A
Q13572,H,58,A,2odt:X,58,No effect.,,,0.0,,,,,,,,,,,,,Q13572_H_58_A
Q13572,K,59,A,2odt:X,59,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_K_59_A
Q13572,R,106,A,2odt:X,106,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_R_106_A
Q13572,K,157,A,2odt:X,157,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_K_157_A
Q13572,H,162,Q,2odt:X,162,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_H_162_Q
Q13572,G,163,A,2odt:X,163,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_G_163_A
Q13572,G,163,P,2odt:X,163,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_G_163_P
Q13572,H,167,A,2odt:X,167,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_H_167_A
Q13572,H,167,Q,2odt:X,167,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_H_167_Q
Q13572,Q,188,A,2odt:X,188,No effect.,,,0.0,,,,,,,,,,,,,Q13572_Q_188_A
Q13572,H,193,A,2odt:X,193,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_H_193_A
Q13572,K,199,A,2odt:X,199,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_K_199_A
Q13572,R,212,A,2odt:X,212,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_R_212_A
Q13572,S,214,A,2odt:X,214,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_S_214_A
Q13572,L,215,A,2odt:X,215,No effect.,,,0.0,,,,,,,,,,,,,Q13572_L_215_A
Q13572,D,281,A,2q7d:B,281,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_D_281_A
Q13572,D,295,A,2q7d:B,295,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_D_295_A
Q13572,N,297,A,2q7d:B,297,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_N_297_A
Q13572,N,297,L,2q7d:B,297,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_N_297_L
Q13572,N,297,D,2q7d:B,297,Induces a strong reduction in kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_N_297_D
Q13572,G,301,A,2q7d:B,301,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q13572_G_301_A
Q9HCI7,H,64,Y,4b7y:C,64,Great reduction in H2B ubiquitination. No effect on MSL1-binding.,0.0,,-1.0,,,,,,,,,,,,,Q9HCI7_H_64_Y
P45983,K,55,D,6zr5:B,55,Abolished protein kinase activity.,,,-1.0,,,,,,,,,,,,,P45983_K_55_D
P45983,T,183,A,6zr5:B,183,Phosphorylation blocked.,,,-1.0,,,,,,,,,,,,,P45983_T_183_A
P45983,Y,185,F,6zr5:B,185,Phosphorylation blocked.,,,-1.0,,,,,,,,,,,,,P45983_Y_185_F
Q7KZI7,T,208,A,3iec:A,208,Prevents phosphorylation and activation by STK11/LKB1 complex.,,,-1.0,,,,,,,,,,,,,Q7KZI7_T_208_A
P34925,N,484,F,6tua:A,484,Gain of an autophosphorylation activity. Gain of an autophosphorylation activity,,,1.0,,,,,,,,,,,,,P34925_N_484_F
P34925,A,485,G,6tua:A,485,Gain of an autophosphorylation activity. Gain of an autophosphorylation activity,,,1.0,,,,,,,,,,,,,P34925_A_485_G
Q96C23,H,107,A,1so0:A,107,Decreased activity by 5-fold.,,,-1.0,,,,,,,,,,,,,Q96C23_H_107_A
Q96C23,H,176,A,1so0:A,176,Decreased activity by 300-fold.,,,-1.0,,,,,,,,,,,,,Q96C23_H_176_A
Q96C23,E,307,A,1so0:A,307,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96C23_E_307_A
Q9H9Z2,H,147,A,2li8:A,147,Abolishes ability to suppress pre-let-7 biogenesis and localization to P-bodies without affecting pre-let-7 binding,,,-1.0,,,,,,,,,1.0,,,,Q9H9Z2_H_147_A
Q9H9Z2,H,169,A,2li8:A,169,Abolishes ability to suppress pre-let-7 biogenesis and localization to P-bodies without affecting pre-let-7 binding,,,-1.0,,,,,,,,,1.0,,,,Q9H9Z2_H_169_A
Q96AP4,S,351,A,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_A
Q96AP4,S,351,Q,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_Q
Q96AP4,S,351,Y,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_Y
Q96AP4,C,360,A,6fge:A,360,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_C_360_A
Q96AP4,D,406,A,6fge:A,406,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_D_406_A
Q96AP4,E,428,A,6fge:A,428,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_E_428_A
Q96AP4,Q,487,A,6fge:A,487,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_Q_487_A
Q96AP4,H,491,A,6fge:A,491,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_H_491_A
Q96AP4,D,512,A,6fge:A,512,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96AP4_D_512_A
P18440,R,64,A,2pqt:A,64,Reduced enzymatic activity.,,,-1.0,,,,,,,,,,,,,P18440_R_64_A
P18440,R,64,M,2pqt:A,64,Reduced enzymatic activity.,,,-1.0,,,,,,,,,,,,,P18440_R_64_M
P18440,R,64,Q,2pqt:A,64,Reduced enzymatic activity.,,,-1.0,,,,,,,,,,,,,P18440_R_64_Q
P18440,R,64,K,2pqt:A,64,Reduced enzymatic activity.,,,-1.0,,,,,,,,,,,,,P18440_R_64_K
Q96I25,D,319,K,2peh:A,319,"Abolishes interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,-1.0,,,,,,,,,,,,,Q96I25_D_319_K
Q96I25,R,375,A,2peh:A,375,"Impairs interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,-1.0,,,,,,,,,,,,,Q96I25_R_375_A
Q96I25,Y,376,A,2peh:A,376,"Impairs interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,-1.0,,,,,,,,,,,,,Q96I25_Y_376_A
Q96I25,F,377,A,2peh:A,377,Impairs interaction with SF1 and U2AF2 and abolishes interaction with SF3B1. Abolishes regulation of alternative splicing.,-1.0,,-1.0,,,,,,,,,,,,,Q96I25_F_377_A
O00308,K,498,R,5tj7:B,498,Does not affect FBXL15-mediated ubiquitination.,,,0.0,,,,,,,,,,,,,O00308_K_498_R
O00308,H,500,K,5tj7:B,500,Does not affect FBXL15-mediated ubiquitination.,,,0.0,,,,,,,,,,,,,O00308_H_500_K
O00308,C,838,A,5tj7:B,838,Abolishes ubiquitination of POU5F1.,,,-1.0,,,,,,,,,,,,,O00308_C_838_A
O95372,S,122,A,5syn:A,122,Abolishes ability to mediate depalmitoylation of ZDHHC6.,,,-1.0,,,,,,,,,,,,,O95372_S_122_A
P21796,S,193,A,5xdo:A,193,Conformation remains open and constitutively allows cytochrome c efflux.,,,1.0,,,,,,,,,,,,,P21796_S_193_A
P21796,S,193,E,5xdo:A,193,Conformation remains closed and prevents cytochrome c leakage.,,,-1.0,,,,,,,,,,,,,P21796_S_193_E
Q9Y657,W,72,A,7bqz:A,72,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_W_72_A
Q9Y657,W,72,R,7bqz:A,72,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_W_72_R
Q9Y657,Y,98,R,7bqz:A,98,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_Y_98_R
Q9Y657,F,141,A,7bqz:A,141,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway. Impaired ability to activate expression of pre-rRNA.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_F_141_A
Q9Y657,Y,170,A,7bqz:A,170,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway. Impaired ability to activate expression of pre-rRNA.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_Y_170_A
Q9Y657,F,251,R,7cna:D,251,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y657_F_251_R
Q9UL25,Q,78,L,1z08:C,78,Defects in GTP hydrolysis. Does not affect the interaction with VAMP8 in response to starvation. Does not affect the interaction with TMED10.,0.0,,-1.0,,,,,,,,,,,,,Q9UL25_Q_78_L
P49841,R,96,A,1j1b:B,596,Prevents the phosphorylation of phosphate-primed glycogen synthase.,,,-1.0,,,,,,,,,,,,,P49841_R_96_A
Q687X5,S,138,Q,6hcy:A,138,Strongly reduced enzyme activity. No effect on trimerization and on heme binding.,0.0,0.0,-1.0,,,,,,,,,,,,,Q687X5_S_138_Q
P56696,D,266,G,7byl:A,266,Resistant to inhibition by potassium channel toxin SsTX. Normal voltage activation.,,-1.0,0.0,,,,,,,,,,,,,P56696_D_266_G
Q9BRQ3,H,156,A,5lor:A,156,Abolishes enzyme activity with UDP-galactose.,,,-1.0,,,,,,,,,,,,,Q9BRQ3_H_156_A
Q9BRQ3,E,189,A,5lor:A,189,Abolishes enzyme activity with UDP-galactose.,,,-1.0,,,,,,,,,,,,,Q9BRQ3_E_189_A
Q9BRQ3,E,193,A,5lor:A,193,Abolishes enzyme activity with UDP-galactose.,,,-1.0,,,,,,,,,,,,,Q9BRQ3_E_193_A
P0DMV8,K,77,Q,3a8y:A,77,No loss of acetylation and ATPase activity. Exhibits normal protein refolding activity during the early phase but exhibits defects in ubiquitin-mediated protein degradation during the later phase.,,,0.0,,-1.0,,,,,,,,,0.0,,P0DMV8_K_77_Q
P0DMV8,K,77,R,3a8y:A,77,Significant loss of acetylation and ATPase activity. Decreased binding to HOPX and HSP90 and increased binding to STUB1 and NAA10. Impaired capacity for protein refolding during the early phase after stress but shows normal protein degradation activity in the late phase.,,,-1.0,,,,,,,,,,,-1.0,,P0DMV8_K_77_R
Q6IQ55,K,50,E,6u0k:B,50,Leads to inactivation/destabilization of the protein.,,,-1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_50_E
Q6IQ55,K,50,A,6u0k:B,50,Leads to inactivation/destabilization of the protein.,,,-1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_50_A
Q6IQ55,K,143,E,6u0k:B,143,Leads to inactivation/destabilization of the protein.,,,-1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_143_E
Q6IQ55,K,143,A,6u0k:B,143,Leads to inactivation/destabilization of the protein.,,,-1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_143_A
Q6IQ55,D,163,A,6u0k:B,163,Abolishes serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q6IQ55_D_163_A
Q6IQ55,R,181,E,6u0k:B,181,Impaired serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q6IQ55_R_181_E
Q6IQ55,R,181,A,6u0k:B,181,Impaired serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q6IQ55_R_181_A
Q6IQ55,A,184,E,6u0k:B,184,Impaired serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q6IQ55_A_184_E
Q6IQ55,A,184,G,6u0k:B,184,Impaired serine/threonine-protein kinase activity.,,,-1.0,,,,,,,,,,,,,Q6IQ55_A_184_G
Q9NQC7,C,601,A,2vhf:B,601,Loss of deubiquitinating activity.,,,-1.0,,,,,,,,,,,,,Q9NQC7_C_601_A
Q9NQC7,C,601,S,2vhf:B,601,Loss of deubiquitinating activity.,,,-1.0,,,,,,,,,,,,,Q9NQC7_C_601_S
Q9NQC7,H,871,N,2vhf:B,871,Loss of deubiquitinating activity.,,,-1.0,,,,,,,,,,,,,Q9NQC7_H_871_N
P09211,Y,8,F,5dal:A,7,Reduces catalytic activity about 50-fold.,,,-1.0,,,,,,,,,,,,,P09211_Y_8_F
P09211,D,99,A,5dal:A,98,Reduces affinity for glutathione. Slightly reduced catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,P09211_D_99_A
Q92888,Y,487,F,3odo:A,487,No effect.,,0.0,0.0,,,,,,,,,,,,,Q92888_Y_487_F
Q92888,Y,738,F,3odo:A,738,Lowers the exchange activity.,,,-1.0,,,,,,,,,,,,,Q92888_Y_738_F
P14384,E,281,Q,1uwy:A,264,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P14384_E_281_Q
Q9H1D0,R,510,E,6e2f:C,470,"Decreases channel opening, and thereby decreases channel activity.",,,-1.0,,,,,,,,,,,,,Q9H1D0_R_510_E
Q9H1D0,Q,523,A,6e2f:C,483,Decreases channel activity.,,,-1.0,,,,,,,,,,,,,Q9H1D0_Q_523_A
Q9H1D0,D,582,A,6e2f:C,542,Abolishes channel activity.,,,-1.0,,,,,,,,,,,,,Q9H1D0_D_582_A
Q9H1D0,A,606,T,6e2f:C,566,"Decreases channel opening, and thereby strongly decreases channel activity.",,,-1.0,,,,,,,,,,,,,Q9H1D0_A_606_T
Q15027,F,280,A,4ckh:A,280,Reduced membrane binding and ability to induce liposome tubulation.,,-1.0,-1.0,,,,,,,,,,,,,Q15027_F_280_A
Q15027,F,280,W,4ckh:A,280,Preserves membrane binding and ability to tubulate liposomes.,,0.0,0.0,,,,,,,,,,,,,Q15027_F_280_W
Q15027,R,448,Q,3t9k:A,448,Loss of GAP activity. No effect on GULP1 binding or association with endosomal tubules when coexpressed with PIP5K1C.,,,-1.0,,,,,,,,,,,,,Q15027_R_448_Q
Q9Y6X9,Y,18,A,5of9:B,18,Abolishes homodimerization. No effect on ATPase activity. Loss of HUSH-dependent gene silencing.,-1.0,,0.0,,,,,,,,,,,,,Q9Y6X9_Y_18_A
Q9Y6X9,N,39,A,5of9:B,39,Loss of ATP-binding and ATPase activity. Does not homodimerizes. Seems to abolish chromatin compaction.,-1.0,-1.0,-1.0,,,,,,,,,,,,,Q9Y6X9_N_39_A
Q9Y6X9,D,68,A,5of9:B,68,Loss of ATP-binding and ATPase activity. Loss of binding to ATP and ATPase activity,,-1.0,-1.0,,,,,,,,,,,,,Q9Y6X9_D_68_A
Q9Y6X9,D,69,A,5of9:B,69,No effect on binding to ATP and ATPase activity,,0.0,0.0,,,,,,,,,,,,,Q9Y6X9_D_69_A
Q9Y6X9,R,266,A,5of9:B,266,Increases HUSH-dependent gene silencing.,,,1.0,,,,,,,,,,,,,Q9Y6X9_R_266_A
Q9Y6X9,R,319,E,5of9:B,319,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_319_E
Q9Y6X9,R,326,E,5of9:B,326,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,-1.0,,,,,,,,,,,,,Q9Y6X9_R_326_E
Q9Y6X9,R,329,E,5of9:B,329,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,-1.0,,,,,,,,,,,,,Q9Y6X9_R_329_E
Q9Y6X9,R,333,E,5of9:B,333,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,-1.0,,,,,,,,,,,,,Q9Y6X9_R_333_E
Q9Y6X9,R,344,E,5of9:B,344,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_344_E
Q9Y6X9,R,351,E,5of9:B,351,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_351_E
Q9Y6X9,R,358,E,5of9:B,358,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_358_E
Q9Y2V2,H,76,Q,3aqq:B,76,Reduced affinity for single-stranded DNA.,,,0.0,,,,,,,,,,,,,Q9Y2V2_H_76_Q
Q92993,G,380,A,2ou2:A,328,Loss of function. Does not affect phosphorylation.,,,-1.0,0.0,,,,,,,,,,,,Q92993_G_380_A
P22303,S,234,A,4bdt:A,203,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22303_S_234_A
P22303,E,365,A,4bdt:A,334,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22303_E_365_A
P22303,D,435,N,4bdt:A,404,"Misfolding, absence of secretion.",,,-1.0,,,,,,,,,,,,,P22303_D_435_N
P22303,H,478,A,4bdt:A,447,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22303_H_478_A
P53778,D,179,A,1cm8:A,179,Emulation of the active state.,,,0.0,,,,,,,,,,,,,P53778_D_179_A
P53778,Y,185,F,1cm8:A,185,Loss of activity.,,,-1.0,,,,,,,,,,,,,P53778_Y_185_F
P53778,F,330,S,6una:B,330,No effect.,,,0.0,,,,,,,,,,,,,P53778_F_330_S
P22307,N,528,D,1qnd:A,104,Strongly reduces sterol carrier and phosphatidylcholine transfer activity,,,-1.0,,,,,,,,,,,,,P22307_N_528_D
P22307,N,528,I,1qnd:A,104,Strongly reduces sterol carrier and phosphatidylcholine transfer activity.,,,-1.0,,,,,,,,,,,,,P22307_N_528_I
P22307,G,530,D,1qnd:A,106,Strongly reduces sterol carrier and phosphatidylcholine transfer activity,,,-1.0,,,,,,,,,,,,,P22307_G_530_D
Q6IMN6,I,1048,R,4oum:A,1048,Impaired homotrimer formation. No effect on LRP6 binding although LRP6 phosphorylation is significantly reduced.,-1.0,,-1.0,,,,,,,,,,,,,Q6IMN6_I_1048_R
Q6IMN6,I,1091,S,4oum:A,1091,Impaired homotrimer formation. No effect on LRP6 binding although LRP6 phosphorylation is significantly reduced.,-1.0,,-1.0,,,,,,,,,,,,,Q6IMN6_I_1091_S
Q5SQI0,Q,58,A,4if5:A,58,Loss of acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_Q_58_A
Q5SQI0,S,61,A,4if5:A,61,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q5SQI0_S_61_A
Q5SQI0,I,64,A,4if5:A,64,Strong reduction in acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_I_64_A
Q5SQI0,R,69,A,4if5:A,69,Strong reduction in acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_R_69_A
Q5SQI0,K,102,A,4if5:A,102,Strong reduction in acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_K_102_A
Q5SQI0,F,105,A,4if5:A,105,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_F_105_A
Q5SQI0,V,106,A,4if5:A,106,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_V_106_A
Q5SQI0,L,107,A,4if5:A,107,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_L_107_A
Q5SQI0,D,108,A,4if5:A,108,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_D_108_A
Q5SQI0,D,109,A,4if5:A,109,Slight increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_109_A
Q5SQI0,D,109,R,4if5:A,109,Marginal increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_109_R
Q5SQI0,E,111,A,4if5:A,111,2-fold increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_E_111_A
Q5SQI0,E,111,R,4if5:A,111,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q5SQI0_E_111_R
Q5SQI0,E,115,A,4if5:A,115,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_E_115_A
Q5SQI0,E,117,A,4if5:A,117,Reduced activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_E_117_A
Q5SQI0,C,120,A,4if5:A,120,Strong reduction in microtubule acetylation.,,,-1.0,,,,,,,,,,,,,Q5SQI0_C_120_A
Q5SQI0,C,120,S,4if5:A,120,Strong reduction in microtubule acetylation.,,,-1.0,,,,,,,,,,,,,Q5SQI0_C_120_S
Q5SQI0,D,157,E,4if5:A,157,Strong reduction in microtubule acetylation.,,,-1.0,,,,,,,,,,,,,Q5SQI0_D_157_E
Q5SQI0,D,157,N,4if5:A,157,Strong reduction in microtubule acetylation.,,,-1.0,,,,,,,,,,,,,Q5SQI0_D_157_N
Q5SQI0,R,158,A,4if5:A,158,20% of wild-type acetyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_R_158_A
Q5SQI0,N,182,A,4if5:A,182,Strong reduction in activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_N_182_A
Q5SQI0,F,183,A,4if5:A,183,Strong reduction in activity.,,,-1.0,,,,,,,,,,,,,Q5SQI0_F_183_A
P0C870,H,178,A,5nfo:A,178,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,-1.0,,,,,,,,,,,,,P0C870_H_178_A
P0C870,D,180,A,5nfo:A,180,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,-1.0,,,,,,,,,,,,,P0C870_D_180_A
P0C870,H,277,A,5nfo:A,277,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,-1.0,,,,,,,,,,,,,P0C870_H_277_A
P62987,K,48,R,5hpl:C,48,No effect on HLTF-mediated polyubiquitination of PCNA.,,,0.0,,,,,,,,,,,,,P62987_K_48_R
P62987,K,63,R,5hpl:C,63,Abolishes HLTF-mediated polyubiquitination of PCNA.,,,-1.0,,,,,,,,,,,,,P62987_K_63_R
P62987,H,68,G,5hpl:C,68,Loss of DTX3L-mediated polyubiquitination of histone H3 and H4.,,,-1.0,,,,,,,,,,,,,P62987_H_68_G
P62987,R,72,G,5hpl:C,72,No effect on ADP-ribosylation.,,,0.0,,,,,,,,,,,,,P62987_R_72_G
P62987,R,74,G,5hpl:C,74,No effect on ADP-ribosylation.,,,0.0,,,,,,,,,,,,,P62987_R_74_G
P62987,G,76,A,5hpl:C,76,Loss of ADP-ribosylation.,,,-1.0,,,,,,,,,,,,,P62987_G_76_A
O95396,C,365,A,3i2v:A,31,Does not affect sulfurtransferase activity.,,,0.0,,,,,,,,,,,,,O95396_C_365_A
O95396,C,412,A,3i2v:A,78,Abolishes sulfurtransferase activity.,,,-1.0,,,,,,,,,,,,,O95396_C_412_A
O95396,K,413,R,3i2v:A,79,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_K_413_R
O95396,L,414,K,3i2v:A,80,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_L_414_K
O95396,G,415,A,3i2v:A,81,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_G_415_A
O95396,N,416,V,3i2v:A,82,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_N_416_V
O95396,D,417,R,3i2v:A,83,Results in 470-fold increased activity.,,,1.0,,,,,,,,,,,,,O95396_D_417_R
O95396,D,417,T,3i2v:A,83,Results in 90-fold increased activity.,,,1.0,,,,,,,,,,,,,O95396_D_417_T
O95396,P,458,G,3i2v:A,124,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_P_458_G
O94925,Y,249,A,5uqe:D,249,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_Y_249_A
O94925,S,286,A,5uqe:D,286,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_S_286_A
O94925,K,289,A,5uqe:D,289,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_K_289_A
O94925,F,318,Y,5uqe:D,318,No effect on catalytic activity. Loss of inhibition by BPTES,-1.0,,0.0,,,,,,,,,,,,,O94925_F_318_Y
O94925,L,321,A,5uqe:D,321,Decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_L_321_A
O94925,F,322,S,5uqe:D,322,No effect on catalytic activity. Loss of inhibition by BPTES,-1.0,,0.0,,,,,,,,,,,,,O94925_F_322_S
O94925,L,323,A,5uqe:D,323,Decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_L_323_A
O94925,Y,394,A,5uqe:D,394,Decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_Y_394_A
O94925,Y,394,L,5uqe:D,394,No effect on catalytic activity. Loss of inhibition by BPTES.,-1.0,,0.0,,,,,,,,,,,,,O94925_Y_394_L
O94925,Y,466,A,5uqe:D,466,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94925_Y_466_A
Q99962,A,63,S,2d4c:B,63,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,-1.0,,,,,,,,,,,,,Q99962_A_63_S
Q99962,A,66,D,2d4c:B,66,"Loss of tubulation of liposomes, no effect on liposome binding.",,0.0,-1.0,,,,,,,,,,,,,Q99962_A_66_D
Q99962,A,66,S,2d4c:B,66,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,-1.0,,,,,,,,,,,,,Q99962_A_66_S
Q99962,M,70,Q,2d4c:B,70,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,-1.0,,,,,,,,,,,,,Q99962_M_70_Q
Q99962,F,202,W,1x03:A,202,No effect. Indol ring not associated with the membrane.,,,0.0,,,,,,,,,,,,,Q99962_F_202_W
P43220,L,32,A,5nx2:A,32,No effect on stimulation of cAMP accumulation and on GLP-1 binding.,0.0,0.0,0.0,,,,,,,,,,,,,P43220_L_32_A
P43220,Y,69,A,5nx2:A,69,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_Y_69_A
P43220,Y,88,A,5nx2:A,88,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_Y_88_A
P43220,L,89,A,5nx2:A,89,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_L_89_A
P43220,P,90,A,5nx2:A,90,Strongly decreased stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_P_90_A
P43220,R,121,A,5nx2:A,121,Strongly decreased stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_R_121_A
P43220,E,127,A,5nx2:A,127,No effect on stimulation of cAMP accumulation in response to GLP-1.,0.0,,0.0,,,,,,,,,,,,,P43220_E_127_A
P43220,E,128,A,5nx2:A,128,Slightly decreases stimulation of cAMP accumulation in response to GLP-1.,-1.0,,-1.0,,,,,,,,,,,,,P43220_E_128_A
P43220,E,128,Q,5nx2:A,128,No effect on stimulation of cAMP accumulation in response to GLP-1.,0.0,,0.0,,,,,,,,,,,,,P43220_E_128_Q
O14732,D,104,N,2ddk:A,104,Loss of activity.,,,-1.0,,,,,,,,,,,,,O14732_D_104_N
P22234,H,303,Y,6yb9:A,303,Loss of AIR carboxylase activity.,,,-1.0,,,,,,,,,,,,,P22234_H_303_Y
P22234,S,332,A,6yb9:A,332,Loss of AIR carboxylase activity.,,,-1.0,,,,,,,,,,,,,P22234_S_332_A
P22234,G,334,A,6yb9:A,334,Loss of AIR carboxylase activity.,,,-1.0,,,,,,,,,,,,,P22234_G_334_A
P22234,S,400,A,6yb9:A,400,No change of AIR carboxylase activity.,,,0.0,,,,,,,,,,,,,P22234_S_400_A
P04792,S,15,D,6dv5:A,15,"Mimicks phosphorylation state, leading to dreased ability to act as molecular chaperones",,,-1.0,,,,,,,,,,1.0,,,P04792_S_15_D
P04792,S,82,D,2n3j:A,82,"Mimicks phosphorylation state, leading to dreased ability to act as molecular chaperones",,,-1.0,,,,,,,,,,1.0,,,P04792_S_82_D
Q9NZD2,I,45,N,4gxg:A,45,18% decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9NZD2_I_45_N
Q9NZD2,D,48,V,4gxg:A,48,Significant inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_D_48_V
Q9NZD2,N,52,I,4gxg:A,52,Significant inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_N_52_I
Q9NZD2,K,55,I,4gxg:A,55,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_K_55_I
Q9NZD2,W,96,A,4gxg:A,96,Almost complete inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_W_96_A
Q9NZD2,W,96,F,4gxg:A,96,Partial inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_W_96_F
Q9NZD2,F,103,S,4gxg:A,103,About 25% decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9NZD2_F_103_S
Q9NZD2,L,136,R,4gxg:A,136,Significant inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_L_136_R
Q9NZD2,H,140,L,4gxg:A,140,Almost complete inactivation,,,-1.0,,,,,,,,,,,,,Q9NZD2_H_140_L
Q9NZD2,F,148,S,4gxg:A,148,About 50% decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9NZD2_F_148_S
Q9NZD2,L,165,R,4gxg:A,165,46% decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9NZD2_L_165_R
Q9NZD2,F,183,S,4gxg:A,183,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_F_183_S
Q9NZD2,Y,207,L,4gxg:A,207,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_Y_207_L
P30838,C,244,S,3sza:B,243,Abolishes activity.,,,-1.0,,,,,,,,,,,,,P30838_C_244_S
Q9UK80,C,221,A,3mtn:A,221,Abolishes ubiquitin thioesterase activity.,,,-1.0,,,,,,,,,,,,,Q9UK80_C_221_A
P04155,C,82,S,1ps2:A,58,Abolishes inhibition of gastric cancer cell growth.,,,-1.0,,,,,,,,,,,,,P04155_C_82_S
Q9Y3B8,D,168,A,6n6j:A,136,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q9Y3B8_D_168_A
P28161,T,210,C,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_C
P28161,T,210,F,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_F
P28161,T,210,H,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_H
P28161,T,210,I,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_I
P28161,T,210,K,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_K
P28161,T,210,L,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_L
P28161,T,210,R,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_R
P28161,T,210,Y,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_Y
P28161,T,210,W,1hna:A,209,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P28161_T_210_W
Q96LD8,D,10,A,2bkr:A,10,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_D_10_A
Q96LD8,W,26,A,2bkr:A,26,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_W_26_A
Q96LD8,D,29,A,2bkr:A,29,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_D_29_A
Q96LD8,D,29,N,2bkr:A,29,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_D_29_N
Q96LD8,V,58,A,2bkr:A,58,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_V_58_A
Q96LD8,F,74,A,2bkr:A,74,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_F_74_A
Q96LD8,P,77,A,2bkr:A,77,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_P_77_A
Q96LD8,N,91,A,2bkr:A,91,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_N_91_A
Q96LD8,H,102,N,2bkr:A,102,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_H_102_N
Q96LD8,W,103,A,2bkr:A,103,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_W_103_A
Q96LD8,W,103,H,2bkr:A,103,Strongly reduces activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_W_103_H
Q96LD8,D,119,A,2bkr:A,119,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_D_119_A
Q96LD8,D,119,N,2bkr:A,119,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_D_119_N
Q96LD8,Q,157,A,2bkr:A,157,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_Q_157_A
Q96LD8,C,163,A,2bkr:A,163,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q96LD8_C_163_A
O75689,C,21,A,3feh:A,21,Loss of GTPase-activating activity.,,,-1.0,,,,,,,,,,,,,O75689_C_21_A
O75689,C,24,A,3feh:A,24,Loss of GTPase-activating activity.,,,-1.0,,,,,,,,,,,,,O75689_C_24_A
P35670,H,1069,A,2arf:A,1069,Loss of ATPase activity. Cannot form an acylphosphate intermediate during catalysis. Does not alter folding of the nucleotide-binding domain.,,,-1.0,,,,,,,,,,,0.0,,P35670_H_1069_A
P35670,H,1069,C,2arf:A,1069,Loss of ATPase activity. Cannot form an acylphosphate intermediate during catalysis. Does not alter folding of the nucleotide-binding domain.,,,-1.0,,,,,,,,,,,0.0,,P35670_H_1069_C
P46527,Y,88,F,1jsu:C,88,"Abolishes LYN-mediated phosphorylation, reduces CDK2-mediated phosphorylation on T-187, has greater cell cycle arrest into S-phase, no effect on binding CDK2 complexes, reduced CDK4 binding and inhibits CDK4 enzyme activity. No nuclear translocation. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding",-1.0,,-1.0,,,,,,,,,1.0,,,,P46527_Y_88_F
Q8IW75,R,302,A,5ei0:A,302,Significantly impairs KLK7 inhibition activity. Slightly enhances KLK7 inhibition activity,,,-1.0,,,,,,,,,,,,,Q8IW75_R_302_A
Q8IW75,R,302,E,5ei0:A,302,Significantly impairs KLK7 inhibition activity. Slightly enhances KLK7 inhibition activity,,,-1.0,,,,,,,,,,,,,Q8IW75_R_302_E
Q8IW75,T,365,R,5ei0:A,365,Fails to inhibit KLK7 activity. Increased protein stability in cleaved form and conformational changes which may allow escape of the substrate.,,-1.0,-1.0,,,,,,,,,,,1.0,,Q8IW75_T_365_R
Q8IW75,A,369,P,5ei0:A,369,Fails to inhibit KLK7 activity. Increased protein stability in cleaved form and conformational changes which may allow escape of the substrate.,,-1.0,-1.0,,,,,,,,,,,1.0,,Q8IW75_A_369_P
Q99497,L,10,P,4zgg:A,10,Abolishes detoxification acivity on methylglyocal-adducted CoA.,,,-1.0,,,,,,,,,,,,,Q99497_L_10_P
Q99497,E,18,A,4zgg:A,18,Strongly decreases enzymatic activity. Almost abolishes detoxification acivity on methylglyocal-adducted CoA.,,,-1.0,,,,,,,,,,,,,Q99497_E_18_A
Q99497,E,18,D,4zgg:A,18,Strongly decreases enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q99497_E_18_D
Q99497,E,18,N,4zgg:A,18,Strongly decreases enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q99497_E_18_N
Q99497,E,18,Q,4zgg:A,18,Strongly decreases enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q99497_E_18_Q
Q99497,C,46,S,4zgg:A,46,No effect on mitochondrial translocation neither on deglycase activity.,,,-1.0,,,,,,,,,0.0,,,,Q99497_C_46_S
Q99497,V,51,A,4zgg:A,51,Disrupts dimer formation and strongly reduces ability to eliminate hydrogen peroxide.,-1.0,,-1.0,,,,,,,,,,,,,Q99497_V_51_A
Q99497,C,53,A,4zgg:A,53,Strongly reduces chaperone activity and ability to eliminate hydrogen peroxide.,,,-1.0,,,,,,,,,,,,,Q99497_C_53_A
Q99497,C,53,S,4zgg:A,53,No effect on mitochondrial translocation neither on deglycase activity.,,,0.0,,,,,,,,,0.0,,,,Q99497_C_53_S
Q99497,C,106,A,4zgg:A,106,"Abolishes enzymatic activity. Abolishes oxidation, association with mitochondria and protease activity. No effect on chaperone activity. Reduces binding to OTUD7B.",-1.0,,-1.0,,,,,,0.0,,,,,,,Q99497_C_106_A
Q99497,C,106,S,4zgg:A,106,Loss of protein and nucleic acid deglycase activity. No effect on mitochondrial translocation. Reduced protease activity. No effect on protection against metal cytotoxicity. No effect on methylglyoxal-adducted glutathione or CoA.,,,-1.0,,,,,,,,,0.0,,,,Q99497_C_106_S
Q99497,H,126,A,4zgg:A,126,Strongly decreases enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q99497_H_126_A
Q99497,A,179,T,4zgg:A,179,No effect on detoxification acivity on methylglyocal-adducted CoA.,,,0.0,,,,,,,,,,,,,Q99497_A_179_T
Q8WY64,Y,265,A,6qly:A,265,Unable to clear LDLR from the plasma membrane.,,,-1.0,,,,,,,,,,,,,Q8WY64_Y_265_A
Q8WY64,T,269,R,6qly:A,269,Unable to clear LDLR from the plasma membrane.,,,-1.0,,,,,,,,,,,,,Q8WY64_T_269_R
Q8WY64,C,387,A,2yho:E,387,Abolishes autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,Q8WY64_C_387_A
Q8WY64,V,389,R,2yho:E,389,Inhibits LDLR degradation.,,,-1.0,,,,,,,,,,,,,Q8WY64_V_389_R
Q8WY64,L,415,E,2yho:E,415,Inhibits LDLR degradation.,,,-1.0,,,,,,,,,,,,,Q8WY64_L_415_E
Q96RI1,T,456,A,3hc6:A,442,Impairs transcriptional activation of ABCB11/BSEP.,,,-1.0,,,,,,,,,,,,,Q96RI1_T_456_A
Q96RI1,K,474,R,3hc6:A,460,"Decreases transcriptional activation SLC51A/OSTA, SLC51B/OSTB and ABCB11/BSEP, no effect on interaction with RXRA and impairs interaction with SETD7.",,,-1.0,,,,,,,,,,,,,Q96RI1_K_474_R
Q02083,V,116,F,6dxw:A,116,Decreased autoproteolytic cleavage and strongly reduced enzyme activity with liposome-bound substrate. Loss of enzyme activity with Triton-solubilized substrate.,,,-1.0,,,,,,,,,,,,,Q02083_V_116_F
Q02083,C,126,A,6dxw:A,126,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02083_C_126_A
Q02083,C,126,S,6dxw:A,126,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02083_C_126_S
Q02083,R,142,G,6dxw:A,142,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02083_R_142_G
Q02083,D,145,A,6dxw:A,145,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02083_D_145_A
Q02083,L,152,F,6dxw:A,152,Strongly reduced enzyme activity both with liposome-bound and Triton-solubilized substrate.,,,-1.0,,,,,,,,,,,,,Q02083_L_152_F
Q02083,E,195,A,6dxw:A,195,Abolishes decrease of enzyme activity at pH 6 and pH 7.,,,1.0,,,,,,,,,,,,,Q02083_E_195_A
Q02083,E,195,Q,6dxw:A,195,Abolishes decrease of enzyme activity at pH 6 and pH 7.,,,1.0,,,,,,,,,,,,,Q02083_E_195_Q
Q02083,N,287,D,6dxw:A,287,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02083_N_287_D
P07948,K,275,A,3a4o:X,44,Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus,,,-1.0,,,,,,,,,1.0,,,,P07948_K_275_A
P07948,K,275,L,3a4o:X,44,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P07948_K_275_L
P07948,K,275,R,3a4o:X,44,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P07948_K_275_R
Q8N3J5,D,298,A,2iq1:A,298,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q8N3J5_D_298_A
Q96FI4,E,3,Q,5itq:A,3,Loss of glycosylase and AP lyase activity.,,,-1.0,,,,,,,,,,,,,Q96FI4_E_3_Q
Q96FI4,K,54,L,5itq:A,54,Loss of glycosylase activity.,,,-1.0,,,,,,,,,,,,,Q96FI4_K_54_L
Q96FI4,R,277,A,5itq:A,277,Strongly reduced glycosylase activity. Has little effect on AP lyase activity.,,,-1.0,,,,,,,,,,,,,Q96FI4_R_277_A
P11387,K,532,A,1sc7:A,532,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P11387_K_532_A
P11387,K,532,R,1sc7:A,532,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P11387_K_532_R
Q02880,E,482,Q,5zad:A,477,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02880_E_482_Q
Q02880,S,485,A,5zad:A,480,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02880_S_485_A
Q02880,R,508,E,5zad:A,503,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02880_R_508_E
Q02880,K,510,E,5zad:A,505,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02880_K_510_E
Q02880,R,515,Q,5zad:A,510,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q02880_R_515_Q
P11766,R,115,A,2fze:A,114,Loss of FDH activity and loss of activation by fatty acids.,,-1.0,-1.0,,,,,,,,,,,,,P11766_R_115_A
P11766,R,115,D,2fze:A,114,Loss of FDH activity and loss of activation by fatty acids.,,-1.0,-1.0,,,,,,,,,,,,,P11766_R_115_D
Q9UNA0,E,411,A,2rjq:A,411,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UNA0_E_411_A
Q9H9S5,D,362,A,6kam:A,362,Decrease in ribitol-5-phosphate transferase activity.,,,-1.0,,,,,,,,,,,,,Q9H9S5_D_362_A
P36888,Y,591,F,6il3:A,591,No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A.,-1.0,,0.0,,,,,,,,,,,,,P36888_Y_591_F
P36888,Y,599,F,6il3:A,599,Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2.,-1.0,,-1.0,,,,,,,,,,,,,P36888_Y_599_F
P36888,K,644,A,6il3:A,644,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,P36888_K_644_A
P50213,Y,153,F,6kdf:E,126,"Complete loss of activity of the heterotetramer, heterodimer composed of IDH3A and IDH3B subunits and the heterodimer composed of IDH3A and IDH3G subunits with no effect on their oligomeric states.",,,-1.0,,,,,,,,,,,,,P50213_Y_153_F
P50213,K,169,A,6kdf:E,142,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-1.0,,,,,,,,,,,,,P50213_K_169_A
P50213,K,200,A,6kdf:E,173,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-1.0,,,,,,,,,,,,,P50213_K_200_A
P50213,N,202,A,6kdf:E,175,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-1.0,,,,,,,,,,,,,P50213_N_202_A
P50213,D,208,A,6kdf:E,181,Complete loss of the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-1.0,,,,,,,,,,,,,P50213_D_208_A
P50213,Y,255,A,6kdf:E,228,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-1.0,,,,,,,,,,,,,P50213_Y_255_A
P36406,C,34,A,5vzv:A,34,Loss of E3 ubiquitin-protein ligase activity.,,,-1.0,,,,,,,,,,,,,P36406_C_34_A
P36406,H,53,A,5vzv:A,53,Loss of E3 ubiquitin-protein ligase activity.,,,-1.0,,,,,,,,,,,,,P36406_H_53_A
P36404,Q,70,L,3doe:A,70,"Induces cell cycle arrest, reduces ability to form microtubules and centrosome fragmentation. Inhibits the interaction with TBCD and does not rescue the TBCD-induced microtubule destruction. Interacts with ARL2BP and PDE6D.",-1.0,,-1.0,,,,,,,,,,,,,P36404_Q_70_L
P49356,D,200,N,1jcq:B,200,Reduced catalytic efficiency.,,,-1.0,,,,,,,,,,,,,P49356_D_200_N
P49356,G,249,V,1jcq:B,249,Reduced catalytic efficiency.,,,-1.0,,,,,,,,,,,,,P49356_G_249_V
P49356,G,349,S,1jcq:B,349,Reduced catalytic efficiency.,,,-1.0,,,,,,,,,,,,,P49356_G_349_S
P11166,I,192,C,6tha:A,192,Strongly decreases glucose transport.,,,-1.0,,,,,,,,,,,,,P11166_I_192_C
P11166,L,204,C,6tha:A,204,Abolishes glucose transport.,,,-1.0,,,,,,,,,,,,,P11166_L_204_C
P11166,P,205,C,6tha:A,205,Abolishes glucose transport.,,,-1.0,,,,,,,,,,,,,P11166_P_205_C
P11166,G,340,C,6tha:A,340,Strongly decreases glucose transport.,,,-1.0,,,,,,,,,,,,,P11166_G_340_C
Q9UBQ0,D,8,A,5osi:A,8,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_D_8_A
Q9UBQ0,N,39,A,5osi:A,39,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_N_39_A
Q9UBQ0,N,39,D,5osi:A,39,No effect on in vitro protein phosphatase activity.,,,0.0,,,,,,,,,,,,,Q9UBQ0_N_39_D
Q9UBQ0,D,62,A,5osi:A,62,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_D_62_A
Q9UBQ0,D,62,N,5osi:A,62,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_D_62_N
Q9UBQ0,H,86,A,5osi:A,86,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_H_86_A
Q9UBQ0,H,117,A,5osi:A,117,Loss of in vitro protein phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9UBQ0_H_117_A
Q8IYT8,K,39,R,6qau:A,39,Decreased kinase activity and decreased autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,Q8IYT8_K_39_R
P22681,G,306,E,5j3x:B,306,"Abolishes interaction with ZAP70 and EPHB1, but does not affect interaction with SLA. Reduces ubiquitination and therefore proteasomal degradation of SPRED2.",-1.0,,-1.0,,,,,,,,,,,,,P22681_G_306_E
P22681,C,381,A,5j3x:B,381,Loss of ubiquitin ligase activity.,,,-1.0,,,,,,,,,,,,,P22681_C_381_A
Q13546,S,25,D,4itj:B,25,Phophomimetic mutant. Significant loss of kinase activity.,,,-1.0,,,,,,,,,,1.0,,,Q13546_S_25_D
Q13546,K,45,A,4itj:B,45,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q13546_K_45_A
Q13546,S,161,A,4itj:B,161,Decreases RIPK1 kinase activity.,,,-1.0,,,,,,,,,,,,,Q13546_S_161_A
Q6ZSG1,M,313,A,5d0k:C,313,Reduced binding to free ubiquitin and reduced E3 ubiquitin-protein ligase activity.,-1.0,,-1.0,,,,,,,,,,,,,Q6ZSG1_M_313_A
Q6ZSG1,R,335,A,5d0k:C,335,Reduced ubiquitin discharge.,,,-1.0,,,,,,,,,,,,,Q6ZSG1_R_335_A
Q9UKK9,W,28,A,2dsb:A,28,Reduces affinity for substrate about 8-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate,,-1.0,-1.0,,,,,,,,,,,,,Q9UKK9_W_28_A
Q9UKK9,W,46,A,2dsb:A,46,Reduces affinity for substrate about 6-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate,,-1.0,-1.0,,,,,,,,,,,,,Q9UKK9_W_46_A
Q9UKK9,R,51,Q,2dsb:A,51,Reduces affinity for substrate about 15-fold and reduces catalytic rate about 17-fold.,,-1.0,-1.0,,,,,,,,,,,,,Q9UKK9_R_51_Q
Q9UKK9,R,84,Q,2dsb:A,84,Reduces affinity for substrate about 5-fold and reduces catalytic rate 67-fold.,,-1.0,-1.0,,,,,,,,,,,,,Q9UKK9_R_84_Q
Q9UKK9,E,112,Q,2dsb:A,112,Catalytic inactive mutant for both ADP-sugar pyrophosphatase and nuclear ATP-synthesis activities. Reduces catalytic rate 6300-fold.,,-1.0,-1.0,,,,,,,,,,,,,Q9UKK9_E_112_Q
Q9UKK9,E,116,Q,2dsb:A,116,Reduces catalytic rate 2000-fold.,,,-1.0,,,,,,,,,,,,,Q9UKK9_E_116_Q
Q9UKK9,E,166,Q,2dsb:A,166,Reduces catalytic rate 120-fold.,,,-1.0,,,,,,,,,,,,,Q9UKK9_E_166_Q
Q96J02,C,871,A,5c7m:A,871,Loss of ubiquitin protein ligase activity. Results in altered endosomal sorting and reduced degradation of CXCR4. Unable to inhibit MAVS-induced activation of INFB.,-1.0,,-1.0,,,,,,,,,1.0,,,,Q96J02_C_871_A
Q07075,T,356,V,4kx7:A,356,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q07075_T_356_V
Q07075,R,887,A,4kx7:A,887,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q07075_R_887_A
P13725,C,74,S,1evs:A,49,Inactive.,,,-1.0,,,,,,,,,,,,,P13725_C_74_S
Q8IUF8,H,179,Y,4bxf:A,179,Abolishes demethylase activity.,,,-1.0,,,,,,,,,,,,,Q8IUF8_H_179_Y
P13051,D,154,E,1yuo:A,145,Loss of activity.,,,-1.0,,,,,,,,,,,,,P13051_D_154_E
P13051,D,154,N,1yuo:A,145,Loss of activity.,,,-1.0,,,,,,,,,,,,,P13051_D_154_N
P47736,E,207,A,3brw:B,207,Reduces GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_E_207_A
P47736,H,267,A,3brw:B,267,Abolishes GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_H_267_A
P47736,R,286,A,3brw:B,286,Reduces GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_R_286_A
P47736,H,287,A,3brw:B,287,Abolishes GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_H_287_A
P47736,N,290,A,3brw:B,290,Abolishes GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_N_290_A
P47736,N,290,K,3brw:B,290,Abolishes GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_N_290_K
P47736,D,291,A,3brw:B,291,Abolishes GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_D_291_A
P47736,R,388,A,3brw:B,388,Reduces GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_R_388_A
P47736,R,388,P,3brw:B,388,Reduces GTPase activation.,,,-1.0,,,,,,,,,,,,,P47736_R_388_P
Q9UL18,P,670,S,4kxt:A,670,Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_P_670_S
Q9UL18,L,674,F,4kxt:A,674,Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_L_674_F
Q9UL18,P,675,Q,4kxt:A,675,Does not confer enzyme activity by itself. Confers low RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_P_675_Q
Q9UL18,R,805,H,4kxt:A,805,Does not confer enzyme activity by itself. Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_R_805_H
P29317,K,646,M,5nkh:A,646,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P29317_K_646_M
Q86UE8,D,613,A,5o0y:A,613,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q86UE8_D_613_A
Q9BV57,E,94,A,4qgn:A,94,Loss of aci-reductone dioxygenase activity.,,,-1.0,,,,,,,,,,,,,Q9BV57_E_94_A
Q9UIF7,D,233,N,3n5n:Y,222,Loss of DNA glycosylase activity.,,,-1.0,,,,,,,,,,,,,Q9UIF7_D_233_N
P51813,Y,566,F,3sxs:A,566,Abolishes almost completely the SRC-induced phosphorylation of BMX.,,,-1.0,,,,,,,,,,,,,P51813_Y_566_F
P34913,D,9,A,4j03:A,9,Loss of phosphatase activity.,,,-1.0,,,,,,,,,,,,,P34913_D_9_A
P34913,C,522,S,4j03:A,522,"Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of epoxide hydrolase activity.",,,-1.0,,,,,,,,,,,,,P34913_C_522_S
P20160,C,52,S,1fy1:A,26,Loss of antibiotic activity.,,,-1.0,,,,,,,,,,,,,P20160_C_52_S
P20160,C,68,S,1fy1:A,42,Loss of antibiotic activity.,,,-1.0,,,,,,,,,,,,,P20160_C_68_S
O15382,C,342,A,1ekp:A,315,Reduces activity about 6-fold.,,,-1.0,,,,,,,,,,,,,O15382_C_342_A
O15382,C,345,A,1ekp:A,318,Slight reduction of activity.,,,-1.0,,,,,,,,,,,,,O15382_C_345_A
Q7L0Y3,D,314,N,5nfj:A,314,Abolished mitochondrial tRNA methylation. Does not affect mitochondrial tRNA 5'-end processing.,,,-1.0,,,,,,,,,,,,,Q7L0Y3_D_314_N
Q9Y265,D,302,N,6hts:E,302,Abolishes ATPase activity,,,-1.0,,,,,,,,,,,,,Q9Y265_D_302_N
Q08211,I,347,A,3llm:A,347,Reduces NUP98-induced mRNA transcription and alternative splicing activities.,,,-1.0,,,,,,,,,,,,,Q08211_I_347_A
Q08211,K,417,R,3llm:A,417,"Inhibits interaction with AGO2, DICER1 and TARBP2. Abrogates helicase activity and transcriptional activation. Does not inhibit binding to origins of DNA replication.",-1.0,0.0,-1.0,,,,,,,,,,,,,Q08211_K_417_R
Q08211,K,417,N,3llm:A,417,"Inhibits interaction with AGO2, DICER1 and TARBP2. Abrogates helicase activity and transcriptional activation. Does not inhibit binding to origins of DNA replication.",-1.0,0.0,-1.0,,,,,,,,,,,,,Q08211_K_417_N
Q9UKT7,C,358,S,4i6j:B,358,"Decrease in binding efficiency with CRY2 and of CRY2 ubiquitination efficiency, loss of binding with CRY1.",-1.0,,-1.0,,,,,,,,,,,,,Q9UKT7_C_358_S
P09661,Y,15,D,1a9n:C,15,Results in defective spliceosome assembly.,-1.0,,-1.0,,,,,,,,,,,,,P09661_Y_15_D
P09661,R,27,Q,1a9n:C,27,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_R_27_Q
P09661,T,68,K,1a9n:C,68,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_T_68_K
P09661,N,72,K,1a9n:C,72,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_N_72_K
P09661,N,73,K,1a9n:C,73,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_N_73_K
P09661,E,92,V,1a9n:C,92,Results in defective spliceosome assembly.,-1.0,,-1.0,,,,,,,,,,,,,P09661_E_92_V
P09661,Q,148,R,1a9n:C,148,Results in defective spliceosome assembly.,-1.0,,-1.0,,,,,,,,,,,,,P09661_Q_148_R
Q86TI0,M,930,A,3qye:A,930,Substantially reduced RabGAP GTPase hydrolysis activity.,,,-1.0,,,,,,,,,,,,,Q86TI0_M_930_A
Q86TI0,L,1019,A,3qye:A,1019,Substantially reduced RabGAP GTPase hydrolysis activity.,,,-1.0,,,,,,,,,,,,,Q86TI0_L_1019_A
Q7Z5Q5,D,623,A,4xvl:A,623,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q7Z5Q5_D_623_A
Q7Z5Q5,E,675,R,4xvl:A,675,Reduces polymerase activity. No effect on accuracy.,,,-1.0,,,,,,,,,,,,,Q7Z5Q5_E_675_R
Q7Z5Q5,K,679,A,4xvl:A,679,No effect on polymerase activity. Increases accuracy by ten-fold.,,,0.0,,,,,,,,,,,,,Q7Z5Q5_K_679_A
Q92947,E,414,D,2r0m:A,370,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q92947_E_414_D
Q92785,F,275,A,5b79:A,16,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,-1.0,,,,,,,,,,,,,Q92785_F_275_A
Q92785,R,300,A,5b79:A,41,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,-1.0,,,,,,,,,,,,,Q92785_R_300_A
Q92785,D,346,A,5b79:A,87,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,-1.0,,,,,,,,,,,,,Q92785_D_346_A
P52788,D,201,A,3c6m:C,201,"100,000-fold decrease in catalytic efficiency.",,,-1.0,,,,,,,,,,,,,P52788_D_201_A
P52788,D,201,N,3c6m:C,201,"100,000-fold decrease in catalytic efficiency.",,,-1.0,,,,,,,,,,,,,P52788_D_201_N
P52788,D,276,N,3c6m:C,276,"200,000-fold decrease in catalytic efficiency.",,,-1.0,,,,,,,,,,,,,P52788_D_276_N
P52788,E,353,Q,3c6m:C,353,800-fold decrease in catalytic efficiency.,,,-1.0,,,,,,,,,,,,,P52788_E_353_Q
P52789,D,209,A,5hfu:B,209,Decreased hexokinase activity.,,,-1.0,,,,,,,,,,,,,P52789_D_209_A
P52789,D,657,A,5hfu:B,657,Decreased hexokinase activity.,,,-1.0,,,,,,,,,,,,,P52789_D_657_A
P20340,Q,72,L,5lef:A,72,Loss of GTPase activity. Interacts with APBA1.,1.0,,-1.0,,,,,,,,,,,,,P20340_Q_72_L
Q96SB4,S,222,A,5mxx:A,222,No effect on protein phosphorylation.,,,0.0,,,,,,,,,,,,,Q96SB4_S_222_A
Q96SB4,S,555,A,3beg:A,555,Protein phosphorylation impaired at this position.,,,-1.0,,,,,,,,,,,,,Q96SB4_S_555_A
Q96SB4,S,619,A,3beg:A,619,No effect on protein phosphorylation.,,,0.0,,,,,,,,,,,,,Q96SB4_S_619_A
O43173,H,354,A,5cxy:A,354,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O43173_H_354_A
Q8N4A0,D,459,H,6h0b:B,459,"Affects the glycopeptide specificity and abolishes ability to glycosylate Muc1, Muc2 and Muc5AC.",,,-1.0,,,,,,,,,,,,,Q8N4A0_D_459_H
Q5VZV1,D,141,A,4mtl:B,141,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q5VZV1_D_141_A
Q14451,Y,480,F,1mw4:A,68,Global loss of tyrosine phosphorylation. Abolishes interaction with FHL2 and HAX1.,-1.0,,-1.0,,,,,,,,,,,,,Q14451_Y_480_F
Q14451,Y,492,F,1mw4:A,80,Global loss of tyrosine phosphorylation. Abolishes interaction with FHL2 and HAX1.,-1.0,,-1.0,,,,,,,,,,,,,Q14451_Y_492_F
Q14451,F,511,R,1mw4:A,99,Abolishes dimerization. Abolishes activation of HRAS.,-1.0,,-1.0,,,,,,,,,,,,,Q14451_F_511_R
Q96LW7,L,17,A,4dwn:A,17,Abolishes the NF-kappa-B inhibitory activity.,,,-1.0,,,,,,,,,,,,,Q96LW7_L_17_A
Q96LW7,L,65,A,4dwn:A,65,Abolishes the NF-kappa-B inhibitory activity.,,,-1.0,,,,,,,,,,,,,Q96LW7_L_65_A
Q9BWS9,W,277,A,3bxw:B,255,No noticeable effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9BWS9_W_277_A
Q13093,S,108,A,3f98:A,108,Activity is higher than wild-type.,,,1.0,,,,,,,,,,,,,Q13093_S_108_A
Q13093,S,273,A,3f98:A,273,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13093_S_273_A
Q13093,D,286,A,3f98:A,286,Almost no activity.,,,-1.0,,,,,,,,,,,,,Q13093_D_286_A
Q13093,D,286,N,3f98:A,286,Diminishes activity.,,,-1.0,,,,,,,,,,,,,Q13093_D_286_N
Q13093,D,296,A,3f98:A,296,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13093_D_296_A
Q13093,D,296,N,3f98:A,296,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13093_D_296_N
Q13093,D,304,A,3f98:A,304,No change in activity.,,,0.0,,,,,,,,,,,,,Q13093_D_304_A
Q13093,D,338,A,3f98:A,338,Activity is higher than wild-type.,,,1.0,,,,,,,,,,,,,Q13093_D_338_A
Q13093,H,351,A,3f98:A,351,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13093_H_351_A
P26358,C,653,G,3swr:A,653,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_653_G
P26358,C,656,G,3swr:A,656,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_656_G
P26358,C,659,G,3swr:A,659,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_659_G
P26358,C,664,F,3swr:A,664,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_664_F
P26358,C,667,G,3swr:A,667,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_667_G
P26358,C,670,G,3swr:A,670,Reduces activity about 10-fold,,,-1.0,,,,,,,,,,,,,P26358_C_670_G
P26358,C,1226,A,3swr:A,1226,Loss of activity.,,,-1.0,,,,,,,,,,,,,P26358_C_1226_A
Q4G0W2,Y,102,H,5y15:A,102,Decreases the already low catalytic activity.,,,-1.0,,,,,,,,,,,,,Q4G0W2_Y_102_H
Q4G0W2,C,103,S,5y15:A,103,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q4G0W2_C_103_S
Q4G0W2,N,105,A,5y15:A,105,Increases activity with phosphotyrosine,,,1.0,,,,,,,,,,,,,Q4G0W2_N_105_A
Q4G0W2,R,107,V,5y15:A,107,Increases activity with phosphotyrosine,,,1.0,,,,,,,,,,,,,Q4G0W2_R_107_V
Q9UQ84,D,78,A,5v0d:Z,78,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. Also reduces DNA-binding to 5'-overhanging flap structures.,,-1.0,-1.0,,,,,,,,,,,,,Q9UQ84_D_78_A
Q9UQ84,D,173,A,5v0d:Z,173,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. No effect on DNA-binding to 5'-overhanging flap structures.,,0.0,-1.0,,,,,,,,,,,,,Q9UQ84_D_173_A
Q9UQ84,D,225,A,5v0d:Z,225,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. Also enhances DNA-binding to 5'-overhanging flap structures.,,1.0,-1.0,,,,,,,,,,,,,Q9UQ84_D_225_A
O14960,Y,104,H,5b0h:A,86,No metalloendopeptidase activity.,,,-1.0,,,,,,,,,,,,,O14960_Y_104_H
O14965,K,162,R,4dee:A,162,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O14965_K_162_R
O14965,G,198,N,4dee:A,198,Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA.,,,-1.0,,,,,,,,,,,,,O14965_G_198_N
O14965,D,274,N,4dee:A,274,Abolishes autophosphorylation.,,,-1.0,,,,,,,,,,,,,O14965_D_274_N
O14965,T,287,A,4dee:A,287,No direct effect on catalytic activity.,,,0.0,,,,,,,,,,,,,O14965_T_287_A
O14965,T,288,D,4dee:A,288,Mimics phosphorylation state and increases kinase activity.,,,1.0,,,,,,,,,,1.0,,,O14965_T_288_D
Q99574,N,161,G,3fgq:A,161,Increases protein stability and abolishes tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_N_161_G
Q99574,L,162,K,3fgq:A,162,Increases protein stability and abolishes tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_L_162_K
Q99574,V,163,I,3fgq:A,163,Increases protein stability and decreases tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,,,Q99574_V_163_I
Q99574,E,289,A,3fgq:A,289,Slightly decreases inhibitory activity. No effect on thermal stability.,,,-1.0,,,,,,,,,,,0.0,,Q99574_E_289_A
Q99574,S,340,A,3fgq:A,340,Increases protein stability and decreases tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_S_340_A
Q9GZU7,D,98,N,1t9z:A,98,Completely abolishes phosphatase activity,,,-1.0,,,,,,,,,,,,,Q9GZU7_D_98_N
P40818,C,786,S,3n3k:A,786,Impairs deubiquitination activity and leads to endosome membrane accumulation.,,,-1.0,,,,,,,,,1.0,,,,P40818_C_786_S
Q15493,E,18,A,4gnc:A,18,Reduces enzyme activity by about 90%.,,,-1.0,,,,,,,,,,,,,Q15493_E_18_A
Q15493,N,103,A,4gnc:A,103,Reduces enzyme activity by about 95%.,,,-1.0,,,,,,,,,,,,,Q15493_N_103_A
Q15493,N,154,A,4gnc:A,154,Reduces enzyme activity by about 95%.,,,-1.0,,,,,,,,,,,,,Q15493_N_154_A
Q15493,D,204,A,4gnc:A,204,Reduces enzyme activity by over 98%.,,,-1.0,,,,,,,,,,,,,Q15493_D_204_A
Q16696,L,110,V,2pg6:A,110,Decreases phenacetin O-deethylation activity 8 fold.,,,-1.0,,,,,,,,,,,,,Q16696_L_110_V
Q16696,A,117,V,2pg6:A,117,Increases phenacetin O-deethylation activity 5 fold.,,,1.0,,,,,,,,,,,,,Q16696_A_117_V
Q16696,S,208,I,2pg6:A,208,Decreases phenacetin O-deethylation activity 10 fold.,,,-1.0,,,,,,,,,,,,,Q16696_S_208_I
Q16696,A,213,S,2pg6:A,213,Decreases phenacetin O-deethylation activity 2 fold.,,,-1.0,,,,,,,,,,,,,Q16696_A_213_S
Q16696,F,300,I,2pg6:A,300,Decreases phenacetin O-deethylation activity 40 fold.,,,-1.0,,,,,,,,,,,,,Q16696_F_300_I
Q16696,A,301,G,2pg6:A,301,Decreases phenacetin O-deethylation activity 20 fold.,,,-1.0,,,,,,,,,,,,,Q16696_A_301_G
Q16696,M,365,V,2pg6:A,365,Decreases phenacetin O-deethylation activity 7 fold.,,,-1.0,,,,,,,,,,,,,Q16696_M_365_V
Q16696,L,366,I,2pg6:A,366,Increases phenacetin O-deethylation activity 3 fold.,,,1.0,,,,,,,,,,,,,Q16696_L_366_I
Q16696,G,369,S,2pg6:A,369,Decreases phenacetin O-deethylation activity 9 fold.,,,-1.0,,,,,,,,,,,,,Q16696_G_369_S
Q16696,H,372,R,2pg6:A,372,Decreases phenacetin O-deethylation activity 3 fold.,,,-1.0,,,,,,,,,,,,,Q16696_H_372_R
O14818,Y,153,F,5ln3:D,153,Displays impaired G1/S transition and S/G2 progression.,,,-1.0,,,,,,,,,,,,,O14818_Y_153_F
P36873,H,125,A,4ut3:A,125,Loss of activity.,,,-1.0,,,,,,,,,,,,,P36873_H_125_A
Q16698,N,148,A,1w73:D,148,Reduces enzyme activity by 97%.,,,-1.0,,,,,,,,,,,,,Q16698_N_148_A
Q16698,Y,199,A,1w73:D,199,Reduces enzyme activity by 99%. Strongly reduced affinity for substrate and for NADP.,,-1.0,-1.0,,,,,,,,,,,,,Q16698_Y_199_A
Q16698,S,210,A,1w73:D,210,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q16698_S_210_A
Q16698,K,214,A,1w73:D,214,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q16698_K_214_A
Q13435,K,507,A,6qx9:B2,507,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,-1.0,,,,,,,,,,,,,Q13435_K_507_A
Q13435,K,507,R,6qx9:B2,507,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,-1.0,,,,,,,,,,,,,Q13435_K_507_R
Q13435,K,509,A,6qx9:B2,509,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,-1.0,,,,,,,,,,,,,Q13435_K_509_A
Q13435,K,509,R,6qx9:B2,509,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,-1.0,,,,,,,,,,,,,Q13435_K_509_R
P04424,K,51,N,1k62:B,51,2-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,P04424_K_51_N
P04424,H,89,Q,1k62:B,89,10-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,P04424_H_89_Q
O95497,E,79,A,4cyg:A,79,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O95497_E_79_A
O95497,K,178,A,4cyg:A,178,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O95497_K_178_A
O60306,K,829,A,7abi:U,829,Decreased affinity for ATP and ADP. Loss of RNA helicase activity. Disrupts spliceosomal pre-mRNA splicing and leads to the accumulation of spliceosomal B complexes.,,-1.0,-1.0,,,,,,,,,,,,,O60306_K_829_A
O60306,Y,1196,A,7abi:U,1196,Strongly reduced RNA helicase activity. No effect on ATPase activity. No effect on spliceosomal pre-mRNA splicing.,,,-1.0,,,,,,,,,,,,,O60306_Y_1196_A
Q6DD88,K,73,A,5vgr:A,73,Alters endoplasmic reticulum morphogenesis.,,,-1.0,,,,,,,,,,,,,Q6DD88_K_73_A
Q6DD88,R,213,Q,5vgr:A,213,Alters endoplasmic reticulum morphogenesis.,,,-1.0,,,,,,,,,,,,,Q6DD88_R_213_Q
Q96QP1,Q,67,A,5z2c:A,67,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_Q_67_A
Q96QP1,R,116,A,5z2c:A,116,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_R_116_A
Q96QP1,R,150,A,5z2c:A,150,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_R_150_A
Q96QP1,R,153,A,5z2c:A,153,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_R_153_A
Q96QP1,D,231,A,5z2c:A,231,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_D_231_A
Q96QP1,K,233,A,5z2c:A,233,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_K_233_A
Q96QP1,T,237,E,5z2c:A,237,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_T_237_E
Q96QP1,F,295,K,5z2c:A,295,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,-1.0,,,,,,,,,,,,,Q96QP1_F_295_K
Q8WXF7,R,77,A,4idp:D,77,Abolishes GTPase activity and impairs homodimerization.,-1.0,,-1.0,,,,,,,,,,,,,Q8WXF7_R_77_A
Q8WXF7,K,80,A,4idp:D,80,Alters endoplasmic reticulum morphogenesis.,,,-1.0,,,,,,,,,,,,,Q8WXF7_K_80_A
Q8WXF7,F,151,S,4idp:D,151,Affects endoplasmic reticulum and Golgi morphology.,,,-1.0,,,,,,,,,,,,,Q8WXF7_F_151_S
Q8WXF7,T,162,P,4idp:D,162,Affects endoplasmic reticulum and Golgi morphology.,,,-1.0,,,,,,,,,,,,,Q8WXF7_T_162_P
Q8WXF7,H,247,R,4idp:D,247,Impairs homodimerization and GTPase activity.,-1.0,,-1.0,,,,,,,,,,,,,Q8WXF7_H_247_R
Q8WXF7,S,398,Y,4idp:D,398,Affects endoplasmic reticulum and Golgi morphology.,,,-1.0,,,,,,,,,,,,,Q8WXF7_S_398_Y
O60907,V,111,N,2xtc:A,60,Reduced interaction with NCOR2 and GPS2. Abolished ability to repress transcription.,-1.0,,-1.0,,,,,,,,,,,,,O60907_V_111_N
O60907,V,111,Q,2xtc:A,60,Reduced interaction with NCOR2 and GPS2. Abolished ability to repress transcription.,-1.0,,-1.0,,,,,,,,,,,,,O60907_V_111_Q
Q96GD4,K,106,R,4af3:A,106,Leads to loss of kinase activity and severely impairs mitotic progression.,,,-1.0,,,,,,,,,,,,,Q96GD4_K_106_R
Q96GD0,D,25,N,5gyn:A,25,Abolishes phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q96GD0_D_25_N
P49773,V,97,D,6g9z:A,97,Loss of dimerization. Strongly reduced enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,P49773_V_97_D
P49773,V,97,E,6g9z:A,97,Loss of dimerization. Strongly reduced enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,P49773_V_97_E
P49773,G,105,A,6g9z:A,105,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,P49773_G_105_A
P49773,S,107,A,6g9z:A,107,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,P49773_S_107_A
P49773,H,114,A,6g9z:A,114,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P49773_H_114_A
P49773,W,123,A,6g9z:A,123,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P49773_W_123_A
P15291,Y,285,F,6fwt:A,285,No change in enzymatic activity.,,,-1.0,,,,,,,,,,,,,P15291_Y_285_F
P50336,R,59,G,3nks:A,59,Decreases enzyme activity by 75%.,,,-1.0,,,,,,,,,,,,,P50336_R_59_G
P50336,R,59,Q,3nks:A,59,Decreases enzyme activity by 90%. Strongly decreases affinity for protoporphyrinogen-IX.,,-1.0,-1.0,,,,,,,,,,,,,P50336_R_59_Q
P50336,L,74,P,3nks:A,74,Abolishes enzyme activity. Impairs protein folding and/or stability.,,,-1.0,,,,,,,,,,,-1.0,,P50336_L_74_P
P50336,R,97,D,3nks:A,97,Decreases enzyme activity by 89%. Impairs protein folding and/or stability.,,,-1.0,,,,,,,,,,,-1.0,,P50336_R_97_D
P50336,L,166,N,4ivo:B,166,Decreases enzyme activity by 95%.,,,-1.0,,,,,,,,,,,,,P50336_L_166_N
P50336,G,169,A,4ivo:B,169,Decreases enzyme activity by 64%.,,,-1.0,,,,,,,,,,,,,P50336_G_169_A
P50336,S,284,I,4ivo:B,284,Decreases enzyme activity by 87%. Impairs protein folding and/or stability.,,,-1.0,,,,,,,,,,,-1.0,,P50336_S_284_I
P50336,V,290,L,4ivo:B,290,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P50336_V_290_L
P50336,F,331,A,4ivo:B,331,Decreases enzyme activity by 50%.,,,-1.0,,,,,,,,,,,,,P50336_F_331_A
P50336,L,334,A,4ivo:B,334,Decreases enzyme activity by 86%.,,,-1.0,,,,,,,,,,,,,P50336_L_334_A
P50336,V,347,A,4ivo:B,347,Decreases enzyme activity by 45%.,,,-1.0,,,,,,,,,,,,,P50336_V_347_A
P50336,M,368,A,4ivo:B,368,Decreases enzyme activity by 52%.,,,-1.0,,,,,,,,,,,,,P50336_M_368_A
P11021,T,229,A,6asy:A,229,Impaired ATPase activity.,,,-1.0,,,,,,,,,,,,,P11021_T_229_A
P15056,M,53,D,5vyk:C,1053,Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.,-1.0,,-1.0,,,,,,,,,,,,,P15056_M_53_D
P15056,K,88,E,5vyk:C,1088,Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.,-1.0,,-1.0,,,,,,,,,,,,,P15056_K_88_E
P15056,K,483,S,6nyb:A,483,Reduces kinase activity with MAP2K1.,-1.0,,-1.0,,,,,,,,,,,,,P15056_K_483_S
P15056,I,666,R,6nyb:A,666,"No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1.",0.0,,-1.0,,,,,,,,,,,,,P15056_I_666_R
P15056,R,671,K,6nyb:A,671,Increased kinase activity and stability in response to EGF treatment.,,,1.0,,,,,,,,,,,1.0,,P15056_R_671_K
P50440,D,170,N,3jdw:A,170,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P50440_D_170_N
P50440,E,233,K,3jdw:A,233,Complete loss of activity,,,-1.0,,,,,,,,,,,,,P50440_E_233_K
P50440,D,254,N,3jdw:A,254,Significantly reduced activity.,,,-1.0,,,,,,,,,,,,,P50440_D_254_N
P50440,H,303,V,3jdw:A,303,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P50440_H_303_V
P50440,D,305,A,3jdw:A,305,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P50440_D_305_A
P50440,R,322,E,3jdw:A,322,Significantly reduced activity.,,,-1.0,,,,,,,,,,,,,P50440_R_322_E
P50440,S,355,A,3jdw:A,355,Significantly reduced activity.,,,-1.0,,,,,,,,,,,,,P50440_S_355_A
P50440,C,407,S,3jdw:A,407,Complete loss of activity,,,-1.0,,,,,,,,,,,,,P50440_C_407_S
P50440,C,410,A,3jdw:A,410,No effect on activity.,,,0.0,,,,,,,,,,,,,P50440_C_410_A
Q9NR71,G,124,R,4wgk:B,124,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_G_124_R
Q9NR71,H,194,A,4wgk:B,194,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_H_194_A
Q9NR71,H,196,A,4wgk:B,196,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_H_196_A
Q9NR71,A,211,R,4wgk:B,211,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_A_211_R
Q9NR71,R,257,A,4wgk:B,257,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_R_257_A
Q9NR71,S,258,A,4wgk:B,258,Decreased ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_S_258_A
Q9NR71,H,303,A,4wgk:B,303,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_H_303_A
Q9NR71,D,352,S,4wgk:B,352,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_D_352_S
Q9NR71,S,354,A,4wgk:B,354,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_S_354_A
Q9NR71,C,362,A,4wgk:B,362,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_C_362_A
Q9NR71,S,374,A,4wgk:B,374,Decreased ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_S_374_A
Q9NR71,S,396,A,4wgk:B,396,No effect on ceramide hydrolase activity.,,,0.0,,,,,,,,,,,,,Q9NR71_S_396_A
Q9NR71,G,465,R,4wgk:B,465,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_G_465_R
Q9NR71,E,540,A,4wgk:B,540,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_E_540_A
Q9NR71,Y,579,F,4wgk:B,579,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_Y_579_F
Q9NR71,Y,591,F,4wgk:B,591,Loss of ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_Y_591_F
Q9NR71,S,595,A,4wgk:B,595,Decreased ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_S_595_A
Q9NR71,S,729,A,4wgk:B,729,Decreased ceramide hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q9NR71_S_729_A
Q9UQB8,K,142,E,1y2o:A,142,Abolishes actin-bundling and filopodia formation,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_K_142_E
Q9UQB8,K,143,E,1y2o:A,143,Abolishes actin-bundling and filopodia formation,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_K_143_E
Q9UQB8,K,146,E,1y2o:A,146,Abolishes actin-bundling and filopodia formation,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_K_146_E
Q9UQB8,K,147,E,1y2o:A,147,Abolishes actin-bundling and filopodia formation,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_K_147_E
Q9UQB8,W,413,G,3rnj:A,413,Impairs the SH3 domain and abolishes the interaction with EPS8.,-1.0,,-1.0,,,,,,,,,,,-1.0,,Q9UQB8_W_413_G
Q9UQB8,F,427,A,3rnj:A,427,Loss of interaction with ENAH and no induction of filopodia,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_F_427_A
Q9UQB8,P,428,A,3rnj:A,428,Loss of interaction with ENAH and no induction of filopodia,-1.0,,-1.0,,,,,,,,,,,,,Q9UQB8_P_428_A
Q9UQB9,K,72,R,6gr9:A,72,Impairs kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UQB9_K_72_R
Q9UQB9,D,166,Y,6gr9:A,166,"Impairs kinase activity, and keeps AURKC with the chromosomes until the end of mitosis.",,,-1.0,,,,,,,,,,,,,Q9UQB9_D_166_Y
Q9UQB9,T,198,A,6gr9:A,198,Impairs kinase activity.,,,-1.0,,,,,,,,,,,,,Q9UQB9_T_198_A
Q13882,W,44,A,2kgt:A,44,Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region.,-1.0,,-1.0,,,,,,,,,,,,,Q13882_W_44_A
Q13882,Y,66,A,2kgt:A,66,Decrease in STAP2 phosphorylation.,,,-1.0,,,,,,,,,,,,,Q13882_Y_66_A
Q13882,R,105,L,1rja:A,31,Decrease in STAP2 phosphorylation.,,,-1.0,,,,,,,,,,,,,Q13882_R_105_L
Q13882,W,184,A,6cz3:A,184,Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1.,-1.0,,-1.0,,,,,,,,,,,,,Q13882_W_184_A
Q13882,K,219,M,5d7v:A,219,"Abolishes kinase activity and cell transformation, and phosphorylation of STAP2.",,,-1.0,,,,,,,,,,,,,Q13882_K_219_M
Q13882,K,219,R,5d7v:A,219,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q13882_K_219_R
Q13882,Y,342,A,5d7v:A,342,"3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation",,,-1.0,,,,,,,,,,,,,Q13882_Y_342_A
Q13888,C,291,A,6o9l:6,291,Reconstituted TFIIH complex lacks p62 and has no transcriptional activity.,,,-1.0,,,,,,,,,,,,,Q13888_C_291_A
Q13888,C,308,A,6o9l:6,308,Reconstituted TFIIH complex lacks p62 and has no transcriptional activity.,,,-1.0,,,,,,,,,,,,,Q13888_C_308_A
Q13888,C,345,A,6o9l:6,345,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_345_A
Q13888,C,360,A,6o9l:6,360,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_360_A
Q13888,C,363,A,6o9l:6,363,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_363_A
Q13888,H,376,A,6o9l:6,376,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_H_376_A
Q13888,H,380,A,6o9l:6,380,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_H_380_A
Q13888,C,382,A,6o9l:6,382,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_382_A
O00141,K,127,M,3hdm:A,127,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,O00141_K_127_M
O00141,T,256,A,2r5t:A,256,Low activity.,,,-1.0,,,,,,,,,,,,,O00141_T_256_A
O00141,T,256,D,2r5t:A,256,Low activity.,,,-1.0,,,,,,,,,,,,,O00141_T_256_D
O00141,T,256,E,2r5t:A,256,Low activity.,,,-1.0,,,,,,,,,,,,,O00141_T_256_E
Q9P2T1,C,186,A,2a7r:A,186,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9P2T1_C_186_A
Q9P2T1,T,188,A,2a7r:A,188,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9P2T1_T_188_A
Q9P2T1,E,289,Q,2a7r:A,289,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9P2T1_E_289_Q
P51795,Y,687,A,2ja3:D,617,"Strongly decreased affinity for ATP, but no effect on chloride transport.",,-1.0,0.0,,,,,,,,,,,,,P51795_Y_687_A
P51795,S,688,A,2ja3:D,618,No effect ATP binding or chloride transport.,,0.0,0.0,,,,,,,,,,,,,P51795_S_688_A
P51795,D,797,A,2ja3:D,727,"Strongly decreased affinity for ATP, but no effect on chloride transport.",,-1.0,0.0,,,,,,,,,,,,,P51795_D_797_A
O14638,K,204,A,6c01:A,204,Strongly decreases affinity for nucleotides and slows their hydrolysis.,,-1.0,-1.0,,,,,,,,,,,,,O14638_K_204_A
O14638,N,227,A,6c01:A,227,No effect on affinity for nucleotides and enzyme activity.,,0.0,0.0,,,,,,,,,,,,,O14638_N_227_A
O14638,E,275,A,6c01:A,275,No effect on substrate specificity. Increases affinity for nucleotides and slows their hydrolysis.,,1.0,-1.0,,,,,,,,,,,,,O14638_E_275_A
P13995,D,168,A,6jid:A,168,Significant loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_D_168_A
P13995,D,168,E,6jid:A,168,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_D_168_E
P13995,D,168,N,6jid:A,168,80% decrease in NAD-dependent dehydrogenase specific activity. 18% decrease in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,-1.0,,,,,,,,,,,,,P13995_D_168_N
P13995,D,168,S,6jid:A,168,82% decrease in NAD-dependent dehydrogenase specific activity. 65% decrease in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,-1.0,,,,,,,,,,,,,P13995_D_168_S
P13995,R,201,A,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_R_201_A
P13995,R,201,S,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_R_201_S
P13995,R,201,K,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_R_201_K
P13995,D,225,A,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_D_225_A
P13995,D,225,S,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_D_225_S
P13995,D,225,E,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_D_225_E
P13995,D,225,N,6jid:A,225,84% decrease in NAD-dependent dehydrogenase specific activity. 36% increase in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,-1.0,,,,,,,,,,,,,P13995_D_225_N
P13995,R,233,A,6jid:A,233,Significant loss of NAD and NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_R_233_A
P13995,R,233,K,6jid:A,233,50% decrease in NAD and NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,,-1.0,,,,,,,,,,,,,P13995_R_233_K
P13995,R,233,S,6jid:A,233,Almost complete loss of NAD-dependent dehydrogenase specific activity. 50% decrease in NADP-dependent dehydrogenase specific activity.,,,-1.0,,,,,,,,,,,,,P13995_R_233_S
P55011,R,294,A,6pzt:A,294,Severely impairs transporter activity.,,,-1.0,,,,,,,,,,,,,P55011_R_294_A
Q9Y2R2,C,129,S,3h2x:A,129,Decreases activity 2 fold.,,,-1.0,,,,,,,,,,,,,Q9Y2R2_C_129_S
Q9Y2R2,C,231,S,3h2x:A,231,Decreases activity 7 fold.,,,-1.0,,,,,,,,,,,,,Q9Y2R2_C_231_S
P51955,K,37,R,5m51:A,37,Loss of kinase activity and of ability to activate NEK11.,-1.0,,-1.0,,,,,,,,,,,,,P51955_K_37_R
P51955,T,170,A,2w5b:A,170,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,P51955_T_170_A
P51955,T,170,E,2w5b:A,170,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_T_170_E
P51955,S,171,A,2w5b:A,171,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,P51955_S_171_A
P51955,S,171,D,2w5b:A,171,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_S_171_D
P51955,T,175,A,2w5b:A,175,Kinase activity decreased by two fold.,,,-1.0,,,,,,,,,,,,,P51955_T_175_A
P51955,T,175,E,2w5b:A,175,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_T_175_E
P51955,T,179,A,2w5b:A,179,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51955_T_179_A
P51955,T,179,E,2w5b:A,179,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51955_T_179_E
P51955,S,241,A,2w5b:A,241,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51955_S_241_A
P51955,S,241,D,2w5b:A,241,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P51955_S_241_D
P30041,S,32,A,5b6m:F,32,"Loss of phospholipase activity, but no effect on peroxidase activity.",,,-1.0,,,,,,,,,,,,,P30041_S_32_A
P30041,C,47,S,5b6m:F,47,"Loss of peroxidase activity, but no effect on phospholipase activity.",,,-1.0,,,,,,,,,,,,,P30041_C_47_S
P30044,C,100,S,1urm:A,47,Loss of antioxidant activity. Loss of S-palmitoylation.,,,-1.0,,,,,,-1.0,,,,,,,P30044_C_100_S
P30044,C,125,S,1urm:A,72,No change in antioxidant activity. No change in S-palmitoylation levels.,,,0.0,,,,,,0.0,,,,,,,P30044_C_125_S
P30044,C,204,S,1urm:A,151,Loss of antioxidant activity. No change in S-palmitoylation levels.,,,-1.0,,,,,,0.0,,,,,,,P30044_C_204_S
Q96EF0,A,253,K,4y7i:A,253,Increases catalytic activity.,,,1.0,,,,,,,,,,,,,Q96EF0_A_253_K
Q96EF0,K,255,A,4y7i:A,255,Decreases catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96EF0_K_255_A
Q9BV20,C,168,S,4ldr:B,168,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9BV20_C_168_S
Q9BV20,D,248,A,4ldr:B,248,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9BV20_D_248_A
Q9NP77,C,12,S,3o2q:E,12,Abolishes phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q9NP77_C_12_S
P08922,K,1980,M,4uxl:A,1980,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P08922_K_1980_M
P62877,C,53,A,2lgv:A,53,Strong reduction in ligase activity,,,-1.0,,,,,,,,,,,,,P62877_C_53_A
P62877,C,56,A,2lgv:A,56,Strong reduction in ligase activity,,,-1.0,,,,,,,,,,,,,P62877_C_56_A
P62877,C,75,A,2lgv:A,75,Strong reduction in ligase activity,,,-1.0,,,,,,,,,,,,,P62877_C_75_A
P62877,H,77,A,2lgv:A,77,Strong reduction in ligase activity,,,-1.0,,,,,,,,,,,,,P62877_H_77_A
P35968,K,868,M,4ase:A,868,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P35968_K_868_M
P35968,Y,996,F,3u6j:A,996,Strongly reduced autophosphorylation. Reduces phosphorylation of PLCG1.,,,-1.0,-1.0,,,,,,,,,,,,P35968_Y_996_F
P35968,C,1045,A,3u6j:A,1045,Significantly higher kinase activity.,,,1.0,,,,,,,,,,,,,P35968_C_1045_A
P35968,Y,1054,F,3u6j:A,1054,Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins,,,-1.0,-1.0,,,,,,,,,,,,P35968_Y_1054_F
P35968,Y,1059,F,3u6j:A,1059,Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins,,,-1.0,-1.0,,,,,,,,,,,,P35968_Y_1059_F
Q86WT6,C,61,A,6yxe:A,61,Loss of E3 ubiquitin-protein ligase activity,,,-1.0,,,,,,,,,,,,,Q86WT6_C_61_A
Q86WT6,C,64,A,6yxe:A,64,Loss of E3 ubiquitin-protein ligase activity,,,-1.0,,,,,,,,,,,,,Q86WT6_C_64_A
Q07912,L,120,Q,4ewh:A,120,No effect on autophosphorylation at Y-284.,,,0.0,0.0,,,,,,,,,,,,Q07912_L_120_Q
Q07912,K,158,R,4ewh:A,158,Loss of autophosphorylation at Y-284.,,,-1.0,-1.0,,,,,,,,,,,,Q07912_K_158_R
Q07912,L,197,Q,4ewh:A,197,No effect on autophosphorylation at Y-284.,,,0.0,0.0,,,,,,,,,,,,Q07912_L_197_Q
Q07912,V,365,R,4ewh:A,365,Increased autophosphorylation at Y-284.,,,1.0,1.0,,,,,,,,,,,,Q07912_V_365_R
O00764,D,235,A,2f7k:A,235,"15-fold decrease in pyridoxal kinase activity, and a 7-fold decrease in affinity for pyridoxal.",,-1.0,-1.0,,,,,,,,,,,,,O00764_D_235_A
O00764,D,235,N,2f7k:A,235,2-fold decrease in pyridoxal kinase activity and pyridoxal affinity.,,-1.0,-1.0,,,,,,,,,,,,,O00764_D_235_N
O00762,C,114,S,1i7k:A,114,Loss of function,,,-1.0,,,,,,,,,,,,,O00762_C_114_S
P28562,C,258,S,6d66:A,458,Loss of phosphatase activity.,,,-1.0,,,,,,,,,,,,,P28562_C_258_S
P78330,S,23,A,1l8o:A,23,Reduces activity by about 50%.,,,-1.0,,,,,,,,,,,,,P78330_S_23_A
P78330,S,23,T,1l8o:A,23,Reduces activity by about 80%.,,,-1.0,,,,,,,,,,,,,P78330_S_23_T
P78330,E,29,D,1l8o:A,29,Reduces activity by about 95%.,,,-1.0,,,,,,,,,,,,,P78330_E_29_D
P78330,E,29,Q,1l8o:A,29,Loss of activity.,,,-1.0,,,,,,,,,,,,,P78330_E_29_Q
P78330,R,65,A,1l8o:A,65,Loss of activity.,,,-1.0,,,,,,,,,,,,,P78330_R_65_A
P78330,R,65,K,1l8o:A,65,Loss of activity.,,,-1.0,,,,,,,,,,,,,P78330_R_65_K
P78330,N,133,A,1l8o:A,133,Reduces activity by about 75%.,,,-1.0,,,,,,,,,,,,,P78330_N_133_A
P78330,T,182,S,1l8o:A,182,Reduces activity by about 99%.,,,-1.0,,,,,,,,,,,,,P78330_T_182_S
P78330,T,182,V,1l8o:A,182,Reduces activity by about 25%.,,,-1.0,,,,,,,,,,,,,P78330_T_182_V
P78330,R,202,A,1l8o:A,202,Reduces activity by about 99%.,,,-1.0,,,,,,,,,,,,,P78330_R_202_A
P78330,R,202,K,1l8o:A,202,Reduces activity by about 95%.,,,-1.0,,,,,,,,,,,,,P78330_R_202_K
P18031,C,215,S,2cni:A,215,Catalytically inactive mutant,,,-1.0,,,,,,,,,,,,,P18031_C_215_S
P78423,R,71,A,1b2t:A,47,Loss of binding to CX3CR1 and ability to induce chemotaxis but no effect on binding to integrins.,-1.0,,-1.0,,,,,,,,,,,,,P78423_R_71_A
Q92932,C,945,S,2qep:A,945,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q92932_C_945_S
Q9H867,E,73,Q,4lg1:A,73,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H867_E_73_Q
Q9H867,D,96,A,4lg1:A,96,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H867_D_96_A
Q9H867,D,96,V,4lg1:A,96,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H867_D_96_V
Q9H867,D,144,V,4lg1:A,144,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H867_D_144_V
O75223,G,23,A,2i5t:A,23,Marked decrease in catalytic efficiency.,,,-1.0,,,,,,,,,,,,,O75223_G_23_A
O75223,E,98,A,2i5t:A,98,Abolishes activity without altering structure.,,,-1.0,,,,,,,,,,,0.0,,O75223_E_98_A
O75223,E,98,Q,2i5t:A,98,Abolishes activity without altering structure.,,,-1.0,,,,,,,,,,,0.0,,O75223_E_98_Q
O75223,Y,105,F,2i5t:A,105,Marked decrease in catalytic efficiency and specific activity.,,,-1.0,,,,,,,,,,,,,O75223_Y_105_F
O75223,Y,125,F,2i5t:A,125,Little or no change in reaction kinetics.,,,0.0,,,,,,,,,,,,,O75223_Y_125_F
Q13153,H,83,L,1f3m:A,83,"Abolishes interaction with CDC42, leading to strongly decreased activity",-1.0,,-1.0,,,,,,,,,,,,,Q13153_H_83_L
Q13153,H,86,L,1f3m:A,86,"Abolishes interaction with CDC42, leading to strongly decreased activity",-1.0,,-1.0,,,,,,,,,,,,,Q13153_H_86_L
Q13153,L,107,F,1f3m:A,107,"Abolishes autoinhibition, leading to constitutive kinase activity.",,,1.0,,,,,,,,,,,,,Q13153_L_107_F
Q13153,K,299,R,5dey:A,299,Strongly decreases activity. Abolishes kinase activity,,,-1.0,,,,,,,,,,,,,Q13153_K_299_R
Q13153,D,389,N,5dey:A,389,Abolishes kinase activity,,,-1.0,,,,,,,,,,,,,Q13153_D_389_N
Q13153,D,393,A,5dey:A,393,Abolishes autophosphorylation at Thr-423.,,,-1.0,-1.0,,,,,,,,,,,,Q13153_D_393_A
Q13153,T,423,A,5dey:A,423,Decreases CDC42-stimulated activity and autophosphorylation.,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q13153_T_423_A
Q13153,T,423,E,5dey:A,423,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,Q13153_T_423_E
Q14191,E,84,A,2fbx:A,84,Abolishes exonuclease activity.,,,-1.0,,,,,,,,,,,,,Q14191_E_84_A
Q14191,L,88,A,2fbx:A,88,No effect on exonuclease activity.,,,0.0,,,,,,,,,,,,,Q14191_L_88_A
Q14191,W,145,A,2fbx:A,145,Reduces exonuclease activity.,,,-1.0,,,,,,,,,,,,,Q14191_W_145_A
Q14191,Y,212,F,2fbx:A,212,Strongly reduces exonuclease activity.,,,-1.0,,,,,,,,,,,,,Q14191_Y_212_F
Q05193,K,44,A,6dlu:P,44,Inhibits receptor-mediated endocytosis.,,,-1.0,,,,,,,,,,,,,Q05193_K_44_A
Q6PHR2,K,44,R,6fdy:U,44,Decreased kinase activity.,,,-1.0,,,,,,,,,,,,,Q6PHR2_K_44_R
Q6PHR2,K,139,R,6fdy:U,139,Loss of kinase activity. Does not promote GLI1 nuclear localization.,,,-1.0,,,,,,,,,,,,,Q6PHR2_K_139_R
P68036,K,9,E,4q5h:C,9,Marked decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P68036_K_9_E
P68036,F,63,A,4q5h:C,63,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P68036_F_63_A
P68036,C,86,S,4q5h:C,86,Loss of catalytic activity. Prevents ubiquitin-dependent proteasomal degradation of UBE2L3.,,,-1.0,,,,,,,,,,,,,P68036_C_86_S
P68036,E,93,R,4q5h:C,93,Decrease in autoubiquitination.,,,-1.0,,,,,,,,,,,,,P68036_E_93_R
P68036,K,96,E,4q5h:C,96,Decrease in autoubiquitination.,,,-1.0,,,,,,,,,,,,,P68036_K_96_E
P68036,K,100,E,4q5h:C,100,Decrease in autoubiquitination.,,,-1.0,,,,,,,,,,,,,P68036_K_100_E
P07814,F,1097,A,4k88:A,97,Almost complete loss of prolyl-tRNA ligase activity.,,,-1.0,,,,,,,,,,,,,P07814_F_1097_A
P07814,F,1097,W,4k88:A,97,No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone.,,-1.0,0.0,,,,,,,,,,,,,P07814_F_1097_W
P07814,R,1152,K,4k88:A,152,No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone.,,-1.0,0.0,,,,,,,,,,,,,P07814_R_1152_K
P07814,R,1152,L,4k88:A,152,Almost complete loss of prolyl-tRNA ligase activity.,,,-1.0,,,,,,,,,,,,,P07814_R_1152_L
Q15910,S,21,A,5ls6:A,21,Enhances methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1.,,,1.0,-1.0,,,,,,,,,,,,Q15910_S_21_A
Q15910,S,21,D,5ls6:A,21,Reduces methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1.,,,-1.0,-1.0,,,,,,,,,,,,Q15910_S_21_D
Q15910,C,588,Y,6wkr:C,588,Strongly impairs methyltransferase activity towards 'Lys-27' of histone H3.,,,-1.0,,,,,,,,,,,,,Q15910_C_588_Y
Q15910,F,667,I,6wkr:C,667,Strongly decreases histone methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q15910_F_667_I
Q15910,H,689,A,6wkr:C,689,Abrogates methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q15910_H_689_A
O75643,R,603,A,6s8q:B,603,Strongly decreased ATP-dependent RNA helicase activity.,,,-1.0,,,,,,,,,,,,,O75643_R_603_A
O75643,R,637,A,6s8q:B,637,Strongly decreased ATP-dependent RNA helicase activity.,,,-1.0,,,,,,,,,,,,,O75643_R_637_A
O75643,K,1544,A,6s8q:B,1544,Decreased ATP-dependent RNA helicase activity.,,,-1.0,,,,,,,,,,,,,O75643_K_1544_A
O75643,H,1548,A,6s8q:B,1548,Strongly decreased ATP-dependent RNA helicase activity.,,,-1.0,,,,,,,,,,,,,O75643_H_1548_A
O75643,T,1578,A,6s8q:B,1578,Decreased ATP-dependent RNA helicase activity.,,,-1.0,,,,,,,,,,,,,O75643_T_1578_A
Q93096,D,71,A,5bx1:A,71,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q93096_D_71_A
Q93096,D,72,A,5bx1:A,72,80% loss of catalytic activity,,,-1.0,,,,,,,,,,,,,Q93096_D_72_A
Q93096,C,104,S,5bx1:A,104,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q93096_C_104_S
O75319,H,166,G,4jmj:A,92,No effect on phosphatase activity with ATP and ADP.,,,0.0,,,,,,,,,,,,,O75319_H_166_G
O75319,C,199,S,4jmj:A,125,Loss of activity. No effect in RNA-binding.,,0.0,-1.0,,,,,,,,,,,,,O75319_C_199_S
O75319,H,201,A,4jmj:A,127,Strongly decreases phosphatase activity with ATP and ADP.,,,-1.0,,,,,,,,,,,,,O75319_H_201_A
O75319,N,204,A,4jmj:A,130,Strongly decreases phosphatase activity with ATP and ADP.,,,-1.0,,,,,,,,,,,,,O75319_N_204_A
O75319,R,239,K,4jmj:A,165,Slightly decreases phosphatase activity with ATP. Strongly decreases phosphatase activity with ADP.,,,-1.0,,,,,,,,,,,,,O75319_R_239_K
Q8N6T7,H,133,Y,5y2f:A,131,Loss of enzyme activity. Abolishes RBBP8 deacetylation and promotion of DNA end resection after DNA damage.,,,-1.0,,,,,,,,,,,,,Q8N6T7_H_133_Y
Q04759,Y,90,F,2enj:A,90,Loss of function in T-cells proliferation. No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q04759_Y_90_F
Q04759,A,148,E,2enn:A,148,Constitutively active form.,,,1.0,,,,,,,,,,,,,Q04759_A_148_E
Q04759,K,409,A,5f9e:A,409,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q04759_K_409_A
Q04759,K,409,E,5f9e:A,409,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q04759_K_409_E
Q04759,T,538,A,5f9e:A,538,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q04759_T_538_A
Q04759,S,676,A,5f9e:A,676,Reduction in kinase activity.,,,-1.0,,,,,,,,,,,,,Q04759_S_676_A
Q04759,S,695,A,5f9e:A,695,Reduction in kinase activity.,,,-1.0,,,,,,,,,,,,,Q04759_S_695_A
P32322,E,221,A,2ger:A,221,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P32322_E_221_A
P05546,R,122,L,1jmo:A,103,Normal thrombin inhibition and glycosaminoglycan affinity.,,0.0,0.0,,,,,,,,,,,,,P05546_R_122_L
P05546,R,122,Q,1jmo:A,103,Greatly reduced thrombin inhibition. Normal glycosaminoglycan affinity.,,0.0,-1.0,,,,,,,,,,,,,P05546_R_122_Q
P05546,R,122,W,1jmo:A,103,Greatly reduced thrombin inhibition. Normal glycosaminoglycan affinity.,,0.0,-1.0,,,,,,,,,,,,,P05546_R_122_W
O43765,C,38,A,4cpg:A,52,Reduces tail-anchored proteins transfer.,,,-1.0,,,,,,,,,,,,,O43765_C_38_A
O75792,D,67,A,3puf:D,67,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_D_67_A
O75792,K,69,A,3puf:D,69,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_K_69_A
O75792,N,112,A,3puf:D,112,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_N_112_A
O75792,Y,210,A,3puf:D,210,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_Y_210_A
O75792,Y,210,F,3puf:D,210,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_Y_210_F
O75792,T,240,A,3puf:D,240,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,O75792_T_240_A
Q02750,K,97,A,3w8q:A,97,Loss of catalytic activity. Strongly reduces phosphorylation upon UV irradiation.,,,-1.0,-1.0,,,,,,,,,,,,Q02750_K_97_A
Q02750,K,97,R,3w8q:A,97,Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization.,0.0,,-1.0,,,,,,,,,,,,,Q02750_K_97_R
Q02750,S,150,A,3w8q:A,150,No loss of activity.,,,-1.0,,,,,,,,,,,,,Q02750_S_150_A
Q02750,S,212,A,3w8q:A,212,No loss of activity.,,,-1.0,,,,,,,,,,,,,Q02750_S_212_A
Q02750,S,218,A,3w8q:A,218,Loss of catalytic activity. No effect on BRAF-KSR1 dimerization,0.0,,-1.0,,,,,,,,,,,,,Q02750_S_218_A
Q02750,S,222,A,3w8q:A,222,Loss of catalytic activity. No effect on BRAF-KSR1 dimerization,0.0,,-1.0,,,,,,,,,,,,,Q02750_S_222_A
O95551,N,120,A,5ino:A,120,Strongly reduced phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_N_120_A
O95551,E,152,A,5ino:A,152,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_E_152_A
O95551,Y,178,F,5ino:A,178,Strongly decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_Y_178_F
O95551,Y,178,W,5ino:A,178,Strongly decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_Y_178_W
O95551,R,206,A,5ino:A,206,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_R_206_A
O95551,R,206,K,5ino:A,206,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_R_206_K
O95551,D,262,A,5ino:A,262,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_D_262_A
O95551,D,262,H,5ino:A,262,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_D_262_H
O95551,D,262,L,5ino:A,262,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_D_262_L
O95551,D,262,M,5ino:A,262,Loss of phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_D_262_M
O95551,L,305,A,5ino:A,305,Decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_L_305_A
O95551,L,305,F,5ino:A,305,Decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_L_305_F
O95551,L,305,W,5ino:A,305,Decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_L_305_W
O95551,D,316,N,5ino:A,316,Strongly decreased phosphodiesterase activity.,,,-1.0,,,,,,,,,,,,,O95551_D_316_N
Q9UNQ0,M,71,V,6hbu:A,71,Decreased protein abundance. No effect on substrate transmembrane transport.,,,0.0,,,,,,,,,,,,,Q9UNQ0_M_71_V
Q9UNQ0,K,86,M,6hbu:A,86,Decreased protein abundance. Decreased localization to the plasma membrane and retained intracellularly. Loss of ATPase-coupled transmembrane transporter activity.,,,-1.0,,,,,,,,,1.0,,,,Q9UNQ0_K_86_M
Q9UNQ0,E,211,Q,6hbu:A,211,Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,-1.0,,,,,,,,,,,,,Q9UNQ0_E_211_Q
Q9UNQ0,N,418,Q,6hbu:A,418,No effect.,,,0.0,,,,,,,,,,,,,Q9UNQ0_N_418_Q
Q9UNQ0,T,435,A,6hbu:A,435,No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased substrate-induced ATP hydrolysis. Increased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_T_435_A
Q9UNQ0,T,435,F,6hbu:A,435,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,-1.0,,,,,,,,,,,0.0,,Q9UNQ0_T_435_F
Q9UNQ0,N,436,A,6hbu:A,436,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,-1.0,,,,,,,,,,,0.0,,Q9UNQ0_N_436_A
Q9UNQ0,F,439,A,6hbu:A,439,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,-1.0,,,,,,,,,,,0.0,,Q9UNQ0_F_439_A
Q9UNQ0,R,482,D,6hbu:A,482,Decreases ATPase activity.,,,-1.0,,,,,,,,,,,,,Q9UNQ0_R_482_D
Q9UNQ0,R,482,G,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_G
Q9UNQ0,R,482,N,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_N
Q9UNQ0,R,482,S,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_S
Q9UNQ0,R,482,T,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_T
Q9UNQ0,R,482,K,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_K
Q9UNQ0,R,482,I,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_I
Q9UNQ0,R,482,M,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_M
Q9UNQ0,R,482,Y,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_Y
Q9UNQ0,V,546,A,6hbu:A,546,No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport.,,,0.0,,,,,,,,,,,0.0,,Q9UNQ0_V_546_A
Q9UNQ0,V,546,F,6hbu:A,546,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Decreased substrate transport.,,,-1.0,,,,,,,,,,,0.0,,Q9UNQ0_V_546_F
Q9UNQ0,M,549,A,6hbu:A,549,No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport.,,,0.0,,,,,,,,,,,0.0,,Q9UNQ0_M_549_A
Q9UNQ0,L,554,A,6hbu:A,554,No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Increased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_L_554_A
Q9UNQ0,N,557,Q,6hbu:A,557,No effect.,,,0.0,,,,,,,,,,,,,Q9UNQ0_N_557_Q
Q8IZT8,R,99,A,3bd9:A,99,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q8IZT8_R_99_A
Q8IZT8,R,104,A,3bd9:A,104,"Reduces enzyme activity by 93%,.",,,-1.0,,,,,,,,,,,,,Q8IZT8_R_104_A
Q8IZT8,K,155,A,3bd9:A,155,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q8IZT8_K_155_A
Q8IZT8,Q,195,A,3bd9:A,195,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q8IZT8_Q_195_A
O60260,C,337,A,6n13:B,337,Impairs the ability to ubiquitinate SNCAIP.,,,-1.0,,,,,,,,,,,,,O60260_C_337_A
O60260,W,403,A,6n13:B,403,Decreased autoinhibition and increased E3 activity.,,,1.0,,,,,,,,,,,,,O60260_W_403_A
O60260,C,421,A,6n13:B,421,Impairs the ability of self-ubiquitination and to ubiquitinate SNCAIP.,,,-1.0,,-1.0,,,,,,,,,,,O60260_C_421_A
O60260,C,431,S,6n13:B,431,Impairs the ability to ubiquitinate target proteins.,,,-1.0,,,,,,,,,,,,,O60260_C_431_S
O60260,H,433,N,6n13:B,433,Impaired activity.,,,-1.0,,,,,,,,,,,,,O60260_H_433_N
O60260,H,433,A,6n13:B,433,Impaired activity.,,,-1.0,,,,,,,,,,,,,O60260_H_433_A
O60260,E,444,Q,6n13:B,444,Impaired activity.,,,-1.0,,,,,,,,,,,,,O60260_E_444_Q
O60260,E,444,A,6n13:B,444,Impaired activity.,,,-1.0,,,,,,,,,,,,,O60260_E_444_A
Q8IWT1,C,58,A,4mz3:A,58,Abolishes regulation of channel activity.,,,-1.0,,,,,,,,,,,,,Q8IWT1_C_58_A
O60264,K,211,R,6ne3:W,211,Loss of ATP hydrolysis and no association of the SMARCA5/cohesin/NuRD complex with chromatin.,-1.0,,-1.0,,,,,,,,,,,,,O60264_K_211_R
P11362,K,514,A,4rwk:A,514,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P11362_K_514_A
P11362,R,577,E,4rwk:A,577,Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.,,,0.0,-1.0,,,,,,,,,,,,P11362_R_577_E
P11362,D,623,A,4rwk:A,623,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P11362_D_623_A
P11362,Y,654,F,4rwk:A,654,Reduced kinase activity. Loss of autophosphorylation and kinase activity,,,-1.0,-1.0,,,,,,,,,,,,P11362_Y_654_F
P11362,Y,766,F,3gqi:A,766,"Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation.",-1.0,,-1.0,,,,,,,,,,,,,P11362_Y_766_F
P11586,S,49,A,1dig:B,1049,No effect on dehydrogenase and cyclohydrolase activity. Strong increase of Km for NADP.,,-1.0,-1.0,,,,,,,,,,,,,P11586_S_49_A
P11586,S,49,Q,1dig:B,1049,"Reduces dehydrogenase by 75% and cyclohydrolase activity by 99%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,-1.0,,,,,,,,,,,,,P11586_S_49_Q
P11586,Y,52,A,1dig:B,1052,"Reduces dehydrogenase activity by 99%. Reduces cyclohydrolase activity by 70%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,-1.0,,,,,,,,,,,,,P11586_Y_52_A
P11586,Y,52,S,1dig:B,1052,"Reduces dehydrogenase activity by 99%. Reduces cyclohydrolase activity by 70%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,-1.0,,,,,,,,,,,,,P11586_Y_52_S
P11586,Y,52,F,1dig:B,1052,"Slightly reduces dehydrogenase and cyclohydrolase activity. Increase of Km for NADP and for 5,10-methenyltetrahydrofolate.",,-1.0,-1.0,,,,,,,,,,,,,P11586_Y_52_F
P11586,K,56,A,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,-1.0,,,,,,,,,,,,,P11586_K_56_A
P11586,K,56,I,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,-1.0,,,,,,,,,,,,,P11586_K_56_I
P11586,K,56,S,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,-1.0,,,,,,,,,,,,,P11586_K_56_S
P11586,K,56,T,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,-1.0,,,,,,,,,,,,,P11586_K_56_T
P11586,K,56,E,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,-1.0,,,,,,,,,,,,,P11586_K_56_E
P11586,K,56,M,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,-1.0,,,,,,,,,,,,,P11586_K_56_M
P11586,K,56,Q,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,-1.0,,,,,,,,,,,,,P11586_K_56_Q
P11586,K,56,R,1dig:B,1056,"Reduces dehydrogenase and cyclohydrolase activity by 99%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,-1.0,,,,,,,,,,,,,P11586_K_56_R
P11586,C,147,Q,1dig:B,1147,Reduces dehydrogenase activity by 50% and cyclohydrolase activity by 87%.,,,-1.0,,,,,,,,,,,,,P11586_C_147_Q
P19971,Y,199,A,2wk5:A,199,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,P19971_Y_199_A
P19971,Y,199,F,2wk5:A,199,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,P19971_Y_199_F
P19971,Y,199,L,2wk5:A,199,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,P19971_Y_199_L
Q8IXJ6,S,53,A,4x3o:A,53,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_S_53_A
Q8IXJ6,R,97,A,1j8f:C,97,No effect on deacetylase activity.,,,0.0,,,,,,,,,,,,,Q8IXJ6_R_97_A
Q8IXJ6,S,98,A,1j8f:C,98,Inhibits deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_S_98_A
Q8IXJ6,S,100,A,1j8f:C,100,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_S_100_A
Q8IXJ6,Q,167,A,1j8f:C,167,Reduces deacetylase activity. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress,,,-1.0,,,,,,,,,,,,,Q8IXJ6_Q_167_A
Q8IXJ6,N,168,A,1j8f:C,168,Abolishes deacetylation of alpha-tubulin. Inhibits deacetylation of histone H3 at 'Lys-18'. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress,,,-1.0,,,,,,,,,,,,,Q8IXJ6_N_168_A
Q8IXJ6,D,170,A,1j8f:C,170,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_D_170_A
Q8IXJ6,D,170,N,1j8f:C,170,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_D_170_N
Q8IXJ6,H,187,Y,1j8f:C,187,"Inhibits deacetylase activity toward histone, alpha-tubulin, FZR1 and CDC20. No effect on CDK2-dependent phosphorylation. Does not inhibit interaction with alpha-tubulin, HDAC6, HIF1A and the cyclin E-CDK2 complex. Inhibits interaction with BEX4 and KMT5A. Abolishes deacetylation, dimeric formation and enzymatic activity increase of G6PD. Prevents histone H4 methylation at 'Lys-20'(H4K20me1) in metaphase chromosomes. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress",-1.0,,-1.0,,,,,,,,,,,,,Q8IXJ6_H_187_Y
Q8IXJ6,H,187,A,1j8f:C,187,"Inhibits deacetylase activity toward histone, alpha-tubulin, FZR1 and CDC20. No effect on CDK2-dependent phosphorylation. Does not inhibit interaction with alpha-tubulin, HDAC6, HIF1A and the cyclin E-CDK2 complex. Inhibits interaction with BEX4 and KMT5A. Abolishes deacetylation, dimeric formation and enzymatic activity increase of G6PD. Prevents histone H4 methylation at 'Lys-20'(H4K20me1) in metaphase chromosomes. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress",-1.0,,-1.0,,,,,,,,,,,,,Q8IXJ6_H_187_A
Q8IXJ6,S,279,A,1j8f:C,279,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_S_279_A
Q8IXJ6,T,280,A,1j8f:C,280,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_T_280_A
Q8IXJ6,S,311,A,1j8f:C,311,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_S_311_A
Q8IXJ6,Y,315,A,1j8f:C,315,Reduces deacetylase activity.,,,-1.0,,,,,,,,,,,,,Q8IXJ6_Y_315_A
O15550,H,1146,A,6g8f:A,1146,Abolishes histone demethylase activity.,,,-1.0,,,,,,,,,,,,,O15550_H_1146_A
P45381,R,71,K,4mri:B,71,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P45381_R_71_K
P45381,Y,164,F,4mri:B,164,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P45381_Y_164_F
P45381,R,168,K,4mri:B,168,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P45381_R_168_K
P45381,E,178,A,4mri:B,178,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P45381_E_178_A
P45381,E,178,D,4mri:B,178,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P45381_E_178_D
P45381,E,178,Q,4mri:B,178,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,P45381_E_178_Q
P45381,E,285,D,4mri:B,285,5-fold decrease in activity.,,,-1.0,,,,,,,,,,,,,P45381_E_285_D
P45381,Y,288,F,4mri:B,288,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P45381_Y_288_F
Q13426,K,210,R,6abo:A,210,Abolishes sumoylation. No nuclear location. 5-fold decrease in recombination efficiency.,,,-1.0,,,,-1.0,,,,,1.0,,,,Q13426_K_210_R
O95487,R,715,A,3eh1:A,715,Decreased ability to package the SNARE SEC22B cargo into COPII vesicles. Has no effect on other cargos packaging.,,,-1.0,,,,,,,,,,,,,O95487_R_715_A
O95486,R,541,A,3egd:B,541,Decreased ability to interact with and package the SNARE SEC22B cargo into COPII vesicles. Has no effect on other cargos packaging.,,,-1.0,,,,,,,,,,,,,O95486_R_541_A
Q712K3,C,93,S,6nyo:A,93,Loss of function.,,,-1.0,,,,,,,,,,,,,Q712K3_C_93_S
Q712K3,L,97,S,6nyo:A,97,Loss of function.,,,-1.0,,,,,,,,,,,,,Q712K3_L_97_S
Q7Z2Z2,T,33,A,5anc:K,33,Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,,,-1.0,,,,,,,,,,,,,Q7Z2Z2_T_33_A
Q7Z2Z2,H,96,A,5anc:K,96,Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,,,-1.0,,,,,,,,,,,,,Q7Z2Z2_H_96_A
Q9HD40,R,75,A,4zdo:B,75,Inactive in vivo.,,,-1.0,,,,,,,,,,,,,Q9HD40_R_75_A
Q9HD40,R,97,A,4zdo:B,97,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_R_97_A
Q9HD40,R,97,Q,4zdo:B,97,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_R_97_Q
Q9HD40,Q,105,A,4zdo:B,105,Inactive in vivo.,,,-1.0,,,,,,,,,,,,,Q9HD40_Q_105_A
Q9HD40,K,173,A,4zdo:B,173,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_K_173_A
Q9HD40,K,173,M,4zdo:B,173,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_K_173_M
Q9HD40,K,284,A,4zdo:B,284,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9HD40_K_284_A
Q9HD40,R,313,A,4zdo:B,313,Inactive in vivo.,,,-1.0,,,,,,,,,,,,,Q9HD40_R_313_A
P30101,C,57,A,3f8u:A,57,No loss of activity. No loss of activity,,,0.0,,,,,,,,,,,,,P30101_C_57_A
P30101,C,57,S,3f8u:A,57,Activity changed to serine protease.,,,1.0,,,,,,,,,,,,,P30101_C_57_S
P30101,C,60,S,3f8u:A,60,Activity changed to serine protease,,,1.0,,,,,,,,,,,,,P30101_C_60_S
P30101,C,406,A,3f8u:A,406,No loss of activity. No loss of activity,,,-1.0,,,,,,,,,,,,,P30101_C_406_A
P30101,C,406,S,3f8u:A,406,Activity changed to serine protease.,,,1.0,,,,,,,,,,,,,P30101_C_406_S
P30101,C,409,S,3f8u:A,409,Activity changed to serine protease,,,1.0,,,,,,,,,,,,,P30101_C_409_S
Q96GG9,C,115,A,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_A
Q96GG9,C,115,G,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_G
Q96GG9,C,115,I,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_I
Q96GG9,C,115,L,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_L
Q96GG9,C,115,T,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_T
Q96GG9,C,115,V,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,-1.0,,,,,,,,,,,,,Q96GG9_C_115_V
Q13526,K,63,A,1nmv:A,63,Loss of peptidyl-prolyl cis/trans isomerase activity.,,,-1.0,,,,,,,,,,,,,Q13526_K_63_A
Q13526,S,71,D,1nmv:A,71,"Loss of peptidyl-prolyl cis/trans isomerase activity, nuclear localization and cellular function.",,,-1.0,,,,,,,,,1.0,,,,Q13526_S_71_D
Q13526,S,71,E,1nmv:A,71,"Loss of peptidyl-prolyl cis/trans isomerase activity, nuclear localization and cellular function.",,,-1.0,,,,,,,,,1.0,,,,Q13526_S_71_E
Q13526,C,113,A,1nmv:A,113,Loss of peptidyl-prolyl cis/trans isomerase activity,,,-1.0,,,,,,,,,,,,,Q13526_C_113_A
P49674,K,38,R,4hok:M,38,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P49674_K_38_R
Q9UBS5,W,182,A,7c7s:A,182,Abolishes signaling via G-proteins. Abolishes antagonist binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9UBS5_W_182_A
Q9UBS5,Y,230,A,7c7s:A,230,Slightly decreases signaling via G-proteins.,,,-1.0,,,,,,,,,,,,,Q9UBS5_Y_230_A
Q9UBS5,Y,234,A,7c7s:A,234,Decreases signaling via G-proteins.,,,-1.0,,,,,,,,,,,,,Q9UBS5_Y_234_A
Q9UBS5,H,287,A,7c7s:A,287,Strongly reduces signaling via G-proteins. Abolishes antagonist binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9UBS5_H_287_A
Q9UBS5,Y,367,A,7c7s:A,367,Strongly reduces signaling via G-proteins. No effect on antagonist binding.,,0.0,-1.0,,,,,,,,,,,,,Q9UBS5_Y_367_A
Q9UBS5,W,395,A,7c7s:A,395,Strongly reduces signaling via G-proteins. Strongly reduces antagonist binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9UBS5_W_395_A
P48730,K,38,M,6gzm:B,38,Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.,,,-1.0,,,,,,,,,1.0,,,,P48730_K_38_M
P48730,T,176,I,6gzm:B,176,Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.,,,-1.0,,,,,,,,,1.0,,,,P48730_T_176_I
P48735,K,413,A,6adi:A,413,44-fold loss in activity.,,,-1.0,,,,,,,,,,,,,P48735_K_413_A
P48735,K,413,Q,6adi:A,413,20-fold decrease in Vmax.,,,-1.0,,,,,,,,,,,,,P48735_K_413_Q
P48735,K,413,R,6adi:A,413,No appreciable difference in Km for isocitrate and NADP.,,0.0,0.0,,,,,,,,,,,,,P48735_K_413_R
P48736,R,947,P,5g55:A,947,Abolishes protein and lipid kinase activity. Does not abolishes interaction with GRK2.,0.0,,-1.0,,,,,,,,,,,,,P48736_R_947_P
Q06278,G,1269,R,4uhw:A,1269,No effect on dimerization. Loss of oxidase activity.,0.0,,-1.0,,,,,,,,,,,,,Q06278_G_1269_R
Q96KN2,H,132,A,3dlj:A,106,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96KN2_H_132_A
Q96KN2,D,165,A,3dlj:A,139,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96KN2_D_165_A
Q96KN2,E,200,A,3dlj:A,174,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q96KN2_E_200_A
Q9NWX6,D,58,A,3otc:A,29,Reduces activity by 99.5%.,,,-1.0,,,,,,,,,,,,,Q9NWX6_D_58_A
Q9NWX6,H,63,A,3otc:A,34,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NWX6_H_63_A
Q9NWX6,S,104,A,3otc:A,75,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NWX6_S_104_A
Q9NWX6,D,105,A,3otc:A,76,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NWX6_D_105_A
Q9NWX6,E,106,A,3otc:A,77,Reduces activity by 95%.,,,-1.0,,,,,,,,,,,,,Q9NWX6_E_106_A
Q9NWX6,T,127,A,3otc:A,98,Abolishes oligomerization. Loss of enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,Q9NWX6_T_127_A
Q9NWX6,H,181,A,3otc:A,152,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NWX6_H_181_A
Q9NWX6,K,216,A,3otc:A,187,Reduces activity by 98.5%.,,,-1.0,,,,,,,,,,,,,Q9NWX6_K_216_A
Q9NWX6,N,227,A,3otc:A,198,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NWX6_N_227_A
P10768,L,54,A,3fcx:B,54,83% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_L_54_A
P10768,S,149,A,3fcx:B,149,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10768_S_149_A
P10768,S,149,T,3fcx:B,149,1.3% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_S_149_T
P10768,M,150,A,3fcx:B,150,62% increase in activity.,,,1.0,,,,,,,,,,,,,P10768_M_150_A
P10768,D,226,A,3fcx:B,226,4.3% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_D_226_A
P10768,D,226,N,3fcx:B,226,9% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_D_226_N
P10768,H,260,A,3fcx:B,260,3% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_H_260_A
P10768,H,260,Q,3fcx:B,260,1.3% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P10768_H_260_Q
Q9Y2C4,S,137,D,5zki:B,137,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q9Y2C4_S_137_D
Q9Y2C4,H,140,A,5zki:B,140,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9Y2C4_H_140_A
Q6IA69,C,175,S,6ofb:A,175,Eliminates glutamine-dependent NAD synthetase activity with the ammonia-dependent activity intact.,,,-1.0,,,,,,,,,,,,,Q6IA69_C_175_S
P61224,G,12,V,4dxa:A,12,Constitutively activated.,,,1.0,,,,,,,,,,,,,P61224_G_12_V
P61224,Y,32,A,4dxa:A,32,25-fold reduction in RAP1GAP-stimulated GTPase activity.,,,-1.0,,,,,,,,,,,,,P61224_Y_32_A
P61224,Y,32,F,4dxa:A,32,2-fold reduction in RAP1GAP-stimulated GTPase activity.,,,-1.0,,,,,,,,,,,,,P61224_Y_32_F
P61224,Q,63,E,4dxa:A,63,Abolishes complex formation with RAP1GAP. Loss GTPase activity.,-1.0,,-1.0,,,,,,,,,,,,,P61224_Q_63_E
P61224,F,64,A,4dxa:A,64,Abolishes complex formation with RAP1GAP. Loss GTPase activity.,-1.0,,-1.0,,,,,,,,,,,,,P61224_F_64_A
Q9BYW2,F,1589,A,5jlb:A,1589,Strongly reduced methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_F_1589_A
Q9BYW2,Y,1604,A,5jlb:A,1604,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_Y_1604_A
Q9BYW2,R,1625,H,5jlb:A,1625,Loss of methyltransferase activity. Abolishes ability to monomethylate STAT1.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1625_H
Q9BYW2,R,1625,G,5jlb:A,1625,Loss of methyltransferase activity. Abolishes ability to monomethylate STAT1.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1625_G
Q9BYW2,C,1631,A,5jlb:A,1631,Does not affect methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q9BYW2_C_1631_A
Q9BYW2,E,1636,A,5jlb:A,1636,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_E_1636_A
Q9BYW2,T,1637,A,5jlb:A,1637,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_T_1637_A
Q9BYW2,F,1668,A,5jlb:A,1668,Strongly reduced methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_F_1668_A
Q9BYW2,Q,1669,A,5jlb:A,1669,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_Q_1669_A
Q9BYW2,R,1670,A,5jlb:A,1670,Impaired methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_A
Q9BYW2,R,1670,V,5jlb:A,1670,Impaired methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_V
Q9BYW2,R,1670,L,5jlb:A,1670,Impaired methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_L
Q9BYW2,R,1670,I,5jlb:A,1670,Impaired methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_I
Q9BYW2,R,1670,F,5jlb:A,1670,Impaired methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_F
Q9BYW2,R,1670,P,5jlb:A,1670,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_P
Q9BYW2,R,1670,W,5jlb:A,1670,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_W
Q9BYW2,R,1670,K,5jlb:A,1670,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_K
Q9BYW2,R,1670,Q,5jlb:A,1670,Loss of methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_R_1670_Q
Q9BYW2,Y,1671,A,5jlb:A,1671,Strongly reduced methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9BYW2_Y_1671_A
O14607,H,1093,A,5fy7:A,1014,Abolishes lysine demethylase activity.,,,-1.0,,,,,,,,,,,,,O14607_H_1093_A
O14607,S,1138,G,5fy7:A,1059,No effect on lysine demethylase activity.,,,0.0,,,,,,,,,,,,,O14607_S_1138_G
O14607,P,1214,I,5fy7:A,1135,Significantly higher lysine demethylase activity.,,,1.0,,,,,,,,,,,,,O14607_P_1214_I
Q13636,Q,64,L,2fg5:A,64,No change in GTPase activity.,,,-1.0,,,,,,,,,,,,,Q13636_Q_64_L
Q13637,Q,85,L,4cz2:B,85,No change in GTPase activity.,,,0.0,,,,,,,,,,,,,Q13637_Q_85_L
P51787,V,324,L,6v00:A,324,Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.,,,0.0,,,,,,,,,,,,,P51787_V_324_L
P51787,K,326,R,6v00:A,326,Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.,-1.0,,0.0,,,,,,,,,,,,,P51787_K_326_R
P51787,T,327,V,6v00:A,327,Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.,-1.0,,0.0,,,,,,,,,,,,,P51787_T_327_V
P51787,I,328,L,6v00:A,328,Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.,-1.0,,0.0,,,,,,,,,,,,,P51787_I_328_L
P51787,S,338,C,6v00:A,338,Inhibits voltage-gated potassium channel activity.,,,-1.0,,,,,,,,,,,,,P51787_S_338_C
P51787,F,340,C,6v00:A,340,Inhibits voltage-gated potassium channel activity.,,,-1.0,,,,,,,,,,,,,P51787_F_340_C
P51787,I,375,D,6v00:A,375,"Reduced protein expression, probably due to misfolding and proteasomal degradation. No detectable electrophysiological activity. Reduced electrophysiological activity in the presence of KCNE1.",,,-1.0,,,,,,,,,,,-1.0,-1.0,P51787_I_375_D
P51787,V,516,D,6v00:A,516,"Reduced protein expression, probably due to misfolding and proteasomal degradation. Significantly reduced electrophysiological activity. Reduced electrophysiological activity in the presence of KCNE1.",,,-1.0,,,,,,,,,,,-1.0,-1.0,P51787_V_516_D
P13987,Y,29,R,5imt:D,4,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_Y_29_R
P13987,N,33,R,5imt:D,8,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_33_R
P13987,N,33,Q,5imt:D,8,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_33_Q
P13987,D,37,R,5imt:D,12,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_D_37_R
P13987,F,48,R,5imt:D,23,Some loss of function. Some lysis.,,,-1.0,,,,,,,,,,,,,P13987_F_48_R
P13987,D,49,R,5imt:D,24,Loss of function. Lysis.,,,-1.0,,,,,,,,,,,,,P13987_D_49_R
P13987,L,58,E,5imt:D,33,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_L_58_E
P13987,K,63,E,5imt:D,38,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_K_63_E
P13987,W,65,E,5imt:D,40,Complete loss of function. Lysis.,,,-1.0,,,,,,,,,,,,,P13987_W_65_E
P13987,K,66,D,5imt:D,41,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_K_66_D
P13987,F,67,K,5imt:D,42,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_F_67_K
P13987,F,72,E,5imt:D,47,Almost complete loss of function. Lysis.,,,-1.0,,,,,,,,,,,,,P13987_F_72_E
P13987,R,78,E,5imt:D,53,Loss of function. Lysis.,,,-1.0,,,,,,,,,,,,,P13987_R_78_E
P13987,L,79,D,5imt:D,54,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_L_79_D
P13987,E,81,R,5imt:D,56,Almost complete loss of function. Lysis.,,,-1.0,,,,,,,,,,,,,P13987_E_81_R
P13987,N,82,K,5imt:D,57,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_82_K
P13987,Y,87,R,5imt:D,62,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_Y_87_R
O60869,T,65,D,6zvh:i,65,No effect on CALM-binding. No effect,0.0,,0.0,,,,,,,,,,,,,O60869_T_65_D
O60869,T,74,D,6zvh:i,74,No effect on CALM-binding. No effect,0.0,,0.0,,,,,,,,,,,,,O60869_T_74_D
P52895,Y,24,A,2hdj:A,24,Strongly decreases affinity for androstenedione. Decreases androstenedione reductase activity about 60-fold.,,-1.0,-1.0,,,,,,,,,,,,,P52895_Y_24_A
P52895,K,31,A,2hdj:A,31,Increases the low androstenedione reductase activity.,,,-1.0,,,,,,,,,,,,,P52895_K_31_A
P52895,K,31,M,2hdj:A,31,Increases the low androstenedione reductase activity.,,,-1.0,,,,,,,,,,,,,P52895_K_31_M
P52895,R,301,A,2hdj:A,301,Decreases 3-alpha-hydroxysteroid reductase activity about 50-fold.,,,-1.0,,,,,,,,,,,,,P52895_R_301_A
P52895,R,304,A,2hdj:A,304,Decreases 3-alpha-hydroxysteroid reductase activity about 500-fold.,,,-1.0,,,,,,,,,,,,,P52895_R_304_A
O00370,N,14,A,1vyb:A,14,Loss of endonuclease activity and reduced transposition efficiency.,,,-1.0,,,,,,,,,,,,,O00370_N_14_A
O00370,E,43,A,1vyb:A,43,Loss of endonuclease activity.,,,-1.0,,,,,,,,,,,,,O00370_E_43_A
O00370,D,145,A,1vyb:A,145,Loss of endonuclease activity and reduced transposition efficiency.,,,-1.0,,,,,,,,,,,,,O00370_D_145_A
O00370,D,205,G,1vyb:A,205,Loss of endonuclease activity and reduced transposition efficiency.,,,-1.0,,,,,,,,,,,,,O00370_D_205_G
O00370,H,230,A,1vyb:A,230,Loss of endonuclease activity and reduced transposition efficiency.,,,-1.0,,,,,,,,,,,,,O00370_H_230_A
Q12923,C,2408,S,1wch:A,2408,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q12923_C_2408_S
Q12923,R,2444,E,1wch:A,2444,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q12923_R_2444_E
Q12923,R,2444,K,1wch:A,2444,Reduces substrate affinity 7 fold.,,,-1.0,,,,,,,,,,,,,Q12923_R_2444_K
Q12923,R,2444,Q,1wch:A,2444,Strongly decreases catalytic activity.,,,-1.0,,,,,,,,,,,,,Q12923_R_2444_Q
Q12923,G,2449,V,1wch:A,2449,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q12923_G_2449_V
Q9Y663,K,161,A,1t8u:B,161,99.6% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_161_A
Q9Y663,K,162,A,1t8u:B,162,99.6% loss of enzymatic activity,,,-1.0,,,,,,,,,,,,,Q9Y663_K_162_A
Q9Y663,R,166,E,1t8u:B,166,99.8% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_R_166_E
Q9Y663,E,170,Q,1t8u:B,170,17% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_E_170_Q
Q9Y663,R,173,S,1t8u:B,173,44.1% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_R_173_S
Q9Y663,G,182,A,1t8u:B,182,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9Y663_G_182_A
Q9Y663,E,184,Q,1t8u:B,184,99.9% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_E_184_Q
Q9Y663,H,186,F,1t8u:B,186,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_H_186_F
Q9Y663,D,189,N,1t8u:B,189,99.1% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_D_189_N
Q9Y663,R,190,E,1t8u:B,190,32% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_R_190_E
Q9Y663,K,194,A,1t8u:B,194,99.5% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_194_A
Q9Y663,K,215,A,1t8u:B,215,99.9% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_215_A
Q9Y663,S,218,A,1t8u:B,218,23.3% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_S_218_A
Q9Y663,E,224,Q,1t8u:B,224,47.6% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_E_224_Q
Q9Y663,Q,255,A,1t8u:B,255,99.6% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_Q_255_A
Q9Y663,K,259,A,1t8u:B,259,48.3% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_259_A
Q9Y663,I,288,A,1t8u:B,288,65% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_I_288_A
Q9Y663,K,293,A,1t8u:B,293,33.6% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_293_A
Q9Y663,H,362,A,1t8u:B,362,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9Y663_H_362_A
Q9Y663,G,365,A,1t8u:B,365,43% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_G_365_A
Q9Y663,K,366,A,1t8u:B,366,99.8% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_366_A
Q9Y663,K,368,A,1t8u:B,368,99.9% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_K_368_A
Q9Y663,R,370,E,1t8u:B,370,99.2% loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y663_R_370_E
P08913,D,128,N,6kux:A,113,No binding to yohimbine. Increase in adenylate cyclase activity.,,-1.0,1.0,,,,,,,,,,,,,P08913_D_128_N
O00506,K,49,R,4nzw:B,49,Loss of kinase activity and autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,O00506_K_49_R
O00506,D,158,A,2xik:A,158,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O00506_D_158_A
Q8IVH8,K,48,E,5j5t:A,48,Loss of kinase activity and ability to activate JNK family.,,,-1.0,,,,,,,,,,,,,Q8IVH8_K_48_E
Q13569,N,140,A,1wyw:A,140,Loss of DNA glycosylase activity but still able to bind DNA.,,0.0,-1.0,,,,,,,,,,,,,Q13569_N_140_A
Q13569,A,145,G,1wyw:A,145,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_A_145_G
Q13569,H,151,A,1wyw:A,151,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_H_151_A
Q13569,H,151,Q,1wyw:A,151,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_H_151_Q
Q13569,N,191,A,1wyw:A,191,Reduced DNA glycosylase activity on G/T and G/U mispairs.,,,-1.0,,,,,,,,,,,,,Q13569_N_191_A
Q13569,T,197,A,1wyw:A,197,Reduced DNA glycosylase activity on G/T mispairs.,,,-1.0,,,,,,,,,,,,,Q13569_T_197_A
Q13569,R,281,A,1wyw:A,281,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_R_281_A
Q13569,E,310,Q,1wyw:A,310,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_E_310_Q
Q13569,F,315,A,1wyw:A,315,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_F_315_A
Q93091,I,36,A,5oab:A,13,"Strongly impairs bactericidal activity, bacterial agglutination activity and binding to bacterial lipopolysaccharide (LPS).",,,-1.0,,,,,,,,,,,,,Q93091_I_36_A
Q9UM00,D,191,A,6w6l:6,140,Abolishes the calcium channel activity.,,,-1.0,,,,,,,,,,,,,Q9UM00_D_191_A
Q9UM00,D,191,E,6w6l:6,140,Retains some of the calcium channel activity.,,,0.0,,,,,,,,,,,,,Q9UM00_D_191_E
Q9UM07,R,374,A,5n0y:A,374,Strongly reduces enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9UM07_R_374_A
Q9UM07,C,645,A,5n0y:A,645,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9UM07_C_645_A
P45954,V,137,L,2jif:A,137,Decreased acyl-CoA dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P45954_V_137_L
P45954,F,138,L,2jif:A,138,Increased acyl-CoA dehydrogenase activity. No effect on substrate specificity.,,0.0,1.0,,,,,,,,,,,,,P45954_F_138_L
P45954,S,210,N,2jif:A,210,Increased acyl-CoA dehydrogenase activity. Changed substrate specificity.,,-1.0,1.0,,,,,,,,,,,,,P45954_S_210_N
P45954,A,416,T,2jif:A,416,Increased acyl-CoA dehydrogenase activity. No effect on substrate specificity.,,0.0,1.0,,,,,,,,,,,,,P45954_A_416_T
Q08495,S,403,E,1qzp:A,74,Reduces F-actin bundling but not F-actin binding activity.,,,0.0,,,,,,,,,,,,,Q08495_S_403_E
P28223,L,229,A,6a94:A,229,"Strongly increases dissociation of bound lysergic acid diethylamine, without affecting binding affinity. Reduces signaling via arrestins, but has no effect on signaling via the phosphatidylinositol-calcium second messenger system.",,0.0,-1.0,,,,,,,,,,,,,P28223_L_229_A
Q9Y530,H,32,A,2lgr:A,32,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y530_H_32_A
Q9Y530,C,33,S,2lgr:A,33,No effect.,,0.0,0.0,,,,,,,,,,,,,Q9Y530_C_33_S
Q9Y530,S,35,A,2lgr:A,35,Reduced catalytic activity. No effect on affinity towards substrate.,,0.0,-1.0,,,,,,,,,,,,,Q9Y530_S_35_A
Q9Y530,T,83,A,2lgr:A,83,Reduced catalytic activity. No effect on affinity towards substrate.,,0.0,-1.0,,,,,,,,,,,,,Q9Y530_T_83_A
Q9Y530,K,84,A,2lgr:A,84,Abolishes enzyme activity and ability to form a stable covalent adduct with the ADP-ribosylated substrate.,,-1.0,-1.0,,,,,,,,,,,,,Q9Y530_K_84_A
Q9Y530,G,123,E,2lgr:A,123,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9Y530_G_123_E
Q9Y530,D,125,A,2lgr:A,125,Abolishes enzyme activity without affecting ability to form a stable covalent adduct with the ADP-ribosylated substrate.,,0.0,-1.0,,,,,,,,,,,,,Q9Y530_D_125_A
P09455,R,22,A,5ljk:A,21,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,-1.0,,,,,,,,,,,,,P09455_R_22_A
P09455,L,30,A,5ljk:A,29,Decreases cellular retinol uptake and impairs retinol storage.,,,-1.0,,,,,,,,,,,,,P09455_L_30_A
P09455,R,31,A,5ljk:A,30,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,-1.0,,,,,,,,,,,,,P09455_R_31_A
P09455,K,32,A,5ljk:A,31,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,-1.0,,,,,,,,,,,,,P09455_K_32_A
P09455,R,59,E,5ljk:A,58,Decreases cellular retinol uptake and impairs retinol storage.,,,-1.0,,,,,,,,,,,,,P09455_R_59_E
Q9P2I0,H,67,A,6v4x:I,67,Inhibits histone 3'-end processing.,,,-1.0,,,,,,,,,,,,,Q9P2I0_H_67_A
Q9P2I0,D,289,A,6v4x:I,289,Does not inhibit histone 3'-end processing.,,,0.0,,,,,,,,,,,,,Q9P2I0_D_289_A
Q9P2I0,R,543,A,6v4x:I,543,Inhibits histone 3'-end processing.,,,-1.0,,,,,,,,,,,,,Q9P2I0_R_543_A
P20807,C,129,S,6bdt:C,129,Loss of activity. No effect on CMYA5-binding.,-1.0,,-1.0,,,,,,,,,,,,,P20807_C_129_S
Q8WVM0,G,65,A,6ajk:A,65,"Abolishes methyltransferase activity, DNA-binding and SAM-binding. Does not abolish transcription activator function.",,-1.0,-1.0,,,,,,,,,,,,,Q8WVM0_G_65_A
Q8WVM0,N,141,A,6ajk:A,141,"Does not affect SAM-binding, DNA-binding nor transcription activator function.",,0.0,0.0,,,,,,,,,,,,,Q8WVM0_N_141_A
Q8WVM0,K,220,A,6ajk:A,220,"Abolishes methyltransferase activity. Does not affect SAM-binding, DNA-binding nor transcription activator function.",,0.0,-1.0,,,,,,,,,,,,,Q8WVM0_K_220_A
Q15561,D,266,A,6ge6:A,266,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_D_266_A
Q15561,K,297,A,6ge6:A,297,Important loss of interaction with YAP1 and complete loss of transforming ability.,-1.0,,-1.0,,,,,,,,,,,,,Q15561_K_297_A
Q15561,W,299,A,6ge6:A,299,Important loss of interaction with YAP1 and complete loss of transforming ability.,-1.0,,-1.0,,,,,,,,,,,,,Q15561_W_299_A
Q15561,F,373,A,5oaq:A,373,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_F_373_A
Q15561,L,380,A,5oaq:A,380,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_L_380_A
Q15561,E,391,A,5oaq:A,391,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_E_391_A
Q15561,F,393,A,5oaq:A,393,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_F_393_A
Q15561,H,427,A,5oaq:A,427,Reduced transforming ability.,,,-1.0,,,,,,,,,,,,,Q15561_H_427_A
Q15561,Y,429,A,5oaq:A,429,Important loss of interaction with YAP1 and complete loss of transforming ability.,-1.0,,-1.0,,,,,,,,,,,,,Q15561_Y_429_A
Q9NRN7,R,47,A,2cg5:A,57,"Reduces affinity for magnesium 7-fold, and enzyme activity 2-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_R_47_A
Q9NRN7,R,86,A,2cg5:A,96,"Reduces affinity for magnesium and coenzyme A, and reduces enzyme activity 7-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_R_86_A
Q9NRN7,H,111,A,2cg5:A,121,"Reduces affinity for magnesium 75-fold, and enzyme activity 150-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_H_111_A
Q9NRN7,Q,112,E,2cg5:A,122,Reduces affinity for magnesium 200-fold and abolishes enzyme activity,,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_Q_112_E
Q9NRN7,D,129,A,2cg5:A,139,"Reduces affinity for magnesium 10-fold, and enzyme activity 30000-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_D_129_A
Q9NRN7,E,181,A,2cg5:A,191,"Reduces affinity for magnesium 40-fold, and enzyme activity 32000-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_E_181_A
Q9NRN7,E,181,Q,2cg5:A,191,"Reduces affinity for magnesium 20-fold, and enzyme activity 6500-fold.",,-1.0,-1.0,,,,,,,,,,,,,Q9NRN7_E_181_Q
Q9NRN7,K,185,A,2cg5:A,195,"Reduces enzyme activity 2000-fold, with only minor change in the affinity for magnesium and coenzyme A.",,0.0,-1.0,,,,,,,,,,,,,Q9NRN7_K_185_A
P35226,K,62,A,4r8p:K,62,Strongly decreases histone H2A ubiquitination,,,-1.0,,,,,,,,,,,,,P35226_K_62_A
P35226,R,64,A,4r8p:K,64,Mildly decreases histone H2A ubiquitination. Strongly decreases histone H2A ubiquitination,,,-1.0,,,,,,,,,,,,,P35226_R_64_A
P35226,K,73,N,4r8p:K,73,Increases stimulation of RNF2 ubiquitin ligase activity,,,1.0,,,,,,,,,,,,,P35226_K_73_N
P35226,D,77,E,4r8p:K,77,Increases stimulation of RNF2 ubiquitin ligase activity,,,1.0,,,,,,,,,,,,,P35226_D_77_E
P35557,S,64,P,3qic:A,64,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_S_64_P
P35557,E,177,K,3qic:A,177,Small change in glucokinase activity.,,,-1.0,,,,,,,,,,,,,P35557_E_177_K
P35557,M,197,V,3qic:A,197,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_M_197_V
P35557,I,211,F,3qic:A,211,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_I_211_F
P35557,Y,214,A,3qic:A,214,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose. No effect on affinity for ATP.,,1.0,1.0,,,,,,,,,,,,,P35557_Y_214_A
P35557,E,256,A,3qic:A,256,Inactive enzyme with no glucokinase activity.,,,-1.0,,,,,,,,,,,,,P35557_E_256_A
P35557,K,414,A,3qic:A,414,Small change in glucokinase activity.,,,-1.0,,,,,,,,,,,,,P35557_K_414_A
P35557,S,453,A,3qic:A,453,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_S_453_A
P35558,S,90,A,1nhx:A,90,"Abolished phosphorylation by AKT1, interaction with INSIG proteins (INSIG1 and INSIG2) and ability to regulate lipogenesis.",-1.0,,-1.0,-1.0,,,,,,,,,,,,P35558_S_90_A
P35558,S,90,E,1nhx:A,90,"Phosphomimetic mutant, promotes the serine protein kinase activity by reducing the binding affinity to oxaloacetate.",,-1.0,1.0,,,,,,,,,,1.0,,,P35558_S_90_E
P35558,C,288,S,1nhx:A,288,Abolished both phosphoenolpyruvate carboxykinase and protein kinase activities.,,,-1.0,,,,,,,,,,,,,P35558_C_288_S
O75582,D,195,A,1vzo:A,195,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O75582_D_195_A
O75582,S,212,A,1vzo:A,212,Inactivates the N-terminal kinase domain.,,,-1.0,,,,,,,,,,,,,O75582_S_212_A
Q96SD1,D,17,N,7afs:A,17,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_17_N
Q96SD1,D,17,A,7afs:A,17,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_17_A
Q96SD1,H,33,A,7afs:A,33,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_H_33_A
Q96SD1,H,35,A,7afs:A,35,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_H_35_A
Q96SD1,D,37,N,7afs:A,37,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_37_N
Q96SD1,D,37,A,7afs:A,37,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_37_A
Q96SD1,H,38,A,7afs:A,38,"Reduces PRKDC-dependent endonuclease activity, although V(D)J recombination is largely normal.",,,-1.0,,,,,,,,,,,,,Q96SD1_H_38_A
Q96SD1,H,115,A,7afs:A,115,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_H_115_A
Q96SD1,D,136,N,7afs:A,136,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_136_N
Q96SD1,D,136,A,7afs:A,136,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_136_A
Q96SD1,D,165,N,7afs:A,165,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_165_N
Q96SD1,D,165,A,7afs:A,165,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_D_165_A
Q96SD1,H,319,A,7afs:A,319,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,-1.0,,,,,,,,,,,,,Q96SD1_H_319_A
P54252,C,14,A,2aga:A,19,Loss of deubiquitination activity.,,,-1.0,,,,,,,,,,,,,P54252_C_14_A
P01225,T,78,E,4mqw:B,60,Increased activation of the follicle-stimulating hormone signaling pathway.,,,1.0,,,,,,,,,,,,,P01225_T_78_E
P15121,D,44,N,1z89:A,43,Reduced glyceraldehyde oxidoreductase activity.,,,-1.0,,,,,,,,,,,,,P15121_D_44_N
P15121,Y,49,F,1z89:A,48,Complete loss of glyceraldehyde oxidoreductase activity.,,,-1.0,,,,,,,,,,,,,P15121_Y_49_F
P15121,K,78,M,1z89:A,77,Reduced glyceraldehyde oxidoreductase activity.,,,-1.0,,,,,,,,,,,,,P15121_K_78_M
P15121,H,111,N,1z89:A,110,Reduced glyceraldehyde oxidoreductase activity.,,,-1.0,,,,,,,,,,,,,P15121_H_111_N
Q9NZK7,N,40,G,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_N_40_G
Q9NZK7,N,40,M,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_N_40_M
Q9NZK7,N,40,W,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_N_40_W
Q9NZK7,D,41,A,5wzv:A,22,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_D_41_A
Q9NZK7,D,41,K,5wzv:A,22,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_D_41_K
Q9NZK7,H,65,A,5wzv:A,46,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9NZK7_H_65_A
Q9NZK7,D,66,A,5wzv:A,47,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9NZK7_D_66_A
Q9NZK7,N,132,A,5wzv:A,113,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_N_132_A
Q9NZK7,N,132,K,5wzv:A,113,Significantly decreases the catalytic efficiency.,,,-1.0,,,,,,,,,,,,,Q9NZK7_N_132_K
P98170,S,87,D,2pop:D,3087,Abolishes dimerization. Interferes with ubiquitination.,-1.0,,-1.0,,,,,,,,,,,,,P98170_S_87_D
P98170,S,87,E,2pop:D,3087,Abolishes dimerization. Interferes with ubiquitination.,-1.0,,-1.0,,,,,,,,,,,,,P98170_S_87_E
P98170,H,467,A,2ecg:A,45,Loss of E3 ubiquitin-protein ligase activity.,,,-1.0,,,,,,,,,,,,,P98170_H_467_A
Q9HAZ1,K,189,R,6fyv:A,191,Loss of function.,,,-1.0,,,,,,,,,,,,,Q9HAZ1_K_189_R
Q04760,Q,34,E,1qip:B,33,Reduces enzyme activity by 99%.,,,-1.0,,,,,,,,,,,,,Q04760_Q_34_E
Q04760,E,100,Q,1qip:B,99,Reduces enzyme activity by over 99%.,,,-1.0,,,,,,,,,,,,,Q04760_E_100_Q
Q04760,E,173,Q,1qip:B,172,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04760_E_173_Q
P23443,K,167,N,4l3l:A,144,Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252.,,,-1.0,-1.0,,,,,,,,,,,,P23443_K_167_N
P00740,Y,305,F,6x5j:A,94,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_Y_305_F
P00740,K,311,T,6x5j:A,100,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_K_311_T
P00740,Y,312,A,6x5j:A,101,Strongly decreases enzyme activity with a synthetic peptide substrate.,,,1.0,,,,,,,,,,,,,P00740_Y_312_A
P00740,Y,391,T,6x5j:A,180,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_Y_391_T
Q9BSM1,S,195,F,4hpl:B,195,Abolishes repressor activity. May be a PKC phosphorylation site.,,,-1.0,-1.0,,,,,,,,,,,,Q9BSM1_S_195_F
O15492,Y,168,F,2bt2:A,168,30% decrease in GAP activity.,,,-1.0,,,,,,,,,,,,,O15492_Y_168_F
O15492,Y,177,F,2bt2:A,177,No effect on GAP activity.,,,0.0,,,,,,,,,,,,,O15492_Y_177_F
O15496,H,88,Q,5g3m:A,46,Loss of PLA2 activity toward PAF. Impairs anti-adenoviral activity.,-1.0,,-1.0,,,,,,,,,,,,,O15496_H_88_Q
O15498,F,42,E,6j7f:C,42,Increases palmitoylation. Targeted to Golgi membranes. Targeted to Golgi and cytosol,,,1.0,,,,,,,,,,,,,O15498_F_42_E
O15498,C,194,S,6j7f:C,194,Decreases palmitoylation by 55%. Prevents palmitoylation,,,-1.0,,,,,,,,,,,,,O15498_C_194_S
P12931,K,298,M,1y57:A,295,Kinase inactive. Abolishes ubiquitination promoted by CBLC.,,,-1.0,,-1.0,,,,,,,,,,,P12931_K_298_M
P12931,P,302,E,1y57:A,299,Kinase active. Interacts with PDLIM4,0.0,,-1.0,,,,,,,,,,,,,P12931_P_302_E
P12931,P,307,E,1y57:A,304,Kinase active. Interacts with PDLIM4,0.0,,-1.0,,,,,,,,,,,,,P12931_P_307_E
P12931,Y,419,F,1y57:A,416,Loss of kinase activity. Loss of interaction with PDLIM4.,-1.0,,-1.0,,,,,,,,,,,,,P12931_Y_419_F
P41279,T,290,A,5iu2:A,290,Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding.,0.0,,-1.0,-1.0,,,,,,,,,,,,P41279_T_290_A
P41279,T,290,D,5iu2:A,290,Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding.,0.0,,-1.0,-1.0,,,,,,,,,,,,P41279_T_290_D
P41279,T,290,E,5iu2:A,290,Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding.,0.0,,-1.0,-1.0,,,,,,,,,,,,P41279_T_290_E
P61088,C,87,A,7bbd:C,87,Loss of polyubiquitination of PCNA. Impairs interaction with SHPRH.,-1.0,,-1.0,,,,,,,,,,,,,P61088_C_87_A
Q13188,K,56,R,4lgd:B,56,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13188_K_56_R
Q6ZMT4,H,282,A,3kv6:D,282,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q6ZMT4_H_282_A
P08686,V,281,I,4y8w:A,282,Normal KM but 50% reduced Vmax.,,,-1.0,,,,,,,,,,,,,P08686_V_281_I
P08686,V,281,T,4y8w:A,282,Normal KM but 10% reduced Vmax.,,,-1.0,,,,,,,,,,,,,P08686_V_281_T
P08686,C,428,M,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,-1.0,,,,,,,,,,,,,P08686_C_428_M
P08686,C,428,S,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,-1.0,,,,,,,,,,,,,P08686_C_428_S
P08686,C,428,T,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,-1.0,,,,,,,,,,,,,P08686_C_428_T
P18433,Y,798,F,6uzt:A,789,"Abolishes integrin-mediated interaction with BCAR1 and BCAR3 and reduces interaction between BCAR1 and CRK and, BCAR1 and SRC. Abolishes integrin-induced SRC-mediated tyrosine phosphorylation of BCAR1. Abolishes integrin-mediated recruitment of BCAR1, BCAR3, CRK and PTPRA to focal adhesions. Reduces integrin-mediated activation and membrane recruitment of RAC1 and CDC42.",-1.0,,-1.0,,,,,,,,,,,,,P18433_Y_798_F
P61328,R,114,A,4jq0:A,57,"Gain of function, affects voltage dependence of SCN8A fast inactivation.",,,1.0,,,,,,,,,,,,,P61328_R_114_A
P61328,R,114,G,4jq0:A,57,"Gain of function, affects voltage dependence of SCN8A fast inactivation.",,,1.0,,,,,,,,,,,,,P61328_R_114_G
Q13454,C,99,S,4m90:A,58,Reduces N-glycosylation of cysteine-proximal acceptor sites,,,-1.0,,,,,,,,,,,,,Q13454_C_99_S
Q13454,C,102,S,4m90:A,61,Reduces N-glycosylation of cysteine-proximal acceptor sites,,,-1.0,,,,,,,,,,,,,Q13454_C_102_S
Q9BYX4,T,829,A,7jl0:A,829,Moderately increases signaling.,,,1.0,,,,,,,,,,,,,Q9BYX4_T_829_A
O43447,W,133,F,1qoi:A,133,Abolishes inhibition by cyclosporin A.,,,-1.0,,,,,,,,,,,,,O43447_W_133_F
Q8IWA4,K,15,A,5go4:A,15,Decreases GTPase activity. Impairs mitochondrial fusion.,,,1.0,,,,,,,,,,,,,Q8IWA4_K_15_A
Q8IWA4,R,74,P,5go4:A,74,Mildly decreases GTPase activity and impairs mitochondrial fusion.,,,-1.0,,,,,,,,,,,,,Q8IWA4_R_74_P
Q8IWA4,K,88,A,5go4:A,88,Abolishes GTPase activity. Abolishes dimerization.,-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_K_88_A
Q8IWA4,K,99,A,5go4:A,99,Mildly decreases GTPase activity.,,,-1.0,,,,,,,,,,,,,Q8IWA4_K_99_A
Q8IWA4,P,102,L,5go4:A,102,Impairs protein folding. Decreases GTPase activity.,,,-1.0,,,,,,,,,,,-1.0,,Q8IWA4_P_102_L
Q8IWA4,H,107,A,5go4:A,107,"Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",,0.0,-1.0,,,,,,,,,,,,,Q8IWA4_H_107_A
Q8IWA4,T,109,A,5go4:A,109,Acts as a dominant negative mutant,,,-1.0,,,,,,,,,,,,,Q8IWA4_T_109_A
Q8IWA4,H,144,A,5go4:A,144,Abolishes GTPase activity. Abolishes dimerization.,-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_H_144_A
Q8IWA4,D,173,A,5go4:A,173,Decreases GTPase activity.,,,-1.0,,,,,,,,,,,,,Q8IWA4_D_173_A
Q8IWA4,E,209,A,5go4:A,209,"Abolishes dimerization. Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_E_209_A
Q8IWA4,R,238,A,5go4:A,238,"Abolishes dimerization. Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_R_238_A
Q8IWA4,W,239,A,5go4:A,239,Abolishes GTP binding and GTPase activity. Loss of function in mitochondrial fusion.,,-1.0,-1.0,,,,,,,,,,,,,Q8IWA4_W_239_A
Q8IWA4,E,245,A,5go4:A,245,Decreases GTPase activity. Abolishes dimerization. Impairs mitochondrial fusion.,-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_E_245_A
Q8IWA4,G,309,P,5go4:A,309,Mildly decreases GTPase activity and impairs mitochondrial fusion.,,,-1.0,,,,,,,,,,,,,Q8IWA4_G_309_P
Q8IWA4,I,328,A,5go4:A,328,Slightly decreases GTPase activity.,,,-1.0,,,,,,,,,,,,,Q8IWA4_I_328_A
Q8IWA4,K,336,N,5go4:A,336,Loss of function in mitochondrial fusion. Abolishes dimerization. Decreases GTPase activity.,-1.0,,-1.0,,,,,,,,,,,,,Q8IWA4_K_336_N
Q8IWA4,K,336,P,5go4:A,336,Decreases GTPase activity and impairs mitochondrial fusion.,,,-1.0,,,,,,,,,,,,,Q8IWA4_K_336_P
P15104,C,209,A,2qc8:A,209,Reduced ability to mediate autopalmitoylation.,,,-1.0,,,,,,-1.0,,,,,,,P15104_C_209_A
P15104,R,324,A,2qc8:A,324,Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.,,,-1.0,,,,,,,,,1.0,,,,P15104_R_324_A
P15104,R,324,C,2qc8:A,324,Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.,,,-1.0,,,,,,,,,1.0,,,,P15104_R_324_C
P25445,I,313,D,1ddf:A,297,"Constitutive activation. Promotes apoptosis, both in the presence and in the absence of stimulation by a ligand.",,,1.0,,,,,,,,,,,,,P25445_I_313_D
P50225,C,70,S,1z28:A,70,Increased sensitivity of enzyme activity to heat inactivation.,,,1.0,,,,,,,,,,,,,P50225_C_70_S
P50225,D,249,G,1z28:A,249,Increased activity towards p-nitrophenol.,,,1.0,,,,,,,,,,,,,P50225_D_249_G
P63092,Q,170,A,6au6:A,170,Increases GDP release but does not affect receptor-mediated activation.,0.0,-1.0,0.0,,,,,,,,,,,,,P63092_Q_170_A
P63092,R,258,A,6au6:A,258,Increases GDP release and impairs receptor-mediated activation,-1.0,-1.0,-1.0,,,,,,,,,,,,,P63092_R_258_A
Q9UBR1,R,130,I,6ftq:A,130,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UBR1_R_130_I
Q9UBR1,K,132,L,6ftq:A,132,"Loss of catalytic activity. Forms dimers, but no higher oligomers.",-1.0,,-1.0,,,,,,,,,,,,,Q9UBR1_K_132_L
Q9UBR1,C,233,A,6ftq:A,233,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UBR1_C_233_A
Q9UBR1,T,299,C,6ftq:A,299,"Loss of catalytic activity. Forms dimers, but no higher oligomers.",-1.0,,-1.0,,,,,,,,,,,,,Q9UBR1_T_299_C
Q8ND25,C,184,A,5ywr:B,184,Loss of E3 activity.,,,-1.0,,,,,,,,,,,,,Q8ND25_C_184_A
P49662,C,258,A,6kmz:A,258,Loss of enzymatic activity. Loss of LPS-induced pyroptosis. No effect on the interaction with LPS. Decrease in cell death induced by TMEM214 overexpression. Does not support IL1B and IL18 secretion following UVB irradiation.,0.0,,-1.0,,,,,,,,,,,,,P49662_C_258_A
P49662,C,258,S,6kmz:A,258,Loss of autocatalysis.,,,-1.0,,,,,,,,,,,,,P49662_C_258_S
O14727,M,368,L,3jbt:A,368,Activation of pro-caspase-9 independent of cytochrome c. Increased ability to induce apoptosis.,,,1.0,,,,,,,,,,,,,O14727_M_368_L
P03956,Y,360,F,4auo:A,341,Partial reduction of tyrosine phosphorylation in the presence of PKDCC/VLK.,,,-1.0,,,,,,,,,,,,,P03956_Y_360_F
Q96BZ9,R,105,A,4hlq:C,105,1000-fold decrease in GAP activity.,,,-1.0,,,,,,,,,,,,,Q96BZ9_R_105_A
Q96BZ9,Q,144,L,4hlq:C,144,1000-fold decrease in GAP activity.,,,-1.0,,,,,,,,,,,,,Q96BZ9_Q_144_L
P48728,D,129,A,1wsv:A,101,Loss of aminomethyltransferase activity.,,,-1.0,,,,,,,,,,,,,P48728_D_129_A
P48728,D,129,N,1wsv:A,101,Loss of aminomethyltransferase activity.,,,-1.0,,,,,,,,,,,,,P48728_D_129_N
Q9H999,E,138,V,2i7p:D,138,Prevents acetyl-CoA production.,,,-1.0,,,,,,,,,,,,,Q9H999_E_138_V
Q9H999,R,207,W,2i7p:D,207,Increases affinity for ATP and decreases affinity for acetyl-CoA. Increases acetyl-CoA production.,,1.0,1.0,,,,,,,,,,,,,Q9H999_R_207_W
Q53H47,N,223,S,3bo5:A,209,Reduces activity in double-strand break repair.,,,-1.0,,,,,,,,,,,,,Q53H47_N_223_S
Q53H47,D,261,S,3bo5:A,247,Reduces activity in double-strand break repair.,,,-1.0,,,,,,,,,,,,,Q53H47_D_261_S
Q53H47,F,473,K,3k9k:B,460,Abolishes homodimerization and DNA-binding and reduces cleavage of single-stranded DNA.,-1.0,-1.0,-1.0,,,,,,,,,,,,,Q53H47_F_473_K
Q53H47,D,496,A,3k9k:B,483,Abolishes DNA cleavage.,,,-1.0,,,,,,,,,,,,,Q53H47_D_496_A
Q53H47,D,503,S,3k9k:B,490,Reduces activity in double-strand break repair.,,,-1.0,,,,,,,,,,,,,Q53H47_D_503_S
Q53H47,N,623,D,3k9j:A,610,Loss of function in DNA repair. Altered DNA-binding properties.,,-1.0,-1.0,,,,,,,,,,,,,Q53H47_N_623_D
Q53H47,N,623,E,3k9j:A,610,Loss of function in DNA repair. Altered DNA-binding properties.,,-1.0,-1.0,,,,,,,,,,,,,Q53H47_N_623_E
P16662,T,373,V,2o6l:A,373,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,-1.0,,,,,,,,,,,,,P16662_T_373_V
P16662,H,374,A,2o6l:A,374,Abolished androsterone glucuronosyltransferase activity,,,-1.0,,,,,,,,,,,,,P16662_H_374_A
P16662,H,374,E,2o6l:A,374,Abolished androsterone glucuronosyltransferase activity,,,-1.0,,,,,,,,,,,,,P16662_H_374_E
P16662,N,378,A,2o6l:A,378,Abolished androsterone glucuronosyltransferase activity,,,-1.0,,,,,,,,,,,,,P16662_N_378_A
P16662,G,379,D,2o6l:A,379,Abolished androsterone glucuronosyltransferase activity,,,-1.0,,,,,,,,,,,,,P16662_G_379_D
P16662,G,379,S,2o6l:A,379,Abolished androsterone glucuronosyltransferase activity,,,-1.0,,,,,,,,,,,,,P16662_G_379_S
P16662,D,398,A,2o6l:A,398,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,-1.0,,,,,,,,,,,,,P16662_D_398_A
P16662,D,398,N,2o6l:A,398,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,-1.0,,,,,,,,,,,,,P16662_D_398_N
P16662,Q,399,A,2o6l:A,399,"Abolished androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,-1.0,,,,,,,,,,,,,P16662_Q_399_A
Q16769,K,144,A,6gbx:A,144,Lowers activity by approximately 40%.,,,-1.0,,,,,,,,,,,,,Q16769_K_144_A
Q16769,F,146,A,6gbx:A,146,Lowers activity by approximately 30%.,,,-1.0,,,,,,,,,,,,,Q16769_F_146_A
Q16769,S,160,A,6gbx:A,160,Reduces activity by about 50%.,,,-1.0,,,,,,,,,,,,,Q16769_S_160_A
Q16769,S,160,G,6gbx:A,160,Reduces activity by 96%.,,,-1.0,,,,,,,,,,,,,Q16769_S_160_G
Q16769,E,201,D,6gbx:A,201,Reduces activity by about 98%.,,,-1.0,,,,,,,,,,,,,Q16769_E_201_D
Q16769,E,201,L,6gbx:A,201,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_E_201_L
Q16769,E,201,Q,6gbx:A,201,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_E_201_Q
Q16769,W,207,L,6gbx:A,207,Greatly lowers activity.,,,-1.0,,,,,,,,,,,,,Q16769_W_207_L
Q16769,D,248,A,6gbx:A,248,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q16769_D_248_A
Q16769,D,248,Q,6gbx:A,248,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_D_248_Q
Q16769,Q,304,L,6gbx:A,304,Lowers activity by approximately 35%.,,,-1.0,,,,,,,,,,,,,Q16769_Q_304_L
Q16769,D,305,A,6gbx:A,305,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_D_305_A
Q16769,D,305,E,6gbx:A,305,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_D_305_E
Q16769,D,305,L,6gbx:A,305,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_D_305_L
Q16769,D,305,N,6gbx:A,305,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,Q16769_D_305_N
Q16769,H,319,L,6gbx:A,319,Reduces activity by 87%.,,,-1.0,,,,,,,,,,,,,Q16769_H_319_L
Q16769,F,325,A,6gbx:A,325,Greatly lowers activity.,,,-1.0,,,,,,,,,,,,,Q16769_F_325_A
Q16769,W,329,A,6gbx:A,329,Abolishes activity.,,,-1.0,,,,,,,,,,,,,Q16769_W_329_A
Q16763,C,95,S,1zdn:A,95,Loss of function.,,,-1.0,,,,,,,,,,,,,Q16763_C_95_S
Q16763,K,117,A,1zdn:A,117,Reduced ubiquitination activity.,,,-1.0,,,,,,,,,,,,,Q16763_K_117_A
Q9UBT2,N,56,A,1y8q:D,56,Abolishes ATP-dependent activation of SUMO proteins.,,,-1.0,,,,,,,,,,,,,Q9UBT2_N_56_A
Q9UBT2,L,57,A,1y8q:D,57,Strongly reduces ATP-dependent activation of SUMO proteins.,,,-1.0,,,,,,,,,,,,,Q9UBT2_L_57_A
Q9UBT2,R,59,A,1y8q:D,59,Strongly reduces ATP-dependent activation of SUMO proteins.,,,-1.0,,,,,,,,,,,,,Q9UBT2_R_59_A
Q9UBT2,K,72,A,1y8q:D,72,Abolishes ATP-dependent activation of SUMO proteins.,,,-1.0,,,,,,,,,,,,,Q9UBT2_K_72_A
Q9UBT2,D,117,A,1y8q:D,117,Abolishes ATP-dependent activation of SUMO proteins.,,,-1.0,,,,,,,,,,,,,Q9UBT2_D_117_A
Q9UBT2,C,173,A,2px9:A,173,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9UBT2_C_173_A
Q9UBT2,T,174,A,2px9:A,174,Slightly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9UBT2_T_174_A
Q9UBT2,H,184,Q,2px9:A,184,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9UBT2_H_184_Q
P47897,H,175,A,4ye9:A,175,Decreases catalytic efficiency about 60-fold.,,,-1.0,,,,,,,,,,,,,P47897_H_175_A
P19835,H,455,Q,1f6w:A,435,Abolishes lipase activity. Decreases Vmax for esterase activity by 2.5-fold.,,,-1.0,,,,,,,,,,,,,P19835_H_455_Q
Q13627,K,188,R,4aze:A,188,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q13627_K_188_R
Q13627,Y,321,F,4aze:A,321,Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues.,,,-1.0,0.0,,,,,,,,,,,,Q13627_Y_321_F
Q96AT9,S,10,A,3qc3:A,10,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q96AT9_S_10_A
Q96AT9,L,12,A,3qc3:A,12,Reduces enzyme activity by half.,,,-1.0,,,,,,,,,,,,,Q96AT9_L_12_A
Q96AT9,H,35,A,3qc3:A,35,Alters protein structure. Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,-1.0,,Q96AT9_H_35_A
Q96AT9,D,37,A,3qc3:A,37,Alters protein structure. Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,-1.0,,Q96AT9_D_37_A
Q96AT9,M,39,A,3qc3:A,39,Lowers enzyme activity by 10%.,,,-1.0,,,,,,,,,,,,,Q96AT9_M_39_A
Q96AT9,M,72,A,3qc3:A,72,Reduces enzyme activity by half.,,,-1.0,,,,,,,,,,,,,Q96AT9_M_72_A
Q96AT9,M,141,A,3qc3:A,141,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q96AT9_M_141_A
P56524,H,803,L,2vqj:A,159,Abolishes histone deacetylase activity.,,,-1.0,,,,,,,,,,,,,P56524_H_803_L
P05154,R,248,E,2ol2:A,229,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Strongly reduces the rate of thrombin inhibition in the presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_R_248_E
P05154,R,253,E,2ol2:A,234,Inhibits strongly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_R_253_E
P05154,E,272,K,2ol2:A,253,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,0.0,,,,,,,,,,,,,P05154_E_272_K
P05154,K,274,E,2ol2:A,255,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_K_274_E
P05154,K,285,E,2ol2:A,266,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_K_285_E
P05154,R,288,E,2ol2:A,269,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_R_288_E
P05154,K,289,E,2ol2:A,270,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Inhibits weakly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_K_289_E
P05154,K,292,E,2ol2:A,273,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_K_292_E
P05154,T,371,R,2ol2:A,352,Increases inhibition of activated protein C/F5 and factor XI/F11 activities. Decreases inhibition of thrombin activity.,,,-1.0,,,,,,,,,,,,,P05154_T_371_R
P05154,F,372,P,2ol2:A,353,Increases inhibition of thrombin activity.,,,1.0,,,,,,,,,,,,,P05154_F_372_P
P05154,F,372,G,2ol2:A,353,Increases inhibition of thrombin activity.,,,1.0,,,,,,,,,,,,,P05154_F_372_G
P05154,R,373,P,2ol2:A,354,Increases inhibition of thrombin activity. Inhibits heterodimer formation with TMPRSS11E.,-1.0,,1.0,,,,,,,,,,,,,P05154_R_373_P
P05154,R,376,P,2ol2:A,357,"Does not change inhibition of thrombin, activated protein C/F5 and factor XI/F11 activities.",,,0.0,,,,,,,,,,,,,P05154_R_376_P
P05154,R,381,E,2ol2:A,362,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,-1.0,,,,,,,,,,,,,P05154_R_381_E
Q6V1X1,D,451,F,6hp8:A,451,Reduced dimerization and reduced enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,Q6V1X1_D_451_F
Q6V1X1,S,755,A,6hp8:A,755,Abolishes activity,,,-1.0,,,,,,,,,,,,,Q6V1X1_S_755_A
Q6V1X1,D,788,A,6hp8:A,788,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q6V1X1_D_788_A
Q6V1X1,D,788,S,6hp8:A,788,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q6V1X1_D_788_S
Q6V1X1,D,788,V,6hp8:A,788,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q6V1X1_D_788_V
Q6V1X1,D,788,E,6hp8:A,788,Loss of enzyme activity. Loss of dimerization.,-1.0,,-1.0,,,,,,,,,,,,,Q6V1X1_D_788_E
Q6V1X1,D,833,A,6hp8:A,833,Abolishes activity,,,-1.0,,,,,,,,,,,,,Q6V1X1_D_833_A
Q6V1X1,H,865,A,6hp8:A,865,Abolishes activity,,,-1.0,,,,,,,,,,,,,Q6V1X1_H_865_A
P55210,C,186,A,4fdl:B,186,No apoptotic activity. Loss of autocatalytic cleavage.,,,-1.0,,,,,,,,,,,,,P55210_C_186_A
P55212,C,163,A,4nbl:A,163,Catalytically inactive active-site mutant.,,,-1.0,,,,,,,,,,,,,P55212_C_163_A
P55212,S,257,A,4n5d:A,257,Suppression of caspase-6 activation.,,,-1.0,,,,,,,,,,,,,P55212_S_257_A
P55212,S,257,D,4n5d:A,257,Prevents caspase-6 autoactivation.,,,-1.0,,,,,,,,,,,,,P55212_S_257_D
P55212,S,257,E,4n5d:A,257,Loss of self-activation.,,,-1.0,,,,,,,,,,,,,P55212_S_257_E
Q9C035,C,15,A,2ecv:A,22,Abolishes E3 ligase activity.,,,-1.0,,,,,,,,,,,,,Q9C035_C_15_A
Q04828,R,304,L,1mrq:A,304,70-fold decrease in progesterone reduction. No effect on DHT reduction.,,,-1.0,,,,,,,,,,,,,Q04828_R_304_L
Q04828,Y,305,F,1mrq:A,305,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_Y_305_F
Q04828,T,307,V,1mrq:A,307,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_T_307_V
Q04828,D,309,V,1mrq:A,309,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_D_309_V
P51684,C,36,A,6wwz:R,36,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_36_A
P51684,C,36,D,6wwz:R,36,Loss of calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_36_D
P51684,C,36,G,6wwz:R,36,Loss of calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_36_G
P51684,C,36,S,6wwz:R,36,"No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and no effect on cell surface expression",-1.0,,-1.0,,,,,,,,,0.0,,,,P51684_C_36_S
P51684,C,57,S,6wwz:R,57,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_57_S
P51684,C,118,S,6wwz:R,118,"Loss of calcium flux and chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and significant reduction in cell surface expression",-1.0,,-1.0,,,,,,,,,1.0,,,,P51684_C_118_S
P51684,C,131,S,6wwz:R,131,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_131_S
P51684,C,138,S,6wwz:R,138,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_138_S
P51684,C,168,S,6wwz:R,168,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_168_S
P51684,C,197,S,6wwz:R,197,"Loss of calcium flux and chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and significant reduction in cell surface expression",-1.0,,-1.0,,,,,,,,,1.0,,,,P51684_C_197_S
P51684,C,233,S,6wwz:R,233,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_233_S
P51684,C,266,S,6wwz:R,266,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_266_S
P51684,C,288,A,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_288_A
P51684,C,288,G,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_288_G
P51684,C,288,R,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,-1.0,,,,,,,,,0.0,,,,P51684_C_288_R
P51684,C,288,S,6wwz:R,288,"No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and no effect on cell surface expression",-1.0,,-1.0,,,,,,,,,0.0,,,,P51684_C_288_S
P51684,C,309,S,6wwz:R,309,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_309_S
P51684,C,310,S,6wwz:R,310,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_310_S
Q12913,C,1239,S,2nz6:A,1239,Catalytically inactive and substrate trapping with higher affinity for substrate.,,1.0,-1.0,,,,,,,,,,,,,Q12913_C_1239_S
Q9UBD6,F,74,L,3hd6:A,74,Reduction of ammonia transport.,,,-1.0,,,,,,,,,,,,,Q9UBD6_F_74_L
Q9UBD6,V,137,I,3hd6:A,137,Reduction of ammonia transport.,,,-1.0,,,,,,,,,,,,,Q9UBD6_V_137_I
Q9UBD6,D,177,N,3hd6:A,177,Loss of function.,,,-1.0,,,,,,,,,,,,,Q9UBD6_D_177_N
Q9UBD6,F,235,V,3hd6:A,235,Reduction of ammonia transport.,,,-1.0,,,,,,,,,,,,,Q9UBD6_F_235_V
P31645,S,611,A,5i6z:A,611,Loss of 10 % of serotonin uptake activity. Loss of 5 % of serotonin uptake activity,,,-1.0,,,,,,,,,,,,,P31645_S_611_A
P31645,S,611,D,5i6z:A,611,Loss of 61 % of serotonin uptake activity. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,-1.0,,,,,,,,,,,,,P31645_S_611_D
P31645,T,613,A,5i6z:A,613,Loss of 26 % of serotonin uptake activity. Loss of 5 % of serotonin uptake activity,,,-1.0,,,,,,,,,,,,,P31645_T_613_A
P31645,T,613,D,5i6z:A,613,Loss of 26 % of serotonin uptake activity. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,-1.0,,,,,,,,,,,,,P31645_T_613_D
P31645,T,616,A,5i6z:A,616,No change. Loss of 5 % of serotonin uptake activity,,,-1.0,,,,,,,,,,,,,P31645_T_616_A
P31645,T,616,D,5i6z:A,616,No change. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,-1.0,,,,,,,,,,,,,P31645_T_616_D
P14859,S,385,A,1gt0:C,107,Loss of inhibition of DNA binding.,,,-1.0,,,,,,,,,,,,,P14859_S_385_A
O00584,H,65,Y,3t0o:A,65,Abolishes the effect on degradation of mitochondrion-associated cytosolic rRNAs.,,,-1.0,,,,,,,,,,,,,O00584_H_65_Y
O00584,H,118,Y,3t0o:A,118,Abolishes the effect on degradation of mitochondrion-associated cytosolic rRNAs.,,,-1.0,,,,,,,,,,,,,O00584_H_118_Y
Q9Y230,D,299,N,6hts:D,299,Abolishes ATPase activity.,,,-1.0,,,,,,,,,,,,,Q9Y230_D_299_N
Q9Y233,D,554,A,4lm1:A,564,Loss of activity and of zinc binding.,,-1.0,-1.0,,,,,,,,,,,,,Q9Y233_D_554_A
Q9Y233,D,554,N,4lm1:A,564,Reduces activity 1000-fold.,,,-1.0,,,,,,,,,,,,,Q9Y233_D_554_N
Q9Y239,V,41,Q,2nz7:B,41,Abolishes caspase-9 activation.,,,-1.0,,,,,,,,,,,,,Q9Y239_V_41_Q
Q9Y239,L,44,A,2nz7:B,44,Abolishes activation of NF-kappa-B. No effect on interaction with RIPK2.,0.0,,-1.0,,,,,,,,,,,,,Q9Y239_L_44_A
Q9Y239,D,48,K,2nz7:B,48,Abolishes activation of NF-kappa-B. No effect on interaction with RIPK2.,0.0,,-1.0,,,,,,,,,,,,,Q9Y239_D_48_K
Q9Y239,E,53,K,2nz7:B,53,No effect on activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,0.0,,,,,,,,,,,,,Q9Y239_E_53_K
Q9Y239,D,54,K,2nz7:B,54,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y239_D_54_K
Q9Y239,E,56,K,2nz7:B,56,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y239_E_56_K
Q9Y239,R,69,E,2nz7:B,69,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y239_R_69_E
A7KAX9,R,407,A,3iug:A,407,Mild effect on GAP activity and neurite-promotion upon nerve growth factor stimulation.,,,-1.0,,,,,,,,,,,,,A7KAX9_R_407_A
A7KAX9,R,407,I,3iug:A,407,Loss of GAP activity.,,,-1.0,,,,,,,,,,,,,A7KAX9_R_407_I
A7KAX9,R,407,M,3iug:A,407,"Loss of GAP activity. In isoform 1, no inhibitory effect on neurite extension.",,,-1.0,,,,,,,,,,,,,A7KAX9_R_407_M
A7KAX9,K,447,A,3iug:A,447,Loss of GAP activity.,,,-1.0,,,,,,,,,,,,,A7KAX9_K_447_A
P08235,S,767,N,3wff:A,767,Loss of transcription transactivation.,,,-1.0,,,,,,,,,,,,,P08235_S_767_N
P08235,S,767,Q,3wff:A,767,Strong decrease of transcription transactivation.,,,-1.0,,,,,,,,,,,,,P08235_S_767_Q
P08235,N,770,A,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_A
P08235,N,770,D,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_D
P08235,N,770,H,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_H
P08235,N,770,Q,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_Q
P08235,N,770,S,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_S
P08235,N,770,T,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_N_770_T
P08235,Q,776,A,3wff:A,776,Reduces aldosterone binding and transcription transactivation.,,,-1.0,,,,,,,,,,,,,P08235_Q_776_A
P08235,R,817,A,3wff:A,817,Reduces aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_R_817_A
P08235,C,849,S,3wff:A,849,Strongly decreases affinity for aldosterone and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_C_849_S
P08235,C,942,S,3wff:A,942,Abolishes steroid binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_C_942_S
P08235,L,952,A,3wff:A,952,Reduces transcription transactivation.,,,-1.0,,,,,,,,,,,,,P08235_L_952_A
P08235,K,953,A,3wff:A,953,Slightly reduces aldosterone binding and abolishes transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_K_953_A
P08235,V,954,A,3wff:A,954,Reduces aldosterone binding and abolishes transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_V_954_A
P08235,F,956,A,3wff:A,956,Abolishes aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_F_956_A
P08235,P,957,A,3wff:A,957,Slightly reduces aldosterone binding and transcription transactivation.,,-1.0,-1.0,,,,,,,,,,,,,P08235_P_957_A
P08238,C,590,A,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,-1.0,,,,,,,,,,,,,P08238_C_590_A
P08238,C,590,N,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,-1.0,,,,,,,,,,,,,P08238_C_590_N
P08238,C,590,D,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,-1.0,,,,,,,,,,,,,P08238_C_590_D
P00918,W,5,A,6qeb:A,5,"Impaired activity, not rescued by 4-methylimidazole (4-MI)",,-1.0,-1.0,,,,,,,,,,,,,P00918_W_5_A
P00918,Y,7,F,6qeb:A,7,Enhanced activity.,,,1.0,,,,,,,,,,,,,P00918_Y_7_F
P00918,Y,7,H,6qeb:A,7,Reduced proton transfer rate.,,,-1.0,,,,,,,,,,,,,P00918_Y_7_H
P00918,N,62,A,6qeb:A,62,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_62_A
P00918,N,62,D,6qeb:A,62,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_62_D
P00918,N,62,H,6qeb:A,62,Reduced proton transfer,,,-1.0,,,,,,,,,,,,,P00918_N_62_H
P00918,N,62,L,6qeb:A,62,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_62_L
P00918,N,62,T,6qeb:A,62,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_62_T
P00918,N,62,V,6qeb:A,62,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_62_V
P00918,H,64,A,6qeb:A,64,"Reduced CO(2) hydrase activity, rescued by 4-methylimidazole (4-MI). Reduced proton transfer",,,-1.0,,,,,,,,,,,,,P00918_H_64_A
P00918,H,64,G,6qeb:A,64,"Impaired activity, not rescued by 4-methylimidazole (4-MI).",,-1.0,-1.0,,,,,,,,,,,,,P00918_H_64_G
P00918,H,64,W,6qeb:A,64,"Impaired activity, rescued by 4-methylimidazole (4-MI). Impaired activity, not rescued by 4-methylimidazole (4-MI)",,,-1.0,,,,,,,,,,,,,P00918_H_64_W
P00918,A,65,F,6qeb:A,65,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_A_65_F
P00918,A,65,S,6qeb:A,65,"2-fold decrease in enzyme efficiency, as determined by kcat/KM ratio, and efficiently inhibited by chlorzolamide",,,-1.0,,,,,,,,,,,,,P00918_A_65_S
P00918,N,67,H,6qeb:A,67,Enhanced proton transfer,,,1.0,,,,,,,,,,,,,P00918_N_67_H
P00918,N,67,L,6qeb:A,67,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_N_67_L
P00918,N,67,Q,6qeb:A,67,"2-fold decrease in enzyme efficiency, as determined by kcat/KM ratio, and efficiently inhibited by chlorzolamide",,,-1.0,,,,,,,,,,,,,P00918_N_67_Q
P00918,H,94,C,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,-1.0,,,,,,,,,,,,,P00918_H_94_C
P00918,H,94,D,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,-1.0,,,,,,,,,,,,,P00918_H_94_D
P00918,H,94,E,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,-1.0,,,,,,,,,,,,,P00918_H_94_E
P00918,H,94,N,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,-1.0,,,,,,,,,,,,,P00918_H_94_N
P00918,H,94,Q,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,-1.0,,,,,,,,,,,,,P00918_H_94_Q
P00918,E,106,A,6qeb:A,106,Strongly reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_E_106_A
P00918,E,106,Q,6qeb:A,106,Strongly reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_E_106_Q
P00918,E,106,D,6qeb:A,106,Normal CO(2) hydrase activity.,,,0.0,,,,,,,,,,,,,P00918_E_106_D
P00918,E,117,Q,6qeb:A,117,Strongly reduced activity and sulfonamide affinity.,,-1.0,-1.0,,,,,,,,,,,,,P00918_E_117_Q
P00918,H,119,D,6qeb:A,119,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_H_119_D
P00918,H,119,N,6qeb:A,119,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_H_119_N
P00918,H,119,Q,6qeb:A,119,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_H_119_Q
P00918,H,119,E,6qeb:A,119,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_H_119_E
P00918,V,121,A,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_A
P00918,V,121,G,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_G
P00918,V,121,I,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_I
P00918,V,121,L,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_L
P00918,V,121,S,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_S
P00918,V,121,K,6qeb:A,121,Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_K
P00918,V,121,R,6qeb:A,121,Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,-1.0,,,,,,,,,,,,,P00918_V_121_R
P00918,V,142,F,6qeb:A,142,Strongly impaired activity.,,,-1.0,,,,,,,,,,,,,P00918_V_142_F
P00918,V,142,Y,6qeb:A,142,Strongly impaired activity.,,,-1.0,,,,,,,,,,,,,P00918_V_142_Y
P00918,V,142,G,6qeb:A,142,Weakly impaired activity.,,,-1.0,,,,,,,,,,,,,P00918_V_142_G
P00918,V,142,H,6qeb:A,142,Impaired activity.,,,-1.0,,,,,,,,,,,,,P00918_V_142_H
P00918,L,197,A,6qeb:A,197,Reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_L_197_A
P00918,L,197,E,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_L_197_E
P00918,L,197,H,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_L_197_H
P00918,L,197,R,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,-1.0,,,,,,,,,,,,,P00918_L_197_R
P00918,L,197,F,6qeb:A,197,Normal activity.,,,0.0,,,,,,,,,,,,,P00918_L_197_F
P00918,T,198,A,6qeb:A,198,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_A
P00918,T,198,C,6qeb:A,198,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_C
P00918,T,198,H,6qeb:A,198,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_H
P00918,T,198,P,6qeb:A,198,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_P
P00918,T,198,D,6qeb:A,198,"Strongly reduced activity, but enhanced zinc affinity.",,1.0,-1.0,,,,,,,,,,,,,P00918_T_198_D
P00918,T,198,E,6qeb:A,198,"Strongly reduced activity, but enhanced zinc affinity.",,1.0,-1.0,,,,,,,,,,,,,P00918_T_198_E
P00918,T,198,S,6qeb:A,198,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_S
P00918,T,198,V,6qeb:A,198,Reduced activity.,,,-1.0,,,,,,,,,,,,,P00918_T_198_V
P00918,T,199,H,6qeb:A,199,Higher affinity for bicarbonate. Enhanced proton transfer capacity,,1.0,1.0,,,,,,,,,,,,,P00918_T_199_H
P00918,T,199,S,6qeb:A,199,"Enhanced p-nitrophenyl acetate esterase activity, but normal CO(2) hydrase activity.",,,1.0,,,,,,,,,,,,,P00918_T_199_S
P00918,P,201,A,6qeb:A,201,"Normal CO(2) hydrase activity, but impaired stability.",,,0.0,,,,,,,,,,,-1.0,,P00918_P_201_A
Q6VAB6,D,786,A,2y4i:B,786,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q6VAB6_D_786_A
P53355,K,42,A,2x0g:A,42,"Loss of activity, apoptotic function and of autophosphorylation.",,,-1.0,-1.0,,,,,,,,,,,,P53355_K_42_A
P53355,S,289,A,2x0g:A,289,Loss of phosphorylation and significant increase in proapoptotic activity.,,,-1.0,-1.0,,,,,,,,,,,,P53355_S_289_A
P53355,S,289,E,2x0g:A,289,Reduction in proapoptotic activity.,,,-1.0,,,,,,,,,,,,,P53355_S_289_E
P53355,S,308,A,2x0g:A,308,Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity.,,1.0,1.0,,,,,,,,,,,,,P53355_S_308_A
P53355,S,308,D,2x0g:A,308,Reduced Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Decreases apoptotic activity.,,-1.0,-1.0,,,,,,,,,,,,,P53355_S_308_D
P53355,S,313,A,2x0g:A,313,Minimal effect on activity.,,,0.0,,,,,,,,,,,,,P53355_S_313_A
P28340,D,402,A,6s1m:A,402,Loss of exonuclease activity. No effect on DNA polymerase activity.,,,-1.0,,,,,,,,,,,,,P28340_D_402_A
Q8N4P3,R,24,A,5vxa:A,24,Abrogates ppGpp hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q8N4P3_R_24_A
Q8N4P3,E,65,A,5vxa:A,65,Abrogates ppGpp hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q8N4P3_E_65_A
Q8N4P3,D,66,A,5vxa:A,66,Reduces ppGpp hydrolase activity.,,,-1.0,,,,,,,,,,,,,Q8N4P3_D_66_A
P53350,K,82,M,5ta8:A,82,Loss of kinase activity. No effect on S-phase progression.,,,-1.0,,,,,,,,,,,,,P53350_K_82_M
P53350,K,82,R,5ta8:A,82,Loss of kinase activity. No effect on RIOK2-binding.,0.0,,-1.0,,,,,,,,,,,,,P53350_K_82_R
P53350,S,137,A,5ta8:A,137,No change in activity. Increases activity and restores recovery after DNA damage checkpoint,,,1.0,,,,,,,,,,,,,P53350_S_137_A
P53350,S,137,D,5ta8:A,137,Increases activity. Results in a block in G1/S.,,,1.0,,,,,,,,,,,,,P53350_S_137_D
P53350,D,176,N,5ta8:A,176,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,P53350_D_176_N
P53350,T,210,A,5ta8:A,210,Abolishes activity. Abolishes checkpoint recovery.,,,-1.0,,,,,,,,,,,,,P53350_T_210_A
P53350,T,210,D,5ta8:A,210,Increases activity and restores recovery after DNA damage checkpoint.,,,1.0,,,,,,,,,,,,,P53350_T_210_D
P53350,T,210,V,5ta8:A,210,"Reduced catalytic activity, but no effect on affinity for ATP.",,0.0,-1.0,,,,,,,,,,,,,P53350_T_210_V
P35236,Y,125,A,3o4s:A,104,Strongly reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,P35236_Y_125_A
P35236,D,257,A,3o4s:A,236,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P35236_D_257_A
P35236,C,291,S,3o4s:A,270,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P35236_C_291_S
P35236,Q,335,A,3o4s:A,314,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,P35236_Q_335_A
P53041,H,304,Q,1wao:1,304,Catalytically inactive,,,-1.0,,,,,,,,,,,,,P53041_H_304_Q
P00352,G,458,N,5l2o:A,458,No significant effect on aldehyde dehydrogenase activity. Prevents the inhibition by ALDH1A1-specific inhibitors.,,-1.0,0.0,,,,,,,,,,,,,P00352_G_458_N
Q9BXJ9,Y,834,F,6c95:A,834,Reduced NatA complex stability and reduced catalytic activity.,1.0,,-1.0,,,,,,,,,,,,,Q9BXJ9_Y_834_F
Q9BXJ9,Y,834,A,6c95:A,834,Reduced NatA complex stability and reduced catalytic activity.,1.0,,-1.0,,,,,,,,,,,,,Q9BXJ9_Y_834_A
Q96PU5,C,942,S,3jvz:C,922,Abolishes activity. No effect on USP36 protein levels.,,,-1.0,,,,,,,,,,,,,Q96PU5_C_942_S
Q8N0X4,D,320,A,5vxs:F,320,Abolishes citramalyl-CoA lyase activity.,,,-1.0,,,,,,,,,,,,,Q8N0X4_D_320_A
Q8N0X4,D,320,N,5vxs:F,320,Abolishes citramalyl-CoA lyase activity.,,,-1.0,,,,,,,,,,,,,Q8N0X4_D_320_N
P67775,D,85,N,2npp:C,85,Loss of phosphatase activity.,,,-1.0,,,,,,,,,,,,,P67775_D_85_N
Q8TEA1,R,126,A,5wws:A,126,Decreases substantially tRNA methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8TEA1_R_126_A
Q8TEA1,Y,131,A,5wws:A,131,Abolishes methylation of tRNA (Cys).,,,-1.0,,,,,,,,,,,,,Q8TEA1_Y_131_A
Q8TEA1,K,159,A,5wws:A,159,Decreases tRNA methyltransferase activiry. Abolishes tRNA methyltransferase activiry,,,-1.0,,,,,,,,,,,,,Q8TEA1_K_159_A
Q8TEA1,K,160,A,5wws:A,160,Decreases tRNA methyltransferase activiry. Abolishes tRNA methyltransferase activiry,,,-1.0,,,,,,,,,,,,,Q8TEA1_K_160_A
Q8TEA1,R,181,A,5wws:A,181,Decreases subtantially tRNA methyltransferase activiry.,,,-1.0,,,,,,,,,,,,,Q8TEA1_R_181_A
Q8TEA1,L,218,A,5wws:A,218,Decreases substantially tRNA methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8TEA1_L_218_A
Q8TEA1,N,220,A,5wws:A,220,Decreases substantially tRNA methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8TEA1_N_220_A
Q8TEA1,S,223,A,5wws:A,223,Dose not affect tRNA methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q8TEA1_S_223_A
Q8TEA1,K,248,A,5wws:A,248,Abolishes tRNA methyltransferase activity. Does not affect S-Adenosylmethionine binding.,,0.0,-1.0,,,,,,,,,,,,,Q8TEA1_K_248_A
Q8TEA1,D,266,A,5wws:A,266,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8TEA1_D_266_A
Q8TEA1,K,271,A,5wws:A,271,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8TEA1_K_271_A
Q8TEA1,D,293,A,5wws:A,293,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8TEA1_D_293_A
Q8TEA1,D,323,A,5wws:B,323,Abolishes tRNA methyltransferase activity. Abolishes S-Adenosylmethionine binding.,,-1.0,-1.0,,,,,,,,,,,,,Q8TEA1_D_323_A
Q8TEA1,C,373,A,5wws:B,373,Does not impair target RNA binding. Abolishes tRNA (cytosine-5-)-methyltransferase activity.,,0.0,-1.0,,,,,,,,,,,,,Q8TEA1_C_373_A
Q8TEA1,F,458,A,5wws:B,458,Abolishes tRNA methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8TEA1_F_458_A
P04062,C,43,S,2j25:A,4,Loss of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,P04062_C_43_S
P04062,C,57,S,2j25:A,18,Loss of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,P04062_C_57_S
P04062,C,62,S,2j25:A,23,Loss of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,P04062_C_62_S
P04062,E,379,G,2j25:A,340,1000-fold decreases of glucosylceramidase activity.,,,-1.0,,,,,,,,,,,,,P04062_E_379_G
Q9BQP7,D,251,A,5zyw:A,251,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9BQP7_D_251_A
Q9BQP7,K,253,A,5zyw:A,253,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9BQP7_K_253_A
O15488,Y,228,F,4ueg:B,197,Loss of autoglucosylation.,,,-1.0,,,-1.0,,,,,,,,,,O15488_Y_228_F
O15488,Y,230,F,4ueg:B,199,No loss of activity.,,,0.0,,,,,,,,,,,,,O15488_Y_230_F
Q9GZT9,C,201,A,3hqr:A,201,Little change in enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9GZT9_C_201_A
Q9GZT9,C,208,A,3hqr:A,208,Little change in enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9GZT9_C_208_A
Q9GZT9,R,252,A,3hqr:A,252,Reduced C-terminal ODD domain (CODD) hydroxylation of HIF1A.,,,-1.0,,,,,,,,,,,,,Q9GZT9_R_252_A
Q9GZT9,D,254,A,3hqr:A,254,Reduced C-terminal ODD domain (CODD) hxdroxylation of HIF1A.,,,-1.0,,,,,,,,,,,,,Q9GZT9_D_254_A
Q9GZT9,D,254,K,3hqr:A,254,Reduced C-terminal ODD domain (CODD) hxdroxylation of HIF1A.,,,-1.0,,,,,,,,,,,,,Q9GZT9_D_254_K
Q9GZT9,C,266,A,3hqr:A,266,Little change in enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9GZT9_C_266_A
Q9GZT9,C,283,A,3hqr:A,283,Little change in enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9GZT9_C_283_A
Q9GZT9,C,302,A,3hqr:A,302,Slight increase in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_302_A
Q9GZT9,Y,303,F,3hqr:A,303,No effect.,,,0.0,,,,,,,,,,,,,Q9GZT9_Y_303_F
Q9GZT9,C,323,A,3hqr:A,323,Little change in enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9GZT9_C_323_A
Q9GZT9,C,326,A,3hqr:A,326,Slight increase in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_326_A
Q9GZT9,R,383,A,3hqr:A,383,Reduces enzyme activity by 95%.,,,-1.0,,,,,,,,,,,,,Q9GZT9_R_383_A
Q9NYL2,K,45,M,6jut:A,45,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9NYL2_K_45_M
Q9NYL2,T,161,A,6jut:A,161,Loss of autophosphorylation activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9NYL2_T_161_A
Q9NYL2,T,162,A,6jut:A,162,Slight loss of autophosphorylation activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9NYL2_T_162_A
Q9NYL2,S,165,A,6jut:A,165,Loss of autophosphorylation activity.,,,-1.0,-1.0,,,,,,,,,,,,Q9NYL2_S_165_A
P17081,Q,67,L,2atx:A,75,Constitutively active. Interacts with PARD6 proteins and GOPC.,1.0,,-1.0,,,,,,,,,,,,,P17081_Q_67_L
O96028,Y,1092,A,5lsu:A,1092,Loss of methyltransferase activity. Reduces levels of H3K36me2 in preadipocytes,,,-1.0,,,,,,,,,,,,,O96028_Y_1092_A
O96028,Y,1179,A,5lsu:A,1179,Loss of methyltransferase activity. Reduces levels of H3K36me2 in preadipocytes,,,-1.0,,,,,,,,,,,,,O96028_Y_1179_A
Q9Y5X4,L,372,R,4log:B,1372,Reduces transcription repressor activity.,,,-1.0,,,,,,,,,,,,,Q9Y5X4_L_372_R
Q9Y5X4,L,375,R,4log:B,1375,Reduces transcription repressor activity.,,,-1.0,,,,,,,,,,,,,Q9Y5X4_L_375_R
O43526,T,217,A,7cr7:A,217,No effect on current or expression.,,,0.0,,,,,,,,,,,,0.0,O43526_T_217_A
O43526,T,217,D,7cr7:A,217,Abolishes currents without reducing channel protein expression.,,,-1.0,,,,,,,,,,,,,O43526_T_217_D
O43526,G,279,S,7cr7:A,279,More than 50% reduction of wt heteromeric current. Ratio of 1,,,-1.0,,,,,,,,,,,,,O43526_G_279_S
Q9UNS1,R,1081,G,4xht:A,1081,Abolishes interaction with PARP1.,-1.0,,-1.0,,,,,,,,,,,,,Q9UNS1_R_1081_G
P19113,K,305,G,4e1o:A,305,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P19113_K_305_G
P19113,Y,334,F,4e1o:A,334,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P19113_Y_334_F
O14842,E,145,A,5tzy:A,145,Constitutive receptor signaling.,,,1.0,,,,,,,,,,,,,O14842_E_145_A
O14842,E,172,A,4phu:A,172,Constitutive receptor signaling.,,,1.0,,,,,,,,,,,,,O14842_E_172_A
P63241,K,47,D,5dlq:F,47,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_47_D
P63241,G,49,A,5dlq:F,49,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_G_49_A
P63241,K,50,A,5dlq:F,50,Decreases significantly the acetylation at position K-47 and causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_50_A
P63241,K,50,I,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_50_I
P63241,K,50,D,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_50_D
P63241,K,50,R,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_50_R
P63241,G,52,A,5dlq:F,52,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_G_52_A
P63241,K,55,A,5dlq:F,55,Causes total inactivation of eIF5A in supporting yeast growth.,,,-1.0,,,,,,,,,,,,,P63241_K_55_A
Q9NZ42,C,15,A,6idf:D,15,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_C_15_A
Q9NZ42,C,15,S,6idf:D,15,No effect on APP processing by the gamma-secretase complex.,,,0.0,,,,,,,,,,,,,Q9NZ42_C_15_S
Q9NZ42,F,25,A,6idf:D,25,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_F_25_A
Q9NZ42,L,26,A,6idf:D,26,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_L_26_A
Q9NZ42,W,30,A,6idf:D,30,"Decreased expression levels, and decreased stimulation of presenilin endoproteolysis.",,,-1.0,,,,,,,,,,,,-1.0,Q9NZ42_W_30_A
Q9NZ42,W,36,A,6idf:D,36,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_W_36_A
Q9NZ42,A,46,N,6idf:D,46,No effect.,,,0.0,,,0.0,,,,,,,,,,Q9NZ42_A_46_N
Q9NZ42,K,54,A,6idf:D,54,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_K_54_A
Q9NZ42,F,94,A,6idf:D,94,Decreased APP processing by the gamma-secretase complex.,,,-1.0,,,,,,,,,,,,,Q9NZ42_F_94_A
Q9UPY3,F,960,A,5zal:A,960,2-fold decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9UPY3_F_960_A
Q9UPY3,Y,971,A,5zal:A,971,10-fold decrease in activity,,,-1.0,,,,,,,,,,,,,Q9UPY3_Y_971_A
Q9UPY3,Y,972,A,5zal:A,972,10-fold decrease in activity,,,-1.0,,,,,,,,,,,,,Q9UPY3_Y_972_A
Q9UPY3,E,1036,A,5zal:A,1036,5-fold decrease in activity.,,,-1.0,,,,,,,,,,,,,Q9UPY3_E_1036_A
Q9UPY3,E,1313,A,5zal:A,1313,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_E_1313_A
Q9UPY3,D,1320,A,5zal:A,1320,Decreased activity. Loss of activity,,,-1.0,,,,,,,,,,,,,Q9UPY3_D_1320_A
Q9UPY3,E,1340,A,5zal:A,1340,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_E_1340_A
Q9UPY3,Q,1702,A,5zal:A,1702,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_Q_1702_A
Q9UPY3,D,1709,A,5zal:A,1709,Decreased activity. Loss of activity,,,-1.0,,,,,,,,,,,,,Q9UPY3_D_1709_A
Q9UPY3,P,1729,E,5zal:A,1729,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_P_1729_E
Q9UPY3,E,1813,A,5zal:A,1813,Decreased activity. Loss of activity,,,-1.0,,,,,,,,,,,,,Q9UPY3_E_1813_A
Q96G74,S,177,D,3tmp:C,177,Loss of deubiquitinase activity. Abolishes activation by protein kinases.,-1.0,,-1.0,,,,,,,,,,,,,Q96G74_S_177_D
Q96G74,S,177,E,3tmp:C,177,Loss of deubiquitinase activity. Abolishes activation by protein kinases.,-1.0,,-1.0,,,,,,,,,,,,,Q96G74_S_177_E
Q96G74,C,224,S,3tmp:A,224,Loss of deubiquitinase activity. Loss of suppression of IFN production.,,,-1.0,,,,,,,,,,,,,Q96G74_C_224_S
Q9UJ41,D,313,A,1txu:A,313,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,Q9UJ41_D_313_A
Q9UJ41,P,317,A,1txu:A,317,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,Q9UJ41_P_317_A
Q9UJ41,Y,354,A,1txu:A,354,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,Q9UJ41_Y_354_A
Q9UJ41,T,357,A,1txu:A,357,Strongly reduced activity.,,,-1.0,,,,,,,,,,,,,Q9UJ41_T_357_A
Q8WUI4,H,843,A,3c0y:A,843,Enhanced deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_A
Q8WUI4,H,843,F,3c0y:A,843,Enhanced deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_F
Q8WUI4,H,843,Y,3c0y:A,843,6000 fold increase in deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_Y
P40616,Q,71,L,1upt:A,71,"Altered Golgi structure with an engorged lumen. Interacts with ARFIP2, GOLGA4, RGPD8, SCOC and UNC119.",1.0,,-1.0,,,,,,,,,,,,,P40616_Q_71_L
Q96GA7,G,72,A,2rkb:A,72,Strongly increased enzyme activity towards threonine.,,,-1.0,,,,,,,,,,,,,Q96GA7_G_72_A
Q96GA7,C,309,A,2rkb:A,309,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q96GA7_C_309_A
P61026,T,23,N,5szj:A,23,Probable dominant negative mutant locked in the inactive GDP-bound form,,1.0,-1.0,,,,,,,,,,,,,P61026_T_23_N
Q9UDY8,C,464,A,4i1p:C,464,Slight decrease in NF-kappa-B activation.,,,-1.0,,,,,,,,,,,,,Q9UDY8_C_464_A
P61020,Q,79,L,2hei:B,79,Constitutively active.,,,1.0,,,,,,,,,,,,,P61020_Q_79_L
Q8IXL7,H,141,G,6q9v:A,109,30-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,Q8IXL7_H_141_G
Q8IXL7,N,160,F,6q9v:A,128,7000-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,Q8IXL7_N_160_F
Q8IXL7,N,160,Y,6q9v:A,128,500-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,Q8IXL7_N_160_Y
Q9NWZ3,K,213,A,6lxy:B,213,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q9NWZ3_K_213_A
Q96BI3,H,171,A,6idf:C,171,Impaired gamma-secretease assembly and reduced proteolytic activity of the gamma-secretase complex.,-1.0,,-1.0,,,,,,,,,,,,,Q96BI3_H_171_A
Q96BI3,H,197,A,6idf:C,197,Impaired gamma-secretease assembly and reduced proteolytic activity of the gamma-secretase complex.,-1.0,,-1.0,,,,,,,,,,,,,Q96BI3_H_197_A
P12277,C,283,S,3dre:A,283,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P12277_C_283_S
P12277,C,283,Y,3dre:A,283,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P12277_C_283_Y
P12277,R,292,H,3dre:A,292,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P12277_R_292_H
P12277,R,292,L,3dre:A,292,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P12277_R_292_L
P12277,R,292,Q,3dre:A,292,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P12277_R_292_Q
P12277,R,292,K,3dre:A,292,42% of wild-type activity.,,,-1.0,,,,,,,,,,,,,P12277_R_292_K
P12277,D,340,E,3dre:A,340,No change in activity.,,,0.0,,,,,,,,,,,,,P12277_D_340_E
Q8NCC3,D,46,A,4x93:B,13,Decreases phospholipase and transacetylase activity. Has no effect on association with membranes.,,,-1.0,,,,,,,,,0.0,,,,Q8NCC3_D_46_A
Q8NCC3,L,83,S,4x93:B,50,No effect on phospholipase activity. Strongly decreases transacetylase activity and association with membranes.,,,-1.0,,,,,,,,,1.0,,,,Q8NCC3_L_83_S
Q8NCC3,V,85,S,4x93:B,52,No effect on phospholipase activity. Strongly decreases transacetylase activity and association with membranes.,,,-1.0,,,,,,,,,1.0,,,,Q8NCC3_V_85_S
Q8NCC3,N,99,A,4x93:B,66,"Loss of glycosylation site. Leads to retention in the endoplasmic reticulum and nearly abolishes the production of the mature, active enzyme.",,,-1.0,,,-1.0,,,,,,1.0,,,-1.0,Q8NCC3_N_99_A
Q8NCC3,S,198,A,4x93:B,165,Abolishes phospholipase and transacetylase activity. Abolishes association with membranes.,,,-1.0,,,,,,,,,1.0,,,,Q8NCC3_S_198_A
Q8NCC3,K,235,A,4x93:B,202,No effect on phospholipase activity. Abolishes transacetylase activity. Has no effect on association with membranes.,,,-1.0,,,,,,,,,0.0,,,,Q8NCC3_K_235_A
Q8NCC3,N,273,A,4x93:B,240,"Loss of glycosylation site. Mildly reduces production of the mature, active enzyme.",,,-1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_273_A
Q8NCC3,N,289,A,4x93:B,256,"Loss of glycosylation site. Mildly reduces production of the mature, active enzyme.",,,-1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_289_A
Q8NCC3,T,362,A,4x93:B,329,No effect on phospholipase activity. Strongly decreases transacetylase activity and abolishes association with membranes.,,,-1.0,,,,,,,,,1.0,,,,Q8NCC3_T_362_A
Q8NCC3,N,398,A,4x93:B,365,"Loss of glycosylation site. Slightly reduces production of the mature, active enzyme.",,,-1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_398_A
Q9NWT6,D,201,A,2yde:A,201,Prevents suppression of HIF CAD activity.,,,-1.0,,,,,,,,,,,,,Q9NWT6_D_201_A
Q9NWT6,D,201,E,2yde:A,201,Loss of HIF1A Asn hydroxylation activity. Slightly stimulates 2-oxoglutarate turnover.,,,-1.0,,,,,,,,,,,,,Q9NWT6_D_201_E
Q9NWT6,Q,239,H,2yde:A,239,No effect on Asp hydroxylation ability.,,,0.0,,,,,,,,,,,,,Q9NWT6_Q_239_H
Q9NWT6,W,296,R,2yde:A,296,Loss of HIF1A Asn hydroxylation activity and slight stimulation of 2-oxoglutarate turnover,,,-1.0,,,,,,,,,,,,,Q9NWT6_W_296_R
Q9NWT6,L,340,R,2yde:A,340,"Impairs dimer formation, leading to loss of HIF1A Asn hydroxylation activity. No stimulation of 2-oxoglutarate turnover",-1.0,,-1.0,,,,,,,,,,,,,Q9NWT6_L_340_R
Q9NWT6,I,344,R,2yde:A,344,No effect on dimer formation and HIF1A Asn hydroxylation activity.,0.0,,0.0,,,,,,,,,,,,,Q9NWT6_I_344_R
Q15286,S,22,N,6if2:B,22,Destabilization of the intercellular bridge during cytokinesis. Strong reduction in fast recycling.,,,-1.0,,,,,,,,,,,,,Q15286_S_22_N
Q15286,Q,67,L,6if2:B,67,Loss of GTPase activity. Increased fast recycling.,,,-1.0,,,,,,,,,,,,,Q15286_Q_67_L
P34972,D,130,A,6pt0:R,130,Loss of ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,-1.0,,,,,,,,,,,,,P34972_D_130_A
P34972,R,131,A,6pt0:R,131,No effect on ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,-1.0,,,,,,,,,,,,,P34972_R_131_A
P34972,L,201,P,6pt0:R,201,Abolishes ligand binding and agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,-1.0,,,,,,,,,,,,,P34972_L_201_P
P34972,Y,207,A,6pt0:R,207,Abolishes agonist-induced inhibitory effect on adenylate cyclase. No effect on ligand binding.,,0.0,-1.0,,,,,,,,,,,,,P34972_Y_207_A
P34972,A,244,E,6pt0:R,244,Loss of ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,-1.0,,,,,,,,,,,,,P34972_A_244_E
Q5D1E8,D,141,N,3v33:A,141,Abolishes RNase activity.,,,-1.0,,,,,,,,,,,,,Q5D1E8_D_141_N
Q5D1E8,N,144,A,3v33:A,144,No change in RNase activity.,,,0.0,,,,,,,,,,,,,Q5D1E8_N_144_A
Q5D1E8,C,157,A,3v33:A,157,Does not inhibit antiviral effects.,,,0.0,,,,,,,,,,,,,Q5D1E8_C_157_A
Q5D1E8,R,214,A,3v33:A,214,Abolishes RNase activity.,,,-1.0,,,,,,,,,,,,,Q5D1E8_R_214_A
Q5D1E8,D,225,A,3v33:A,225,"Loss of pre-miRNA RNase activity, IL17A mRNA instability and antiviral effects",,,-1.0,,,,,,,,,,,,,Q5D1E8_D_225_A
Q5D1E8,D,226,A,3v33:A,226,"Loss of pre-miRNA RNase activity, IL17A mRNA instability and antiviral effects",,,-1.0,,,,,,,,,,,,,Q5D1E8_D_226_A
Q13613,C,438,S,5c16:A,438,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q13613_C_438_S
Q13613,D,443,A,5c16:A,443,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q13613_D_443_A
Q13613,R,444,A,5c16:A,444,"Abolishes enzyme activity with phosphatidylinositol 3-phosphate. Reduces activity with phosphatidylinositol (3,5)-bisphosphate.",,,-1.0,,,,,,,,,,,,,Q13613_R_444_A
Q13613,R,484,A,5c16:A,484,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q13613_R_484_A
Q9NS18,S,78,P,2cq9:A,38,Specifically increases the specific activity but decreases affinity for glutathionylated substrates.,,-1.0,1.0,,,,,,,,,,,,,Q9NS18_S_78_P
Q9NS18,C,80,S,2cq9:A,40,Strongly impairs enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9NS18_C_80_S
P34947,K,215,R,6pjx:A,215,Failed to phosphorylate p53/TP53.,,,-1.0,,,,,,,,,,,,,P34947_K_215_R
P34947,S,484,A,6pjx:A,484,15-20 fold defects in kinase activity,,,-1.0,,,,,,,,,,,,,P34947_S_484_A
P34947,T,485,A,6pjx:A,485,15-20 fold defects in kinase activity,,,-1.0,,,,,,,,,,,,,P34947_T_485_A
P50613,K,41,A,6o9l:8,41,Total loss of activity.,,,-1.0,,,,,,,,,,,,,P50613_K_41_A
P50613,S,164,A,6o9l:8,164,No mitotic repression of transcriptional activity of the reconstituted TFIIH complex.,,,-1.0,,,,,,,,,,,,,P50613_S_164_A
P50613,T,170,A,6o9l:8,170,Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex.,,,-1.0,,,,,,,,,,,,,P50613_T_170_A
Q06141,E,114,Q,4mth:A,114,Reduces peptidoglycan binding and antibacterial activity.,,-1.0,-1.0,,,,,,,,,,,,,Q06141_E_114_Q
Q06141,E,118,Q,4mth:A,118,Reduces antibacterial activity but no effect on peptidoglycan binding.,,0.0,-1.0,,,,,,,,,,,,,Q06141_E_118_Q
Q9BYC5,R,365,A,6vld:B,365,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_R_365_A
Q9BYC5,R,365,K,6vld:B,365,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_R_365_K
Q9BYC5,R,366,A,6vld:B,366,Decreases activity to 3%.,,,-1.0,,,,,,,,,,,,,Q9BYC5_R_366_A
Q9BYC5,R,366,K,6vld:B,366,Decreases activity to 3%.,,,-1.0,,,,,,,,,,,,,Q9BYC5_R_366_K
Q9BYC5,D,368,A,6vld:B,368,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_D_368_A
Q9BYC5,K,369,A,6vld:B,369,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_K_369_A
Q9BYC5,E,373,A,6vld:B,373,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_E_373_A
Q9BYC5,Y,382,A,6vld:B,382,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_Y_382_A
Q9BYC5,D,409,A,6vld:B,409,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_D_409_A
Q9BYC5,D,410,A,6vld:B,410,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9BYC5_D_410_A
Q9BYC5,D,453,A,6vld:B,453,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_D_453_A
Q9BYC5,S,469,A,6vld:B,469,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BYC5_S_469_A
O15033,C,790,A,6jx5:A,790,Failure to form ubiquitin thioester complex and does not inhibit apoptosis.,,,-1.0,,,,,,,,,,,,,O15033_C_790_A
Q9BRZ2,C,21,A,5jw7:B,21,"Complete loss of autoubiquitination. Complete loss of autoubiquitination, loss of antiviral activity against yellow fever virus and human coronavirus virus OC43, but normal induction of interferon-beta following Sendai virus infection",,,-1.0,,-1.0,,,,,,,,,,,Q9BRZ2_C_21_A
Q9BRZ2,C,24,A,5jw7:B,24,"Complete loss of autoubiquitination, loss of antiviral activity against yellow fever virus and human coronavirus virus OC43, but normal induction of interferon-beta following Sendia virus infection",,,-1.0,,-1.0,,,,,,,,,,,Q9BRZ2_C_24_A
Q9BUB5,K,78,M,2hw6:A,78,Loss of kinase activity,,,-1.0,,,,,,,,,,,,,Q9BUB5_K_78_M
P37173,K,277,R,5e92:A,277,"Abolishes kinase activity, TGF-beta signaling and interaction with DAXX.",,,-1.0,,,,,,,,,,,,,P37173_K_277_R
P19447,K,346,R,6o9m:7,346,No transcriptional activity of the reconstituted TFIIH complex.,,,-1.0,,,,,,,,,,,,,P19447_K_346_R
P58753,P,125,H,2ndh:A,125,Abolishes NF-kappa-B activation.,,,-1.0,,,,,,,,,,,,,P58753_P_125_H
P09960,Q,135,A,3b7r:L,134,Srongly increased epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_Q_135_A
P09960,Q,135,L,3b7r:L,134,Srongly increased epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_Q_135_L
P09960,Q,137,A,3b7r:L,136,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_Q_137_A
P09960,Q,137,L,3b7r:L,136,"Aminopeptidase activity strongly impaired, but keeps LTA4 activity.",,,-1.0,,,,,,,,,,,,,P09960_Q_137_L
P09960,Q,137,N,3b7r:L,136,"Aminopeptidase activity almost absent, but keeps LTA4 activity.",,,-1.0,,,,,,,,,,,,,P09960_Q_137_N
P09960,H,140,Q,3b7r:L,139,"Aminopeptidase activity almost absent, but keeps LTA4 activity.",,,-1.0,,,,,,,,,,,,,P09960_H_140_Q
P09960,G,269,A,3b7r:L,268,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_G_269_A
P09960,G,270,A,3b7r:L,269,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_G_270_A
P09960,M,271,L,3b7r:L,270,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_M_271_L
P09960,E,272,A,3b7r:L,271,Complete loss of epoxide hydrolase activity and aminopeptidase activity.,,,-1.0,,,,,,,,,,,,,P09960_E_272_A
P09960,E,272,D,3b7r:L,271,Complete loss of epoxide hydrolase activity and aminopeptidase activity.,,,-1.0,,,,,,,,,,,,,P09960_E_272_D
P09960,E,272,Q,3b7r:L,271,"Loss of LTA4 hydrolase activity, and aminopeptidase activity strongly impaired.",,,-1.0,,,,,,,,,,,,,P09960_E_272_Q
P09960,N,273,A,3b7r:L,272,No loss of epoxide hydrolase activity and aminopeptidase activity.,,,0.0,,,,,,,,,,,,,P09960_N_273_A
P09960,H,296,Y,3b7r:L,295,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,-1.0,,,,,,,,,,,,,P09960_H_296_Y
P09960,E,297,A,3b7r:L,296,Loss of epoxide hydrolase and aminopeptidase activities.,,,-1.0,,,,,,,,,,,,,P09960_E_297_A
P09960,E,297,K,3b7r:L,296,Loss of epoxide hydrolase and aminopeptidase activities.,,,-1.0,,,,,,,,,,,,,P09960_E_297_K
P09960,E,297,Q,3b7r:L,296,"Loss of aminopeptidase activity, but keeps LTA4 hydrolase activity.",,,-1.0,,,,,,,,,,,,,P09960_E_297_Q
P09960,H,300,L,3b7r:L,299,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,-1.0,,,,,,,,,,,,,P09960_H_300_L
P09960,E,319,A,3b7r:L,318,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,-1.0,,,,,,,,,,,,,P09960_E_319_A
P09960,D,372,N,3b7r:L,371,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_D_372_N
P09960,D,374,N,3b7r:L,373,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_D_374_N
P09960,D,376,A,3b7r:L,375,Strongly reduced hydrolysis of peptides starting with Arg. Small effect on hydrolysis of peptides starting with Ala. Abolishes epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_D_376_A
P09960,D,376,E,3b7r:L,375,Strongly reduced aminopeptidase activity. Abolishes epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_D_376_E
P09960,D,376,N,3b7r:L,375,Abolishes aminopeptidase activity. Decreased epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_D_376_N
P09960,E,385,Q,3b7r:L,384,Reduced aminopeptidase activity. Minor effect on epoxide hydrolase activity.,,,-1.0,,,,,,,,,,,,,P09960_E_385_Q
P09960,R,564,A,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,-1.0,,,,,,,,,,,,,P09960_R_564_A
P09960,R,564,K,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,-1.0,,,,,,,,,,,,,P09960_R_564_K
P09960,R,564,M,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,-1.0,,,,,,,,,,,,,P09960_R_564_M
P09960,K,566,A,3b7r:L,565,Strongly reduced affinity for peptide substrates. Reduced epoxide hydrolase and aminopeptidase activity.,,-1.0,-1.0,,,,,,,,,,,,,P09960_K_566_A
P09960,K,566,M,3b7r:L,565,Strongly reduced affinity for peptide substrates. Reduced epoxide hydrolase and aminopeptidase activity.,,-1.0,-1.0,,,,,,,,,,,,,P09960_K_566_M
P09960,K,566,R,3b7r:L,565,No effect on epoxide hydrolase and aminopeptidase activity.,,,0.0,,,,,,,,,,,,,P09960_K_566_R
P16591,R,483,Q,2kk6:A,42,Abolishes kinase activity. Abolishes location at microtubules.,,,-1.0,,,,,,,,,1.0,,,,P16591_R_483_Q
Q9BU02,K,11,A,3bhd:B,11,Mildly decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BU02_K_11_A
Q9BU02,D,37,A,3bhd:B,37,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU02_D_37_A
Q9BU02,Y,39,A,3bhd:B,39,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU02_Y_39_A
Q9BU02,W,53,A,3bhd:B,53,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU02_W_53_A
Q9BU02,K,65,A,3bhd:B,65,Strongly decreases enzyme activity. No effect on affinity for thiamine triphosphate.,,0.0,-1.0,,,,,,,,,,,,,Q9BU02_K_65_A
Q9BU02,Y,79,A,3bhd:B,79,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BU02_Y_79_A
Q9BU02,E,81,A,3bhd:B,81,Mildly decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BU02_E_81_A
Q9BU02,D,147,A,3bhd:B,147,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU02_D_147_A
Q9BU02,K,193,A,3bhd:B,193,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,Q9BU02_K_193_A
P49903,T,85,A,3fd5:B,85,Strongly reduced ADP hydrolysis.,,,-1.0,,,,,,,,,,,,,P49903_T_85_A
P62937,R,55,A,1cwh:A,55,Loss of peptidyl-prolyl cis-trans isomerase activity. No loss of its interaction with BSG/CD147 or its ability to induce leukocyte chemotaxis. No effect on its interaction with MAP3K5/ASK1. Loss of its ability to negatively regulate oxidative stress-induced apoptosis mediated by MAP3K5/ASK1. Reduced interaction with TARDBP. No loss of interaction with influenza A virus matrix protein 1 or its ability to inhibit viral replication.,,,-1.0,,,,,,,,,,,,,P62937_R_55_A
P62937,F,60,A,1cwh:A,60,Loss of ability to stimulate MAPK/ERK phosphorylation.,,,-1.0,,,,,,,,,,,,,P62937_F_60_A
P62937,R,69,A,1cwh:A,69,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,-1.0,,,,,,,,,,,,,P62937_R_69_A
P62937,H,70,A,1cwh:A,70,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,-1.0,,,,,,,,,,,,,P62937_H_70_A
P62937,T,107,A,1cwh:A,107,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,-1.0,,,,,,,,,,,,,P62937_T_107_A
P62937,F,113,A,1cwh:A,113,Reduced ability to stimulate MAPK/ERK phosphorylation.,,,-1.0,,,,,,,,,,,,,P62937_F_113_A
P62937,W,121,A,1cwh:A,121,200-fold decrease of sensitivity to CsA. Reduced ability to stimulate MAPK/ERK phosphorylation.,,-1.0,-1.0,,,,,,,,,,,,,P62937_W_121_A
P62937,W,121,E,1cwh:A,121,Loss of peptidyl-prolyl cis-trans isomerase activity.,,,-1.0,,,,,,,,,,,,,P62937_W_121_E
P62937,W,121,H,1cwh:A,121,No effect on peptidyl-prolyl cis-trans isomerase activity.,,,-1.0,,,,,,,,,,,,,P62937_W_121_H
P62937,H,126,A,1cwh:A,126,Loss of peptidyl-prolyl cis-trans isomerase activity and interaction with HCV NS5A. Loss of ability to stimulate MAPK/ERK phosphorylation.,-1.0,,-1.0,,,,,,,,,,,,,P62937_H_126_A
P09622,K,89,E,1zmc:D,54,Abolishes dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,-1.0,,,,,,,,,,,,,P09622_K_89_E
P09622,H,383,A,1zmc:D,348,Reduces dihydrolipoyl dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P09622_H_383_A
P09622,H,383,L,1zmc:D,348,Reduces dihydrolipoyl dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P09622_H_383_L
P09622,D,448,A,1zmc:D,413,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_D_448_A
P09622,D,448,N,1zmc:D,413,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_D_448_N
P09622,E,466,A,1zmc:D,431,Decreases dehydrogenase activity. Loss of proteolytic activity.,,,-1.0,,,,,,,,,,,,,P09622_E_466_A
P09622,Y,473,A,1zmc:D,438,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_Y_473_A
P09622,Y,473,F,1zmc:D,438,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_Y_473_F
P09622,Y,473,H,1zmc:D,438,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_Y_473_H
P09622,R,482,A,1zmc:D,447,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_R_482_A
P09622,S,491,A,1zmc:D,456,Loss of proteolytic activity. Does not affect dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P09622_S_491_A
P09622,E,492,Q,1zmc:D,457,Reduces dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,-1.0,,,,,,,,,,,,,P09622_E_492_Q
P09622,K,505,M,1zmc:D,470,Reduces dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,-1.0,,,,,,,,,,,,,P09622_K_505_M
Q92905,H,138,Q,6r7h:E,138,"Abolishes ability to deneddylate cullins, without affecting the 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex.",,,-1.0,,,,,,,,,,,,,Q92905_H_138_Q
Q15120,N,120,H,1y8p:A,120,No effect on kinase activity,,,0.0,,,,,,,,,,,,,Q15120_N_120_H
Q15120,D,121,N,1y8p:A,121,No effect on kinase activity,,,0.0,,,,,,,,,,,,,Q15120_D_121_N
Q15125,W,68,A,6ohu:A,68,Reduces catalytic activity to less than 35% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_W_68_A
Q15125,I,75,A,6ohu:A,75,Reduces catalytic activity to less than 35% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_I_75_A
Q15125,H,76,A,6ohu:A,76,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_H_76_A
Q15125,E,80,A,6ohu:A,80,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_E_80_A
Q15125,Y,111,W,6ohu:A,111,Reduces catalytic activity to less than 2% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_Y_111_W
Q15125,M,121,A,6ohu:A,121,Reduces catalytic activity to less than 35% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_M_121_A
Q15125,M,121,V,6ohu:A,121,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q15125_M_121_V
Q15125,E,122,A,6ohu:A,122,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_E_122_A
Q15125,T,125,A,6ohu:A,125,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_T_125_A
Q15125,Y,188,A,6ohu:A,188,Reduces catalytic activity to less than 35% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_Y_188_A
Q15125,F,189,A,6ohu:A,189,Reduces catalytic activity to less than 35% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_F_189_A
Q15125,F,189,L,6ohu:A,189,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q15125_F_189_L
Q15125,N,193,A,6ohu:A,193,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_N_193_A
Q15125,W,196,A,6ohu:A,196,Reduces catalytic activity to less than 10% of wild-type.,,,-1.0,,,,,,,,,,,,,Q15125_W_196_A
Q15126,K,17,M,3ch4:B,17,Approximately 8-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_K_17_M
Q15126,R,18,Q,3ch4:B,18,Approximately 85-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_18_Q
Q15126,K,19,M,3ch4:B,19,Approximately 9-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_K_19_M
Q15126,K,22,M,3ch4:B,22,Approximately 100000-fold decrease in Vmax for MgATP.,,,-1.0,,,,,,,,,,,,,Q15126_K_22_M
Q15126,D,23,N,3ch4:B,23,Approximately 7-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in KM for MgATP and 5-fold increase in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_D_23_N
Q15126,K,48,M,3ch4:B,48,Approximately 1400-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_K_48_M
Q15126,K,69,M,3ch4:B,69,Approximately 500-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_K_69_M
Q15126,R,73,M,3ch4:B,73,Approximately 3000-fold decrease in Vmax for MgATP and R-MVP. No change in KM for MgATP and approximately 3-fold increase in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_73_M
Q15126,R,84,M,3ch4:B,84,Approximately 10-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and 50-fold increase in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_84_M
Q15126,R,93,M,3ch4:B,93,Almost no change in KM and Vmax for MgATP and R-MVP.,,0.0,0.0,,,,,,,,,,,,,Q15126_R_93_M
Q15126,R,110,M,3ch4:B,110,Approximately 20000-fold decrease in Vmax for MgATP.,,,-1.0,,,,,,,,,,,,,Q15126_R_110_M
Q15126,R,111,M,3ch4:B,111,Approximately 65-fold decrease in Vmax for MgATP and R-MVP. Approximately 8-fold increase in KM for MgATP and 60-fold increase in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_111_M
Q15126,R,130,M,3ch4:B,130,Approximately 4-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_130_M
Q15126,R,138,M,3ch4:B,138,Approximately 3-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and no change in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_138_M
Q15126,R,141,M,3ch4:B,141,Approximately 15-fold decrease in Vmax for MgATP and R-MVP. Approximately 50-fold increase in KM for MgATP and approximately 7-fold in KM for R-MVP.,,-1.0,-1.0,,,,,,,,,,,,,Q15126_R_141_M
Q86W47,T,11,D,6v22:E,2011,Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics,,,-1.0,,,,,,,,,,,,,Q86W47_T_11_D
Q86W47,S,17,E,6v22:E,2017,Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics,,,-1.0,,,,,,,,,,,,,Q86W47_S_17_E
P09467,D,119,A,5q0b:A,118,Reduced activity.,,,-1.0,,,,,,,,,,,,,P09467_D_119_A
P09467,D,122,A,5q0b:A,121,Reduced activity.,,,-1.0,,,,,,,,,,,,,P09467_D_122_A
P43250,I,6,A,3nyo:A,6,12-13 fold defects in kinase activity,,,-1.0,,,,,,,,,,,,,P43250_I_6_A
P43250,V,7,A,3nyo:A,7,12-13 fold defects in kinase activity,,,-1.0,,,,,,,,,,,,,P43250_V_7_A
P43250,N,9,A,3nyo:A,9,140-fold defects in kinase activity.,,,-1.0,,,,,,,,,,,,,P43250_N_9_A
P43250,L,12,A,3nyo:A,12,1100-fold defects in kinase activity.,,,-1.0,,,,,,,,,,,,,P43250_L_12_A
P0DPD7,D,88,A,2pxx:A,88,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_D_88_A
P0DPD7,E,129,A,2pxx:A,129,Abolishes protein-lysine N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_E_129_A
P0DPD7,K,130,A,2pxx:A,130,Abolishes protein-lysine N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_K_130_A
P0DPD7,T,132,A,2pxx:A,132,Reduces protein-lysine N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_T_132_A
P0DPD7,L,133,A,2pxx:A,133,Reduces protein-lysine N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_L_133_A
P0DPD7,D,134,A,2pxx:A,134,Abolishes protein-lysine N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,P0DPD7_D_134_A
O75907,L,346,W,6vz1:A,346,Strongly reduced diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_L_346_W
O75907,T,371,A,6vz1:A,371,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_T_371_A
O75907,Q,375,A,6vz1:A,375,Slightly decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_Q_375_A
O75907,W,377,F,6vz1:A,377,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_W_377_F
O75907,N,378,A,6vz1:A,378,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_N_378_A
O75907,N,378,L,6vz1:A,378,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_N_378_L
O75907,V,381,A,6vz1:A,381,Does not affect diacylglycerol O-acyltransferase activity.,,,0.0,,,,,,,,,,,,,O75907_V_381_A
O75907,V,381,W,6vz1:A,381,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_V_381_W
O75907,H,382,A,6vz1:A,382,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_H_382_A
O75907,C,385,W,6vz1:A,385,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_C_385_W
O75907,I,386,A,6vz1:A,386,Slightly decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_I_386_A
O75907,Y,390,A,6vz1:A,390,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_Y_390_A
O75907,K,391,A,6vz1:A,391,Slightly decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_K_391_A
O75907,K,400,L,6vz1:A,400,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_K_400_L
O75907,R,404,A,6vz1:A,404,Does not affect diacylglycerol O-acyltransferase activity.,,,0.0,,,,,,,,,,,,,O75907_R_404_A
O75907,R,404,L,6vz1:A,404,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_R_404_L
O75907,V,407,F,6vz1:A,407,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_V_407_F
O75907,S,411,A,6vz1:A,411,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_S_411_A
O75907,S,411,W,6vz1:A,411,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_S_411_W
O75907,S,411,I,6vz1:A,411,Decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_S_411_I
O75907,H,415,A,6vz1:A,415,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_H_415_A
O75907,E,416,A,6vz1:A,416,Abolished diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_E_416_A
O75907,M,434,A,6vz1:A,434,Reduced diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_M_434_A
O75907,M,434,I,6vz1:A,434,Reduced diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_M_434_I
O75907,Q,437,A,6vz1:A,437,Reduced diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_Q_437_A
O75907,Q,465,A,6vz1:A,465,Reduced diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_Q_465_A
O75907,V,469,A,6vz1:A,469,Slightly decreased diacylglycerol O-acyltransferase activity.,,,-1.0,,,,,,,,,,,,,O75907_V_469_A
Q9UK55,Y,408,A,3f1s:A,387,Loss of inhibitory activity.,,,-1.0,,,,,,,,,,,,,Q9UK55_Y_408_A
Q9UK53,W,378,A,2qic:A,235,Unable to stimulate DNA repair after UV irradiation or promote DNA-damage-induced apoptosis.,,,-1.0,,,,,,,,,,,,,Q9UK53_W_378_A
O75473,D,146,F,4bsr:A,146,Abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,O75473_D_146_F
O75473,D,170,F,4bsr:A,170,Abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,O75473_D_170_F
O75473,A,190,D,4bsr:A,190,Abolishes activation of Wnt signaling.,,,-1.0,,,,,,,,,,,,,O75473_A_190_D
Q13158,F,25,R,2gf5:A,25,Loss of interaction with FAS. Loss of self-association. Abolishes induction of apoptosis.,-1.0,,-1.0,,,,,,,,,,,,,Q13158_F_25_R
Q13158,D,44,R,2gf5:A,44,Loss of interaction with CASP8. Abolishes induction of apoptosis. Decreased interaction with FAS.,-1.0,,-1.0,,,,,,,,,,,,,Q13158_D_44_R
Q9H611,K,234,A,6hph:A,234,Loss of ATPase activity. Lower activity for single-stranded DNA.,,,-1.0,,,,,,,,,,,,,Q9H611_K_234_A
Q969G6,E,79,Q,1q9s:A,86,Loss of kinase activity. No effect on TNFRSF1A- and CYBA-binding.,,0.0,-1.0,,,,,,,,,,,,,Q969G6_E_79_Q
Q13535,K,2327,R,5yz0:A,2327,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q13535_K_2327_R
Q13535,D,2475,A,5yz0:A,2475,Abolishes kinase activity,,,-1.0,,,,,,,,,,,,,Q13535_D_2475_A
Q13535,D,2494,E,5yz0:A,2494,Abolishes kinase activity,,,-1.0,,,,,,,,,,,,,Q13535_D_2494_E
P54278,E,41,A,1ea6:A,41,Decreased DNA mismatch repair activity.,,,-1.0,,,,,,,,,,,,,P54278_E_41_A
P54278,D,70,N,1ea6:A,70,"No effect on protein abundance, no effect on subcellular localization and loss of DNA mismatch repair activity.",,,-1.0,,,,,,,,,0.0,,,0.0,P54278_D_70_N
P46597,L,11,F,4a6e:A,11,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P46597_L_11_F
P46597,L,31,H,4a6e:A,31,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P46597_L_31_H
P46597,T,296,M,4a6e:A,296,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P46597_T_296_M
P46597,H,318,D,4a6e:A,318,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P46597_H_318_D
P18054,H,355,Q,3d3l:A,355,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P18054_H_355_Q
P18054,H,360,Q,3d3l:A,360,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P18054_H_360_Q
P18054,H,360,Y,3d3l:A,360,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P18054_H_360_Y
P18054,H,365,Q,3d3l:A,365,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P18054_H_365_Q
P18054,H,383,Q,3d3l:A,383,Altered catalytic activity and protein expression.,,,-1.0,,,,,,,,,,,,-1.0,P18054_H_383_Q
P18054,H,392,Q,3d3l:A,392,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P18054_H_392_Q
P18054,H,540,Q,3d3l:B,540,Complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,P18054_H_540_Q
P08575,C,853,S,1ygu:B,828,Loss of activity. Abolishes interaction with SKAP1.,-1.0,,-1.0,,,,,,,,,,,,,P08575_C_853_S
Q96P11,C,308,S,2b9e:A,308,Abolished methyltransferase activity without affecting nucleolar localization,,,-1.0,,,,,,,,,0.0,,,,Q96P11_C_308_S
Q96P11,C,359,S,2b9e:A,359,Abolished methyltransferase activity without affecting nucleolar localization,,,-1.0,,,,,,,,,0.0,,,,Q96P11_C_359_S
P10721,R,381,A,2e9w:A,381,Reduces autophosphorylation in response to KITLG/SCF.,,,-1.0,-1.0,,,,,,,,,,,,P10721_R_381_A
P10721,E,386,A,2e9w:A,386,Reduces autophosphorylation in response to KITLG/SCF.,,,-1.0,-1.0,,,,,,,,,,,,P10721_E_386_A
P10721,Y,823,F,4hvs:A,823,No decrease in activity. Leads to autophosphorylation at Tyr-900.,,,0.0,1.0,,,,,,,,,,,,P10721_Y_823_F
P54619,D,90,A,4rew:G,89,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Reduced ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,-1.0,,,,,,,,,,,,,P54619_D_90_A
P54619,D,245,A,4rew:G,244,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Reduced ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,-1.0,,,,,,,,,,,,,P54619_D_245_A
P54619,D,317,A,4rew:G,316,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Does not affect ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,-1.0,,,,,,,,,,,,,P54619_D_317_A
Q9Y5Y6,H,656,A,5lyo:A,656,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9Y5Y6_H_656_A
Q9Y5Y6,D,711,A,5lyo:A,711,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9Y5Y6_D_711_A
Q9Y5Y6,S,805,A,5lyo:A,805,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9Y5Y6_S_805_A
P53671,D,451,A,5nxd:A,451,Abrogates kinase activity.,,,-1.0,,,,,,,,,,,,,P53671_D_451_A
P53671,T,505,V,4tpt:A,505,Abolishes cofilin phosphorylation and enhancement of stress fiber formation.,,,-1.0,,,,,,,,,,,,,P53671_T_505_V
Q76I76,C,392,S,2nt2:A,392,Abrogates phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q76I76_C_392_S
Q14149,E,35,A,6o1e:A,35,Fails to localize to PML nuclear bodies and activate TP53.,,,-1.0,,,,,,,,,1.0,,,,Q14149_E_35_A
P10826,E,106,A,1hra:A,26,"As a heterodimer with RXRA, abolishes transcriptional repression on DR1, reduces transcriptional activation on DR5 and binding affinity for DR1 and DR5 DNA elements.",,,-1.0,,,,,,,,,,,,,P10826_E_106_A
P10826,R,113,A,1hra:A,33,"As a heterodimer with RXRA, abolishes transcriptional repression on DR1 and reduces transcriptional activation on DR5.",,,-1.0,,,,,,,,,,,,,P10826_R_113_A
P10826,M,120,E,1hra:A,40,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces binding affinity for DR1 and DR5 DNA elements",,,-1.0,,,,,,,,,,,,,P10826_M_120_E
P10826,T,123,V,1hra:A,43,Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5,,,-1.0,,,,,,,,,,,,,P10826_T_123_V
P10826,T,188,I,4dm6:A,190,No effect on transcriptional activation in the absence of hormone.,,,0.0,,,,,,,,,,,,,P10826_T_188_I
P10826,I,191,V,4dm6:A,193,No effect on transcriptional activation in the absence of hormone.,,,0.0,,,,,,,,,,,,,P10826_I_191_V
P10826,L,222,I,4dm6:A,224,Reduced transcriptional activation in the absence of hormone. Even greater reduction in transcriptional activation in the absence of hormone,,,-1.0,,,,,,,,,,,,,P10826_L_222_I
P10826,G,223,D,4dm6:A,225,Greatly reduced transcriptional activation in the absence of hormone. Even greater reduction in transcriptional activation in the absence of hormone,,,-1.0,,,,,,,,,,,,,P10826_G_223_D
P10826,A,232,S,4dm6:A,234,Reduced transcriptional activation in the absence of hormone. Some further reduction of transcriptional activity in the absence of hormone,,,-1.0,,,,,,,,,,,,,P10826_A_232_S
P10826,K,365,E,4dm6:A,367,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,,-1.0,,,,,,,,,,,,,P10826_K_365_E
P10826,R,366,E,4dm6:A,368,"As a heterodimer with RXRA, reduces binding affinity for DR5 DNA element and no change in binding to DR1. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,-1.0,-1.0,,,,,,,,,,,,,P10826_R_366_E
P10826,R,367,E,4dm6:A,369,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,,-1.0,,,,,,,,,,,,,P10826_R_367_E
P10826,S,369,E,4dm6:A,371,Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5,,,-1.0,,,,,,,,,,,,,P10826_S_369_E
P10826,K,370,E,4dm6:A,372,Reduces transcriptional repression on DR1 and reduced transcriptional activation on DR5,,,-1.0,,,,,,,,,,,,,P10826_K_370_E
Q99653,E,134,A,2e30:A,134,Reduces calcium-binding and SLC9A1-dependent Na(+)/H(+) exchange activity. Does not reduce colocalization and interaction with SLC9A1. Reduces colocalization and interaction with SLC9A1,-1.0,-1.0,-1.0,,,,,,,,,,,,,Q99653_E_134_A
Q99653,E,175,A,2e30:A,175,Reduces calcium-binding and SLC9A1-dependent Na(+)/H(+) exchange activity. Does not reduce colocalization and interaction with SLC9A1. Reduces colocalization and interaction with SLC9A1,-1.0,-1.0,-1.0,,,,,,,,,,,,,Q99653_E_175_A
O43463,W,64,A,3mts:A,64,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,O43463_W_64_A
O43463,Y,67,A,3mts:A,67,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,O43463_Y_67_A
O43464,S,306,A,5fht:A,173,Loss of protease activity.,,,-1.0,,,,,,,,,,,,,O43464_S_306_A
Q13472,Y,362,F,4cgy:A,362,Decreased DNA decatenation.,,,-1.0,,,,,,,,,,,,,Q13472_Y_362_F
O95453,I,113,A,2a1s:B,113,Loss of dimerization. Loss of activity.,-1.0,,-1.0,,,,,,,,,,,,,O95453_I_113_A
O95453,F,115,A,2a1s:B,115,Reduced affinity for poly(A). Little effect on activity.,-1.0,,0.0,,,,,,,,,,,,,O95453_F_115_A
O95453,F,123,A,2a1s:B,123,Loss of dimerization. Loss of activity.,-1.0,,-1.0,,,,,,,,,,,,,O95453_F_123_A
O95453,D,292,A,2a1s:A,292,Loss of function but does not abolish ability to bind RNA.,,0.0,-1.0,,,,,,,,,,,,,O95453_D_292_A
O95453,D,292,C,2a1s:A,292,"Loss of function in the presence of Mg(2+) but not in the presence of Mn(2+), Zn(2+), Co(2+) or Cd(2+).",,,-1.0,,,,,,,,,,,,,O95453_D_292_C
O95453,K,326,A,2a1s:A,326,Reduced affinity for poly(A). Little effect on activity.,-1.0,,0.0,,,,,,,,,,,,,O95453_K_326_A
O95453,H,377,A,2a1s:A,377,Loss of activity.,,,-1.0,,,,,,,,,,,,,O95453_H_377_A
O95453,D,382,A,2a1s:A,382,Loss of function but does not abolish ability to bind RNA. Induces a decrease in degradation of mRNAs containing AREs.,,0.0,-1.0,,,,,,,,,,,,,O95453_D_382_A
O95453,D,382,C,2a1s:A,382,"Loss of function in the presence of Mg(2+) but not in the presence of Mn(2+), Zn(2+), Co(2+) or Cd(2+).",,,-1.0,,,,,,,,,,,,,O95453_D_382_C
O60343,R,972,K,3qyb:A,973,Loss of Rab GTPase activation. Only 20% reduction of GLUT4 translocation,-1.0,,-1.0,,,,,,,,,,,,,O60343_R_972_K
O60341,N,535,A,5l3f:A,535,Strongly reduces demethylase activity.,,,-1.0,,,,,,,,,,,,,O60341_N_535_A
O60341,H,564,A,5l3f:A,564,Strongly reduces demethylase activity.,,,-1.0,,,,,,,,,,,,,O60341_H_564_A
O60341,K,661,A,5l3f:A,661,Abolishes histone demethylase activity.,,,-1.0,,,,,,,,,,,,,O60341_K_661_A
O60341,Y,761,A,5l3f:A,761,Strongly reduces demethylase activity.,,,-1.0,,,,,,,,,,,,,O60341_Y_761_A
Q9UBT6,D,198,A,6cst:A,198,Loss of DNA polymerase activity,,,-1.0,,,,,,,,,,,,,Q9UBT6_D_198_A
Q9UBT6,E,199,A,6cst:A,199,Loss of DNA polymerase activity,,,-1.0,,,,,,,,,,,,,Q9UBT6_E_199_A
P49407,R,169,E,6pwc:A,169,Constitutive active,,,1.0,,,,,,,,,,,,,P49407_R_169_E
Q96D96,D,112,A,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_A
Q96D96,D,112,F,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_F
Q96D96,D,112,N,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_N
Q96D96,D,112,S,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_S
Q96D96,D,112,E,5oqk:A,112,No effect on channel activity and proton selectivity.,,,0.0,,,,,,,,,,,,,Q96D96_D_112_E
Q96D96,D,112,V,5oqk:A,112,Abolishes channel activity.,,,-1.0,,,,,,,,,,,,,Q96D96_D_112_V
Q96D96,H,140,A,5oqk:A,140,Exhibits selectivity to protons but sensitivity to zinc ions is abolished,,,-1.0,,,,,,,,,,,,,Q96D96_H_140_A
Q96D96,H,193,A,5oqk:A,193,Exhibits selectivity to protons but sensitivity to zinc ions is abolished,,,-1.0,,,,,,,,,,,,,Q96D96_H_193_A
Q96D96,R,205,A,5oqk:A,205,Faster channel activation and deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_205_A
Q96D96,R,208,A,5oqk:A,208,Faster channel activation and deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_208_A
Q96D96,R,211,A,5oqk:A,211,Faster channel deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_211_A
Q9Y5K5,C,88,A,3ris:A,88,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9Y5K5_C_88_A
Q9UHP3,K,99,R,2mux:A,99,Abolishes sumoylation. Decreased enzymatic activity.,,,-1.0,,,,-1.0,,,,,,,,,Q9UHP3_K_99_R
Q96PU4,K,548,R,4pw7:A,548,No effect on autosumoylation.,,,0.0,,,,0.0,,,,,,,,,Q96PU4_K_548_R
Q96PU4,C,735,S,1z6u:A,735,"No effect on autosumoylation, nor on ZNF131 sumoylation.",,,0.0,,,,0.0,,,,,,,,,Q96PU4_C_735_S
Q9BQF6,F,775,W,3eay:A,709,Slightly increased deconjugation activity.,,,1.0,,,,,,,,,,,,,Q9BQF6_F_775_W
Q9BQF6,V,779,E,3eay:A,713,Reduces deconjugation activity.,,,-1.0,,,,,,,,,,,,,Q9BQF6_V_779_E
P34897,E,98,L,5v7i:A,98,"Abolishes serine hydroxymethyltransferase activity, leading to oxidative phosphorylation deficiency",,,-1.0,,,,,,,,,,,,,P34897_E_98_L
P34897,K,103,R,5v7i:A,103,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_103_R
P34897,K,103,E,5v7i:A,103,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_103_E
P34897,Y,106,F,5v7i:A,106,"Abolishes serine hydroxymethyltransferase activity, leading to oxidative phosphorylation deficiency",,,-1.0,,,,,,,,,,,,,P34897_Y_106_F
P34897,K,280,R,5v7i:A,280,Decreased succinylation level and hydroxymethyltransferase activity.,,,-1.0,,,,,,,,,,,,,P34897_K_280_R
P34897,K,280,E,5v7i:A,280,Decreased succinylation level and hydroxymethyltransferase activity.,,,-1.0,,,,,,,,,,,,,P34897_K_280_E
P34897,K,302,R,5v7i:A,302,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_302_R
P34897,K,302,E,5v7i:A,302,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_302_E
P34897,K,356,R,5v7i:A,356,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_356_R
P34897,K,356,E,5v7i:A,356,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_356_E
P34897,K,464,R,5v7i:A,464,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_464_R
P34897,K,464,E,5v7i:A,464,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_464_E
P34897,K,469,R,5v7i:A,469,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_469_R
P34897,K,469,E,5v7i:A,469,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_469_E
P34897,K,474,R,5v7i:A,474,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_474_R
P34897,K,474,E,5v7i:A,474,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_474_E
Q9NWW6,K,16,A,2p0e:A,15,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NWW6_K_16_A
Q9NWW6,D,36,A,2p0e:A,35,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NWW6_D_36_A
Q9NWW6,D,56,A,2p0e:A,55,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NWW6_D_56_A
Q9NWW6,E,98,A,2qg6:A,98,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NWW6_E_98_A
Q9NWW6,D,138,A,2qg6:A,138,Almost no effect.,,,0.0,,,,,,,,,,,,,Q9NWW6_D_138_A
Q9Y2L1,D,146,N,6h25:J,146,Loss of endonuclease activity,,,-1.0,,,,,,,,,,,,,Q9Y2L1_D_146_N
Q9Y2L1,D,487,N,6h25:J,487,Loss of exonuclease activity. Loss of endonuclease activity,,,-1.0,,,,,,,,,,,,,Q9Y2L1_D_487_N
Q8TBK2,Y,285,A,3qxy:A,285,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8TBK2_Y_285_A
Q15438,E,157,A,1bc9:A,157,Reduces guanine exchange factor activity by over 90%.,,,-1.0,,,,,,,,,,,,,Q15438_E_157_A
Q15438,E,157,K,1bc9:A,157,Reduces guanine exchange factor activity by over 90%.,,,-1.0,,,,,,,,,,,,,Q15438_E_157_K
Q15438,Y,187,A,1bc9:A,187,Reduces guanine exchange factor activity by over 90%.,,,-1.0,,,,,,,,,,,,,Q15438_Y_187_A
Q15438,M,195,A,1bc9:A,195,Reduces guanine exchange factor activity by over 90%.,,,-1.0,,,,,,,,,,,,,Q15438_M_195_A
O95671,S,19,A,2p5x:A,19,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_S_19_A
O95671,S,21,A,2p5x:A,21,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_S_21_A
O95671,R,23,A,2p5x:A,23,Decrease in pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_R_23_A
O95671,R,24,A,2p5x:A,24,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_R_24_A
O95671,E,44,A,2p5x:A,44,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_E_44_A
O95671,Y,57,A,2p5x:A,57,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_Y_57_A
O95671,K,65,A,2p5x:A,65,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_K_65_A
O95671,D,88,A,2p5x:A,88,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_D_88_A
O95671,D,88,N,2p5x:A,88,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_D_88_N
O95671,E,99,A,2p5x:A,99,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_E_99_A
O95671,Q,179,A,2p5x:A,179,Loss of pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_Q_179_A
O95671,Q,179,E,2p5x:A,179,Strong decrease in pyrophosphatase activity.,,,-1.0,,,,,,,,,,,,,O95671_Q_179_E
P41743,Y,265,F,3a8x:A,256,No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta.,-1.0,,-1.0,0.0,,,,,,,,,,,,P41743_Y_265_F
P41743,K,274,R,3a8x:A,265,No effect on activity.,,,-1.0,,,,,,,,,,,,,P41743_K_274_R
P41743,K,274,W,3a8x:A,265,Abolishes activity.,,,-1.0,,,,,,,,,,,,,P41743_K_274_W
P41743,Y,280,F,3a8x:A,271,No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B.,,,0.0,0.0,,,,,,,,,,,,P41743_Y_280_F
P41743,Y,334,F,3a8x:A,325,No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival.,,,-1.0,0.0,,,,,,,,,,,,P41743_Y_334_F
O14672,E,384,A,6be6:C,384,Abrogates APP cleavage. Reduces Notch signaling. Loss of proteolytic activity.,,,-1.0,,,,,,,,,,,,,O14672_E_384_A
Q8WXB1,D,94,A,4lec:A,94,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8WXB1_D_94_A
P15309,W,206,F,1nd6:B,1173,"Greatly reduced enzyme activity, marked decrease in structural stability, and increased binding of the inhibitor, L(+)-tartrate.",,1.0,-1.0,,,,,,,,,,,-1.0,,P15309_W_206_F
P15309,W,206,L,1nd6:B,1173,"Reduced enzyme activity, marked decrease in structural stability, and increased binding of the inhibitor, L(+)-tartrate.",,1.0,-1.0,,,,,,,,,,,-1.0,,P15309_W_206_L
P11509,I,208,S,3ebs:A,208,Increases phenacetin O-deethylation activity 10 fold,,,1.0,,,,,,,,,,,,,P11509_I_208_S
P11509,S,213,A,3ebs:A,213,No effect on phenacetin O-deethylation activity.,,,0.0,,,,,,,,,,,,,P11509_S_213_A
P11509,I,300,F,3ebs:A,300,Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 8 fold,,,1.0,,,,,,,,,,,,,P11509_I_300_F
P11509,G,301,A,3ebs:A,301,Slightly decreases phenacetin O-deethylation activity. Increases phenacetin O-deethylation activity 8 fold,,,-1.0,,,,,,,,,,,,,P11509_G_301_A
P11509,S,369,G,3ebs:A,369,Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 38 fold,,,1.0,,,,,,,,,,,,,P11509_S_369_G
P11509,R,372,H,3ebs:A,372,Increases phenacetin O-deethylation activity 2 fold.,,,1.0,,,,,,,,,,,,,P11509_R_372_H
P55055,K,409,R,4nqa:B,410,Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response,,,-1.0,,,,,,,,,,,,,P55055_K_409_R
P55055,K,447,R,4nqa:B,448,Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response,,,-1.0,,,,,,,,,,,,,P55055_K_447_R
Q8NBP7,C,67,A,2w2n:P,67,Does not affect multimerization or zymogen processing.,0.0,,0.0,,,,,,,,,,,,,Q8NBP7_C_67_A
Q5S007,T,1343,G,6ojf:A,1343,Decreased kinase activity,,,-1.0,,,,,,,,,,,,,Q5S007_T_1343_G
Q5S007,T,1348,N,6ojf:A,1348,Loss of GTP binding. Inhibits autophosphorylation and RAB10 phosphorylation,,-1.0,-1.0,-1.0,,,,,,,,,,,,Q5S007_T_1348_N
Q5S007,R,1398,Q,6ojf:A,1398,Decreased kinase activity,,,-1.0,,,,,,,,,,,,,Q5S007_R_1398_Q
Q5S007,R,1441,G,6ojf:A,1441,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,-1.0,-1.0,,,,,,,,,,,,Q5S007_R_1441_G
Q5S007,Y,1699,C,6xr4:A,1699,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,-1.0,-1.0,,,,,,,,,,,,Q5S007_Y_1699_C
Q5S007,K,1906,A,6xr4:A,1906,Loss of kinase activity. Decreases proteosomal degradation of MAPT,,,-1.0,,,,,,,,,,,,,Q5S007_K_1906_A
Q5S007,D,1994,A,6xr4:A,1994,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q5S007_D_1994_A
Q5S007,D,1994,N,6xr4:A,1994,Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT,0.0,,-1.0,,,,,,,,,,,,,Q5S007_D_1994_N
Q5S007,D,2017,A,6xr4:A,2017,Loss of kinase activity. Decreases proteosomal degradation of MAPT,,,-1.0,,,,,,,,,,,,,Q5S007_D_2017_A
Q5S007,G,2019,S,6xr4:A,2019,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,-1.0,-1.0,,,,,,,,1.0,,,,Q5S007_G_2019_S
Q5S007,L,2343,D,6vno:A,2343,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_L_2343_D
Q5S007,F,2344,A,6vno:A,2344,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_F_2344_A
Q5S007,S,2345,D,6vno:A,2345,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_S_2345_D
Q5S007,Y,2346,A,6vno:A,2346,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_Y_2346_A
Q5S007,H,2391,D,6vno:A,2391,Increases kinase activity.,,,1.0,,,,,,,,,,,,,Q5S007_H_2391_D
Q5S007,R,2394,E,6vno:A,2394,Decreases WD domain homodimerization. Increases kinase activity and autophosphorylation at Ser-1292.,-1.0,,1.0,1.0,,,,,,,,,,,,Q5S007_R_2394_E
Q5S007,E,2395,R,6vno:A,2395,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_E_2395_R
Q9BVS5,D,335,A,2b25:A,192,Loss of ability to catalyze the formation of 1-methyladenosine at position 947 of mitochondrial 16S ribosomal RNA.,,,-1.0,,,,,,,,,,,,,Q9BVS5_D_335_A
Q9BVS4,K,123,A,6hk6:A,123,Abolishes autophosphorylation,,,-1.0,-1.0,,,,,,,,,,,,Q9BVS4_K_123_A
Q9BVS4,D,246,A,6fdo:A,246,Abolishes autophosphorylation,,,-1.0,-1.0,,,,,,,,,,,,Q9BVS4_D_246_A
P06746,K,35,Q,1tv9:A,35,Reduces DNA lyase activity slightly.,,,-1.0,,,,,,,,,,,,,P06746_K_35_Q
P06746,K,35,R,1tv9:A,35,Reduces DNA lyase activity slightly.,,,-1.0,,,,,,,,,,,,,P06746_K_35_R
P06746,Y,39,Q,1tv9:A,39,Abolishes DNA polymerase and DNA lyase activity.,,,-1.0,,,,,,,,,,,,,P06746_Y_39_Q
P06746,K,68,Q,1tv9:A,68,Reduces DNA lyase activity slightly.,,,-1.0,,,,,,,,,,,,,P06746_K_68_Q
P06746,K,68,R,1tv9:A,68,Reduces DNA lyase activity slightly.,,,-1.0,,,,,,,,,,,,,P06746_K_68_R
P06746,K,72,Q,1tv9:A,72,Abolishes DNA lyase activity. No effect on DNA polymerase activity.,,,-1.0,,,,,,,,,,,,,P06746_K_72_Q
P06746,K,72,R,1tv9:A,72,Abolishes DNA lyase activity. No effect on DNA polymerase activity.,,,-1.0,,,,,,,,,,,,,P06746_K_72_R
P06746,R,83,K,1tv9:A,83,Slight effect. Abolishes methylation by PRMT6 and impairs the polymerase activity,,,-1.0,,,,,,,,,,,,,P06746_R_83_K
P06746,K,84,R,1tv9:A,84,No effect.,,,0.0,,0.0,,,,,,,,,,,P06746_K_84_R
P06746,R,152,K,1tv9:A,152,Slight effect. Abolishes methylation by PRMT6 and impairs the polymerase activity,,,-1.0,,,,,,,,,,,,,P06746_R_152_K
P06744,S,185,A,1jiq:A,185,Retained full enzymatic activity.,,,0.0,,,,,,,,,,,,,P06744_S_185_A
P06744,S,185,E,1jiq:A,185,Decreased enzymatic activity.,,,-1.0,,,,,,,,,,,,,P06744_S_185_E
P47989,R,881,M,2e1q:A,881,Abolishes xanthine oxidase activity.,,,-1.0,,,,,,,,,,,,,P47989_R_881_M
P20472,D,52,A,1rjv:A,52,Inactivation.,,,-1.0,,,,,,,,,,,,,P20472_D_52_A
P20472,E,63,V,1rjv:A,63,Inactivation.,,,-1.0,,,,,,,,,,,,,P20472_E_63_V
P20472,D,91,A,1rjv:A,91,Inactivation.,,,-1.0,,,,,,,,,,,,,P20472_D_91_A
P20472,E,102,V,1rjv:A,102,Inactivation.,,,-1.0,,,,,,,,,,,,,P20472_E_102_V
Q9NQW7,E,41,A,3ctz:A,41,Reduces activity by 10%.,,,-1.0,,,,,,,,,,,,,Q9NQW7_E_41_A
Q9NQW7,W,477,E,3ctz:A,477,Interferes with dimerization and reduces activity by 94%.,-1.0,,-1.0,,,,,,,,,,,,,Q9NQW7_W_477_E
Q6P587,H,30,A,6fog:A,30,Impaired oxaloacetate decarboxylase activity.,,,-1.0,,,,,,,,,,,,,Q6P587_H_30_A
Q6P587,E,33,A,6fog:A,33,Impaired oxaloacetate decarboxylase activity.,,,-1.0,,,,,,,,,,,,,Q6P587_E_33_A
Q6P587,D,102,A,6fog:A,102,Loss of catalytic activity,,,-1.0,,,,,,,,,,,,,Q6P587_D_102_A
Q6P587,R,106,A,6fog:A,106,Loss of catalytic activity,,,-1.0,,,,,,,,,,,,,Q6P587_R_106_A
O00291,F,432,G,2qa7:C,432,Abolishes HIP1-induced cell death.,,,-1.0,,,,,,,,,,,,,O00291_F_432_G
O00299,C,24,S,4jzq:A,24,Loss of dimerization and of ion transport activity.,-1.0,,-1.0,,,,,,,,,,,,,O00299_C_24_S
O00299,C,59,S,4jzq:A,59,Loss of dimerization and of ion transport activity.,-1.0,,-1.0,,,,,,,,,,,,,O00299_C_59_S
Q96EP0,C,699,S,6sc8:A,699,Abolishes polyubiquitination activity of LUBAC,,,-1.0,,,,,,,,,,,,,Q96EP0_C_699_S
Q96EP0,C,702,S,6sc8:A,702,Abolishes polyubiquitination activity of LUBAC,,,-1.0,,,,,,,,,,,,,Q96EP0_C_702_S
Q96EP0,C,871,S,6sc8:A,871,Abolishes polyubiquitination activity of LUBAC,,,-1.0,,,,,,,,,,,,,Q96EP0_C_871_S
Q96EP0,C,874,S,6sc8:A,874,Abolishes polyubiquitination activity of LUBAC,,,-1.0,,,,,,,,,,,,,Q96EP0_C_874_S
P52333,K,855,A,6gl9:A,855,More than 90% loss of STAT5a activation.,,,-1.0,,,,,,,,,,,,,P52333_K_855_A
P52333,Y,904,F,6gl9:A,904,About 40% loss of STAT5a activation.,,,-1.0,,,,,,,,,,,,,P52333_Y_904_F
P52333,Y,939,F,6gl9:A,939,About 80% loss of STAT5a activation.,,,-1.0,,,,,,,,,,,,,P52333_Y_939_F
O00444,K,41,M,4jxf:A,41,Abolishes ability to phosphorylate CDC25C and CHEK2.,,,-1.0,,,,,,,,,,,,,O00444_K_41_M
O00444,D,154,A,4jxf:A,154,Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed.,,,-1.0,,,,,,,,,,,,,O00444_D_154_A
P51649,R,213,A,2w8r:A,213,Reduces catalytic activity to less than 15% of wild-type.,,,-1.0,,,,,,,,,,,,,P51649_R_213_A
P51649,R,334,A,2w8r:A,334,Reduces catalytic activity to less than 15% of wild-type.,,,-1.0,,,,,,,,,,,,,P51649_R_334_A
P51649,S,498,A,2w8r:A,498,Reduces catalytic activity to less than 15% of wild-type.,,,-1.0,,,,,,,,,,,,,P51649_S_498_A
Q04609,N,76,A,5o5t:A,76,Loss of glycosylation. Reduces enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_76_A
Q04609,N,121,A,5o5t:A,121,Loss of glycosylation. Severely reduced enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_121_A
Q04609,N,140,A,5o5t:A,140,Loss of glycosylation. Severely reduced enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_140_A
Q04609,N,153,A,5o5t:A,153,Loss of glycosylation. Severely reduced enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_153_A
Q04609,N,195,A,5o5t:A,195,Loss of glycosylation. Severely reduced enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_195_A
Q04609,N,336,A,5o5t:A,336,Loss of glycosylation. Reduces enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_336_A
Q04609,H,377,A,5o5t:A,377,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_H_377_A
Q04609,H,377,G,5o5t:A,377,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_H_377_G
Q04609,H,377,Q,5o5t:A,377,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_H_377_Q
Q04609,D,379,E,5o5t:A,379,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_379_E
Q04609,D,379,N,5o5t:A,379,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_379_N
Q04609,D,387,E,5o5t:A,387,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_387_E
Q04609,D,387,L,5o5t:A,387,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_387_L
Q04609,D,387,N,5o5t:A,387,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q04609_D_387_N
Q04609,P,388,A,5o5t:A,388,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q04609_P_388_A
Q04609,E,424,A,5o5t:A,424,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_E_424_A
Q04609,E,424,D,5o5t:A,424,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04609_E_424_D
Q04609,E,424,Q,5o5t:A,424,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04609_E_424_Q
Q04609,E,425,Q,5o5t:A,425,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_E_425_Q
Q04609,E,425,D,5o5t:A,425,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_E_425_D
Q04609,D,453,N,5o5t:A,453,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_453_N
Q04609,D,453,L,5o5t:A,453,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_453_L
Q04609,D,453,Q,5o5t:A,453,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04609_D_453_Q
Q04609,S,454,A,5o5t:A,454,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04609_S_454_A
Q04609,N,459,A,5o5t:A,459,Loss of glycosylation. Reduces enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_459_A
Q04609,N,476,A,5o5t:A,476,Loss of glycosylation. Reduces enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_476_A
Q04609,N,638,A,5o5t:A,638,Loss of glycosylation. Abolishes enzyme activity.,,,-1.0,,,-1.0,,,,,,,,,,Q04609_N_638_A
Q04609,T,640,A,5o5t:A,640,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q04609_T_640_A
P11802,T,172,A,3g33:A,177,"Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3.",0.0,,-1.0,,,,,,,,,,,,,P11802_T_172_A
P11802,T,172,E,3g33:A,177,Retains moderate enzyme activity.,,,0.0,,,,,,,,,,,,,P11802_T_172_E
P11802,P,173,S,3g33:A,178,No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity.,,,-1.0,-1.0,,,,,,,,,,,,P11802_P_173_S
O15111,T,23,A,5ebz:A,23,Loss of phosphorylation and decrease of kinase activity.,,,-1.0,-1.0,,,,,,,,,,,,O15111_T_23_A
O15111,K,44,A,5ebz:A,44,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O15111_K_44_A
O15111,S,176,A,5ebz:A,176,Loss of phosphorylation and of activity.,,,-1.0,-1.0,,,,,,,,,,,,O15111_S_176_A
O15111,S,176,E,5ebz:A,176,Full activation.,,,1.0,,,,,,,,,,,,,O15111_S_176_E
Q12809,F,29,A,2l4r:A,29,Slows down deactivation.,,,-1.0,,,,,,,,,,,,,Q12809_F_29_A
Q12809,Y,43,A,2l4r:A,43,Slows down deactivation.,,,-1.0,,,,,,,,,,,,,Q12809_Y_43_A
P49916,K,410,E,3l2p:A,323,"Nearly abolishes ligase activity with blunt-ended DNA, but not with nicked DNA.",,,-1.0,,,,,,,,,,,,,P49916_K_410_E
P49916,R,414,E,3l2p:A,327,"Abolishes ligase activity with blunt-ended DNA, but not with nicked DNA.",,,-1.0,,,,,,,,,,,,,P49916_R_414_E
P49914,K,10,A,3hy6:A,10,Reduces activity by 93%.,,,-1.0,,,,,,,,,,,,,P49914_K_10_A
P49914,R,14,A,3hy6:A,14,Reduces activity by 87%.,,,-1.0,,,,,,,,,,,,,P49914_R_14_A
P49914,E,61,A,3hy6:A,61,Reduces activity by 94%.,,,-1.0,,,,,,,,,,,,,P49914_E_61_A
P49914,R,145,A,3hy6:A,145,Reduces activity by 98%.,,,-1.0,,,,,,,,,,,,,P49914_R_145_A
P49914,Y,153,A,3hy6:A,153,Reduces activity by 97%.,,,-1.0,,,,,,,,,,,,,P49914_Y_153_A
P49914,D,154,A,3hy6:A,154,Reduces activity by 99%.,,,-1.0,,,,,,,,,,,,,P49914_D_154_A
P0C0L5,L,1120,P,6ysq:A,1120,"No effect on hemolytic activity, nor on C1-dependent binding to IgG.",0.0,,0.0,,,,,,,,,,,,,P0C0L5_L_1120_P
P0C0L5,S,1121,C,6ysq:A,1121,30-40% decrease in hemolytic activity and C1-dependent binding to IgG.,1.0,,-1.0,,,,,,,,,,,,,P0C0L5_S_1121_C
P0C0L5,I,1124,A,6ysq:A,1124,50-60% decrease in hemolytic activity and C1-dependent binding to IgG.,1.0,,-1.0,,,,,,,,,,,,,P0C0L5_I_1124_A
P0C0L5,H,1125,A,6ysq:A,1125,"20% decrease in hemolytic activity, 2-fold increase in C1-dependent binding to IgG.",1.0,,-1.0,,,,,,,,,,,,,P0C0L5_H_1125_A
P0C0L5,H,1125,D,6ysq:A,1125,"2.5-3 fold-decrease in hemolytic activity, 3-fold increase in C1-dependent binding to IgG.",1.0,,-1.0,,,,,,,,,,,,,P0C0L5_H_1125_D
Q8TAI7,D,60,K,3oes:A,60,Significant decrease in NF-kappa B activation.,-1.0,,-1.0,,,,,,,,,,,,,Q8TAI7_D_60_K
Q8TAI7,Q,64,L,3oes:A,64,Constitutively active.,,,1.0,,,,,,,,,,,,,Q8TAI7_Q_64_L
O75884,S,75,A,2qs9:A,75,Loss of catalytic activity. Fails to block TGF-beta-mediated anti-proliferative signal in tumor cells.,,,-1.0,,,,,,,,,,,,,O75884_S_75_A
P00973,K,66,A,4ig8:A,66,Decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,P00973_K_66_A
P00973,D,75,A,4ig8:A,75,Loss of activity,,,-1.0,,,,,,,,,,,,,P00973_D_75_A
P00973,D,77,A,4ig8:A,77,Loss of activity,,,-1.0,,,,,,,,,,,,,P00973_D_77_A
P00973,D,148,A,4ig8:A,148,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P00973_D_148_A
P00973,E,233,A,4ig8:A,233,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P00973_E_233_A
P00973,C,331,A,4ig8:A,331,Loss of activity,,,-1.0,,,,,,,,,,,,,P00973_C_331_A
P00973,F,332,A,4ig8:A,332,Loss of activity,,,-1.0,,,,,,,,,,,,,P00973_F_332_A
P00973,K,333,A,4ig8:A,333,Loss of activity,,,-1.0,,,,,,,,,,,,,P00973_K_333_A
O60502,Y,69,K,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,O60502_Y_69_K
O60502,Y,69,Q,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,O60502_Y_69_Q
O60502,Y,69,S,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,-1.0,,,,,,,,,,,,,O60502_Y_69_S
O60502,D,174,A,6hki:B,174,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_D_174_A
O60502,D,175,A,6hki:B,175,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_D_175_A
O60502,D,175,N,6hki:B,175,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_D_175_N
O60502,V,255,G,6hki:B,255,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_V_255_G
O60502,V,255,T,6hki:B,255,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_V_255_T
O60502,Y,286,S,6hki:B,286,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_Y_286_S
O60502,D,287,A,6hki:B,287,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_D_287_A
O60502,W,679,N,6hki:A,679,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O60502_W_679_N
Q10469,R,198,A,5vcs:A,198,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,-1.0,,,,,,,,,,,,,Q10469_R_198_A
Q10469,D,217,A,5vcs:A,217,Nearly abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q10469_D_217_A
Q10469,E,259,A,5vcs:A,259,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q10469_E_259_A
Q10469,Y,294,A,5vcs:A,294,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,-1.0,,,,,,,,,,,,,Q10469_Y_294_A
Q10469,N,318,A,5vcs:A,318,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,-1.0,,,,,,,,,,,,,Q10469_N_318_A
Q10469,Y,344,A,5vcs:A,344,Nearly abolishes catalytic activity and strongly decreases affinity for UDP-GlcNAc.,,-1.0,-1.0,,,,,,,,,,,,,Q10469_Y_344_A
Q10469,W,346,A,5vcs:A,346,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q10469_W_346_A
Q10469,D,347,A,5vcs:A,347,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q10469_D_347_A
P42345,S,2159,A,4jt6:A,2159,Reduces mTORC1-associated S-2481 autophosphorylation,,,-1.0,-1.0,,,,,,,,,,,,P42345_S_2159_A
P42345,S,2159,D,4jt6:A,2159,Stronger phosphorylation of RPS6KB1,,,-1.0,,,,,,,,,,,,,P42345_S_2159_D
P42345,T,2164,A,4jt6:A,2164,Reduces mTORC1-associated S-2481 autophosphorylation,,,-1.0,-1.0,,,,,,,,,,,,P42345_T_2164_A
P42345,T,2164,E,4jt6:A,2164,Stronger phosphorylation of RPS6KB1,,,1.0,,,,,,,,,,,,,P42345_T_2164_E
P42345,T,2173,A,4jt6:A,2173,Increased mTOR kinase activity.,,,1.0,,,,,,,,,,,,,P42345_T_2173_A
P42345,H,2340,A,4jt6:A,2340,Barely detectable kinase activity.,,,-1.0,,,,,,,,,,,,,P42345_H_2340_A
P42345,D,2357,E,4jt6:A,2357,"Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization",-1.0,,-1.0,,,,,,,,,1.0,,,,P42345_D_2357_E
P42345,V,2364,I,4jt6:A,2364,"Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization",-1.0,,-1.0,,,,,,,,,1.0,,,,P42345_V_2364_I
Q86W56,N,740,A,4b1j:A,740,Reduced poly(ADP-ribose) glycohydrolase activity.,,,-1.0,,,,,,,,,,,,,Q86W56_N_740_A
Q86W56,E,755,A,4b1j:A,755,Abolished poly(ADP-ribose) glycohydrolase activity.,,,-1.0,,,,,,,,,,,,,Q86W56_E_755_A
Q86W56,E,756,A,4b1j:A,756,Abolished poly(ADP-ribose) glycohydrolase activity.,,,-1.0,,,,,,,,,,,,,Q86W56_E_756_A
Q86W56,A,874,W,4b1j:A,874,Reduced poly(ADP-ribose) glycohydrolase activity.,,,-1.0,,,,,,,,,,,,,Q86W56_A_874_W
Q86W56,F,875,A,4b1j:A,875,Abolished poly(ADP-ribose) glycohydrolase activity.,,,-1.0,,,,,,,,,,,,,Q86W56_F_875_A
P43246,K,675,R,2o8f:A,675,"No effect on mismatch binding, complete loss of DNA repair function when associated with MSH6 mutant R-1140.",,0.0,-1.0,,,,,,,,,,,,,P43246_K_675_R
P39748,R,29,A,5kse:A,29,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_R_29_A
P39748,D,34,A,5kse:A,34,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,-1.0,,,,,,,,,,,,,P39748_D_34_A
P39748,R,47,A,5kse:A,47,Significantly reduced exonuclease activity and reduced substrate binding. The positions of the cleavage sites are also shifted.,,-1.0,-1.0,,,,,,,,,,,,,P39748_R_47_A
P39748,R,70,A,5kse:A,70,Loss of exonuclease activity and reduced endonuclease activity. Reduced substrate binding.,,-1.0,-1.0,,,,,,,,,,,,,P39748_R_70_A
P39748,R,73,A,5kse:A,73,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_R_73_A
P39748,K,80,A,5kse:A,80,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_K_80_A
P39748,D,86,A,5kse:A,86,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,-1.0,,,,,,,,,,,,,P39748_D_86_A
P39748,R,103,A,5kse:A,103,No effect on flap endonuclease activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P39748_R_103_A
P39748,E,158,A,5kse:A,158,Loss of flap endonuclease activity and substrate binding.,,-1.0,-1.0,,,,,,,,,,,,,P39748_E_158_A
P39748,D,179,A,5kse:A,179,No effect on flap endonuclease activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P39748_D_179_A
P39748,D,181,A,5kse:A,181,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,-1.0,,,,,,,,,,,,,P39748_D_181_A
P39748,G,231,A,5kse:A,231,Loss of flap endonuclease activity and substrate binding.,,,-1.0,,,,,,,,,,,,,P39748_G_231_A
P39748,D,233,A,5kse:A,233,Loss of flap endonuclease activity and substrate binding.,,,-1.0,,,,,,,,,,,,,P39748_D_233_A
Q15907,S,25,N,2f9m:A,25,Dominant negative mutant locked in the inactive GDP-bound form,,1.0,-1.0,,,,,,,,,,,,,Q15907_S_25_N
Q15907,Q,70,L,2f9m:A,70,Constitutively active mutant locked in the active GTP-bound form,,1.0,-1.0,,,,,,,,,,,,,Q15907_Q_70_L
O15294,W,208,E,1w3b:A,198,Abolishes homodimerization of the TPR domain. Slightly reduced enzyme activity,-1.0,,-1.0,,,,,,,,,,,,,O15294_W_208_E
O15294,I,211,D,1w3b:A,201,Abolishes homodimerization of the TPR domain. Slightly reduced enzyme activity,-1.0,,-1.0,,,,,,,,,,,,,O15294_I_211_D
O15294,H,508,A,5lvv:A,498,Loss of enzyme activity. Moderate increase in KMT2E ubiquitination. Moderate increase in KMT2E ubiquitination,,,-1.0,,1.0,,,,,,,,,,,O15294_H_508_A
O15294,H,568,A,5lvv:A,558,Reduces enzyme activity by about 95%. Moderate increase in KMT2E ubiquitination,,,-1.0,,1.0,,,,,,,,,,,O15294_H_568_A
O15294,H,911,A,4gz5:A,901,Reduces enzyme activity by over 90%.,,,-1.0,,,,,,,,,,,,,O15294_H_911_A
Q6B8I1,C,129,S,5xjv:B,129,Loss of enzyme activity. No effect on interaction with MAP3K5.,0.0,,-1.0,,,,,,,,,,,,,Q6B8I1_C_129_S
P15498,C,529,R,6new:A,529,Abolishes transforming activity.,,,-1.0,,,,,,,,,,,,,P15498_C_529_R
Q8NBL1,G,169,E,5l0r:A,169,Loss of O-glucosyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8NBL1_G_169_E
P83110,S,305,A,4ri0:A,305,Abolishes protease activity. Stabilizes the protein.,,,-1.0,,,,,,,,,,,,,P83110_S_305_A
Q9Y3D8,H,79,G,3iij:A,79,"Induces homodimerization. Reduces adenylate kinase activity by 72% and ATPase activity by 76%. Significantly changes Cajal body organization in the nucleus, resulting in enhanced apoptosis and reduced proliferation.",1.0,,-1.0,,,,,,,,,,,,,Q9Y3D8_H_79_G
O75460,K,599,A,6w3c:A,599,Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest.,,,-1.0,-1.0,,,,,,,,,,,,O75460_K_599_A
Q9H3H5,P,30,S,6bw6:A,30,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_P_30_S
Q9H3H5,I,69,N,6bw6:A,69,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_I_69_N
Q9H3H5,A,114,G,5o5e:A,114,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_A_114_G
Q9H3H5,D,115,A,5o5e:A,115,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_D_115_A
Q9H3H5,D,115,N,5o5e:A,115,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_D_115_N
Q9H3H5,D,115,E,5o5e:A,115,Mildly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_D_115_E
Q9H3H5,D,116,A,5o5e:A,116,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_D_116_A
Q9H3H5,D,116,N,5o5e:A,116,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_D_116_N
Q9H3H5,W,122,A,5o5e:A,122,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_W_122_A
Q9H3H5,K,125,A,5o5e:A,125,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_K_125_A
Q9H3H5,K,125,E,5o5e:A,125,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_K_125_E
Q9H3H5,K,125,N,5o5e:A,125,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_K_125_N
Q9H3H5,L,168,P,6fm9:A,168,Strongly reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_L_168_P
Q9H3H5,N,182,A,6fm9:A,182,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_N_182_A
Q9H3H5,N,185,A,6fm9:A,185,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_N_185_A
Q9H3H5,N,185,D,6fm9:A,185,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_N_185_D
Q9H3H5,D,252,A,6fm9:A,252,Reduces binding to inhibitor. Nearly abolishes enzyme activity.,-1.0,,-1.0,,,,,,,,,,,,,Q9H3H5_D_252_A
Q9H3H5,V,264,M,6fm9:A,264,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_V_264_M
Q9H3H5,R,301,C,6fm9:A,301,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_R_301_C
Q9H3H5,R,301,H,6fm9:A,301,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_R_301_H
Q9H3H5,H,302,A,6fm9:A,302,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_H_302_A
Q9H3H5,R,303,A,6fm9:A,303,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9H3H5_R_303_A
Q9H3H5,L,385,R,6fm9:A,385,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_L_385_R
P41227,K,136,R,6c95:B,136,Loss of its ability to acetylate HSPA1A and HSPA1B.,,,-1.0,,,,,,,,,,,,,P41227_K_136_R
P00374,L,23,R,1dls:A,22,Strongly decreased affinity for methotrexate. Decreases catalytic rate constant 200-fold. Decreases affinity for NADP and dihydrofolate over 10-fold.,,-1.0,-1.0,,,,,,,,,,,,,P00374_L_23_R
P27708,H,1471,A,4c6f:A,1471,No zinc-binding and no catalytic activity.,,0.0,-1.0,,,,,,,,,,,,,P27708_H_1471_A
P27708,H,1471,N,4c6f:A,1471,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1471_N
P27708,H,1473,A,4c6f:A,1473,No zinc-binding and no catalytic activity.,,-1.0,-1.0,,,,,,,,,,,,,P27708_H_1473_A
P27708,D,1512,N,4c6f:A,1512,No change in catalytic activity.,,,0.0,,,,,,,,,,,,,P27708_D_1512_N
P27708,T,1562,A,4c6f:A,1562,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_T_1562_A
P27708,F,1563,A,4c6f:A,1563,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_F_1563_A
P27708,H,1590,A,4c6f:A,1590,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1590_A
P27708,H,1590,N,4c6f:A,1590,No catalytic activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1590_N
P27708,C,1613,S,4c6f:A,1613,Reduces dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_C_1613_S
P27708,H,1614,A,4c6f:A,1614,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1614_A
P27708,E,1637,T,4c6f:A,1637,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_E_1637_T
P27708,H,1642,N,4c6f:A,1642,11.5% of wild-type catalytic activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1642_N
P27708,D,1686,N,4c6f:A,1686,Abolishes dihydroorotase activity.,,,-1.0,,,,,,,,,,,,,P27708_D_1686_N
P27708,H,1690,N,4c6f:A,1690,3% of wild-type catalytic activity.,,,-1.0,,,,,,,,,,,,,P27708_H_1690_N
P08581,Y,1234,F,3dkc:A,1234,Complete loss of kinase activity and of ligand-induced ubiquitination. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2,-1.0,,-1.0,,-1.0,,,,,,,,,,,P08581_Y_1234_F
P08581,Y,1235,F,3dkc:A,1235,Complete loss of kinase activity. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2,-1.0,,-1.0,,,,,,,,,,,,,P08581_Y_1235_F
Q86XR7,P,116,H,2m1w:A,116,Loss of ability to dimerize. Significant loss of RANTES-inducing activity. Loss of ability to induce NF-kappa-B activation.,-1.0,,-1.0,,,,,,,,,,,,,Q86XR7_P_116_H
Q86XR7,C,117,H,2m1w:A,117,Loss of ability to dimerize. Loss of RANTES-inducing activity and ability to induce NF-kappa-B activation. Inhibition of TLR4-dependent activation of IRF3 and IRF7. Loss of interaction with TLR4.,-1.0,,-1.0,,,,,,,,,,,,,Q86XR7_C_117_H
Q86XR7,Y,154,F,2m1w:A,154,No effect on phosphorylation.,,,0.0,,,,,,,,,,,,,Q86XR7_Y_154_F
Q86XR7,Y,167,F,2m1w:A,167,Complete loss of phosphorylation in response to LPS.,,,-1.0,,,,,,,,,,,,,Q86XR7_Y_167_F
Q8NEJ0,D,73,A,2esb:A,73,Abolishes most of in vitro phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q8NEJ0_D_73_A
Q8NEJ0,L,102,V,2esb:A,102,No effect on in vitro phosphatase activity.,,,0.0,,,,,,,,,,,,,Q8NEJ0_L_102_V
Q8NEJ0,C,104,S,2esb:A,104,Abolishes most of in vitro phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q8NEJ0_C_104_S
Q8NEJ0,R,110,K,2esb:A,110,Abolishes most of in vitro phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q8NEJ0_R_110_K
Q8NEJ0,S,111,A,2esb:A,111,Abolishes most of in vitro phosphatase activity.,,,-1.0,,,,,,,,,,,,,Q8NEJ0_S_111_A
Q13285,A,269,F,4qk4:A,269,Strongly reduced transactivation.,,,-1.0,,,,,,,,,,,,,Q13285_A_269_F
Q13285,G,341,E,4qk4:A,341,Reduced transactivation. Strongly reduced transactivation,,,-1.0,,,,,,,,,,,,,Q13285_G_341_E
Q13285,L,344,F,4qk4:A,344,Reduced transactivation. Strongly reduced transactivation,,,-1.0,,,,,,,,,,,,,Q13285_L_344_F
Q13285,A,433,F,4qk4:A,433,Strongly reduced transactivation.,,,-1.0,,,,,,,,,,,,,Q13285_A_433_F
Q13285,Y,436,F,4qk4:A,436,Loss of transactivation,,,-1.0,,,,,,,,,,,,,Q13285_Y_436_F
Q13285,K,440,A,4qk4:A,440,Loss of transactivation,,,-1.0,,,,,,,,,,,,,Q13285_K_440_A
O75608,S,119,A,6qgs:B,119,Loss of thioesterase and lysophospholipase activity.,,,-1.0,,,,,,,,,,,,,O75608_S_119_A
P49137,K,93,R,6tca:G,93,"Kinase defective mutant, abolishes activity.",,,-1.0,,,,,,,,,,,,,P49137_K_93_R
P49137,D,207,A,6tca:G,207,"Kinase defective mutant, abolishes activity.",,,-1.0,,,,,,,,,,,,,P49137_D_207_A
P49137,T,222,A,6tca:G,222,Strong decrease in kinase activity.,,,-1.0,,,,,,,,,,,,,P49137_T_222_A
P49137,T,222,D,6tca:G,222,"Mimicks phosphorylation state, leading to slight increase of basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_222_D
P49137,T,222,E,6tca:G,222,Mimicks phosphorylation state and constitutive protein kinase activity,,,1.0,,,,,,,,,,1.0,,,P49137_T_222_E
P49137,S,272,A,2pzy:C,272,Strong decrease in kinase activity.,,,-1.0,,,,,,,,,,,,,P49137_S_272_A
P49137,S,272,D,2pzy:C,272,"Mimicks phosphorylation state, leading to slight increase of basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_S_272_D
P49137,T,334,A,2pzy:C,334,Slight decrease in kinase activity.,,,-1.0,,,,,,,,,,,,,P49137_T_334_A
P49137,T,334,D,2pzy:C,334,"Mimicks phosphorylation state, leading to elevated basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_334_D
P49137,T,334,E,2pzy:C,334,"Mimicks phosphorylation state, leading to elevated basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_334_E
P49137,K,353,R,2pzy:C,353,Induces decreased sumoylation and increase in protein kinase activity.,,,1.0,,,,-1.0,,,,,,,,,P49137_K_353_R
O75604,C,276,A,3nhe:A,276,Loss of enzymatic activity. Increases the steady-state level of CCND1.,,,-1.0,,,,,,,,,,,,,O75604_C_276_A
O75604,H,549,A,3nhe:A,549,Loss of enzymatic activity. Increases the steady-state level of MDM2 and MDM4 that leads to attenuation of MDM2-mediated degradation of p53/TP53 and MDM4. Increases the level of p53/TP53 and MDM4 ubiquitin conjugates.,,,-1.0,,1.0,,,,,,,,,,,O75604_H_549_A
Q13043,K,59,R,6yat:A,59,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13043_K_59_R
Q13043,T,175,A,6yat:A,175,No effect on activity.,,,0.0,,,,,,,,,,,,,Q13043_T_175_A
Q13043,T,177,A,6yat:A,177,No effect on activity.,,,0.0,,,,,,,,,,,,,Q13043_T_177_A
Q13043,T,183,A,6yat:A,183,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q13043_T_183_A
Q53EL6,E,174,A,2kzt:A,174,Reduced inhibition of EIF4A1 helicase activity.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_E_174_A
Q53EL6,E,210,A,2kzt:A,210,Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_E_210_A
Q53EL6,L,252,A,2kzt:A,252,Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_L_252_A
Q53EL6,D,253,A,2kzt:A,253,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_D_253_A
Q53EL6,P,255,A,2kzt:A,255,Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_P_255_A
Q53EL6,M,333,A,2zu6:B,333,No effect on inhibition of EIF4A1 and on inhibition of translation,0.0,,0.0,,,,,,,,,,,,,Q53EL6_M_333_A
Q53EL6,E,337,A,2zu6:B,337,No effect on inhibition of EIF4A1 and on inhibition of translation.,0.0,,0.0,,,,,,,,,,,,,Q53EL6_E_337_A
Q53EL6,L,340,A,2zu6:B,340,No effect on inhibition of EIF4A1 and on inhibition of translation,0.0,,0.0,,,,,,,,,,,,,Q53EL6_L_340_A
Q53EL6,F,359,A,2zu6:B,359,Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_F_359_A
Q53EL6,H,361,A,2zu6:B,361,Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_H_361_A
Q53EL6,D,414,A,2zu6:B,414,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_D_414_A
Q53EL6,D,418,A,2zu6:B,418,Reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_D_418_A
Q53EL6,P,420,A,2zu6:B,420,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,-1.0,,,,,,,,,,,,,Q53EL6_P_420_A
Q96KS0,H,297,A,5v1b:A,297,Eliminates hydroxylase activity.,,,-1.0,,,,,,,,,,,,,Q96KS0_H_297_A
Q96KS0,D,299,A,5v1b:A,299,Eliminates hydroxylase activity.,,,-1.0,,,,,,,,,,,,,Q96KS0_D_299_A
Q96KS0,H,358,A,5v1b:A,358,Eliminates hydroxylase activity.,,,-1.0,,,,,,,,,,,,,Q96KS0_H_358_A
Q96KS0,R,367,A,5v1b:A,367,Eliminates hydroxylase activity.,,,-1.0,,,,,,,,,,,,,Q96KS0_R_367_A
Q96KS0,R,367,K,5v1b:A,367,Eliminates hydroxylase activity on a HIF1A peptide.,,,-1.0,,,,,,,,,,,,,Q96KS0_R_367_K
P01375,L,105,S,7kpb:A,29,Low activity.,,,-1.0,,,,,,,,,,,,,P01375_L_105_S
P01375,R,108,W,7kpb:A,32,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_R_108_W
P01375,L,112,F,7kpb:A,36,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_L_112_F
P01375,A,160,V,7kpb:A,84,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_A_160_V
P01375,S,162,F,7kpb:A,86,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_S_162_F
P01375,V,167,A,7kpb:A,91,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_V_167_A
P01375,V,167,D,7kpb:A,91,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_V_167_D
P01375,E,222,K,7kpb:A,146,Biologically inactive.,,,-1.0,,,,,,,,,,,,,P01375_E_222_K
Q14393,R,310,E,2c5d:A,310,Strongly reduced affinity for AXL. Abolishes phosphorylation of AXL.,-1.0,,-1.0,,,,,,,,,,,,,Q14393_R_310_E
Q14393,K,312,E,2c5d:A,312,Strongly reduced affinity for AXL. Abolishes phosphorylation of AXL.,-1.0,,-1.0,,,,,,,,,,,,,Q14393_K_312_E
Q9H9G7,E,638,A,5vm9:C,638,Loss of RNA slicer activity.,,,-1.0,,,,,,,,,,,,,Q9H9G7_E_638_A
Q9Y5Z0,D,110,A,4bfb:A,48,Loss of autoproteolytic cleavage.,,,-1.0,,,,,,,,,,,,,Q9Y5Z0_D_110_A
Q9Y5Z0,D,110,N,4bfb:A,48,Loss of autoproteolytic cleavage.,,,-1.0,,,,,,,,,,,,,Q9Y5Z0_D_110_N
Q9Y5Z0,D,303,A,2ewy:A,241,Loss of autoproteolytic cleavage.,,,-1.0,,,,,,,,,,,,,Q9Y5Z0_D_303_A
Q05209,S,19,E,5hde:A,19,Loss of phosphorylation site.,,,-1.0,-1.0,,,,,,,,,,,,Q05209_S_19_E
Q05209,R,36,A,5hde:A,36,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_R_36_A
Q05209,R,63,A,5hde:A,63,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_R_63_A
Q05209,Y,64,A,5hde:A,64,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_Y_64_A
Q05209,D,66,A,5hde:A,66,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_D_66_A
Q05209,I,67,A,5hde:A,67,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_I_67_A
Q05209,D,199,A,5hde:A,199,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_D_199_A
Q05209,H,200,A,5hde:A,200,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_H_200_A
Q05209,R,270,A,5hde:A,270,Decreases enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_R_270_A
Q05209,Q,278,A,5hde:A,278,Nearly abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,Q05209_Q_278_A
Q9H4M9,K,483,E,2jq6:A,88,Loss of accumulation at the ciliary pocket. Loss of function in ciliogenesis. Loss of association with tubulovesicular structures and altered MICALL1 localization. No effect on MICALL1 localization,-1.0,,-1.0,,,,,,,,,1.0,,,,Q9H4M9_K_483_E
Q9H4M9,W,485,A,2jq6:A,90,Loss of accumulation at the ciliary pocket. Loss of function in ciliogenesis. Abolishes interaction with RAB11FIP2. No effect on MICALL1 localization,-1.0,,-1.0,,,,,,,,,1.0,,,,Q9H4M9_W_485_A
Q6PIW4,K,447,A,3d8b:A,447,Inhibits HR-mediated DNA repair.,-1.0,,-1.0,,,,,,,,,,,,,Q6PIW4_K_447_A
Q6PIW4,D,500,A,3d8b:A,500,Inhibits HR-mediated DNA repair.,-1.0,,-1.0,,,,,,,,,,,,,Q6PIW4_D_500_A
Q53FA7,Y,51,A,2oby:A,51,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q53FA7_Y_51_A
Q53FA7,Y,51,F,2oby:A,51,Increased enzyme activity.,,,1.0,,,,,,,,,,,,,Q53FA7_Y_51_F
Q53FA7,S,151,V,2oby:A,151,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q53FA7_S_151_V
Q8N4J0,F,313,A,5yf0:B,313,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_F_313_A
Q8N4J0,D,316,A,5yf0:B,316,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_D_316_A
Q8N4J0,D,316,E,5yf0:B,316,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_D_316_E
Q8N4J0,D,316,N,5yf0:B,316,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_D_316_N
Q8N4J0,P,343,A,5yf0:B,343,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_P_343_A
Q8N4J0,L,345,A,5yf0:B,345,Significantly reduces N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_L_345_A
Q8N4J0,H,347,A,5yf0:B,347,Impairs binding to S-adenosyl-L-methionine. Significantly reduces N-methyltransferase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8N4J0_H_347_A
Q8N4J0,H,347,F,5yf0:B,347,Impairs binding to S-adenosyl-L-methionine. Significantly reduces N-methyltransferase activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8N4J0_H_347_F
Q8N4J0,Y,386,A,5yf0:B,386,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_386_A
Q8N4J0,Y,386,F,5yf0:B,386,Reduces N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_386_F
Q8N4J0,Y,386,W,5yf0:B,386,Reduces N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_386_W
Q8N4J0,Y,396,A,5yf0:B,396,Reduces N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_396_A
Q8N4J0,Y,396,D,5yf0:B,396,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_396_D
Q8N4J0,Y,398,A,5yf0:B,398,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_398_A
Q8N4J0,Y,398,F,5yf0:B,398,Impairs N-methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q8N4J0_Y_398_F
P49354,K,164,N,2h6h:A,164,Reduced activity.,,,-1.0,,,,,,,,,,,,,P49354_K_164_N
P49354,N,199,K,2h6h:A,199,Reduced catalytic efficiency.,,,-1.0,,,,,,,,,,,,,P49354_N_199_K
P11498,F,1077,A,3bg3:A,1077,"Loss of tetramerization and enzyme activity, resulting in an inactive homodimer.",-1.0,,-1.0,,,,,,,,,,,,,P11498_F_1077_A
P11498,F,1077,E,3bg3:A,1077,"Loss of tetramerization and enzyme activity, resulting in an inactive homodimer.",-1.0,,-1.0,,,,,,,,,,,,,P11498_F_1077_E
Q99418,E,156,D,1r8m:E,156,Inhibits GTP GDP exchange activity. Abolishes recruitment of ARF6 to the plasma membrane.,,,-1.0,,,,,,,,,,,,,Q99418_E_156_D
P31939,Y,104,A,1p4r:A,104,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_Y_104_A
P31939,Y,104,F,1p4r:A,104,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_Y_104_F
P31939,D,125,A,1p4r:A,125,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_D_125_A
P31939,D,125,E,1p4r:A,125,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_D_125_E
P31939,D,125,N,1p4r:A,125,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_D_125_N
P31939,K,137,A,1p4r:A,137,Decreased affinity to FAICAR,,,-1.0,,,,,,,,,,,,,P31939_K_137_A
P31939,K,137,R,1p4r:A,137,Decreased FAICAR cyclization activity,,,-1.0,,,,,,,,,,,,,P31939_K_137_R
P31939,H,213,A,1p4r:A,213,Loss of AICAR transformylase activity.,,,-1.0,,,,,,,,,,,,,P31939_H_213_A
P31939,H,267,A,1p4r:A,267,Loss of AICAR transformylase activity.,,,-1.0,,,,,,,,,,,,,P31939_H_267_A
A1Z1Q3,N,92,A,4iqy:B,92,Reduced ADP-ribosyl hydrolase activity,,,-1.0,,,,,,,,,,,,,A1Z1Q3_N_92_A
A1Z1Q3,G,100,A,4iqy:B,100,Abolished hydrolase activity and ability to bind ADP-D-ribose.,,,-1.0,,,,,,,,,,,,,A1Z1Q3_G_100_A
A1Z1Q3,D,102,A,4iqy:B,102,Reduced ADP-ribosyl hydrolase activity. Reduced ADP-ribosyl hydrolase activity,,,-1.0,,,,,,,,,,,,,A1Z1Q3_D_102_A
A1Z1Q3,H,106,A,4iqy:B,106,Reduced hydrolase activity.,,,-1.0,,,,,,,,,,,,,A1Z1Q3_H_106_A
A1Z1Q3,G,188,E,4iqy:B,188,Abolishes interaction with ADP-ribosylated proteins. Strongly reduced ADP-ribosyl hydrolase activity.,-1.0,,-1.0,,,,,,,,,,,,,A1Z1Q3_G_188_E
P21397,C,165,S,2z5x:A,165,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_165_S
P21397,C,266,S,2z5x:A,266,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_266_S
P21397,C,306,S,2z5x:A,306,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_306_S
P21397,C,321,S,2z5x:A,321,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_321_S
P21397,C,323,S,2z5x:A,323,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_323_S
P21397,C,374,S,2z5x:A,374,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P21397_C_374_S
P21397,C,398,S,2z5x:A,398,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_398_S
P21397,C,406,S,2z5x:A,406,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P21397_C_406_S
P61006,Q,67,L,7bwt:B,67,Probable constitutively active mutant locked in the active GTP-bound form. Stimulates interaction with MICALL1.,1.0,1.0,1.0,,,,,,,,,,,,,P61006_Q_67_L
P21399,C,300,S,2b3x:A,300,No effect on aconitase activity or on RNA binding.,,0.0,0.0,,,,,,,,,,,,,P21399_C_300_S
P21399,C,503,S,2b3x:A,503,"Loss of aconitase activity. Leads to constitutive RNA binding, irrespective of iron levels.",,1.0,-1.0,,,,,,,,,,,,,P21399_C_503_S
P21399,C,506,S,2b3x:A,506,Loss of aconitase activity. Leads of iron levels.,,,-1.0,,,,,,,,,,,,,P21399_C_506_S
P21399,S,778,A,2b3x:A,778,No effect on iron-regulated RNA binding. Loss of aconitase activity.,,0.0,-1.0,,,,,,,,,,,,,P21399_S_778_A
P48775,Y,42,A,6ud5:A,42,Reduces enzyme activity by 99%.,,,-1.0,,,,,,,,,,,,,P48775_Y_42_A
P48775,Y,45,A,6ud5:A,45,Reduces enzyme activity by 99%.,,,-1.0,,,,,,,,,,,,,P48775_Y_45_A
P48775,F,72,A,6ud5:A,72,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P48775_F_72_A
P48775,H,76,A,6ud5:A,76,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P48775_H_76_A
P48775,F,140,A,6ud5:A,140,Reduces enzyme activity by 99%.,,,-1.0,,,,,,,,,,,,,P48775_F_140_A
P48775,R,144,A,6ud5:A,144,Reduces enzyme activity by 99%.,,,-1.0,,,,,,,,,,,,,P48775_R_144_A
P48775,S,151,A,6ud5:A,151,Reduces enzyme activity by 90%.,,,-1.0,,,,,,,,,,,,,P48775_S_151_A
P48775,Y,175,G,6ud5:A,175,Reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,P48775_Y_175_G
P48775,H,328,A,6ud5:A,328,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P48775_H_328_A
Q96BY9,E,148,A,6o2v:A,148,Dominant-negative mutant,,,-1.0,,,,,,,,,,,,,Q96BY9_E_148_A
Q9NUI1,D,86,A,4fc6:B,86,Reduces enzyme activity by 98%.,,,-1.0,,,,,,,,,,,,,Q9NUI1_D_86_A
Q9NUI1,D,137,A,4fc6:B,137,Reduces enzyme activity by 97%.,,,-1.0,,,,,,,,,,,,,Q9NUI1_D_137_A
Q9NUI1,D,186,A,4fc6:B,186,Reduces enzyme activity by about 95%.,,,-1.0,,,,,,,,,,,,,Q9NUI1_D_186_A
Q9NUI1,D,268,A,4fc6:B,268,Reduces enzyme activity by 97%.,,,-1.0,,,,,,,,,,,,,Q9NUI1_D_268_A
Q9H5Q4,G,105,A,6erq:F,105,Abolishes methyltransferase activity.,,,-1.0,,,,,,,,,,,,,Q9H5Q4_G_105_A
Q9H5Q4,R,330,A,6ero:A,247,Impairs transcription initiation,,,-1.0,,,,,,,,,,,,,Q9H5Q4_R_330_A
Q9H5Q4,R,331,A,6ero:A,248,Impairs transcription initiation,,,-1.0,,,,,,,,,,,,,Q9H5Q4_R_331_A
P14550,Y,50,F,2alr:A,49,Complete loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,P14550_Y_50_F
P14550,Y,50,H,2alr:A,49,Complete loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,P14550_Y_50_H
P14550,K,80,M,2alr:A,79,Complete loss of enzymatic activity.,,,-1.0,,,,,,,,,,,,,P14550_K_80_M
P14550,H,113,Q,2alr:A,112,Strong decrease in enzymatic activity.,,,-1.0,,,,,,,,,,,,,P14550_H_113_Q
P14550,I,299,A,2alr:A,298,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_I_299_A
P14550,I,299,C,2alr:A,298,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_I_299_C
P14550,V,300,C,2alr:A,299,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_V_300_C
P14555,R,27,E,1db4:A,7,Reduces bactericidal activity to 20% against B. subtilis and to 4% against S. aureus. Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_R_27_E
P14555,K,30,E,1db4:A,10,Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_30_E
P14555,K,35,E,1db4:A,15,Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_35_E
P14555,K,57,E,1db4:A,37,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_57_E
P14555,H,67,Q,1db4:A,47,Catalytically inactive but does not affect integrin binding. Impairs leukotriene B4 synthesis in activated neutrophils.,0.0,,-1.0,,,,,,,,,,,,,P14555_H_67_Q
P14555,K,72,E,1db4:A,52,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_72_E
P14555,R,73,E,1db4:A,53,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_R_73_E
P14555,R,77,E,1db4:A,57,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_R_77_E
P14555,K,87,E,1db4:A,67,Reduces bactericidal activity to 20% against B. subtilis and to 10% against S. aureus. Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_87_E
P14555,R,94,E,1db4:A,74,Moderately reduced integrin binding. Greatly reduced integrin binding but no effect on catalytic activity,-1.0,,0.0,,,,,,,,,,,,,P14555_R_94_E
P14555,K,99,E,1db4:A,79,Reduces bactericidal activity to 25% against B. subtilis and to 10% against S. aureus. Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_99_E
P14555,R,104,E,1db4:A,84,Reduces bactericidal activity to 18% against B. subtilis and to 12% against S. aureus. Complete loss of bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_R_104_E
P14555,R,120,E,1db4:A,100,Moderately reduced integrin binding. Greatly reduced integrin binding but no effect on catalytic activity,-1.0,,0.0,,,,,,,,,,,,,P14555_R_120_E
P14555,K,122,E,1db4:A,102,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_122_E
P14555,K,127,E,1db4:A,107,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_127_E
P14555,K,128,E,1db4:A,108,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_128_E
P14555,K,135,E,1db4:A,115,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_K_135_E
P14555,R,138,D,1db4:A,118,Impairs bactericidal activity,,,-1.0,,,,,,,,,,,,,P14555_R_138_D
Q06830,T,90,D,3hy2:A,90,87% reduction in enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q06830_T_90_D
P49748,F,458,T,3b96:A,418,Decreased acyl-CoA dehydrogenase activity. Decreased affinity for acyl-CoA. No effect on FAD cofactor-binding.,,-1.0,-1.0,,,,,,,,,,,,,P49748_F_458_T
P49748,F,458,V,3b96:A,418,Loss of acyl-CoA dehydrogenase activity. Loss of FAD cofactor-binding.,,-1.0,-1.0,,,,,,,,,,,,,P49748_F_458_V
P49748,F,458,Y,3b96:A,418,Decreased acyl-CoA dehydrogenase activity. No effect on affinity for acyl-CoA. Decreased FAD cofactor-binding.,,-1.0,-1.0,,,,,,,,,,,,,P49748_F_458_Y
P49748,E,462,D,3b96:A,422,Decreased acyl-CoA dehydrogenase activity. No effect on affinity for acyl-CoA. No effect on FAD cofactor-binding.,,0.0,-1.0,,,,,,,,,,,,,P49748_E_462_D
P49748,E,462,Q,3b96:A,422,Loss of acyl-CoA dehydrogenase activity. No effect on FAD cofactor-binding.,,0.0,-1.0,,,,,,,,,,,,,P49748_E_462_Q
Q9P0U3,D,441,A,2xre:A,441,No effect on SUMO2 processing and SUMO2 deconjugating activities.,,,0.0,,,,,,,,,,,,,Q9P0U3_D_441_A
Q9P0U3,W,465,A,2xre:A,465,Impairs SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_W_465_A
Q9P0U3,D,468,A,2xre:A,468,Slightly impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,-1.0,,,,,,,,,,,,,Q9P0U3_D_468_A
Q9P0U3,F,496,A,2xre:A,496,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,-1.0,,,,,,,,,,,,,Q9P0U3_F_496_A
Q9P0U3,R,511,A,2xre:A,511,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,-1.0,,,,,,,,,,,,,Q9P0U3_R_511_A
Q9P0U3,W,512,A,2xre:A,512,Impairs SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_W_512_A
Q9P0U3,H,529,A,2xre:A,529,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,-1.0,,,,,,,,,,,,,Q9P0U3_H_529_A
Q9P0U3,V,532,A,2xre:A,532,No effect on SUMO2 processing and SUMO2 deconjugating activities.,,,0.0,,,,,,,,,,,,,Q9P0U3_V_532_A
Q9P0U3,H,533,A,2xre:A,533,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_H_533_A
Q9P0U3,W,534,A,2xre:A,534,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_W_534_A
Q9P0U3,D,550,A,2xre:A,550,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_D_550_A
Q9P0U3,Q,597,A,2xre:A,597,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_Q_597_A
Q9P0U3,C,603,A,2xre:A,603,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_C_603_A
Q9P0U3,C,603,S,2xre:A,603,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,-1.0,,,,,,,,,,,,,Q9P0U3_C_603_S
Q9BV47,C,152,A,5gtj:B,152,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BV47_C_152_A
Q9BV47,C,152,S,5gtj:B,152,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9BV47_C_152_S
Q9H6E5,D,216,A,5wu5:C,216,Abolishes adenylyltransferase activity,,,-1.0,,,,,,,,,,,,,Q9H6E5_D_216_A
Q9H6E5,D,218,A,5wu5:C,218,Abolishes adenylyltransferase activity,,,-1.0,,,,,,,,,,,,,Q9H6E5_D_218_A
Q9H6E5,R,779,A,5wu1:A,779,Reduced terminal uridylyltransferase activity,,,-1.0,,,,,,,,,,,,,Q9H6E5_R_779_A
Q9H6E5,R,783,A,5wu1:A,783,Reduced terminal uridylyltransferase activity,,,-1.0,,,,,,,,,,,,,Q9H6E5_R_783_A
P30419,G,492,D,5o9v:A,492,Reduced activity.,,,-1.0,,,,,,,,,,,,,P30419_G_492_D
P30419,G,492,K,5o9v:A,492,Reduced activity.,,,-1.0,,,,,,,,,,,,,P30419_G_492_K
P15374,C,95,S,1xd3:A,95,Abolishes enzymatic activity. Increased interaction with diubiquitin.,,,-1.0,,1.0,,,,,,,,,,,P15374_C_95_S
P06733,K,281,R,2psn:C,280,Decreased 2-hydroxyisobutyrylation leading to decreased phosphopyruvate hydratase activity.,,,-1.0,,,,,,,,,,,,,P06733_K_281_R
P06733,L,384,A,2psn:C,383,Loss of transcriptional repression and cell growth inhibition,,,-1.0,,,,,,,,,,,,,P06733_L_384_A
P06733,L,388,A,2psn:C,387,Loss of transcriptional repression and cell growth inhibition,,,-1.0,,,,,,,,,,,,,P06733_L_388_A
P17787,F,197,Y,6cnj:B,172,Increases ligand activation in LS and HS nAChR subtypes.,,,1.0,,,,,,,,,,,,,P17787_F_197_Y
Q7Z4W1,N,107,L,1pr9:A,107,Loss of function. Probably due to defects in formation of the active site and binding of coenzyme.,,-1.0,-1.0,,,,,,,,,,,,,Q7Z4W1_N_107_L
Q7Z4W1,N,107,D,1pr9:A,107,Loss of function. Probably due to defects in formation of the active site and binding of coenzyme.,,-1.0,-1.0,,,,,,,,,,,,,Q7Z4W1_N_107_D
Q9NQV7,D,199,Y,6nm4:A,199,Increases histone-lysine N-methyltransferase activity,,,1.0,,,,,,,,,,,,,Q9NQV7_D_199_Y
Q9NQV7,K,374,D,6nm4:A,374,Increases histone-lysine N-methyltransferase activity,,,1.0,,,,,,,,,,,,,Q9NQV7_K_374_D
P07602,I,240,C,4v2o:A,46,Strongly decreases stimulation of cerebroside sulfate hydrolysis.,,,-1.0,,,,,,,,,,,,,P07602_I_240_C
P51659,Y,347,A,1s9c:G,30,No hydratase activity.,,,-1.0,,,,,,,,,,,,,P51659_Y_347_A
P51659,E,366,A,1s9c:G,49,No hydratase activity.,,,-1.0,,,,,,,,,,,,,P51659_E_366_A
P51659,D,370,A,1s9c:G,53,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_370_A
P51659,H,406,A,1s9c:G,89,No effect.,,,0.0,,,,,,,,,,,,,P51659_H_406_A
P51659,E,408,A,1s9c:G,91,No effect.,,,0.0,,,,,,,,,,,,,P51659_E_408_A
P51659,Y,410,A,1s9c:G,93,No effect.,,,0.0,,,,,,,,,,,,,P51659_Y_410_A
P51659,D,490,A,1s9c:G,173,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_490_A
P51659,Y,505,A,1s9c:G,188,Completely inactive.,,,-1.0,,,,,,,,,,,,,P51659_Y_505_A
P51659,D,510,A,1s9c:G,193,No hydratase activity.,,,-1.0,,,,,,,,,,,,,P51659_D_510_A
P51659,H,515,A,1s9c:G,198,Completely inactive.,,,-1.0,,,,,,,,,,,,,P51659_H_515_A
P51659,D,517,A,1s9c:G,200,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_517_A
P51659,H,532,A,1s9c:G,215,No effect.,,,0.0,,,,,,,,,,,,,P51659_H_532_A
P56192,R,857,A,2djv:A,30,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P56192_R_857_A
P56192,K,863,A,2djv:A,36,Slightly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,P56192_K_863_A
P56192,K,866,A,2djv:A,39,Slightly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,P56192_K_866_A
O95271,H,1184,A,4n4v:A,1184,Loss of activity,,,-1.0,,,,,,,,,,,,,O95271_H_1184_A
O95271,E,1291,A,4n4v:A,1291,Loss of activity,,,-1.0,,,,,,,,,,,,,O95271_E_1291_A
Q9H2G2,K,63,R,2j51:A,63,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9H2G2_K_63_R
P35869,R,40,D,5nj8:C,40,Decreases transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_R_40_D
P35869,L,50,D,5nj8:C,50,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_L_50_D
P35869,V,74,D,5nj8:C,74,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_V_74_D
P35869,A,79,D,5nj8:C,79,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_A_79_D
P35869,F,82,D,5nj8:C,82,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_F_82_D
P35869,L,118,D,5nj8:A,118,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_L_118_D
P35869,L,122,D,5nj8:A,122,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_L_122_D
P35869,F,136,D,5nj8:A,136,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_F_136_D
P35869,I,154,D,5nj8:A,154,Interfers with transcription factor activity.,,,-1.0,,,,,,,,,,,,,P35869_I_154_D
P28065,K,53,A,6avo:A,33,Impairs correct processing at the consensus site.,,,-1.0,,,,,,,,,,,,,P28065_K_53_A
P00966,K,165,Q,2nz2:A,165,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_165_Q
P00966,K,165,R,2nz2:A,165,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_165_R
P00966,K,176,Q,2nz2:A,176,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_176_Q
P00966,K,176,R,2nz2:A,176,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_176_R
Q15382,E,40,G,1xtr:A,40,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q15382_E_40_G
Q15382,F,43,C,1xtr:A,43,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q15382_F_43_C
Q15382,T,48,A,1xtr:A,48,Causes slightly reduced phosphorylation of EIF4EBP1.,,,-1.0,,,,,,,,,,,,,Q15382_T_48_A
Q15382,V,49,A,1xtr:A,49,Causes slightly reduced phosphorylation of EIF4EBP1.,,,-1.0,,,,,,,,,,,,,Q15382_V_49_A
Q15382,E,53,A,1xtr:A,53,Causes slightly reduced phosphorylation of EIF4EBP1.,,,-1.0,,,,,,,,,,,,,Q15382_E_53_A
Q15382,Y,54,A,1xtr:A,54,Partially deficient in guanine nucleotide binding. Fully impairs EIF4EBP1 phosphorylation and S6K1 activation.,,-1.0,-1.0,,,,,,,,,,,,,Q15382_Y_54_A
Q15382,L,56,A,1xtr:A,56,Partially deficient in guanine nucleotide binding. Fully impairs EIF4EBP1 phosphorylation and S6K1 activation.,,-1.0,-1.0,,,,,,,,,,,,,Q15382_L_56_A
Q15382,Q,64,L,1xtr:A,64,"Has a higher basal GTPase level, however, is still sensitive to TSC2 GAP activity.",,,1.0,,,,,,,,,,,,,Q15382_Q_64_L
O00422,D,118,A,2hde:A,118,Abolishes splicing regulation activity and interaction with RNPS1 and ACIN1,-1.0,,-1.0,,,,,,,,,,,,,O00422_D_118_A
O00422,T,121,A,2hde:A,121,Abolishes splicing regulation activity and interaction with RNPS1 and ACIN1,-1.0,,-1.0,,,,,,,,,,,,,O00422_T_121_A
O00422,K,126,A,2hde:A,126,No effect on splicing regulation activity.,,,0.0,,,,,,,,,,,,,O00422_K_126_A
Q10471,W,282,A,4d0t:A,282,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q10471_W_282_A
Q10471,F,361,A,4d0t:A,361,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q10471_F_361_A
P10253,W,516,R,5nn4:A,516,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10253_W_516_R
P10253,D,518,G,5nn4:A,518,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10253_D_518_G
P10253,D,518,N,5nn4:A,518,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10253_D_518_N
P10253,D,518,E,5nn4:A,518,Loss of activity.,,,-1.0,,,,,,,,,,,,,P10253_D_518_E
P35914,E,37,D,3mp4:A,37,Normal activity.,,,0.0,,,,,,,,,,,,,P35914_E_37_D
P35914,R,41,M,3mp4:A,41,"Reduced activity, and loss of proton exchange.",,,-1.0,,,,,,,,,,,,,P35914_R_41_M
P35914,D,42,A,3mp4:A,42,"Loss of activity, and reduced proton exchange rate.",,,-1.0,,,,,,,,,,,,,P35914_D_42_A
P35914,D,42,N,3mp4:A,42,"Loss of activity, and reduced proton exchange rate.",,,-1.0,,,,,,,,,,,,,P35914_D_42_N
P35914,E,72,A,3mp4:A,72,"Loss of activity, and reduced affinity for metal cofactor and substrate.",,-1.0,-1.0,,,,,,,,,,,,,P35914_E_72_A
P35914,D,204,A,3mp4:A,204,"Reduced activity, and reduced affinity for metal cofactor and substrate.",,-1.0,-1.0,,,,,,,,,,,,,P35914_D_204_A
P35914,H,233,A,3mp4:A,233,"Loss of activity, and reduced proton exchange rate.",,,-1.0,,,,,,,,,,,,,P35914_H_233_A
P35914,C,266,A,3mp4:A,266,Loss of activity.,,,-1.0,,,,,,,,,,,,,P35914_C_266_A
P35914,E,279,A,3mp4:A,279,"Reduced thermal stability, but normal activity.",,,0.0,,,,,,,,,,,-1.0,,P35914_E_279_A
P35914,D,280,A,3mp4:A,280,Normal activity.,,,0.0,,,,,,,,,,,,,P35914_D_280_A
P35916,T,446,E,4bsj:A,446,Decreases autophosphorylation on tyrosine residues upon ligand binding,,,-1.0,,,,,,,,,,,,,P35916_T_446_E
P35916,K,516,A,4bsj:A,516,Decreases autophosphorylation on tyrosine residues upon ligand binding,,,-1.0,,,,,,,,,,,,,P35916_K_516_A
Q9H0U4,I,73,N,5szh:B,73,Abolishes interaction with REP1/CHM. No prenylation. Much lower GDP/GTP ratio.,-1.0,,-1.0,,,,,,-1.0,,,,,,,Q9H0U4_I_73_N
Q9H0U4,Y,78,D,5szh:B,78,Abolishes interaction with REP1/CHM and GDI1. No prenylation. Much lower GDP/GTP ratio. No membrane association.,-1.0,,-1.0,,,,,,-1.0,,,,,,,Q9H0U4_Y_78_D
Q9H0U4,A,81,D,5szh:B,81,Abolishes interaction with REP1/CHM. No prenylation. Lowers GDP/GTP ratio by half.,-1.0,,-1.0,,,,,,-1.0,,,,,,,Q9H0U4_A_81_D
Q9P2M4,R,472,A,2qq8:A,457,Loss of inhibition of autophagosome formation,,,-1.0,,,,,,,,,,,,,Q9P2M4_R_472_A
Q9P2M4,Q,508,A,2qq8:A,493,Loss of inhibition of autophagosome formation,,,-1.0,,,,,,,,,,,,,Q9P2M4_Q_508_A
Q9Y4K3,C,70,A,3hcs:A,70,"Loss of ligase activity, autoubiquitination and signaling capacity.",,,-1.0,,,,,,,,,,,,,Q9Y4K3_C_70_A
Q9Y4K3,R,88,A,3hcs:A,88,Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis. Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis,-1.0,,-1.0,,,,,,,,,,,,,Q9Y4K3_R_88_A
Q9Y4K3,F,118,A,3hcs:A,118,Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis.,-1.0,,-1.0,,,,,,,,,,,,,Q9Y4K3_F_118_A
Q9Y4K3,F,118,W,3hcs:A,118,Partially impaired polyubiquitin synthesis.,,,-1.0,,,,,,,,,,,,,Q9Y4K3_F_118_W
Q9Y4K3,F,118,Y,3hcs:A,118,Partially impaired polyubiquitin synthesis.,,,-1.0,,,,,,,,,,,,,Q9Y4K3_F_118_Y
Q9Y4K3,F,122,A,3hcs:A,122,Loss of TRAF6 homodimerization and partially impaired polyubiquitin synthesis. Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis,-1.0,,-1.0,,,,,,,,,,,,,Q9Y4K3_F_122_A
P27487,N,85,A,2bgr:A,85,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_85_A
P27487,N,92,A,2bgr:A,92,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_92_A
P27487,N,150,A,2bgr:A,150,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_150_A
P27487,E,205,K,2bgr:A,205,Inhibits dipeptidyl peptidase activity.,,,-1.0,,,,,,,,,,,,,P27487_E_205_K
P27487,E,206,L,2bgr:A,206,Inhibits dipeptidyl peptidase activity.,,,-1.0,,,,,,,,,,,,,P27487_E_206_L
P27487,N,219,A,2bgr:A,219,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_219_A
P27487,N,229,A,2bgr:A,229,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_229_A
P27487,N,281,A,2bgr:A,281,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_281_A
P27487,N,321,A,2bgr:A,321,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_321_A
P27487,N,520,A,2bgr:A,520,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_520_A
P27487,N,685,A,2bgr:A,685,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_685_A
P27487,H,750,A,2bgr:A,750,Inhibits weakly homodimerization and dipeptidyl peptidase activity.,-1.0,,-1.0,,,,,,,,,,,,,P27487_H_750_A
P27487,H,750,E,2bgr:A,750,"Inhibits strongly homodimerization, dipeptidyl peptidase activity, interaction with CARD11 and T-cell costimulation activity.",-1.0,,-1.0,,,,,,,,,,,,,P27487_H_750_E
Q9UK39,N,149,A,6mal:A,149,Slightly decreased activity as transcriptional repressor.,,,-1.0,,,,,,,,,,,,,Q9UK39_N_149_A
Q9UK39,D,160,A,6mal:A,160,Lack of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_D_160_A
Q9UK39,K,219,A,6mal:A,219,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_K_219_A
Q9UK39,H,286,A,6mal:A,286,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_H_286_A
Q9UK39,H,286,N,6mal:A,286,Lack of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_H_286_N
Q9UK39,K,288,A,6mal:A,288,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_K_288_A
Q9UK39,R,290,A,6mal:A,290,Lack of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_R_290_A
Q9UK39,D,324,A,6mal:A,324,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_D_324_A
Q9UK39,N,326,A,6mal:A,326,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_N_326_A
Q9UK39,K,365,A,6mal:A,365,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q9UK39_K_365_A
Q9UK39,R,367,A,6mal:A,367,Reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q9UK39_R_367_A
P00367,S,501,A,1l1f:A,448,Reduces activity and inhibition by GTP.,,,-1.0,,,,,,,,,,,,,P00367_S_501_A
P00813,L,58,A,3iar:A,58,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,-1.0,,,,,,,,,,,,,P00813_L_58_A
P00813,D,60,A,3iar:A,60,Moderately reduces enzyme activity,,,-1.0,,,,,,,,,,,,,P00813_D_60_A
P00813,F,61,A,3iar:A,61,Decreases enzyme activity by reducing maximum velocity,,,-1.0,,,,,,,,,,,,,P00813_F_61_A
P00813,L,62,A,3iar:A,62,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,-1.0,,,,,,,,,,,,,P00813_L_62_A
P00813,K,64,A,3iar:A,64,Moderately reduces enzyme activity,,,-1.0,,,,,,,,,,,,,P00813_K_64_A
P00813,F,65,A,3iar:A,65,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,-1.0,,,,,,,,,,,,,P00813_F_65_A
P00813,D,66,A,3iar:A,66,No change in enzyme activity,,,0.0,,,,,,,,,,,,,P00813_D_66_A
P00813,M,69,A,3iar:A,69,Decreases enzyme activity by reducing maximum velocity,,,-1.0,,,,,,,,,,,,,P00813_M_69_A
P00813,I,115,A,3iar:A,115,No change in enzyme activity,,,0.0,,,,,,,,,,,,,P00813_I_115_A
P00813,N,118,A,3iar:A,118,Moderately reduces enzyme activity,,,-1.0,,,,,,,,,,,,,P00813_N_118_A
P00813,M,155,A,3iar:A,155,Decreases enzyme activity by reducing substrate affinity and maximum velocity.,,-1.0,-1.0,,,,,,,,,,,,,P00813_M_155_A
P00813,H,157,A,3iar:A,157,Moderately reduces enzyme activity,,,-1.0,,,,,,,,,,,,,P00813_H_157_A
P00813,G,184,Q,3iar:A,184,Moderately reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,P00813_G_184_Q
P00813,D,185,A,3iar:A,185,Moderately reduces enzyme activity.,,,-1.0,,,,,,,,,,,,,P00813_D_185_A
P00813,L,194,A,3iar:A,194,No change in enzyme activity.,,,0.0,,,,,,,,,,,,,P00813_L_194_A
Q09328,E,280,A,6yjv:AAA,280,Decreased catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_280_A
Q09328,E,287,A,6yjv:AAA,287,Decreased catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_287_A
Q09328,E,297,A,6yjv:AAA,297,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_297_A
Q09328,E,429,A,6yjr:AAA,429,Decreased catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_429_A
Q09328,E,520,A,6yjr:AAA,520,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_520_A
Q09328,E,526,A,6yjr:AAA,526,Loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q09328_E_526_A
Q7L0Q8,Q,107,L,2q3h:A,107,Constitutively active. Results in increased rates of stress fiber dissolution and cell migration. No effect on ARHGAP30-binding.,,0.0,1.0,,,,,,,,,,,,,Q7L0Q8_Q_107_L
Q59H18,K,490,R,4yfi:A,490,Loss of autophosphorylation activity.,,,-1.0,,,,,,,,,,,,,Q59H18_K_490_R
P54922,S,54,A,3hfw:A,54,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P54922_S_54_A
P54922,D,55,N,3hfw:A,55,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P54922_D_55_N
P54922,D,56,N,3hfw:A,56,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P54922_D_56_N
P54922,D,302,N,3hfw:A,302,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P54922_D_302_N
P54922,S,305,A,3hfw:A,305,Complete loss of activity.,,,-1.0,,,,,,,,,,,,,P54922_S_305_A
P08559,S,293,A,6cfo:A,264,Reduces enzyme activity. Abolishes inactivation by phosphorylation,,,-1.0,,,,,,,,,,,,,P08559_S_293_A
Q9H492,G,120,A,3wan:B,136,No processing of precursor.,,,-1.0,,,,,,,,,,,,,Q9H492_G_120_A
P14618,P,403,A,6gg3:B,403,Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A,,,-1.0,,,,,,,,,,,,,P14618_P_403_A
P14618,P,408,A,6gg3:B,408,Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A,,,-1.0,,,,,,,,,,,,,P14618_P_408_A
P14618,S,437,Y,6gg3:B,437,Unable to bind FBP but still activated by serine.,1.0,,0.0,,,,,,,,,,,,,P14618_S_437_Y
P14618,H,464,A,6gg3:B,464,Abolishes serine binding and allosteric activation.,,-1.0,-1.0,,,,,,,,,,,,,P14618_H_464_A
O96017,D,347,A,4bdi:A,347,Loss of kinase activity and of the ability to phosphorylate CDC25A.,,,-1.0,,,,,,,,,,,,,O96017_D_347_A
O96017,D,368,N,4bdi:A,368,Loss of autophosphorylation activity.,,,-1.0,-1.0,,,,,,,,,,,,O96017_D_368_N
O96013,S,445,N,2q0n:A,445,Approximately 30-fold increased autophosphorylation (constitutively active mutant).,,,1.0,1.0,,,,,,,,,,,,O96013_S_445_N
O96013,S,474,E,2q0n:A,474,Approximately 3-fold increased autophosphorylation.,,,1.0,1.0,,,,,,,,,,,,O96013_S_474_E
O94923,Y,146,A,6i02:B,146,Reduces enzyme activity by about 60%.,,,-1.0,,,,,,,,,,,,,O94923_Y_146_A
O94923,Y,162,A,6i02:B,162,Reduces enzyme activity by about 75%.,,,-1.0,,,,,,,,,,,,,O94923_Y_162_A
O94923,Y,168,A,6i02:B,168,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O94923_Y_168_A
O94923,Y,210,A,6i02:B,210,Reduces enzyme activity by about 30%.,,,-1.0,,,,,,,,,,,,,O94923_Y_210_A
O94923,Y,222,A,6i02:B,222,Almost abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,O94923_Y_222_A
O94923,E,499,Q,6i02:B,499,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94923_E_499_Q
O94923,Y,500,F,6i02:B,500,Mildly decreased enzyme activity.,,,-1.0,,,,,,,,,,,,,O94923_Y_500_F
O94923,Y,578,F,6i02:B,578,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O94923_Y_578_F
P42126,E,178,A,1sg4:B,136,Loss of activity.,,,-1.0,,,,,,,,,,,,,P42126_E_178_A
Q8NFA2,R,40,Q,2l73:A,40,Loss of ability to activate NOX1 associated with loss of lipid-binding and plasma membrane localization.,,,-1.0,,,,,,,,,1.0,,,,Q8NFA2_R_40_Q
Q99714,S,20,F,1u7t:A,20,Decreased dehydrogenase activity. Does not affect mitochondrial tRNA 5'-end processing. Does not affect tRNA methylation.,,,-1.0,,,,,,,,,,,,,Q99714_S_20_F
Q99714,K,172,A,1u7t:A,172,Abolishes dehydrogenase activity. Does not affect mitochondrial tRNA 5'-end processing. Does not affect tRNA methylation. Does not affect homotetramerization.,0.0,,-1.0,,,,,,,,,,,,,Q99714_K_172_A
P14780,E,402,Q,1l6j:A,402,Loss of activity.,,,-1.0,,,,,,,,,,,,,P14780_E_402_Q
P27707,A,100,V,2no9:A,100,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_A_100_V
P27707,R,104,L,2no9:A,104,Strongly increased catalytic efficiency towards deoxythymidine,,,1.0,,,,,,,,,,,,,P27707_R_104_L
P27707,R,104,M,2no9:A,104,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_R_104_M
P27707,D,133,A,2no9:A,133,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_D_133_A
P11310,L,86,M,1t9g:C,61,Strongly reduced rate of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_L_86_M
P11310,L,98,W,1t9g:C,73,Strongly reduced rate of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_L_98_W
P11310,L,100,Y,1t9g:C,75,Strongly reduced rate of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_L_100_Y
P11310,I,108,M,1t9g:C,83,Strongly reduced rate of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_I_108_M
P11310,W,191,A,1t9g:C,166,Loss of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_W_191_A
P11310,W,191,F,1t9g:C,166,Reduces rate of electron transfer to ETF about six-fold.,,,-1.0,,,,,,,,,,,,,P11310_W_191_F
P11310,E,237,A,1t9g:C,212,Strongly reduced rate of electron transfer to ETF.,,,-1.0,,,,,,,,,,,,,P11310_E_237_A
P11310,E,384,A,1t9g:C,359,Reduces rate of electron transfer to ETF three-fold.,,,-1.0,,,,,,,,,,,,,P11310_E_384_A
P11310,E,384,Q,1t9g:C,359,Reduces rate of electron transfer to ETF two-fold.,,,-1.0,,,,,,,,,,,,,P11310_E_384_Q
P11310,E,401,Q,1t9g:C,376,Loss of acyl-CoA dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P11310_E_401_Q
P11310,E,401,T,1t9g:C,376,Loss of acyl-CoA dehydrogenase activity,,,-1.0,,,,,,,,,,,,,P11310_E_401_T
Q96JA3,W,407,A,5kdi:A,407,Loss of glucosylceramide transfer activity from the TGN to the plasma membrane.,,,-1.0,,,,,,,,,,,,,Q96JA3_W_407_A
P26440,E,286,Q,1ivh:A,254,Loss of isovaleryl-CoA dehydrogenase activity.,,,-1.0,,,,,,,,,,,,,P26440_E_286_Q
P26440,A,407,E,1ivh:A,375,Does not affect isovaleryl-CoA dehydrogenase activity,,,0.0,,,,,,,,,,,,,P26440_A_407_E
P11597,T,155,Y,2obd:A,138,Reduces triglyceride transfer and cholesteryl ester transfer 5-fold.,,,-1.0,,,,,,,,,,,,,P11597_T_155_Y
P11597,V,215,W,2obd:A,198,Reduces triglyceride transfer 10-fold. No effect on cholesteryl ester transfer.,,,0.0,,,,,,,,,,,,,P11597_V_215_W
P11597,R,218,S,2obd:A,201,Reduces triglyceride transfer 10-fold. Slight reduction of cholesteryl ester transfer.,,,-1.0,,,,,,,,,,,,,P11597_R_218_S
P11597,S,247,A,2obd:A,230,Reduces triglyceride transfer 5-fold. Slight reduction of cholesteryl ester transfer.,,,-1.0,,,,,,,,,,,,,P11597_S_247_A
P11597,L,313,Q,2obd:A,296,Reduces cholesteryl ester transfer by 60%.,,,-1.0,,,,,,,,,,,,,P11597_L_313_Q
P11597,V,433,R,2obd:A,416,Reduces activity by 60%.,,,-1.0,,,,,,,,,,,,,P11597_V_433_R
Q16832,K,608,A,6fer:D,655,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q16832_K_608_A
Q16832,Y,736,F,6fer:D,783,Reduces autophosphorylation. Abolishes phosphorylation by SRC,,,-1.0,-1.0,,,,,,,,,,,,Q16832_Y_736_F
Q16832,Y,740,F,6fer:D,787,Promotes autophosphorylation. Abolishes phosphorylation by SRC,,,1.0,-1.0,,,,,,,,,,,,Q16832_Y_740_F
Q16832,Y,741,F,6fer:D,788,Reduces autophosphorylation. Abolishes phosphorylation by SRC,,,-1.0,-1.0,,,,,,,,,,,,Q16832_Y_741_F
O95470,E,132,G,4q6r:B,132,No effect on the sphinganine-1-phosphate aldolase activity,,,0.0,,,,,,,,,,,,,O95470_E_132_G
O95470,C,218,G,4q6r:B,218,Loss of sphinganine-1-phosphate aldolase activity.,,,-1.0,,,,,,,,,,,,,O95470_C_218_G
O95470,C,317,S,4q6r:B,317,Almost no sphinganine-1-phosphate aldolase activity.,,,-1.0,,,,,,,,,,,,,O95470_C_317_S
O95470,K,353,L,4q6r:B,353,Loss of sphinganine-1-phosphate aldolase activity.,,,-1.0,,,,,,,,,,,,,O95470_K_353_L
O95477,S,100,C,5xjy:A,100,Highly decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.,,,-1.0,,,,,,,,,,,,-1.0,O95477_S_100_C
O95477,F,593,L,5xjy:A,593,Moderately decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.,,,-1.0,,,,,,,,,,,,-1.0,O95477_F_593_L
O95477,K,939,M,5xjy:A,939,Inhibits ATPase activity,,,-1.0,,,,,,,,,,,,,O95477_K_939_M
O95477,T,1512,M,5xjy:A,1512,Moderately decreased protein abundance. Does not affect ATPase activity. Moderately decreased phospholipid translocase activity.,,,-1.0,,,,,,,,,,,-1.0,,O95477_T_1512_M
O95477,K,1952,M,5xjy:A,1952,Inhibits ATPase activity,,,-1.0,,,,,,,,,,,,,O95477_K_1952_M
P49366,N,106,A,6xxm:A,106,Strongly reduced NAD and spermidine binding. Reduced activity.,,-1.0,-1.0,,,,,,,,,,,,,P49366_N_106_A
P49366,S,109,A,6xxm:A,109,Strongly reduced spermidine binding. Reduced activity.,,-1.0,-1.0,,,,,,,,,,,,,P49366_S_109_A
P49366,E,137,A,6xxm:A,137,Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,-1.0,,,,,,,,,,,,,P49366_E_137_A
P49366,D,238,A,6xxm:A,238,Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,-1.0,,,,,,,,,,,,,P49366_D_238_A
P49366,D,243,A,6xxm:A,243,Reduces spermidine binding by 98%. Strongly reduced formation of covalent intermediate.,,-1.0,-1.0,,,,,,,,,,,,,P49366_D_243_A
P49366,K,287,A,6xxm:A,287,Reduces covalent intermediate formation and deoxyhypusine synthesis by 99.5%. Retains low spermidine cleavage activity.,,,-1.0,,,,,,,,,,,,,P49366_K_287_A
P49366,H,288,A,6xxm:A,288,Reduces spermidine binding by 98%. Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,-1.0,,,,,,,,,,,,,P49366_H_288_A
P49366,Y,305,A,6xxm:A,305,Strongly reduced NAD binding. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P49366_Y_305_A
P49366,D,316,A,6xxm:A,316,Reduces spermidine binding by 98%. Loss of covalent intermediate formation and deoxyhypusine synthesis.,,-1.0,-1.0,,,,,,,,,,,,,P49366_D_316_A
P49366,S,317,A,6xxm:A,317,Strongly reduced NAD binding. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P49366_S_317_A
P49366,E,323,A,6xxm:A,323,Reduces spermidine binding by 98%. Strongly reduced formation of covalent intermediate.,,-1.0,-1.0,,,,,,,,,,,,,P49366_E_323_A
P49366,W,327,A,6xxm:A,327,Reduces spermidine binding by 98%. Loss of covalent intermediate formation and deoxyhypusine synthesis.,,-1.0,-1.0,,,,,,,,,,,,,P49366_W_327_A
P49366,K,329,A,6xxm:A,329,Loss of covalent intermediate formation and deoxyhypusine synthesis.,,,-1.0,,,,,,,,,,,,,P49366_K_329_A
P49366,K,329,R,6xxm:A,329,Loss of covalent intermediate formation and deoxyhypusine synthesis.,,,-1.0,,,,,,,,,,,,,P49366_K_329_R
P49366,D,342,A,6xxm:A,342,Strongly reduced NAD binding. Strongly reduced activity.,,-1.0,-1.0,,,,,,,,,,,,,P49366_D_342_A
P26196,E,247,Q,4ct5:A,247,Abolished helicase activity and ability to regulate RNA metabolism.,,,-1.0,,,,,,,,,,,,,P26196_E_247_Q
P26196,R,386,E,4ct5:A,386,Abolished ability to regulate RNA metabolism.,,,-1.0,,,,,,,,,,,,,P26196_R_386_E
P11441,L,43,A,2dzi:A,50,Reduces tail-anchored proteins delivery.,,,-1.0,,,,,,,,,,,,,P11441_L_43_A
O95786,T,55,I,4p4h:B,55,No IRF3 signaling activity,,,-1.0,,,,,,,,,,,,,O95786_T_55_I
O95786,K,270,A,6kyv:B,270,No IRF3 signaling activity.,,,-1.0,,,,,,,,,,,,,O95786_K_270_A
O95786,K,788,R,5f9f:E,788,Decreased polyubiquitination. Loss of function in RIG-I signaling pathway. Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,,-1.0,,-1.0,,,,,,,,,,,O95786_K_788_R
O95786,K,849,R,5f9f:E,849,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,-1.0,,-1.0,,,,,,,,,,,O95786_K_849_R
O95786,K,851,R,5f9f:E,851,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,-1.0,,-1.0,,,,,,,,,,,O95786_K_851_R
O95786,K,888,R,5f9f:E,888,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,-1.0,,-1.0,,,,,,,,,,,O95786_K_888_R
O95786,K,907,R,5f9f:E,907,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,-1.0,,-1.0,,,,,,,,,,,O95786_K_907_R
O95786,K,909,R,5f9f:E,909,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,-1.0,,-1.0,,,,,,,,,,,O95786_K_909_R
P61077,N,77,S,3l1z:A,77,Activity is restricted HECT-type and not RING-containing E3 ubiquitin-protein ligases. Exhibits ubiquitin transfer with ARIH1 and PRKN.,,,-1.0,,,,,,,,,,,,,P61077_N_77_S
P61077,C,85,A,3l1z:A,85,Loss of function.,,,-1.0,,,,,,,,,,,,,P61077_C_85_A
P61077,D,87,E,3l1z:A,87,Has intermediate lysine reactivity.,,,-1.0,,,,,,,,,,,,,P61077_D_87_E
P61077,D,87,P,3l1z:A,87,Has intermediate lysine reactivity.,,,-1.0,,,,,,,,,,,,,P61077_D_87_P
P61077,D,87,K,3l1z:A,87,Abolishes affect lysine reactivity.,,,-1.0,,,,,,,,,,,,,P61077_D_87_K
P61077,D,87,N,3l1z:A,87,Does not affect lysine reactivity.,,,0.0,,,,,,,,,,,,,P61077_D_87_N
P61077,D,117,H,3l1z:A,117,Strongly impairs lysine reactivity but retains some ability to transfer ubiquitin to BRCA1.,,,-1.0,,,,,,,,,,,,,P61077_D_117_H
O43314,R,213,A,3t9c:A,213,Reduces enzyme activity by about 99%.,,,-1.0,,,,,,,,,,,,,O43314_R_213_A
O43314,R,213,K,3t9c:A,213,Reduces enzyme activity by about 99%.,,,-1.0,,,,,,,,,,,,,O43314_R_213_K
O43314,K,248,A,3t9c:A,248,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,O43314_K_248_A
O43314,R,262,A,3t9c:A,262,Reduces enzyme activity by about 99%.,,,-1.0,,,,,,,,,,,,,O43314_R_262_A
Q9NUW8,H,263,A,1qzq:A,263,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9NUW8_H_263_A
Q9NUW8,K,265,A,1qzq:A,265,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,-1.0,,,,,,,,,,,,,Q9NUW8_K_265_A
Q9NUW8,K,265,S,1qzq:A,265,Reduces the activity to nearly undetectable levels.,,,-1.0,,,,,,,,,,,,,Q9NUW8_K_265_S
Q9NUW8,N,283,A,1qzq:A,283,No effect.,,,0.0,,,,,,,,,,,,,Q9NUW8_N_283_A
Q9NUW8,Q,294,A,1qzq:A,294,Slightly reduced hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,-1.0,,,,,,,,,,,,,Q9NUW8_Q_294_A
Q9NUW8,H,493,A,1qzq:A,493,3000-fold reduction in activity,,,-1.0,,,,,,,,,,,,,Q9NUW8_H_493_A
Q9NUW8,H,493,N,1qzq:A,493,15000-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,Q9NUW8_H_493_N
Q9NUW8,K,495,A,1qzq:A,495,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,-1.0,,,,,,,,,,,,,Q9NUW8_K_495_A
Q9NUW8,K,495,S,1qzq:A,495,125-fold reduction in activity.,,,-1.0,,,,,,,,,,,,,Q9NUW8_K_495_S
Q9NUW8,N,516,A,1qzq:A,516,Reduced hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,-1.0,,,,,,,,,,,,,Q9NUW8_N_516_A
Q9NUW8,E,538,A,1qzq:A,538,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,-1.0,,,,,,,,,,,,,Q9NUW8_E_538_A
Q8IXI2,P,13,V,6d71:A,13,Causes constitutive activation inducing an aggregation of the mitochondrial network.,,,1.0,,,,,,,,,,,,,Q8IXI2_P_13_V
Q8IXI2,T,18,N,6d71:A,18,Causes constitutive inactivation.,,,-1.0,,,,,,,,,,,,,Q8IXI2_T_18_N
Q8IXI2,K,427,V,5ksz:A,427,No effect.,,,0.0,,,,,,,,,,,,,Q8IXI2_K_427_V
Q8IXI2,S,432,N,5ksz:A,432,No effect.,,,0.0,,,,,,,,,,,,,Q8IXI2_S_432_N
O43318,K,63,W,5gjd:A,63,Loss of kinase activity. Loss of autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,O43318_K_63_W
O14656,E,171,Q,6oif:A,171,Loss of ATP hydrolysis. Loss of interaction with KLHL14. Localizes in the nuclear envelope. No effect on interaction with TOR1AIP1.,-1.0,,-1.0,,,,,,,,,1.0,,,,O14656_E_171_Q
P22830,F,110,A,2qd1:A,110,Increases activity inhibition upon interaction with PGRMC1.,,,1.0,,,,,,,,,,,,,P22830_F_110_A
P22830,C,196,S,2qd1:A,196,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_196_S
P22830,C,360,S,2qd1:A,360,No loss of activity.,,,0.0,,,,,,,,,,,,,P22830_C_360_S
P22830,C,395,S,2qd1:A,395,No loss of activity.,,,0.0,,,,,,,,,,,,,P22830_C_395_S
P22830,C,403,D,2qd1:A,403,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_403_D
P22830,C,403,H,2qd1:A,403,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_403_H
P22830,C,406,D,2qd1:A,406,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_406_D
P22830,C,406,H,2qd1:A,406,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_406_H
P22830,C,406,S,2qd1:A,406,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_406_S
P22830,C,411,H,2qd1:A,411,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_411_H
P22830,C,411,S,2qd1:A,411,Loss of activity.,,,-1.0,,,,,,,,,,,,,P22830_C_411_S
P22830,F,417,L,2qd1:A,417,Decreased activity.,,,-1.0,,,,,,,,,,,,,P22830_F_417_L
P22830,F,417,Y,2qd1:A,417,Greatly reduced activity.,,,-1.0,,,,,,,,,,,,,P22830_F_417_Y
P22830,F,417,W,2qd1:A,417,Greatly reduced activity.,,,-1.0,,,,,,,,,,,,,P22830_F_417_W
P61586,G,14,V,1cc0:A,14,Increased Rho protein signal transduction. Constitutively active.,,,1.0,,,,,,,,,,,,,P61586_G_14_V
P61586,Q,63,L,1cc0:A,63,Causes constitutive activation.,,,1.0,,,,,,,,,,,,,P61586_Q_63_L
Q96E22,H,100,A,6z1n:B,100,3.5-fold reduction in catalytic activity and no marked change in affinity for FPP and IPP.,,0.0,-1.0,,,,,,,,,,,,,Q96E22_H_100_A
Q96E22,G,292,A,6z1n:B,292,Almost complete loss of catalytic activity.,,,-1.0,,,,,,,,,,,,,Q96E22_G_292_A
Q9ULG1,E,653,Q,6hts:G,653,Abolishes DNA-dependent ATPase and nucleosome remodeling activities.,,,-1.0,,,,,,,,,,,,,Q9ULG1_E_653_Q
P31751,T,309,E,3d0e:A,309,Constitutively active,,,1.0,,,,,,,,,,,,,P31751_T_309_E
Q86XE5,S,77,A,3s5o:A,77,2-fold decrease in Kcat and a nearly 8-fold increase in KM.,,-1.0,-1.0,,,,,,,,,,,,,Q86XE5_S_77_A
Q86XE5,S,77,T,3s5o:A,77,Significant loss of activity.,,,-1.0,,,,,,,,,,,,,Q86XE5_S_77_T
Q86XE5,N,78,A,3s5o:A,78,6-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_N_78_A
Q86XE5,N,78,Q,3s5o:A,78,25-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_N_78_Q
Q86XE5,Y,140,F,3s5o:A,140,No change in activity.,,,0.0,,,,,,,,,,,,,Q86XE5_Y_140_F
Q86XE5,Y,168,F,3s5o:A,168,No enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q86XE5_Y_168_F
Q86XE5,K,196,A,3s5o:A,196,No enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q86XE5_K_196_A
Q86XE5,S,198,A,3s5o:A,198,2.5-fold decrease in Kcat and 4.2 fold increase in KM.,,-1.0,-1.0,,,,,,,,,,,,,Q86XE5_S_198_A
Q86XE5,S,198,T,3s5o:A,198,7-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_S_198_T
Q9H6P5,D,233,A,2a8i:B,233,0.1% enzymatic activity,,,-1.0,,,,,,,,,,,,,Q9H6P5_D_233_A
Q9H6P5,T,234,A,2a8i:B,234,Complete loss of enzymatic activity,,,-1.0,,,,,,,,,,,,,Q9H6P5_T_234_A
P51668,K,4,E,4ap4:B,4,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_K_4_E
P51668,D,42,R,4ap4:B,42,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_D_42_R
P51668,F,62,A,4ap4:B,62,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_F_62_A
P51668,D,87,R,4ap4:B,87,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_D_87_R
P51668,S,94,E,4ap4:B,94,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_S_94_E
P51668,T,98,E,4ap4:B,98,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_T_98_E
P51668,D,112,R,4ap4:B,112,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_D_112_R
P51668,D,116,R,4ap4:B,116,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_D_116_R
P51668,D,117,R,4ap4:B,117,Decrease in autoubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P51668_D_117_R
Q969V5,H,319,A,6k2k:A,319,Abolishes ligase activity. No effect on mitochondrial localization.,,,-1.0,,,,,,,,,0.0,,,,Q969V5_H_319_A
Q969V5,C,339,A,6k2k:A,339,Abolishes ligase activity.,,,-1.0,,,,,,,,,,,,,Q969V5_C_339_A
Q9BZP6,D,138,A,3fxy:A,138,Loss of chitinase activity. No effect on protection against apoptosis or on AKT1 activation.,,,-1.0,,,,,,,,,,,,,Q9BZP6_D_138_A
P52848,K,614,A,1nst:A,614,Loss of sulfotransferase activity.,,,-1.0,,,,,,,,,,,,,P52848_K_614_A
Q96PS8,E,27,Q,6f7h:D,27,Abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_E_27_Q
Q96PS8,G,73,A,6f7h:D,73,Increased permeability to glycerol at acidic pH.,,,1.0,,,,,,,,,,,,,Q96PS8_G_73_A
Q96PS8,G,73,F,6f7h:D,73,Abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_G_73_F
Q96PS8,S,77,A,6f7h:D,77,Nearly abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_S_77_A
Q96PS8,S,77,D,6f7h:D,77,Nearly abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_S_77_D
Q96PS8,H,80,A,6f7h:D,80,Abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_H_80_A
Q96PS8,F,85,A,6f7h:D,85,Nearly abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_F_85_A
Q96PS8,R,94,A,6f7h:D,94,Abolishes permeability to glycerol.,,,-1.0,,,,,,,,,,,,,Q96PS8_R_94_A
Q9UMR5,S,111,A,1pja:A,111,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9UMR5_S_111_A
Q9UMR5,D,228,A,1pja:A,228,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9UMR5_D_228_A
Q9UMR5,H,283,A,1pja:A,283,Abolishes enzymatic activity.,,,-1.0,,,,,,,,,,,,,Q9UMR5_H_283_A
Q9UMR5,H,287,A,1pja:A,287,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9UMR5_H_287_A
Q9H0R8,G,116,A,5lxi:D,116,No processing of precursor.,,,-1.0,,,,,,,,,,,,,Q9H0R8_G_116_A
Q9UMR2,E,243,Q,6b4j:E,243,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q9UMR2_E_243_Q
O15264,T,180,A,4myg:A,180,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O15264_T_180_A
O15264,Y,182,A,4myg:A,182,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,O15264_Y_182_A
O95881,C,66,S,2k8v:A,51,Loss of oxidase activity.,,,-1.0,,,,,,,,,,,,,O95881_C_66_S
O95881,C,69,S,2k8v:A,54,Loss of oxidase activity.,,,-1.0,,,,,,,,,,,,,O95881_C_69_S
O75449,K,255,A,5zql:A,255,Abolishes ATP dependent microtubule severing activity and localization to spindle poles.,,,-1.0,,,,,,,,,1.0,,,,O75449_K_255_A
O75449,D,308,N,5zql:A,308,Abolishes ATP dependent microtubule severing activity and localization to spindle poles,,,-1.0,,,,,,,,,1.0,,,,O75449_D_308_N
O75449,E,309,N,5zql:A,309,Abolishes ATP dependent microtubule severing activity and localization to spindle poles,,,-1.0,,,,,,,,,1.0,,,,O75449_E_309_N
P20591,K,83,A,4p4s:A,83,Loss of GTP-binding. Loss of potentiation of TRPC6 activity. Loss of protection against viral infection.,,-1.0,-1.0,,,,,,,,,,,,,P20591_K_83_A
P20591,K,83,M,4p4s:A,83,Loss of GTP-binding. Loss of protection against viral infection.,,,-1.0,,,,,,,,,,,,,P20591_K_83_M
P20591,T,103,A,4p4s:A,103,Loss of GTP-binding. Loss of potentiation of TRPC6 activity. Loss of protection against viral infection.,,,-1.0,,,,,,,,,,,,,P20591_T_103_A
P20591,L,612,K,3szr:A,612,"Loss of GTP-hydrolysis. No effect on GTP-binding, nor on potentiation of TRPC6 activity.",,0.0,-1.0,,,,,,,,,,,,,P20591_L_612_K
P20591,E,632,A,3szr:A,632,Reduced antiviral activity.,,,-1.0,,,,,,,,,,,,,P20591_E_632_A
P20591,R,640,A,3szr:A,640,"Fails to sequester viral nucleoproteins, no antiviral activity.",-1.0,,-1.0,,,,,,,,,,,,,P20591_R_640_A
P20591,E,645,R,3szr:A,645,Loss of antiviral activity towards CCHFV and LACV.,,,-1.0,,,,,,,,,,,,,P20591_E_645_R
P17612,K,48,R,4ujb:A,47,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_K_48_R
P17612,L,96,Q,4ujb:A,95,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_L_96_Q
P17612,M,121,L,4ujb:A,120,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_M_121_L
P17612,V,124,A,4ujb:A,123,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_V_124_A
P17612,Q,182,K,4ujb:A,181,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_Q_182_K
P17612,T,184,A,4ujb:A,183,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_T_184_A
P17612,R,195,A,4ujb:A,194,No phosphorylation.,,,-1.0,,,,,,,,,,,,,P17612_R_195_A
P17612,G,201,A,4ujb:A,200,No phosphorylation.,,,-1.0,,,,,,,,,,,,,P17612_G_201_A
P17612,T,202,A,4ujb:A,201,No phosphorylation.,,,-1.0,,,,,,,,,,,,,P17612_T_202_A
P35270,S,213,A,7dsf:A,213,Abolishes phosphorylation by CaMK2. No effect on kinetic parameters.,,,0.0,-1.0,,,,,,,,,,,,P35270_S_213_A
Q9H3N1,C,56,S,1x5e:A,34,Loss of reductase activity,,,-1.0,,,,,,,,,,,,,Q9H3N1_C_56_S
Q9H3N1,C,59,S,1x5e:A,37,Loss of reductase activity,,,-1.0,,,,,,,,,,,,,Q9H3N1_C_59_S
Q9H488,R,240,A,5ux6:A,240,Strongly impaired ability to activate NOTCH signaling.,,,-1.0,,,,,,,,,,,,,Q9H488_R_240_A
Q9H488,R,240,C,5ux6:A,240,Strongly impaired ability to activate NOTCH signaling.,,,-1.0,,,,,,,,,,,,,Q9H488_R_240_C
Q9H488,M,262,T,5ux6:A,262,No effect on ability to activate NOTCH signaling.,,,0.0,,,,,,,,,,,,,Q9H488_M_262_T
Q9H488,S,356,F,5ux6:A,356,Abolishes ability to activate NOTCH signaling.,,,-1.0,,,,,,,,,,,,,Q9H488_S_356_F
Q9H488,R,366,W,5ux6:A,366,Strongly impaired ability to activate NOTCH signaling.,,,-1.0,,,,,,,,,,,,,Q9H488_R_366_W
Q92820,C,134,A,1l9x:A,110,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q92820_C_134_A
Q92820,H,195,N,1l9x:A,171,Reduces activity 250-fold.,,,-1.0,,,,,,,,,,,,,Q92820_H_195_N
Q92820,H,244,A,1l9x:A,220,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q92820_H_244_A
Q92820,E,246,A,1l9x:A,222,Slightly reduced catalytic activity.,,,-1.0,,,,,,,,,,,,,Q92820_E_246_A
P17948,K,861,M,3hng:A,861,Abolishes enzyme activity. Abolishes interaction with PLCG.,-1.0,,-1.0,,,,,,,,,,,,,P17948_K_861_M
P17948,N,1050,D,3hng:A,1050,Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells.,,,1.0,,,,,,,,,,,,,P17948_N_1050_D
Q15084,C,55,S,3w8j:A,55,50% decrease in enzyme activity,,,-1.0,,,,,,,,,,,,,Q15084_C_55_S
Q15084,C,58,A,3w8j:A,58,Accelerates dephosphorylation of ERN1,,,1.0,,,,,,,,,,,,,Q15084_C_58_A
Q15084,C,58,S,3w8j:A,58,50% decrease in enzyme activity,,,-1.0,,,,,,,,,,,,,Q15084_C_58_S
Q15084,C,190,S,1x5d:A,37,25% decrease in enzyme activity,,,-1.0,,,,,,,,,,,,,Q15084_C_190_S
Q15084,C,193,A,1x5d:A,40,Accelerates dephosphorylation of ERN1,,,1.0,,,,,,,,,,,,,Q15084_C_193_A
Q15084,C,193,S,1x5d:A,40,90% decrease in enzyme activity,,,-1.0,,,,,,,,,,,,,Q15084_C_193_S
Q14289,K,457,A,3cc6:A,457,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q14289_K_457_A
P45452,E,223,A,4g0d:A,223,Abolishes enzyme activity.,,,-1.0,,,,,,,,,,,,,P45452_E_223_A
P42330,K,75,E,4zfc:B,75,No effect on 17beta-HSD activity.,,,0.0,,,,,,,,,,,,,P42330_K_75_E
Q9BRA2,C,43,S,1wou:A,43,Loss of peroxidase activity.,,,-1.0,,,,,,,,,,,,,Q9BRA2_C_43_S
Q9BRA2,C,46,S,1wou:A,46,Loss of peroxidase activity.,,,-1.0,,,,,,,,,,,,,Q9BRA2_C_46_S
P53396,K,540,R,6uuw:A,540,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_540_R
P53396,K,540,Q,6uuw:A,540,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_540_Q
P53396,K,546,R,6uuw:A,546,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_546_R
P53396,K,546,Q,6uuw:A,546,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_546_Q
P53396,K,554,R,6uuw:A,554,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_554_R
P53396,K,554,Q,6uuw:A,554,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_554_Q
P53396,H,760,A,6uuw:A,760,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,P53396_H_760_A
Q14376,S,132,A,1i3k:A,132,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q14376_S_132_A
Q14376,Y,157,F,1i3k:A,157,Loss of activity.,,,-1.0,,,,,,,,,,,,,Q14376_Y_157_F
Q14376,C,307,Y,1i3k:A,307,No effect on activity towards UDP-galactose. Loss of activity towards UDP-N-acetylgalactosamine.,,,-1.0,,,,,,,,,,,,,Q14376_C_307_Y
P22455,K,503,R,6jpj:A,503,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,P22455_K_503_R
P41220,L,79,A,2af0:A,79,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_L_79_A
P41220,E,86,A,2af0:A,86,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_E_86_A
P41220,L,87,A,2af0:A,87,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_L_87_A
P41220,S,90,A,2af0:A,90,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_S_90_A
P41220,K,102,A,2af0:A,102,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_K_102_A
P41220,F,105,A,2af0:A,105,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_F_105_A
P41220,I,110,A,2af0:A,110,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_I_110_A
P41220,E,111,A,2af0:A,111,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_E_111_A
P41220,L,114,A,2af0:A,114,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,-1.0,,,,,,,,,,,,,P41220_L_114_A
P41220,N,149,A,2af0:A,149,"Decreases GTPase accelerating function but has no effect on translation inhibitory activity, suggesting that its role in translation is independent of its effects on G proteins.",,,-1.0,,,,,,,,,,,,,P41220_N_149_A
P41222,K,59,A,4ory:F,59,Increases enzyme activity about two-fold.,,,0.0,,,,,,,,,,,,,P41222_K_59_A
P41222,M,64,A,4ory:F,64,Reduces enzyme activity almost ten-fold.,,,-1.0,,,,,,,,,,,,,P41222_M_64_A
P41222,C,65,A,4ory:F,65,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,P41222_C_65_A
P41222,L,79,A,4ory:F,79,Reduces enzyme activity over ten-fold.,,,-1.0,,,,,,,,,,,,,P41222_L_79_A
P41222,F,83,A,4ory:F,83,Reduces enzyme activity about five-fold.,,,-1.0,,,,,,,,,,,,,P41222_F_83_A
P41222,L,131,A,4ory:F,131,Reduces enzyme activity almost ten-fold.,,,-1.0,,,,,,,,,,,,,P41222_L_131_A
P41222,Y,149,A,4ory:F,149,Increases enzyme activity about two-fold.,,,1.0,,,,,,,,,,,,,P41222_Y_149_A
Q8IV48,K,111,A,1zbh:A,111,Reduces RNA-binding to the stem-loop structure but not 3'-end histone mRNA exonuclease activity,,-1.0,-1.0,,,,,,,,,,,,,Q8IV48_K_111_A
Q8IV48,K,112,A,1zbh:A,112,Reduces RNA-binding to the stem-loop structure but not 3'-end histone mRNA exonuclease activity,,-1.0,-1.0,,,,,,,,,,,,,Q8IV48_K_112_A
Q8IV48,D,234,A,1zbh:A,234,Inhibits 3'-end histone mRNA exonuclease activity.,,,-1.0,,,,,,,,,,,,,Q8IV48_D_234_A
Q8IV48,M,235,A,1zbh:A,235,Inhibits RNA-binding to the stem-loop structure and 3'-end histone mRNA exonuclease activity.,,-1.0,-1.0,,,,,,,,,,,,,Q8IV48_M_235_A
Q8IV48,D,298,A,1zbh:A,298,Inhibits 3'-end histone mRNA exonuclease activity.,,,-1.0,,,,,,,,,,,,,Q8IV48_D_298_A
P11309,H,68,Y,1xr1:A,68,Increased kinase activity.,,,1.0,,,,,,,,,,,,,P11309_H_68_Y
P11309,P,81,S,1xr1:A,81,Decreased kinase activity.,,,-1.0,,,,,,,,,,,,,P11309_P_81_S
P11309,N,82,K,1xr1:A,82,Decreased kinase activity.,,,-1.0,,,,,,,,,,,,,P11309_N_82_K
P11309,L,193,F,1xr1:A,193,Decreased kinase activity.,,,-1.0,,,,,,,,,,,,,P11309_L_193_F
P41240,Y,304,F,3d7u:A,304,Decreases activity by two-thirds and alters conformation.,,,-1.0,,,,,,,,,,,-1.0,,P41240_Y_304_F
P20339,Q,79,L,1r2q:A,79,Loss of GTPase activity. Does not inhibit filopodia formation.,,,-1.0,,,,,,,,,,,,,P20339_Q_79_L
P36776,K,529,R,7ng5:A,529,"Abolishes ATPase activity, and presumably ATP-driven protein unfolding, but does not block access to the proteolytic active site or prevent a substrate from binding to it.",,0.0,-1.0,,,,,,,,,,,,,P36776_K_529_R
P36776,W,770,A,7ng5:A,770,"Has low basal, but normal stimulated ATPase activity, and retains peptidase activity.",,,-1.0,,,,,,,,,,,,,P36776_W_770_A
P36776,W,770,P,7ng5:A,770,"Has normal basal, but low stimulated ATPase activity, and abolishes peptidase activity.",,,-1.0,,,,,,,,,,,,,P36776_W_770_P
P36776,S,855,A,7ng5:A,855,"Lacks both ATPase and protease activity, but retains DNA binding activity.",,0.0,-1.0,,,,,,,,,,,,,P36776_S_855_A
P36776,T,880,V,7ng5:A,880,"Enhances the basal, but not the stimulated ATPase activity.",,,1.0,,,,,,,,,,,,,P36776_T_880_V
P36776,G,893,A,7ng5:A,893,"Has low basal, but normal stimulated ATPase activity, and retains peptidase activity.",,,-1.0,,,,,,,,,,,,,P36776_G_893_A
P36776,G,893,P,7ng5:A,893,"Has normal basal, but low stimulated ATPase activity, and abolishes peptidase activity.",,,-1.0,,,,,,,,,,,,,P36776_G_893_P
P36776,G,894,A,7ng5:A,894,"Enhances the basal, but not the stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_894_A
P36776,G,894,S,7ng5:A,894,"Enhances the basal, but not the stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_894_S
P41594,S,613,A,6n51:A,613,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_S_613_A
P41594,S,613,K,6n51:A,613,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_S_613_K
P41594,S,614,D,6n51:A,614,Decreased constitutive signaling activity.,,,-1.0,,,,,,,,,,,,,P41594_S_614_D
P41594,K,665,A,6n51:A,665,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_K_665_A
P41594,E,770,A,6n51:A,770,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_E_770_A
Q9NZ08,Y,438,F,6mgq:C,438,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9NZ08_Y_438_F
Q96HE7,C,85,A,3ahr:A,85,Alters protein folding and stability. Loss of regulatory disulfide bond formation and increased activity towards P4HB,,,1.0,,,,,,-1.0,,,,,-1.0,,Q96HE7_C_85_A
Q96HE7,C,85,S,3ahr:A,85,Induces a decrease in activity.,,,-1.0,,,,,,,,,,,,,Q96HE7_C_85_S
Q96HE7,C,241,A,3ahr:A,241,No effect.,0.0,,0.0,,,,,,,,,,,0.0,,Q96HE7_C_241_A
Q96HE7,C,241,S,3ahr:A,241,No effect.,0.0,,0.0,,,,,,,,,,,0.0,,Q96HE7_C_241_S
Q96HE7,N,280,A,3ahr:A,280,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96HE7_N_280_A
Q96HE7,N,384,A,3ahr:A,384,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96HE7_N_384_A
Q96HE7,C,391,A,3ahr:A,391,Alters protein folding. Prevents formation of regulatory disulfide bond and down-regulation of activity. Decreases association with P4HB.,-1.0,,-1.0,,,,,,-1.0,,,,,-1.0,,Q96HE7_C_391_A
Q96HE7,C,394,A,3ahr:A,394,Retains activity towards P4HB. Does not act as a dominant negative mutant. Induces defects in folding. Remains associated with P4HB.,0.0,,-1.0,,,,,,,,,,,-1.0,,Q96HE7_C_394_A
Q96HE7,F,395,D,3ahr:A,395,Increased catalytical activity.,,,1.0,,,,,,,,,,,,,Q96HE7_F_395_D
Q96HE7,C,397,A,3ahr:A,397,Acts as a dominant negative mutant,,,-1.0,,,,,,,,,,,,,Q96HE7_C_397_A
Q13485,R,416,S,1dd1:B,416,No effect on heterotrimerization. Partially diminished transcriptional activation.,0.0,,-1.0,,,,,,,,,,,,,Q13485_R_416_S
Q13485,R,496,S,1dd1:B,496,No effect on heterotrimerization. Partially diminished transcriptional activation.,0.0,,-1.0,,,,,,,,,,,,,Q13485_R_496_S
Q13485,R,502,S,1dd1:B,502,No effect on heterotrimerization. Greatly reduced transcriptional activation.,0.0,,-1.0,,,,,,,,,,,,,Q13485_R_502_S
O75151,H,249,A,3ptr:B,249,Abolishes demethylase activity.,,,-1.0,,,,,,,,,,,,,O75151_H_249_A
O75151,Y,321,H,3ptr:B,321,Does not alter iron-binding nor activates histone demethylase activity.,,0.0,0.0,,,,,,,,,,,,,O75151_Y_321_H
Q16539,A,34,V,2lgc:A,34,Lowered kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_A_34_V
Q16539,K,53,R,2lgc:A,53,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_K_53_R
Q16539,K,54,R,2lgc:A,54,Impairs MAP2K6/MKK6-dependent autophosphorylation.,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q16539_K_54_R
Q16539,Y,69,H,2lgc:A,69,Lowered kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_Y_69_H
Q16539,D,168,A,2lgc:A,168,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_D_168_A
Q16539,T,175,A,2lgc:A,175,No effect on either the kinase activity or tyrosine phosphorylation.,,,0.0,,,,,,,,,,,,,Q16539_T_175_A
Q16539,D,176,A,2lgc:A,176,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_D_176_A
Q16539,D,177,A,2lgc:A,177,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_D_177_A
Q16539,T,180,E,2lgc:A,180,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_T_180_E
Q16539,Y,182,F,2lgc:A,182,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_Y_182_F
Q16539,A,320,T,2lgc:A,320,Lowered kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_A_320_T
Q16539,F,327,L,2lgc:A,327,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_F_327_L
Q16539,F,327,S,2lgc:A,327,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_F_327_S
Q16539,W,337,R,2lgc:A,337,Loss of kinase activity.,,,-1.0,,,,,,,,,,,,,Q16539_W_337_R
O95822,C,206,S,4f0x:A,206,Abolishes formation of disulfide-linked homotetramers. Abolishes the cooperative enzyme kinetics that are seen under oxidative conditions.,-1.0,,-1.0,,,,,,,,,,,,,O95822_C_206_S
O95822,C,243,S,4f0x:A,243,Does not abolish formation of disulfide-linked homotetramers. No effect on development of cooperative enzyme kinetics in response to oxidative conditions.,0.0,,0.0,,,,,,,,,,,,,O95822_C_243_S
O95822,S,290,F,4f0x:A,290,2-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,O95822_S_290_F
O95822,E,302,G,4f0x:A,302,Decreases catalytic activity. Increases affinity for malonyl-CoA.,,1.0,-1.0,,,,,,,,,,,,,O95822_E_302_G
O95822,S,329,A,4f0x:A,329,110-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,O95822_S_329_A
O95822,H,423,N,4f0x:A,423,7-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,O95822_H_423_N
O95822,Y,456,S,4f0x:A,456,3.5-fold reduction in catalytic activity.,,,-1.0,,,,,,,,,,,,,O95822_Y_456_S
P21860,K,742,M,3kex:A,723,Strongly reduced autophosphorylation.,,,-1.0,-1.0,,,,,,,,,,,,P21860_K_742_M
P22607,K,508,A,4k33:A,508,Loss of kinase activity. Abolishes ubiquitination.,,,-1.0,,-1.0,,,,,,,,,,,P22607_K_508_A
P22607,Y,577,F,4k33:A,577,Minor effect on kinase activity.,,,0.0,,,,,,,,,,,,,P22607_Y_577_F
P22607,K,650,D,6pnx:A,650,Constitutively activated kinase.,,,1.0,,,,,,,,,,,,,P22607_K_650_D
P22607,K,650,L,6pnx:A,650,Constitutively activated kinase.,,,1.0,,,,,,,,,,,,,P22607_K_650_L
P22607,Y,724,F,6pnx:A,724,Strongly reduced kinase activity. Strongly reduced mitogen activity.,,,-1.0,,,,,,,,,,,,,P22607_Y_724_F
Q16288,K,572,N,6kzd:A,572,Loss of autophosphorylation and loss of NTRK3 signaling.,-1.0,,-1.0,-1.0,,,,,,,,,,,,Q16288_K_572_N
Q96FW1,Q,33,R,4ddi:A,1033,Impairs inhibition of UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_Q_33_R
Q96FW1,I,37,T,4ddi:A,1037,Impairs inhibition of UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_I_37_T
Q96FW1,Q,39,L,4ddi:A,1039,Does not affect activity in DNA repair and ability to inhibit UBE2N/UBC13.,,,0.0,,,,,,,,,,,,,Q96FW1_Q_39_L
Q96FW1,P,87,G,4ddi:A,1087,Slightly improves ability to cleave 'K63'-linked ubiquitin.,,,1.0,,,,,,,,,,,,,Q96FW1_P_87_G
Q96FW1,D,88,E,4ddi:A,1088,Abolishes hydrolase activity in vitro. Abolishes ability to inhibit RNF168,,,-1.0,,,,,,,,,,,,,Q96FW1_D_88_E
Q96FW1,C,91,S,4ddi:A,1091,Abolishes hydrolase activity in vitro. Does not affect ability to inhibit RNF168. Abolishes ability to inhibit RNF168,0.0,,-1.0,,,,,,,,,,,,,Q96FW1_C_91_S
Q96FW1,A,116,T,4ddi:A,1116,Does not affect ability to inhibit UBE2N/UBC13.,0.0,,0.0,,,,,,,,,,,,,Q96FW1_A_116_T
Q96FW1,T,134,R,4ddi:A,1134,Impairs inhibition of UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_T_134_R
Q96FW1,D,137,G,4ddi:A,1137,Impairs inhibition of UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_D_137_G
Q96FW1,F,190,S,4ddi:A,1190,Fails to inhibit ubiquitin conjugation by UBE2N/UBC13.,,,-1.0,,,,,,,,,,,,,Q96FW1_F_190_S
Q96FW1,Y,261,H,4ddi:A,1261,Impairs inhibition of UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_Y_261_H
Q96FW1,P,263,L,4ddi:A,1263,Fails to inhibit ubiquitin conjugation by UBE2N/UBC13.,-1.0,,-1.0,,,,,,,,,,,,,Q96FW1_P_263_L
Q96FW1,H,265,R,4ddi:A,1265,Abolishes hydrolase activity in vitro.,,,-1.0,,,,,,,,,,,,,Q96FW1_H_265_R
Q9NYV4,D,877,N,6td3:B,877,Abolishes kinase activity.,,,-1.0,,,,,,,,,,,,,Q9NYV4_D_877_N
P20592,T,151,A,5uot:0,151,Defective GTP-hydrolysis. Disruption of nuclear import and cell-cycle progression.,,,-1.0,,,,,,,,,1.0,,,,P20592_T_151_A
Q96PZ0,D,294,A,5kkp:A,294,Loss of function.,,,-1.0,,,,,,,,,,,,,Q96PZ0_D_294_A
Q9BQ69,D,160,A,6lh4:A,160,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BQ69_D_160_A
Q9BQ69,D,167,A,6lh4:A,167,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BQ69_D_167_A
Q9BQ69,N,171,A,6lh4:A,171,Reduced enzyme activity. No significant effect on affinity for substrate.,,,-1.0,,,,,,,,,,,,,Q9BQ69_N_171_A
Q9BQ69,N,174,A,6lh4:A,174,Slightly reduced ADP-ribosyl hydrolase activity,,,-1.0,,,,,,,,,,,,,Q9BQ69_N_174_A
Q9BQ69,D,184,A,6lh4:A,184,Slightly reduced ADP-ribosyl hydrolase activity,,,-1.0,,,,,,,,,,,,,Q9BQ69_D_184_A
Q9BQ69,H,188,A,6lh4:A,188,Reduced enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BQ69_H_188_A
Q9BQ69,S,268,A,6lh4:A,268,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9BQ69_S_268_A
Q9BQ69,G,270,E,6lh4:A,270,Loss of enzyme activity.,,,-1.0,,,,,,,,,,,,,Q9BQ69_G_270_E
Q9BQ65,H,120,A,4h7w:A,120,Abolishes exoribonuclease activity.,,,-1.0,,,,,,,,,,,,,Q9BQ65_H_120_A
Q9BQ65,H,208,A,4h7w:A,208,Abolishes exoribonuclease activity. No rescue of the molecular phenotype caused by USB1 depletion.,,,-1.0,,,,,,,,,,,,,Q9BQ65_H_208_A
Q14974,I,178,A,1qgk:A,178,Largely reduced binding to FxFG repeats and reduced nuclear import.,-1.0,,-1.0,,,,,,,,,,,,,Q14974_I_178_A
Q14974,I,178,F,1qgk:A,178,Loss of binding to FxFG repeats and reduced nuclear import.,-1.0,,-1.0,,,,,,,,,,,,,Q14974_I_178_F
Q14974,I,178,D,1qgk:A,178,Loss of binding to FxFG repeats and reduced nuclear import.,-1.0,,-1.0,,,,,,,,,,,,,Q14974_I_178_D
Q6ZRY4,L,49,E,2m9k:A,49,Strongly reduces homodimerization and interaction with EEF2. Strongly reduces NOG mRNA binding. Loss of function in gastrointestinal smooth muscle cell differentiation.,-1.0,-1.0,-1.0,,,,,,,,,,,,,Q6ZRY4_L_49_E
Q6ZRY4,L,49,Q,2m9k:A,49,No effect on homodimerization. No effect on function in gastrointestinal smooth muscle cell differentiation.,0.0,,0.0,,,,,,,,,,,,,Q6ZRY4_L_49_Q
P21266,Y,120,A,3gtu:B,119,No effect.,,,0.0,,,,,,,,,,,,,P21266_Y_120_A
P21266,Y,120,F,3gtu:B,119,Strongly increased catalytic activity.,,,1.0,,,,,,,,,,,,,P21266_Y_120_F
P21266,N,213,F,3gtu:B,212,Strongly increased catalytic activity.,,,1.0,,,,,,,,,,,,,P21266_N_213_F
P21266,N,213,G,3gtu:B,212,No effect.,,,0.0,,,,,,,,,,,,,P21266_N_213_G
A2RUC4,R,108,A,3al5:B,108,Abolishes enzyme activity and ability to bind tRNA.,,-1.0,-1.0,,,,,,,,,,,,,A2RUC4_R_108_A
A2RUC4,R,149,A,3al5:B,149,Abolishes enzyme activity and ability to bind tRNA.,,-1.0,-1.0,,,,,,,,,,,,,A2RUC4_R_149_A
Q460N3,H,559,Y,4f0e:B,537,Abolishes catalytic activity.,,,-1.0,,,,,,,,,,,,,Q460N3_H_559_Y
Q460N3,G,560,A,4f0e:B,538,Slightly reduces catalytic activity. Abolishes activity,,,-1.0,,,,,,,,,,,,,Q460N3_G_560_A
Q460N3,Y,604,C,4f0e:B,582,Reduces catalytic activity 20-fold. Abolishes activity,,,-1.0,,,,,,,,,,,,,Q460N3_Y_604_C
Q9UJX2,N,339,A,6q6h:V,339,Inhibits APC/FZR1 E3 ubiquitin-protein ligase complex activity,,,-1.0,,,,,,,,,,,,,Q9UJX2_N_339_A
Q9UJX2,E,374,A,6q6h:V,374,Inhibits APC/FZR1 E3 ubiquitin-protein ligase complex activity,,,-1.0,,,,,,,,,,,,,Q9UJX2_E_374_A
Q16665,S,247,A,4h6j:A,247,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,Q16665_S_247_A
Q16665,S,247,D,4h6j:A,247,Impaired kinase activity.,,,-1.0,,,,,,,,,,,,,Q16665_S_247_D
Q16665,L,795,A,1l8c:B,118,Inhibits interaction with EP300 and transactivation activity.,-1.0,,-1.0,,,,,,,,,,,,,Q16665_L_795_A
